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!Acquired! brain! injury! (ABI)! refers! to! any! damage! to! the! brain! occurring! after! birth.!Brain!damage,!the!destruction!and!degeneration!of!brain!cells,!affects!people!of!all!ages!and! has! a! variety! of! causes,! including! but! not! limited! to,! trauma,! neurodegenerative!disease!and!aging.!The!pathophysiological!processes!resulting!in!loss!of!neural!cells!and!tissue! are! common! to! many! neurological! disorders,! virtually! all! neurodegenerative!diseases!and!are!often!evident!in!cases!of!brain!trauma.!
Mesenchymal!stem!cells!(MSCs)!are!currently!being!investigated!for!their!potential!use!in! therapeutic! applications! including! the! regeneration! and! repair! of! neural! tissue!following! injury.! MSCs! are! adult! multipotent! stem! cells! capable! of! differentiation!toward!a!number!of!lineages,!the!most!common!of!which!are!bone,!cartilage!and!fat.!!In!addition,!MSCs! retain! the! ability! to!differentiate! toward!neural! cell! lineages! including!neurons,!astrocytes!and!oligodendrocytes.!!




study!aimed! to! investigate! the!potential! for!HSPG!directed!neural! fate!specification! in!hMSCs,!which!may!provide!a!new!model!for!brain!damage!repair.!
!We! examined! the! role! of! the! localised!microenvironment,! or! niche,! in! particular! the!HSPGs,! on! the!morphological! changes! observed! during! extended! in+ vitro! culture! and!neural! lineage! specification! of! hMSCs.! Commercially! available! human! MSC! (hMSC)!populations!were!expanded! in+vitro! for!more!than!20!passages,!equating!to!more!than!60! days! in! culture! and! 50! population! doublings.! At! passages! (P+)! representing! each!phase!of!growth!identified!during!expansion!(P+5:!Phase!A;!P+7:!Phase!B;!P+13:!Phase!C),! the! cells!were! characterised! for! their! SPG!profile! along!with!markers!of! stemness,!MSC! and!neural,! as!well! as!markers! of! specific! neural! lineages,! including! syndecand1,!syndecand4,! glypicand1,! glypicand4,! nestin,! glial! fibrillic! acidic! protein! (GFAP)! and!microtubule! associated! protein! 2! (MAP2).! We! determined! that! MSC! stemness! was!maintained!for!more!than!40!days!in!culture!with!continued!successful!adipogenic!and!osteogenic!differentiation!at!each!growth!phase,!as!determined!by!Oil!Red!O,!Alizarian!red!and!von!Kossa!staining.!




This!study!also!determined!the!basal!expression!profile!for!HSPGs!in!hMSC!populations.!!Following! modulation! of! the! in+ vitro! niche! using! exogenous! heparin! and! sodium!chlorate! changes! in! gene! expression!were! examined! for! a! number! of! genes! including!HSPG!core!proteins,!chain! initiation!and!modification!enzymes!as!well!as!an!extended!panel! of! MSC! and! neural! markers.! Correlations! between! gene! expression! changes! of!HSPG!core!proteins,!such!as!syndecand4!(SDC4)!with!neural!makers!such!as!glial!fibrillic!acidic!protein!(GFAP)!were!observed.!In!addition!to!correlations!in!the!basal!expression!profile,!both!HSPGs!and!neural!markers!were!responsive! to!modulation!of! the! in+vitro!niche.! At! P+7,! both! the! HSPG! core! protein! syndecand1! and! nestin! demonstrated!increased! expression! following! treatment! of! cultures! with! heparin,! and! significantly!decreased! expression! following! treatment! with! chlorate! (SDC1:! P=0.005;! Nestin:!
P=0.037).! In! contrast,! at! all!passages!examined!glypicand1,! the!neuronal!marker!βdIIIdtubulin!and!the!astrocyte!marker!glial!fibrillic!acidic!protein!all!demonstrated!decreased!expression!following!treatment!with!heparin.!These!results!suggest!a!role!for!HSPGs!in!neural!lineage!differentiation!of!hMSCs.!




described!above.!Cultures! induced!via! intermediate! sphere! induction!were!allowed! to!differentiate! for! 28! days!with!morphological! and! phenotypical! changes! to! the! hMSCs!monitored! throughout.!Populations!were!differentiated!using!each!protocol!at!each!of!the!passages!(P+5,!P+7,!P+13)!identified!during!expansion!to!represent!different!growth!phases!(Phase!A,!Phase!B,!Phase!C).!!
We!determined!that!hMSCs!retain!the!ability!to!differentiate!toward!neural!lineages!via!both! terminal! differentiation! and! via! intermediate! sphere! formation! at! early! (P+5),!intermediate! (P+7)! and! late! (P+13)! passages.! A! comparison! of! the! two! methods!revealed!that!hMSCs!differentiated!at!early!passages!(P+5)!retained!a!higher!capacity!to!produce! NSCdlike! spheres! prior! to! terminal! differentiation! as! determined! by! larger!(400μm)! spheres.! Analysis! also! revealed! that! these! populations! retain! the! ability! to!differentiate! toward! neural! lineages! at! late! passages! (P+13)! despite! the! reduced!proliferation!rate!observed!in!undifferentiated!cultures!prior!to!differentiation.!!




the! feasibility! of! the! identification! of! specific! combinations! of! HSPGs! to! modify! the!microenvironment! for! specified! fate! differentiation.! Following! lineagedspecific!differentiation,! the! functional! capacity! of! the! cells! was! assessed! using! a! sterophillic!membrane! dye,! however,! stimulation! of! cellular! calcium! channels! with! potassium!chloride! did! not! provide! conclusive! evidence! as! to! the! functional! activity! of! cellular!membranes!of!the!differentiated!cells.!!
This! study!determined! that!not!only!do!hMSCs! retain! their! stemness! into! late! in+vitro!growth! phases,! but! that! they! also! continue! to! express! markers! of! neural! lineages!throughout!expansion.!In!addition,!these!cells!retain!the!ability!to!form!NSCdlike!spheres!at! different! growth! phases! with! the! ability! to! form! spheres! inhibited! as! expansion!continues.!In!contrast,!terminal!differentiation!of!hMSCs!at!each!growth!phase!revealed!differentiated!hMSC!cultures!maintained!the!ability!to!form!cultures!with!morphological!and!phenotypical! characteristics!of!neural! cells.!While!neither!differentiation!protocol!revealed!conclusive!functional!activity,!the!data!presented!in!this!study!supports!a!role!for!the!critical!involvement!of!HSPGs!in!neural!specification!of!hMSCs.!
HSPGs!contribute!to!the!MSC!niche!through!signalling!pathways,!celldECM!interactions,!cell! surface! molecules! and! the! ECM.! Here! we! provide! evidence! supporting! the!importance! of! HSPGs! in! the! localised! cellular!microenvironment! during! hMSC! neural!lineage!fate!specification.!By!examining!HSPGs!in!hMSCs!characterised!and!expanded!in+
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1.1 Acquired Brain Injury 
ABI!as!defined!by!the!Australian!Institute!for!Health!and!Welfare!refers!to!any!damage!to! the! brain! occurring! after! birth! (AIHW,! 2007).! ! Brain! damage,! the! destruction! and!degeneration!of!brain!cells,!affects!people!of!all!ages,!and!can!be!caused!in!a!number!of!ways! including,! trauma,! hypoxia,! infection,! tumour,! substance! abuse,! stroke,!neurodegenerative! disease,! cancer! and! ageing! (AIHW,! 2007,! Blennow+ et+ al.,! 2012,!Fortune! and! Wen,! 1999).! Damage! often! occurs! within! days! of! injury! or! disease!development,!and!earlier!intervention!along!with!repair!to!limit!damage!would!increase!recovery!and!limit!disability.!The!nature!of!damage!and!parts!of!the!brain!affected!are!as!variable! as! the! cause.! In! some! cases! damage! is! diffuse! and!widespread! (Fortune! and!Wen,!1999),!while!in!others!damage!is!localised!and!focal.!!





In!addition,!neurological!diseases,!characterised!by!dysfunction!associated!with!the!loss!of!neural!cells!and!tissue!(Sadan+et+al.,!2009a)!are!defined!according!to!location!within!the! brain! and! the! cell! type! involved.! Despite! gross! dissimilarities,!many! neurological!disorders,! and! virtually! all! neurodegenerative! diseases,! display! common!pathophysiological! processes! (Sadan! et! al.,! 2009a).! These! same! pathophysiological!processes!are!often!evident!in!traumatic!brain!injury.!
1.2 Brain Trauma While!ABI! is! a! term!used! to! describe! disability! arising! from!any!damage! to! the! brain!acquired!after!birth,!regardless!of!cause,!the!term!traumatic!brain!injury!(TBI)!refers!to!acquired!brain!injuries!specifically!caused!by!traumatic!events!such!as!a!traffic!accident!or! blows! to! the! head.! The! National! Community! Services! Data! Dictionary,! version! 4!defines!ABI!as:!multiple+disabilities+arising+from+damage+to+the+brain+acquired+after+birth.+
It+results+ in+deterioration+ in+cognitive,+physical,+emotional+or+ independent+ functioning.+ It+
can+ be+ a+ result+ of+ accidents,+ stroke,+ brain+ tumours,+ infection,+ poisoning,+ lack+ of+ oxygen,+
degenerative+neurological+disease+etc.!(AIHW,!2007).!The!consequences!of!ABI!or!TBI!are!complex,!and!individuals!are!affected!differently!(Fortune!and!Wen,!1999).!




Primary!brain!injury!is!the!direct!injury!to!the!brain!cells!incurred!at!the!time!of!initial!impact,! resulting! in! a! series! of! biochemical! processes! producing! a! secondary! brain!injury! (Veenith+ et+ al.,! 2009)! that! spreads! via! multiple! molecular! mechanisms! of!pathogenesis!(Ray+et+al.,!2002).!Following!primary!injury,!often!triggered!by!an!external!mechanical! impact! to! the! head,! secondary! injury! develops! over! a! period! of! hours! or!days!after!the!initial!impact!(Sanberg+et+al.,!2012,!Veenith!et!al.,!2009).!Secondary!brain!injury! is! caused! by! the! dynamic! interplay! between! ischaemic,! inflammatory! and!cytotoxic! processes! (Veenith! et! al.,! 2009).! Most! of! the! postRtraumatic! neurochemical!mediators! of! secondary! injury! alter! cerebral! blood! flow,! ion! homeostasis! and!metabolism!and!are!thought!to!act!as!neurodestructive!compounds!(Ray!et!al.,!2002).!!
The! complex! cascade! of! cellular! inflammatory! responses! following! TBI! propagates!secondary! brain! damage.! This! inflammatory! process! often! lasts! from! hours! to! days!contributing! continuously! to! secondary! brain! damage! (Ghirnikar+ et+ al.,! 1998).! In!addition,! TBI! can! induce! neuronal! cells! to! synthesize! and! secrete! inflammatory!cytokines!such!as! the!peptides!of! interleukin!(IL)! family!and!tumour!necrosis! factorRα!(TNFRα)!(Goodman+et+al.,!1990,!McClain+et+al.,!1991,!Ott+et+al.,!1994,!Young+et+al.,!1988).!These!inflammatory!cytokines!facilitate!neurotoxicity!by!encouraging!excitotoxicity!and!the! inflammatory! response,! but! simultaneously! they! can! facilitate! neurotrophic!mechanisms! and! the! induction! of! neuroprotective! cell! growth! factors! (MorgantiRKossmann+et+al.,!2007).!Patients!with!severe!head!injuries!have!increased!levels!of!ILR1,!ILR6!and!TNFRα!in!circulation!and!the!cerebrospinal!fluid!(Goodman!et!al.,!1990,!McClain!et!al.,!1991,!Ott!et!al.,!1994,!Young!et!al.,!1988).!





Type!1!cells!show!a!classic!necrotic!pattern!(following!primary!brain!injury)!and!type!2!cells!show!a!classic!apoptotic!pattern!when!examined!by!microscopy!(Rink!et!al.,!1995,!Clark+et+al.,!1999).!In!contrast!to!cells!that!undergo!necrosis,!cells!undergoing!apoptosis!die! without!membrane! rupture! and! therefore! elicit! a! reduced! inflammatory! reaction!(Tolias!and!Bullock,!2004).!This!suggests!that!neuronal!apoptosis!following!TBI!may!be!a!protective!response!by!the!brain!in!order!to!remove!injured!cells!whilst!having!little!effect!on!remaining!brain!tissue!(Raghupathi,!2004).!Interestingly,!apoptotic!cells!can!be!identified!within!contusions!in!the!acute!postRtraumatic!period,!and!in!regions!remote!from!the!site!of!injury!days!and!weeks!after!trauma!(Veenith!et!al.,!2009).!




due!to!disease!or!trauma!will!cost!the!US!alone!more!than!US$500!billion!in!the!years!to!2050!(G20!World!Brain!Mapping!and!Therapeutics!Summit,!2014)(G20RWBMTS,!2014).!Based! on! the!most! recent! analyses! of! the! Australian! Bureau! of! Statistics! (ABS)! 2003!Survey!of!Disability,!Aging!and!Carers:!ABI!is!common,!occurring!in!approximately!1!in!45! Australians! (432,700! people! had! ABI! with! activity! limitations! or! participation!restrictions!due!to!disability).!Almost!three!quarters!of!those!affected!were!less!than!65!years!of!age.!ABI!prevalence!rates!increase!with!age,!with!people!65!years!or!over!more!than!twice!as!likely!as!those!under!65!years!old!to!have!ABI!with!activity!limitations!or!participation! restrictions.! According! to! hospital! records,! there! were! almost! 21,! 800!hospital! stays! related! to! TBI! in! 2004R2005! in! Australia.! Of! these,! there! were! almost!twice!as!many!men!presenting!with!TBI!than!women!(AIHW,!2007,!Ray!et!al.,!2002).!!
Physical!problems!commonly!reported!by!people!with!ABI! include!headaches,! fatigue,!seizures,! poor! balance,! visual! and! hearing! disturbances,! chronic! pain! and! paralysis.!Many! people! with! ABI! experience! cognitive! problems! including! poor! memory! and!concentration,! reduced! ability! to! plan! and! problem! solve! and! inflexible! thinking,! and!psychosocial/emotional!problems,!such!as!depression,!emotional!instability,!irritability,!and! impulsive! or! inappropriate! behaviour! (AIHW,! 2007,! BIAQ,! 2007).! A!NSW! Inmate!Health!Survey!calculated!that!41%!of!women!and!23%!of!men!who!had!suffered!a!TBI!continue! to! experience! side! effects! including! those!mentioned! above! as!well! as! poor!concentration!and!personality!changes!(Butler!and!Milner,!2003).!
1.3 Human mesenchymal stem cells 









For!a!long!time,!adult!stem!cells!have!been!considered!to!be!developmentally!committed!in!such!a!way!that!they!appear!restricted!to!produce!specific!cell!lineages,!namely!those!from! the! tissue! in!which! the! stem! cell! resides! (Minguell! et! al.,! 2001).! Several! studies!have! shown! that! stem! cells! may! also! give! rise! to! a! set! of! unacquainted! progenitors,!along! with! differentiating! into! the! predicted! collection! of! cells! characteristic! of! the!tissue!in!which!they!reside!(Minguell!et!al.,!2001).!A!feature!of!stem!cells!is!their!ability!to! leave! their! “tissue”! niche! and! circulate! in! the! blood! stream,! as! occurs! with!haematopoietic!and!mesenchymal!stem!cells!(Erices!et!al.,!2000,!Fernandez!et!al.,!1997,!Reading!et!al.,!2000,!Shields!and!Andrews,!1998,!Siena+et+al.,!1989).!Many!adult!tissues!contain! populations! of! stem! cells! that! have! the! capacity! for! renewal! after! trauma,!disease,!or!aging!(Pittenger+et+al.,!1999),!however,!in!order!to!undergo!its!differentiation!program,! a! circulating! stem! cell! must! home! into! an! appropriate! microenvironment!(Tavassoli!and!Minguell,!1991,!Watt!and!Hogan,!2000).!
!Within!the!field,!it!is!generally!accepted!that!MSCs!from!all!sources!give!rise!to!a!variety!of! mesenchymal! phenotypes! including! bone,! cartilage,! muscle,! ligament,! tendon,!adipose!and!stroma!(Friedenstein+ et+al.,!1987,!Haynesworth+ et+al.,!1992,!Kuznetsov+ et+




 MSC source and multi-lineage potential 1.3.1The!term!mesenchyme!describes!the!embryonic!loose!connective!tissue!that!is!derived!from! the! mesoderm! and! that! develops! into! haematopoietic! and! connective! tissues!(Lindner+et+al.,!2010).!MSCs,!like!most!adult!stem!cells,!are!multipotent!and!can!produce!a!number!of!cell!types!from!a!limited!number!of!population!doublings.!!!




subcultivation! impairs! cell! function! evident! by! signs! of! senescence! (Digirolamo+ et+ al.,!1999),! and/or! apoptosis! (Conget! and! Minguell,! 1999).! From! the! different! assay!conditions! required! for! efficient! differentiation,! Pittenger! et! al! (1999)! concluded! that!basal!nutrients,!cell!density,!spatial!organisation,!mechanical!forces,!growth!factors!and!cytokines!have!a!profound!influence!on!MSC!differentiation!(Pittenger!et!al.,!1999).!




Evidence! that!MSCs! actively! participate! in! the! dynamic!marrow!microenvironment! is!strengthened! by! data! demonstrating! their! production! of! a! vast! array! of! matrix!molecules,! including! fibronectin,! laminin,! collagen,!and!proteoglycans! (Pittenger!et!al.,!1999),!along!with!their!expression!of!several!counterRreceptors!associated!with!matrixR!and! cellRcell! interactions.+ Additional! plasticity! for! differentiation! of! MSCs! into!cardiogenic!and!myogenic!as!well!as!nonRmesodermal!cell!types!such!as!neuronal!cells!has! been! proposed! (Ferrari+ et+ al.,! 1998,! Hakuno+ et+ al.,! 2002,! Makino+ et+ al.,! 1999).!Several! studies! have! confirmed! neuronal! differentiation! of! human! MSCs! in+ vitro! via!intermediate! neural! stem! cell! (NSC)Rlike! spheres! or! direct! terminal! differentiation!(Alexanian,!2010,!Bae+et+al.,!2011,!Fox+et+al.,!2010,!Hermann+et+al.,!2004).! In!a!murine!model,! the! neural! differentiation! of! MSCs! in+ vivo! has! also! been! observed! following!injection! of! these! cells! into! the! lateral! ventricle! and! subsequent! cell! migration!monitored! and! traced! throughout! the! forebrain! and! cerebellum! (Kopen+ et+ al.,! 1999,!Reyes!and!Verfaillie,!1999).!
1.4 Use of MSCs in clinical applications The! potential! use! of! MSCs! as! a! therapeutic! option! for! the! repair! of! brain! damage! is!supported! by! demonstrations! that! MSCs! display! significant! antiRproliferative,! antiRinflammatory! and!antiRapoptotic! features! (Uccelli+ et+ al.,! 2011).! In! addition,! significant!rescue!of!neural!cells!has!been!demonstrated!following!administration!of!MSCs!in!areas!of!brain!ischemia!in!animals!undergoing!brain!or!spinal!cord!injury!(Uccelli!et!al.,!2011).!Friedenstein!first!identified!MSCs!as!stromal!cells!from!the!bone!marrow!(Friedenstein+





Experimental!evidence!in!preclinical!models!of!neurological!disease!suggests!that!MSCs!are! a! promising! approach! to! achieve! neural! repair! and! protection.! Currently,! it! is!postulated! that! this! does! not! occur! through! cell! replacement.! Many! other! paracrine!mechanisms,! including! potent! antiRinflammatory! capacity,! the! direct! release! of! antiRapoptotic!and!neurotrophic!factors,!the!ability!to!induce!other!cells,!such!as!microglia,!to!acquire! a! protective! phenotype! and! to! induce! proliferation! of! local! neural! progenitor!cells! possibly! leading! to! remyelination,! are! likely! to! sustain! the! protective! effects!observed!in!preclinical!trials!(Uccelli!et!al.,!2011).!




mechanism! that! together!with! their! ability! to! inhibit! immuneRmediated! damage,!may!explain!the!reduced!axonal!loss!observed!in!mice!with!EAE!(Gerdoni!et!al.,!2007,!Zhang+
et+al.,!2006).!This!antiRapoptotic!effect,!together!with!the!reported!capacity!of!releasing!neurotrophic! molecules! may! well! explain! the! remarkable! effect! obtained! with! the!administration! of! MSCs,! either! intravenously! or! locally,! in! experimental! models! of!stroke!and!spinal!cord!injury!(Chen+et+al.,!2003,!Uccelli!et!al.,!2011).!
The! mechanism! of! repair! by! MSCs! may! include! promoting! plasticity! of! the! ischemic!damaged!neurons!or!by! stimulating!glial! cells! to! secrete!neurotrophins! such!as!BDNF!and!NGF,!reducing!apoptosis!in!the!penumbral!zone!of!the!lesion!and!the!proliferation!of!the!endogenous!cells!in!the!subventricular!zone!(Li+et+al.,!2002).!These!effects!can!be!explained! by! the! secretion! of! different! trophic! factors! including! nerve! growth! factor!(NGF),! vascular! endothelial! growth! factor! (VEGF),! ciliary! neurotrophic! factor! (CNTF),!fibroblast!growth!factor!2!(FGFR2)!and!BMI1!protoRoncogene!polycomb!ringfinger!(BMIR1)!by!the!MSCs!contributing!to!the!increase!in!neurogenesis!by!acting!directly!on!local!precursors! but! also! activating! nearby! astrocytes,! which! independently! may! increase!neurogenesis!(Munoz+et+al.,!2005).!
In!support!of!neural!predisposition,!MSCs!have!been!shown!to!express,!at!a!basal!level,!neural!genes,!including!Nestin,!neuronRspecific!enolase!and!βRtubulin!III!(Blondheim+et+




SanchezRRamos+ et+al.,! 2000,!Mareschi+ et+al.,! 2006,!Levy+ et+al.,! 2003,!Khoo+ et+al.,! 2008,!Khare,!2002,!Kan+et+al.,!2007,!Barzilay+et+al.,!2008).!To!date,!the!vast!majority!of!studies!have! demonstrated! the! neural! phenotype! only! in+ vitro,! which! raises! the! question! of!whether! these! differentiated! cells! are! able! to! maintain! their! neuronal! identity! and!integrate!into!the!CNS!in+vivo!(Sadan!et!al.,!2009b).!!




MSCs!provide! a!promising! autologous! source! for!use! in! stem!cell! therapies,! primarily!due! to! their! safety! and! abundance! (Sadan! et! al.,! 2009b,! Connick+ et+ al.,! 2012).!Additionally,! MSCs! possess! the! useful! characteristics! of! homing! and! chemokine!secretion! (Sadan!et! al.,! 2009b),!with!MSCRbased! therapies!potentially!able! to!alleviate!neurological! disease! symptoms! through! various! mechanisms! (Sadan! et! al.,! 2009b,!Galindo! et! al.,! 2011).! Analysing! how! transplanted! MSCs! influence! neurodegenerative!diseases! is! challenging,! as! it! is! difficult! to! determine!whether! the! disease! is! affecting!MSC! behaviour! or! the! MSCs! are! secreting! proteins! that! affect! disease! progression!(Sadan!et!al.,!2009b).!It!is!possible!that!MSCs!react!to!extrinsic!signals!and!change!their!phenotype!accordingly,!and/or!that!there!is!heterogeneity!and!hence!subpopulations!of!MSCs,!one!of!which!becomes!dominant!depending!on!tissue!and!niche!context!(Sadan!et!al.,!2009b).!
1.5 MSC and the neural lineage Until!more!recently,!it!was!thought!that!differentiation!potential!of!MSCs!was!restricted!to! lineages! specific! to! their! tissue! of! origin! (Tropel+ et+ al.,! 2006),! however! neural!phenotypes! including! the! expression!of! neural! specific!markers!has!been!observed! in!cells! derived! from! adult! mouse! bone! marrow! transplanted! into! the! murine! central!nervous!system!(Brazelton+et+al.,!2000).!Since!these!early!studies!recognising!the!neural!potential! of!MSCs,!numerous! studies!have!been! conducted! into! the!production!of! and!differentiation!to!functional!neural!cells!derived!from!MSCs!for!therapeutic!applications.!A! number! of! methods! involving! the! use! of! growth! factors! and/or! pharmacological!agents!have!been!developed!to!achieve!this!goal.!!




achieved! through! direct! terminal! differentiation! (Hermann+ et+ al.,! 2006).! The! most!successful! method! generated! by! Alexanian! and! colleagues! (2010)! for! direct! terminal!differentiation! utilises! simultaneous! treatment! of! hMSCs! with! inhibitors! of! DNA!methylation! and! histone! deacetylation! as! well! as! pharmacological! agents! to! increase!intracellular! cAMP! (Alexanian,! 2010).! In! contrast,! in! conversion! via! neuroprogenitorRlike! cells,! spheres! are! produced! in! appropriate! growth! conditions! including! uncoated!flasks! and! the! presence! of! EFG/FGFR2.! Neuronal! cells! with! reduced! expression! of!proneural! genes! (SOX1,!OTX1,!NeuroD1!and!Neurog2)!and! increased! levels!of!mature!neural!markers!(GFAP,!MBP!and!TH)!result!after!the!removal!of!EGF!and!FGFR2!from!the!sphere!media,!plating!of!cells!onto!polyRLRlysine!coated!slides!and!subsequent!addition!of!BDNF!and!retinoic!acid!(Hermann!et!al.,!2004).!Successful!differentiation!to!neuralRlike! cells! has! been! demonstrated! via! the! detection! of! neural! markers,! through!immunocytochemistry! and! gene! expression,! as! well! as! the! secretion! of! neurotrophic!factors!(BDNF,!GDNF)!required!for!the!survival!and!growth!of!neuronal!cells!(Alexanian,!2010).!In!addition,!the!intermediate!sphereRlike!structures!produced!during!the!process!of! differentiation! have! been! found! to! express! high! levels! of! early! neuroectodermal!(NeuroD1,! Neurog2,! MSI1)! markers! as! well! as! the! loss! of! expression! of! mesodermal!stromal! cell! markers! (fibronectin)! (Hermann! et! al.,! 2004).! ! These! NSCRlike! cells!differentiated! into! the! three! neural! lineages! (astroglia,! oligodendroglia! and! neurons)!exhibiting!both!morphological!and!functional!neural!cell!characteristics!(Hermann!et!al.,!2004).!




produced,! others! are! only! expressed! after! stimulation! (Haynesworth! et! al.,! 1996).!Immunophenotyping! results! have! shown! that! the! antigenic! phenotype! of! MSC! is! not!unique,!but!borrows!features!of!mesenchymal,!endothelial,!epithelial,!and!muscle!cells!(Pittenger!et!al.,!1999,!Conget!and!Minguell,!1999).!The!dynamic!participation!of!MSCs!in!the!marrow!microenvironment!is!strengthened!by!data!showing!they!produce!a!vast!array! of!matrix!molecules,! including! fibronectin,! laminin,! collagen,! and! proteoglycans!(Prockop,! 1997,! Pittenger! et! al.,! 1999,! Chichester+ et+ al.,! 1993),! and! that! they! express!several!counterRreceptors!associated!with!matrixR!and!cellRtoRcell!adhesive!interactions.!This! includes! the! hyaluronan! receptor! (CD44),!which! as! described! previously! plays! a!central! role! in! the! ECM! and!MSC! niche! (Yamazaki+ et+ al.,! 1999,! Pittenger! et! al.,! 1999,!Minguell,!1993,!Conget!and!Minguell,!1999).!!
1.7 The stem cell niche – why is it important? 





Cells!within!the!niche!are!centrally!involved!in!the!dynamic!assembly!and!remodelling!of! the!ECM! (Rozario! and!DeSimone,! 2010)!where! effectively! the!ECM! functions! as! an!adhesive!substrate!to!direct!migratory!cells!and!to!establish!concentration!gradients!for!haptotactic! migration.! By! providing! structure,! the! ECM! defines! tissue! boundaries,!provides! integrity! and! elasticity! to! developing! organs,! and! serves! as! a! degradable!barrier!to!invasive!cells!during!development!and!disease.!The!ECM!can!present!growth!factors! to! receptors,! controlling! spatial! distribution! and! sequester! growth! factors! for!controlled! release,! maintaining! morphogen! gradients! and! niche! specific! interactions!(Wipff!and!Hinz,!2008,!Patel+et+al.,!2007,!Chen,!2010,!Carey,!1997).!In!addition,!the!ECM!also! plays! a! role! in! mechanical! signalling,! influencing! cell! differentiation! and!downstream!intracellular!signalling!(Rozario!and!DeSimone,!2010).!




spatial! distribution! of! a! diffusible! morphogens,! or! sequester! factors! for! subsequent!release!(Wipff!and!Hinz,!2008).!
A!number!of! studies!have!also!demonstrated! the!ability!of!different!niches! to!support!neural!phenotypes!in+vitro.!In!a!study!by!Mezey!et+al,!transplanted!mouse!bone!marrow!cells!were!shown!to!migrate!from!the!bone!marrow!to!the!brain!and!differentiate!into!cells!expressing!neural!antigens!suggesting!the!bone!marrow!as!an!alternative!source!of!neural! progenitor! cells! (Mezey+ et+ al.,! 2000).! In! addition,! cells! derived! from! Ewing’s!sarcoma!(ES,!metastatic!bone!marrow)!were!differentiated!to!neuronal!cells!through!the!addition!of!cholera!toxin!B!(CTB)!or!5RbromoR2’Rdeoxyuridine!(BrdU)!(Ohta+et+al.,!1991).!!Following!treatment!with!CTB,!the!cells!exhibited!a!gradual! increase! in!neural!marker!expression! demonstrating! modification! of! the! localised! in+ vitro! niche! and! the! cell’s!interaction!with!it!can!influence!neuronal!fate!specification!of!MSCs!(Ohta!et!al.,!1991).!!
1.8 Proteoglycans – why they like to be involved in everything 




Iozzo,!1998).!PGs!have!been!identified!as!important!extracellular!modulators!of!protein!gradient! formation! and! signal! transduction! (Hacker! et! al.,! 2005)! and! include! the!heparan!sulfate!(HS)!(membrane!bound!glypicans,!syndecans)!and!chondroitin!sulfate!(CS)! proteoglycans! (matrix! localised)! (Hacker! et! al.,! 2005).! HS! chains! interact!with! a!large! number! of! ligands! including! growth! factors! and!morphogens! (FGF,!Wnts),! their!receptors! (FGFRs),! and! ECM! structural! molecules! (fibronectin)! where! they! regulate!activity,!as!well!as!ligand!stability!(Habuchi+et+al.,!2004,!Hacker!et!al.,!2005).!!HS!and!CS!GAG! chains! are! created! by! an! elaborate! postRtranslational! biosynthesis! (Ling+ et+ al.,!2006,!Sugahara!and!Kitagawa,!2002),!which!occurs!on!genetically!distinct!acceptor!core!proteins! within! the! Golgi,! followed! by! rapid! translocation! to! the! cell! surface!(Hardingham!and!Fosang,!1992)!resulting!in!highly!sulfated!variable!length!side!chains!attached!to!a!core!protein!(Bandtlow!and!Zimmermann,!2000,!Sugahara!and!Kitagawa,!2002).!The!introduction!of!N6!and!O6sulfation!at!different!points!combine!to!produce!a!combination!of!chain!length!and!sulfation!pattern!that!confers!biological!diversity!onto!the! HS! and! CS! chains! and! subsequently! the! core! proteins! to! which! they! are! linked!(Habuchi!et!al.,!2004,!Lindahl!et!al.,!1998).!









Figure!1)1: Schematic+ outlining+ the+ complex+ biosynthesis+ process+ required+ to+ synthesise+
heparan+ sulfate+ proteoglycans+ (HSPGs)+ and+ chondroitin+ sulfate+ proteoglycans+ (CSPGs).+ The+
complexity+of+length+and+sulfation+pattern+incorporated+into+the+side+chains+during+this+process+
determines+ the+ ability+ of+ HSPGs+ and+ CSPGs+ to+ interact+ with+ binding+ partners+ triggering+
downstream+signalling+cascades+(Okolicsanyi+et+al.,+2014)+
!
1.9 Heparan Sulfate Proteoglycans  




and!Selleck,!2001,!Zimmermann!and!David,!1999).!As!HS!functions!as!a!cofactor!in!cell!adhesion,! motility,! proliferation,! differentiation,! and! tissue! morphogenesis! by!interacting! with! diverse! protein! ligands! through! specific! saccharide! sequences!(Bernfield+ et+ al.,! 1999,! Rosenberg+ et+ al.,! 1997,! Salmivirta! et! al.,! 1996),! numerous!proteins!involved!in!organising!structure!of!the!body!depend!upon!HS!for!their!function!(Carey,!1997).!With!HS!chains!responsible!for!much!of!the!biological!role!of!HSPGs,!their!core! proteins! have! evolved! to! maximise! their! efficiency! in! their! supportive! roles!(Bernfield!et!al.,!1999).!Interestingly,!HS!chains!on!the!same!core!protein!from!different!cell!types!show!consistent!and!reproducible!structural!differences!including!variations!in!domain!number,!spacing,!size!and!ORsulfation!pattern!(Bandtlow!and!Zimmermann,!2000)! suggesting! tissue! and! microenvironmental! (niche)! specific! synthesis! and!function.! An! active! hypothesis! for! the! diverse! roles! cell! surface! HS! play! in! multiple!cellular! events! includes! the! catalysis! of! molecular! interactions! at! the! cell! surface!(Lander,! 1998)! with! a! large! number! of! proteins! including! heparinRbinding! growth!factors!the!FGFs,!VEGFs,!TGFRβ!and!PDGF.!!!
They! syndecans! and! glypicans! are! two! major! families! of! HSPG! core! proteins.! The!syndecan!family!consists!of!four!type!I!transmembrane!proteins!(Bernfield!et!al.,!1999,!Carey,! 1997,! Rapraeger! and! Ott,! 1998)! with! a! short! cytoplasmic! domain,! a! single!transmembrane!domain!and!an!extracellular!domain!that!has!attachment!sites!for!three!to!five!GAG!chains!(Tkachenko+et+al.,!2005)!allowing!syndecans!to!carry!both!HS!and!CS!chains!(Elenius!and!Jalkanen,!1994).!!




syndecans!are!expressed!in!both!the!developing!brain!and!adult!brain!tissue!(Bandtlow!and! Zimmermann,! 2000)! however! they! also! exhibit! tissue! specific! functions! and!expression! in! the! adult.! Predominantly,! syndecanR1! is! expressed! in! epithelial! tissue,!syndecanR2!in!the!mesenchyme,!syndecanR3!in!neural!tissue!while!syndecanR4!displays!the!most!ubiquitous!expression!(Leonova!and!Galzitskaya,!2013).!Specifically,!evidence!suggests!roles!for!syndecanR1!in!cytoskeletal!rearrangement!(Leonova!and!Galzitskaya,!2013,!Thi+ et+ al.,! 2004,!Weinbaum+ et+ al.,! 2007)! as!well! as! cell! adhesion! and!migration!(Sulka+ et+ al.,! 2009)! and! proliferation! (Lendorf+ et+ al.,! 2011,! Okolicsanyi! et! al.,! 2014).!Important!roles!for!syndecanR2!have!been!identified!in!angiogenesis!(Chen+et+al.,!2004)!as!well! as! the! formation! of! dendrites!within! the! hippocampus! (Chen+ et+ al.,! 2011).! In!addition,!syndecanR2!has!well!documented! interacts!with!PDGF,!FGF,!VEGF!and!TGFRβ!(Gulyas! and!Hjerpe,! 2003,!Muto+ et+ al.,! 2007).!With! predominantly! neural! expression,!syndecanR3!plays!an!important!role!in!the!regulation!of!synaptic!plasticity!in!the!brain!through! its! high! affinity! interactions! with! glial! cell! lineRderived! neurotrophic! factor!(GDNF)!(Bespalov+ et+al.,!2011).!SyndecanR4! is! the!most!widespread!of! the! family!with!important!roles!in!focal!adhesion!and!stress!fibril!formation!(Leonova!and!Galzitskaya,!2013).! Interactions! between! the! transmembrane! proteins! and! macromolecular!complexes! consisting! of! structural! proteins! within! the! cytoplasm! assist! in! the!stabilisation! of! focal! adhesions! (Denhez+ et+ al.,! 2002,! Leonova! and! Galzitskaya,! 2013).!The! result! of! these! extensive! interactions! is! a! family! of! proteins! capable! of! dynamic!regulation! of! cellular! processes! critical! in! the! development! of! the! organism,! damage!repair,!angiogenesis!and!neurogenesis!(Leonova!and!Galzitskaya,!2013).!




localisation.!!The!six!glypicans!share!an!insertion!site!for!HS!chains,!which!seems!to!be!restricted!to!the! last!50!amino!acids!at! the!CRterminus,! locating!the!HS!chains!close!to!the! cell!membrane! (Veugelers+ et+ al.,! 1999).!This! localisation! suggests! a! role! for!HS! in!mediating! glypican! interaction! with! other! cellRsurface! molecules! including! growth!factor!receptors!(Filmus+et+al.,!2008).!It!has!been!proposed!that!the!glycolipidRenriched!cellRmembrane! subdomains! of! the! glypicans! facilitate! selective! proteinRprotein!interactions!that!establish!transient!cellRsignalling!platforms!(Hancock,!2006).!!
While!predominantly!bound!to!the!cell!membrane,!glypicans!can!also!be!localised!in!the!extracellular! environment! and! in! the! cytoplasm! (Capurro+ et+ al.,! 2003).! In+ vivo! and! in+
vitro+ evidence! indicates! that! the!main! function! of!membraneRattached! glypicans! is! to!regulate!the!signalling!of!WinglessRrelated!integration!site!proteins!(Wnts;!(Capurro+et+
al.,! 2014,! Gao+ et+ al.,! 2014,! Nusse! and! Varmus,! 2012),! Hedgehogs,! fibroblastic! growth!factors!(FGFs)!and!bone!morphogenetic!proteins!(BMPs)!(Dwivedi+et+al.,!2013,!Fico+et+




1.10 hMSCs, the niche PGs and cell fate 
The!differentiation!of!MSCs!toward!specific!lineages!in+vitro!requires!seeding!the!cells!at!appropriate!densities,!with!both!cell!density!and!cell!shape!playing! important!roles! in!lineage!commitment.!Engler!et+al!(2006)!demonstrated!that!MSC!lineage!specification!is!influenced!by!ECM! substrate! stiffness.!MSCs!plated!on! collagen! gels! “tuned”! to!mimic!the!elasticity!of! the!brain,!muscle!or!bone!microenvironments!give!rise! to!neurogenic,!myogenic! and! osteogenic! cells,! respectively! (Engler+ et+ al.,! 2006).! Specifically,! ECM!substrates!can!be!designed!to!promote!particular!cellular!shapes!(rounded,!elongated!or!spread)! to! influence! cell! fate,! with! conditions! favouring! elongated! cells! resulting! in!MSCs!differentiated!toward!smooth!muscle!cells,!whereas!conditions!favouring!a!round!shape! inhibited! smooth! muscle! differentiation! (Engler! et! al.,! 2006).! Manipulating!surface!topography!and!controlling!cell!attachment,!shape!and!polarity!to!mediate!MSC!differentiation! highlight! the! remarkable! lineage! potential! of! these! cells.! With! lineage!specification! dependent! on! cell! morphology,! it! is! not! surprising! that! cell! density!mediates!the!cells’!ability!to!spread!or!contract!against!a!surface.!Lower!cell!densities,!have! been! shown! to! allow! hMSCs! to! display! a! spread! shape,! favouring! osteogenic!differentiation! with! higher! cell! densities! used! to! condense! cells! to! become! round,!driving! them! toward!adipogenesis! (Engler!et! al.,! 2006,!Ling+ et+al.,! 2009).! Indeed,!well!spread!cells!express!calcifying!bone!proteins!common!in!osteoblasts,!in!contrast!poorly!spread!cells!develop!large!lipid!deposits!typical!of!adipocytes!(Engler!et!al.,!2006)!and!are! limited! in! their! spreading! and! tension.! In! addition,! the! expression! levels! of!WntRsignalling!molecules! in!MSCs!are!reported!to!be! influenced!by!cell!density!(Gregory+et+




2003).!With!tuning!of!substrates!well!documented!for!differentiation!of!hMSCs!toward!traditional! lineages,! a! recent! study! has! investigated! the! role! of! substrate! stiffness! in!differentiation!toward!specific!neural!lineages.!Her!et+al+(2013)!determined!that!a!less!stiff! (1! kPa)! substrate!was! conducive! to!neuronal! differentiation!of! hMSCs!while! glial!differentiation!was!achieved!on!a!more!stiff!(10kPa)!substrate!(Her+et+al.,!2013).!In!this!study! an! artificial! matrix! (GeltrexTM)! designed! to! support! the! growth! of! neural! stem!cells!was! utilised! to! provide! an! ECM! substrate! conducive! to! differentiation! of! hMSCs!toward!neural!lineages.!




With! these! differences! postulated! to! vary! due! to! the! vascularity! of! the! tissue/organ!investigated,! this! suggests! both! localised! and! global! factors! influence! the! niche! and!hence!cell!fate!and!function.!!




shown! to! be! involved! in! axon! guidance! through! modulation! of! FGF! signalling!(McFarlane+ et+ al.,! 1996,!McFarlane+ et+ al.,! 1995,!Walz+ et+ al.,! 1997,!Wang!and!Denburg,!1992,!Yamaguchi,!2001).!HSPGs!therefore,!not!only!provide!a!storage!depot!for!heparinRbinding! molecules! in! the! cell! microenvironment,! but! also! decisively! regulate! their!accessibility,!function!and!mode!of!action!(Vlodavsky+et+al.,!2011).!!
1.11 The niche, PGs and the neural linage  
Several! reports! have! related! the! variable! sulfation! patterns! of! HS! with! roles! in!differentiation! (Habuchi! et! al.,! 2004,! Haupt! et! al.,! 2009,! Lindahl! et! al.,! 1998)! or!transformation!of!cells!in!culture!(Jayson+et+al.,!1998,!Safaiyan+et+al.,!1998).!!Despite!the!lack!of!a!unified!picture,! the!data!demonstrate! that! the!structure!of!HS!produced!by!a!single!cell!may!be!modulated!because!of!distinct!stimuli!(Kjellen+et+al.,!1983).!With!the!ECM!and!its!constituents!able!to!modulate!cellular!phenotypes,!cellRcell!interactions!and!signalling!cascades,!the!complexity!of!heparan!sulfate!(HS)!and!chondroitin!sulfate!(CS)!chains,!determined!by!the!variety! in! length!and!sulfation!patterns,!are!thought!to!give!these!proteins!their!niche!specificity,!that!is,!specific!functions!in!specific!tissues!(Haupt!et!al.,!2009).!!




on!cells!deficient!of!appropriately!sulfated!HSPGs!(Ornitz+et+al.,!1992,!Rapraeger+et+al.,!1991)!indicating!that!FGFR2,!its!tyrosine!kinase!receptor!and!a!cell!surface!HSPG!form!a!ternary!complex!before!the!growth!factor!signal!is!transduced!through!multimerisation!and! transphosphorylation! inside! the! cell! (Dupree+ et+ al.,! 2006,! Ibrahimi+ et+ al.,! 2004,!Rapraeger!et!al.,!1991).!!
With! members! of! the! syndecan! family! expressed! by! all! adhesive! cells,! these! HSPGs!augment!FGF!action! in+vivo! (Elenius!and!Jalkanen,!1994),!where!normal!cell!growth!is!associated! with! syndecanR1! upregulation! and! abrogation! of! this! HSPG! suppressing!proliferation.! The! syndecanR1/FGF! growth! regulatory! interaction! has! been! further!demonstrated! in+ vitro+ where! syndecanR1! overexpression! abrogated! the! growthRstimulatory! effect! of! FGFR1! (Elenius! and! Jalkanen,! 1994).! This! may! be! through!presentation!of! the! ligand! to! the!receptor,!but! it! is!also!possible! that!cells!deficient! in!syndecanR1,!which!anchors!them!to!the!ECM,!have!an!altered!morphology!and!become!free!to!divide!and!migrate.!Indeed,!the!mechanisms!by!which!cell!surface!HS!molecules!can!affect!growth!factorRregulated!growth!control!may,!in!addition!to!cell!surface!level,!also! include!events!taking!place!at! the!periRcellular,!extracellular!or! intracellular! level.!Proteolytic! cleavage! of! syndecan! ectodomains! enables! their! translocation! to! the! ECM!where!they!may!have!the!activities!described!for!matrix!HSPGs!i.e.!to!form!a!reservoir!of!FGFs,!to!control!diffusion!of!FGFs!or!to!protect!FGFs!from!proteolytic!activation!(Elenius!and!Jalkanen,!1994).!




(Ling! et! al.,! 2009).! ! Wnt! pathway! activity! is! regulated! by! intracellular! signalling!components! as! well! as! extracellular! factors! specifically! the! HSPGs! where! through!variation! in! binding! affinity,! HS! fineRtunes! the! access! of! Wnts! to! their! receptors!(frizzled)!regulating!several!developmental!processes!(Perrimon!and!Bernfield,!2000).!Dependent!upon! the!biological! context,! the!HSPG!glypicans!either! stimulate!or! inhibit!signalling! activity! (Filmus! et! al.,! 2008).! In! addition! to! their! localisation! on! the! cell!membrane!and!in!the!extracellular!environment,!glypicans!can!also!be!localised!to!the!cytoplasm! as!with! glypicanR3! in! liver! cancer! cells! (Capurro! et! al.,! 2003).!Most! in+ vivo!evidence!indicates!the!main!function!of!membraneRattached!glypicans!is!the!regulation!of!Wnt,!Hh,!FGF!and!BMP!signalling!(Ohkawara!et!al.,!2003,!Song!et!al.,!2005),!however,!the!HS!chains!on!glypicans!only!partially!contribute!to!this!regulatory!role!(Capurro!et!al.,!2008,!Song!et!al.,!2005).!In!addition,!glypicans!can!also!be!shed!into!the!extracellular!environment! where! they! play! a! role! in! the! transport! of! these! molecules! during!morphogen!gradient!formation!(Akiyama+et+al.,!2008).!!




tissue! stiffness! imparted! by! the! ECM! plays! an! important! role! in!morphogenesis,! it! is!clear! that! tissue! “pliability”! and! elasticity! are! also! critical! (reviewed! in! (Mithieux! and!Weiss,! 2005)).! Cells! migrate! along! individual! ECM! molecules! dependent! upon! niche!specific! migratory! behaviours! and! requirements.! Proteases! from! both! the! MMP! and!ADAM!families!have!been! identified! in! localised!degradation!of! the!ECM!to!enable!cell!migration! during! neural! crest! formation! (Alfandari+ et+ al.,! 2001),! and! although! both!these!molecular!families!are!known!to!degrade!ECM!components,!their!substrates!also!include! components! of! signalling! pathways! such! as! various! growth! factor! receptors,!Eph/Ephrins,!notch!and!delta!(Rozario!and!DeSimone,!2010).!




neural!differentiation!(Hagihara+et+al.,!2000).!GlypicanR1!and!glypicanR2!are!expressed!in! postRmitotic! neurons! and!while! glypican! 1! can! be! found! on! differentiated! neurons!late!in!embryonic!development!(Litwack+et+al.,!1998),!when!investigated!in+vivo!in!a!rat!model,!glypicanR2! is!expressed! in!axon! tracts!during! the!active!axon!elongation!phase!(Ivins+et+al.,!1997,!Stipp+et+al.,!1994).!These!examples!demonstrate! function!and!niche!specificity!for!HSPGs!in!the!neural!niche.!What!has!yet!to!be!fully!investigated!is!the!role!of!PGs!in!neural!lineage!fate!determination,!and!if!and!how!this!role!can!be!modulated!or!influenced.!




generated! neurons! toward! genetically! determined! locations,! extension! of! axons! and!dendrites!and!establishment!of!neural!connectivity.!!There!are!roles!for!HSPGs!in!all!of!these!diverse!processes!(Yamaguchi,!2001).!!For!example,!neural!development!involves!molecular! interactions! on! the! cell! surface! and! PGs! modulate! cell! surface! molecular!interactions!through!ligandRreceptor,!cellRcell!or!cellRmatrix!interactions,!with!evidence!of! the! role! of! ECM! laminins,! agrin,! collagen,! tenascins! and! PGs! in! synapse! formation!(reviewed!in!(Dityatev+et+al.,!2010,!MatsumotoRMiyai+et+al.,!2009)).!
Due!to!the!ectodermal!origin!of!neurons,!it!is!not!surprising!that!their!fate!is!intimately!determined!by!interactions!with!the!ECM!(Bandtlow!and!Zimmermann,!2000).!With!the!majority! of! PGs! in! the! CNS! carrying! either! CS! or! HS! side! chains! (Bandtlow! and!Zimmermann,!2000)! these!proteins! are!key! constituents!of! the!ECM! (e.g.! hyalectans),!intercalated!into!the!cell!membrane!by!a!transmembrane!domain!(syndecans,!NG2)!or!bound!to! the!cell! surface! through!a!GPI!anchor!(glypicans).!As!detailed!above,!both! in+
vitro! and! in+ vivo,! PGs!display! affinity! to! a! variety!of! ligands,! including!growth! factors,!adhesion! molecules,! matrix! components,! enzymes! and! enzyme! inhibitors! (Bandtlow!and!Zimmermann,!2000).!Thus!PGs!appear!not!only!to!function!as!structural!elements!supporting! cells! providing! tissue! turgor! but! also! appear! to! mediate! crucial! events!during!brain!development!(Bandtlow!and!Zimmermann,!2000).!!
1.12 Summary 
Evidence!supporting!the!importance!of!PGs!in!the!localised!cellular!microenvironment!during! hMSC! lineage! fate! specification! suggests! PGs! contribute! to! the! MSC! niche!through! signalling! pathways,! cellRECM! interactions,! cell! surface! molecules! and! the!structure!of!the!ECM!itself.!By!examining!PGs!in!hMSCs!characterised!and!expanded!in+




microenvironment! during! neural! lineage! differentiation.! This! combined! with! data!outlining! the! central! role! of! HSPGs!within! the! neural! niche! during! development!may!provide!new!targets!and!a!new!model!for!the!examination!and!repair!of!localised!brain!damage.!!
2.1 Hypothesis: 
Progression+ of+ mesenchymal+ stem+ cells+ toward+ the+ neuronal+ lineage+ is+ mediated+ by+
chondroitin+ sulfate+ proteoglycans+ (CSPGs)+ and+ heparan+ sulfate+ proteoglycans+ (HSPGs)+
within+the+niche.+By+targeting+these+proteoglycans+(PGs)+within+the+neuronal+niche,+we+can+
mediate+ lineage+ commitment+ in+ order+ to+ provide+ improved+models+ for+ the+ treatment+ of+
brain+damage.+
2.2 Aims: This! project! examined! Mesenchymal! Stem! Cells! (MSCs)! as! they! progress! down! the!neuronal! differentiative! pathway.! Cellular! processes! at! key!points! along! this! pathway!were!examined!to!identify!and!manipulate!markers!of!cell!fate!specificity.!!The!focus!of!this! study! was! the! proteoglycan! (PG)! family! of! glycoproteins,! the! heparan! sulfate!proteoglycans!(HSPGs).!PGs!are!ubiquitous!members!of!the!extracellular!matrix!(ECM)!and! key! mediators! of! cell! signalling! pathways.! By! examining! the! role! of! HSPGs!throughout! neuronal! lineage! commitment! we! aimed! to! provide! improved! models! of!repair!and!localised!brain!damage.!




being!further!optimised!to!overcome!the!primary!complication!of!lineage!differentiation!protocols!and!insufficient!cell!numbers!at!completion!of!differentiation.!Improvement!in!the! differentiation! protocols! to! overcome! insufficient! cell! numbers,! low! viability! and!limited! cell! proliferation,!will! validate! the! involvement! of! key!PGs,! such! as! syndecans!and!glypicans,! identified! in! this!study!as!potential! targets! for! their! role! in!MSC!neural!fate! determination.! The! continued! validation! of! these! PGs! core! proteins! (syndecans,!glypicans),! initiation! and! modification! enzymes! and! their! signalling! partners! (FGFs,!Wnts,!BMPs)!in!undifferentiated!hMSCs!will!likely!achieve!improved!models!of!neuronal!differentiation.!
1.13 Research Design Human! mesenchymal! stem! cells! (hMSCs)! were! utilised! in! this! study! as! a! model! to!examine!the!role!of!these!cells!in!the!neuronal!niche!as!well!as!the!identification!of!stem!cell!fate!markers!at!key!stages!of!neuronal!lineage!commitment.!hMSCs!can!differentiate!into! distinct! lineages! with! specific! lineage! commitment! of! hMSC! differentiation!controlled!by!the!tissueRspecific!microenvironment!or!niche!(Chen!2010).!
 Specific Aims: 1.13.1
1. Characterisation!of!MSC!toward!a!neuronal!lineage.!!




differentiation! experiments.! During! expansion! we! identified! distinct! growth!phases,!represented!by!specific!passages,!examined!in!subsequent!experiments.!
1.2. Utilised+human+breast+cancer+(HBC)+cell+lines+for+optimisation+of+in+vitro+heparan+
sulfate+proteoglycan+(HSPG)+assays.!Two!HBC!cell!lines!(MCFR7!and!MDARMBR231!cells)!were!utilised!to!optimise!in+vitro!assays!including!dose!response!and!gene!expression! analyses.! This! involved! cell! culture! of! immortalised! lines,! flow!cytometry!and!QRPCR!!
1.3. Established+and+optimised+in+vitro+protocols+for+examining+maintenance+of+hMSC+
cultures.! MultiRlineage! markers! as! well! as! gene! expression! markers! were!identified! and! used! to! confirm! multipotency! of! the! cells! at! specific! passages.!This! involved! primary! cell! culture,! standard! cell! culture,! flow! cytometry,!fluorescent!immunohistochemistry!and!QRPCR.!
1.4. Established+ and+ optimised+ in+ vitro+ protocols+ for+ examining+ proteoglycan+ (PG)+
expression+ profile+ in+ hMSCs.! Using! protocols! optimised! by! the! use! of! the! HBC!model! in! Aim! 1.2,! and! the! passages! representing! growth! phases! identified! in!Aim!1.1,!we!examined!the!cells!at!three!time!points,!day!1,!day!3!and!day!5.!At!each!of! these! time!points!RNA!was!extracted!and!used! in!Aim!2.1! to!generate!basal!expression!profiles.!This!involved!primary!cell!culture,!flow!cytometry!and!quantitative!realRtime!PCR!(QRPCR).!





1.6. Confirm+ multi6lineage+ potential+ of+ hMSCs+ via+ classical+ differentiation.+ ! hMSC!populations!were! differentiated! toward! two! classical! lineages! (osteogenic! and!adipogenic)!at!each!selected!passage!(P+5,!P_7,!P+13)!to!confirm!multiRlineage!potential!prior!to!neural!differentiation.!In!addition!we!examined!the!basal!gene!expression!profile!of!a!number!of!specific!lineage!markers!for!MSC!multipotency!and! lineage! specification.! The! multiRlineage! differentiation! of! primary! cells!occurred! under! differentiative! culture! conditions.! Basal! expression! profiles!were! generated! using! QRPCR! and! an! MSC! cell! surface! profile! was! generated!using!flow!cytometry.!
2. Identification!of!key!PGs!(CSPGs!&!HSPGs)!in!neuronal!lineage!commitment.!!
2.1. Characterise+ hMSC+ basal+ expression+ profile+ of+ HSPGs+ core+ proteins+ and+
modification+ enzymes.! ! Using! QRPCR! we! established! a! basal! gene! expression!profile!of!hMSCs!over!three!timepoints!at!different!phases!of!growth.!Timepoints!were! selected! using! dose! response! experiments! allowing! examination! of!immediate! versus! sustained! response,! while! growth! phases! were! identified!during!expansion!of!in+vitro!cultures!allowing!investigation!of!changes!resulting!from! extended! in+ vitro! intervals.! We! investigated! the! expression! of!approximately!30!HSPG!related!genes!including!core!proteins,!along!with!chain!initiation,! modification! and! sulfation! enzymes.! This! involved! primary! cell!culture,!RNA!extractions!and!QRPCR.!!




heparin! (an! analogue! of! heparan! sulfate;! HS)! or! chlorate! (an! inhibitor! of! HS!sulfation).! This! involved! primary! cell! culture,! niche! modification,! QRPCR! and!fluorescent!microscopy.!
2.3. Determine+effect/s+of+modulation+of+ the+niche+on+ lineage+specificity.!Markers! for!triRlineage!and!neuronal!potential!were!examined!using!flow!cytometrey,!QRPCR!and! fluorescent! immunohistochemistry.! Following! modulation! of! the! niche!comprising!treatment!of!cultures!with!heparan!or!chlorate,!these!markers!were!reRexamined!to!determine!any!changes!in!lineage!marker!expression!and!to!aid!in!the!identification!of!key!timepoints!and!markers!of!lineage!specification.!
2.4. Determine+effect/s+of+modulation+of+the+niche+(heparin)+on+neuronal+commitment.!hMSCs! were! differentiated! to! neuronalRlike! cells! using! a! protocols! modified!from! previously! published! differentiation! protocols.! Following! heparin!modulation! of! the! niche,! hMSC! ability! to! differentiate! toward! neural! lineages!was! assessed! and! characterised! involving! primary! cell! culture,! QRPCR! and!fluorescent!ICC.!!
3. Provide!models!of!limiting!and!repairing!brain!damage.!!
3.1. Examination+of+key+PG+markers+at+ specific+ stages+of+ fate+determination.! Specific!HSPG! core! proteins! identified! in! Aim! 2! were! examined! for! their! role! in! fate!determination!of!MSCs.!!
3.2. Determine+ whether+ specific+ in+ vitro+ intervals+ favour+ lineage+ specific+




3.3. Modulation+ of+ key+ PG+markers+ of+ MSC+ neural+ differentiation.! As! determined! in!Aim! 2! and! building! on! correlations! drawn! from! Aim! 3.1,! specific! PGs! were!hypothesised! to! be! key! proteins! in! the! differentiation! of!MSCs! toward! neural!lineages.!!We!examined!these!key!PGs!throughout!neural!differentiation.!



















 Chapter 2: Materials and Methods 
Data!obtained! from!optimisation!experiments!utilising!human!breast! cancer! cell! lines!has!been!published!in!the!Journal(of(Cellular(Biochemistry.!
Okolicsanyi! RK,! van! Winjen! AJ,! Cool! SM,! Stein! GS,! Griffiths! LR,! Haupt! LM.! (2014)!Heparan! sulfate!proteoglycans!and!human!breast! cancer!epithelial! cell! tumorigenicity!
Journal(of(Cellular(Biochemistry.(May;(115(5):(967?76).(doi:(10.1002/jcb.24746.![IF!3.062]!
Two! further!manuscripts! are! being! finalised! for! publication! from! this! data! generated!using!the!human!breast!cancer!model.!These!papers!are!titled:!“Inhibition(of(sulfation(of(
heparan( sulfate( influences( invasive( potential( in( a( human( breast( cancer( model”,! and!“Influence(of(heparin(and(sodium(chlorate(on(heparan(sulfate(proteoglycans( in(a(human(
breast(cancer(model”.!
!
2.1 Cell Culture 
2.1.1 Optimisation Cell Lines Two!human!breast!cancer!cell!lines!were!used!to!optimise!cell!culture!conditions!and!in(




proteins! (Okolicsanyi( et( al.,! 2014b).! In! addition,! they! were! to! be! used! as! a! positive!control! for! QXPCR,! as! they! are! known! to! respond! to! heparin! and! chlorate! treatment,!allowing!for!their!use!as!optimisation!cell!lines!(Okolicsanyi!et!al.,!2014b).!
2.1.2 Cell Culture Conditions The! two! cell! lines! were! originally! obtained! from! ATCC! and! grown! routinely! as! a!monolayer! in!culture.!MCFX7!cells!were!maintained! in!50%!DMEM!(Life!Technologies,!Australia),! 50%! RPMI! (Life! Technologies)! medium! (+LXGlutamine)! containing! 10%!foetal! calf! serum!and!100!U/mL!penicillin/streptomycin! (Lonza,!Australia).!MDAXMBX231!cells!were!maintained!in!RPMI!medium!(+LXGlutamine)!containing!10%!foetal!calf!serum!and!100!U/mL!penicillin/streptomycin.!!Both!cell!lines!were!grown!in!a!5%!CO2!humidified! atmosphere! at! 37oC.! ! For! routine!maintenance,! cells!were! plated! at! 5x105!cells! in! a!T75,! as!determined!by! cell! counts,! and!passaged!at!70X80%!confluence.! For!dose!experiments,!cells!were!plated!at!1x104/cm2!in!100mm!dishes!(Corning,!Australia)!in!media!containing!heparin!or!chlorate,!as!described!in!section!3.1.4.!!!!Dose!conditions!were!maintained!for!one,!three!or!five!days!with!media!supplemented!with!appropriate!concentrations! of! heparin! or! sodium! chlorate.! Media! was! changed! every! two! days.!Optimisation!and!dosing!experiments!were!conducted!on!both!MCFX7!and!MDAXMBX231!cells!in!triplicate.!Cell!culture!medium!was!obtained!from!Lonza,!Australia.!!Heparin!and!sodium!chlorate!were!obtained!from!Sigma!Aldrich,!Australia.!




dissociated! from! the! surface! (examined! under! phase! microscopy).! Cell! suspensions!were!then!neutralised!via!the!addition!of!an!equal!volume!of!growth!media!containing!foetal! calf! serum!(TNS)!and! the!cell! suspension!mixed! thoroughly.!Cell!numbers!were!estimated!as!detailed!below.!The!cell!suspension!was!then!centrifuged!at!500!rpm!for!5!min! to! pellet! the! cells.! Conditioned! media/TNS! solution! was! removed! using! a! glass!pasteur!pipette!attached!to!a!vacuum!pump!and!the!cells!resuspended!in!fresh!media!or!freeze! media.! ! Cells! were! replated! into! fresh! tissue! culture! vessels! at! densities!appropriate!for!growth!and!expansion!or!specific!experiments!as!detailed!in!following!sections.!






generated( using( the( ViaCount( assay.( (Guava( EasyCyte( Plus( System( User’s( Guide( –( Guava(
CytoSoftTM(Software(v5.2,(2008)(For!routine!cell!counts!after!establishment!of!growth!curve!and!dose!response,!a!BioRad!automated!cell!counter!was!used!(Vlad;!BioRad,!Australia).!10μL!of!cell!suspension!was!mixed!with!10μL!of!trypan!blue!(0.4%)!and!loaded!into!a!counting!slide.!!The!automated!cell!counter!compared!the!number!of!cells!that!had!taken!up!the!trypan!blue!to!the!total!number!of!cells!counted!to!calculate!viability.!





Figure'2)2: Average( cell( counts/mL( correlating( two( different( counting( methods.( Cell( counts(
were(taken(at(each(passage((P2?P13).(The(counts(generated(using(Guava(correlated(well(with(
the( automated( cell( counter( (Vlad)( allowing( use( of( Vlad( for( routine( cell( counts( throughout(
expansion.(







2.1.5 Modulation of the in vitro niche Initial!modulation!experiments!were!carried!out!using!the!breast!cancer!cell!lines!MCFX7!and!MDAXMB231.!This!was! to!ensure!correct!seeding!densities,!concentration!range!and!time!course!for!dose!response!experiments.!Modulation!of!the!niche!took!the!form!of! addition!of! exogenous!heparin,! and!analogue!of!heparan! sulfate! (HS)!or!exogenous!sodium!chlorate,!to!inhibit!further!sulfation!of!the!HS/chondroitin!sulfate!(CS)!chains.!!
Many!aspects!of!HS!biosynthesis!are!shared!by!the!structural!analogue!heparin,!which!is!synthesised!in!mast!cells!and!other!mammalian!cells.!It!has!a!severalXfold!higher!degree!of!polymerisation!and!more!extensive!modification!than!heparan!sulfate!(Sugahara!and!Kitagawa,! 2002).! As! such,! heparin! is! a! short,! highly! sulfated! protein,! which! can!competitively! bind! HS! targets! inhibiting! HSXprotein! interactions,! and! due! to! its!availability!is!used!in!cell!culture!and!in(vitro!models!as!a!HS!substitute.!Sodium!chlorate!competitively! inhibits! the! formation! of! the! highXenergy! sulfate! donor! in! cellular!sulfation!reactions!(Rapraeger(et(al.,!1991).!Treatment!of!cultures!with!50mM!chlorate!has! been! shown! to! inhibit! overall! OXsulfation! of! HS! by! ~! 70%! with! NXsulfation!remaining! unchanged! (Safaiyan( et( al.,! 1999),! with! lower! concentrations! of! sodium!chlorate!(5X20mM)!selectively!reduce!the!6XOXsulfation,!while!50mM!reduced!both!2XO?!and!6XO?sulfation!(Safaiyan!et!al.,!1999).!




response! to! heparin! (Figure! 2X3).! In! the! MCFX7! cells,! the! greatest! increase! in! cell!number! following! treatment!was! observed! between!day! 3! (D3)! and!day! 5! (D5),!with!only! a! small! increase! in! cell! number! between! D3! and! D5! observed! in! the! low! dose!conditions.!!As!the!dose!increased!(10μg/mL!and!above),!cell!numbers!decline!between!D3!and!D5!in!MCFX7!cells!(Figure!2X3A).! ! In!contrast,! the!MDAXMBX231!cells!showed!a!steady! increase! in!cell!number!at!all!doses!at!all! time!points!(D1!to!D3!and!D3!to!D5)!with!the!difference!in!cell!number!between!D3!and!D5!plateauing!at!doses!higher!than!10μg/mL.!!However,!it!is!important!to!note!that!at!D1!and!D3,!total!cell!number!did!not!differ! between! doses.! ! The! most! marked! difference! in! cell! number! between! doses!occurred!in!the!MDAXMBX231!cell!line!at!D5!(Figure!2X3B).!In!both!cell!lines,!in!response!to! chlorate! treatment,! increased! cell! number! between!D1! and!D3!were! in! proportion!and! constant! across! doses! up! to! 50mM! (Figure! 2X3CXD).! ! At! doses! higher! than! this!(100mM,!500mM),!even!at!D1,! there!was!a!marked!reduction! in!cell!number!with! the!50mM!dose!resulting!in!a!13%!reduction!in!cell!number!in!both!cell!lines!by!D5!(Figure!2X3CXD,!Figure!2X4).!!In!MCFX7!cells!this!resulted!in!an!overall!reduction!in!cell!number!by! D3! with! a! further! reduction! at! 50mM! of! 8%! apparent! by! D5! when! compared! to!control!cell!cultures!(Figure!2X4).!!!









Figure'2)3: Dose( response( of( MCF?7( and( MDA?MB?231( cell( lines( to( heparin( or( chlorate(
treatment.(In((A)(MCF?7(cells(following(heparin(treatment(we(see(a(comparable(increase(in(cell(



















dose( (10μg/mL( heparin)( (A)( MCF?7( had( an( overall( reduction( in( cell( number( compared( to(
control(of(2%(by(day(5((D5)((B)(MDA?MB?231(cell(numbers(had(increased(by(75%(over(control(
by( D5.( MCF?7( cells( are( not( as( sensitive( to( heparin( treatment( as( MDA?MB?231( cells( as(
demonstrated(by(their(small(changes( in(cell(number(following(treatment.(Chlorate(treatment(
of( (C)(MCF?7( resulted( in( an( 8%( reduction( in( cell( number( by( D5( (D)(MDA?MB?231( cells( had(
increased( in( cell( number( by( 13%(over( control( following( chlorate( treatment( at( optimal( dose(
(50mM( chlorate).(While(MDA?MB?231( cells( showed( increased( cell( proliferation( over( control,(
proliferation( is( greatly( reduced( compared( to( rates( seen( following( heparin( treatment.( ( Solid(
line:( ( Control;( Dash( line:( 10μg/mL( Heparin;( Dash?Dot( line:( 50mM( Chlorate.( Error( bars(
represent(standard(deviation,(n=3.(











• Minimum! of! eight! weeks! between! bone!marrow! donations! or! participation! in!other!donor!programs!
• Donors! may! donate! a! maximum! of! four! times! per! calendar! year! and! six!donations!in!total.!
• Signed!and!witnessed!informed!consent!forms!required!
• Negative! medical! history! for! heart! disease,! kidney! disease,! cancer,! bleeding!ulcers,!diabetes,!jaundice,!liver!disease,!hepatitis!and!epilepsy!
• Negative! medical! history! for! bacterial! or! viral! infections! which! may! be!hazardous!to!the!researchers!




to!be!positive! for:! adipogenic! lineage! indicated!by!neutral! lipid;! chondrogenic! lineage!indicated!by!collagen!type!II!and!osteogenic!lineage!indicated!by!calcium!mineralisation!(Lonza,!Poietics!Human!Mesenchymal!Stem!Cell!System).!Demographic!information!for!the!hMSC!populations!used!in!this!study!is!presented!in!table!2X1.!
Table'2)1: Demographic( information( for( the( four( hMSC( populations( expanded.( A( duplicate(

















! ! 16! 24! 45!
hMSCD
19604!
20! F! 16! 24! 46!
hMSCD
20176!
33! M! 9! 16! 35!
hMSCD
21558!
39! M! 10! 16! 46!
Average! 30! ! 13! 20! 43!!




Following!the!initial!time!lapse!to!first!passage!(between!4X10!days)!cells!were!passaged!at!approximately!70X80%!confluence.!Cells!were!then!plated!into!T75!culture!flasks!at!a!density!of!2.5!x!105/!T75!(approximately!3400!cells/!cm2)!and!passaged!every!3X5!days.!At!each!passage,!cells!were!reXplated!at!2.5!x!105! in!a!T75!(approximately!3400!cells/!cm2)!with!surplus!cells!stored! in! liquid!nitrogen! in!1mL!aliquots!at!a!concentration!of!2.5!x!105/mL.! For! dose! experiments,! cells! were! plated! at! 5000! cells/cm2! to! ensure!sufficient! cells! for! early! time! points! as!well! as!maintaining! the! initial! plating! density!across!all!time!points.!
Cells!were!passaged!when!around!80%!confluent.!!Briefly,!conditioned!media!(CM)!was!removed!from!the!cell!monolayer!then!washed!with!1x!phosphate!buffered!saline!(PBS).!For!a!T75!flask,!5mL!of!Trypsin/Versene!mix!or!0/25%!Trypsin!was!added!to!the!cell!monolayer,! the! cells! incubated! at! 37oC! for! at! least! 5! minutes! or! until! the! cells! had!detached! from! the! flask! surface.! 5mL! of! hMSCGM! was! then! added! to! neutralise! the!trypsin.!Cells!were!counted!using!two!different!methods!prior!to!reXplating.!!




Once!established!and!expanded,!the!MSC!populations!were!examined!at!representative!passages! from! each! of! the! observed! growth! phases! (Figure! 2X1):! the! first! phase! of!logarithmic! growth! (phase!A);! the! first! plateau! phase! (phase!B);! the! second!phase! of!logarithmic! growth! (phase! C);! and! second! plateau! phase! (phase! D).! The! passages!chosen!to!represent!these!phases!were!passage!5!(P+5;!Phase!A),!passage!7!(P+7;!Phase!B),!passage!13!(P+13;!Phase!C).!
Following! successful! expansion! of! five! hMSC! populations,! three! populations! were!selected!based!on!their!similarities! in!growth! including! the!number!of!days! in!culture!between! passages! (Figure! 2X5).! These! populations! were! used! for! subsequent!experiments!and!designated!hMSCX1!(hMSCX19604),!hMSCX2!(hMSCX20176)!and!hMSCX3!(hMSCX21558)!(Table!2X2).!





















hMSCD1! 16! 12! 24! 21! 46! 43!
hMSCD2! 9! 11! 16! 17! 35! 35!
hMSCD3! 10! 16! 16! 23! 46! 41!





Figure'2)5: Expansion(of(hMSC(populations.( (A)(Passages( representing(each(phase(of(growth(
were( selected( (highlighted( in( red)( based( on( similarities( in(morphology( and( growth( rate( for(
total( days( in( culture( and( total( population( doubling( to( reach( each( passage( (see( Table( 2?2).(
These( passages( were( used( to( examine( the( three( selected( populations( throughout( further(





Following! expansion! of! cultures! and! identification! of! distinct! growth! phases,! optimal!concentrations!of!heparin!and!chlorate!were!determined!for!in(vitro!niche!modification.!These!processes!are!outlined!in!Figure!2X6.!
!
Figure'2)6: Schematic(outlining(hMSC(expansion(steps.(First(culture(conditions(were(optimised(
using(human(mesenchymal( stem( cell( growth(medium( (hMSCGM),( then( cell( populations(were(
expanded(for(more(than(20(passages((P+)(equating(to(more(than(70(population(doublings(and(
more( than(90(days( in(culture.( (This(aided( in( the( identification(of(passages(representing(each(
growth(phase(allowing( for( selection(of(appropriate(passages( for(niche(modification.( (Finally,(





2.1.8 Modulation of the in vitro hMSC Niche Modulation!of!the!in(vitro!niche!was!achieved!through!treatment!of!hMSC!cultures!with!chemicals!and!growth!factors!such!as!heparin,!chlorate.!!
A!dose!response!curve!experiment!was!performed!in!order!to!assess!the!most!effective!dose!of!heparin!or!chlorate!for!further!experimentation!on!hMSCs.!Cells!were!grown!in!varying!concentrations!of!heparin!or!sodium!chlorate!over!one,! three!and!five!days!to!asses! their! proliferative! responses! to! these! chemicals.! A! schematic! outlining! this!process!can!be!found!in!Figure!2X7.!
!
Figure'2)7: Schematic( outlining( the( experiments( conducted( following( niche( modification.(
hMSC(populations(were(examined(using(expression(studies(and(protein(studies(including(Q?PCR(










Figure'2)8: hMSC( dose( response( following( treatment(with( heparin( or( chlorate.( Cell( numbers(
presented( are( the( average( of( the( three( populations( to( be( used( for( subsequent( experiments,(




the( selected(optimised(concentration(of(heparin( (10μg/mL)(or(chlorate( (50mM).( (A)(hMSC?1(





2.1.8.1 RNA and Protein studies For!RNA!and!protein!studies,!cells!were!plated!in!6!well!culture!dishes!at!5x104!cells/!well.!Cells!were!plated!in!triplicate!with!3!wells!treated!with!either!heparin!or!chlorate!and!3!wells!untreated!as!a!control.!!Plates!were!seeded!in!duplicate!at!each!time!point!to!allow!for!harvesting!of!cells!for!RNA!and!protein!at!completion!of!the!experiment.!The!experiment!ran!over!5!days!with!samples!collected!at!day!1!(D1),!day!3!(D3)!and!day!5!(D5).!Detailed!protocols!for!protein!extraction,!quantification!and!western!blots!as!well!as!RNA!extraction!and!QXPCR!can!be!found!in!sections!3.4X!3.7.!









Figure'2)10: hMSC( RNA( and( protein( expression( studies.( Schematic( outlining( equipment( and(
protocols(used(for((A)(RNA(and((B)(protein(expression(studies.(




2.2 Lineage Characterisation Although!hMSCs!have!high!expansive!potential,!when!propagated! in(vitro,! the!cells!are!not! immortal!with! limited! growth!potential! and!number! of! population!doublings.!We!have!expanded!several!hMSC!populations!for!>20!passages!(>60!days!in!culture!and!>50!population! doublings)!with! populations! derived! from!multiple! donors! demonstrating!similar! growth! patterns.! These! commercially! available! hMSCs! were! obtained! (Lonza,!Australia)! after! isolation! from! the!bone!marrow!of! the!posterior! iliac! crest! of! normal!donors!and!characterised!to!confirm!that!when!expanded!they!remain!positive!for!MSC!lineage! markers.! A! commercially! available! characterisation! panel! was! selected! with!antibodies!suitable! for!use! in! immunocytochemistry!and! flow!cytometry!(summarised!in!Table!2X3,!Figure!2X11).!!Protocols!for!these!methods!are!described!in!section!2.4!and!2.5!below.!
Table'2)3: Mesenchymal(Stem(Cell(marker(panel.(The(table(below(outlines(the(makers(used(in(
the( commercially( available( panel( to( identify( and( characterise(MSC(by( immunocytochemistry(




Gene Lineage Function +ve/ 
-ve 







CD44 CD44 CD44 Antigen (Indian 
Blood Group) 
MSC/Epithelial Hyaluronic Acid Receptor 
Cell Adhesion/ Migration 
Cell-Cell 
+ 





Haematopoietic cells, but 
NOT Erythrocytes and 
Platelets 
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Mediates activation of white 
blood cells to enodothelial 
cells 
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Figure'2)11: Representative( immunocytochemistry( images( of( hMSC?2(at( P+7,( positive( for(MSC(
lineage(markers.( (A)( CD44( (ab6124)(1/200(dilution((B)( CD29( (ab52971)(1/200(dilution((C)(
CD105( (ab44967)( 1/1000( dilution.( Secondary( antibodies( were( (yellow)( Chromeo( 546( and(
(green)(Chromeo(488(at(1/250(dilution(for(2(hours.(Fluoroshield(mounting(medium(with(DAPI(
(ab104139)(was(used(to(stain(nuclei((blue).((Okolicsanyi(et(al.,(2014a)(In!addition!examination!of! the!cell!surface!marker!profile!of!hMSCs!was!performed!to!confirm! lineage! potential,! with! classical! differentiation! toward! osteogenic! and!adipogenic! lineages! also! conducted.! ! Protocols! can!be! found! in! the! following! sections!(Section!2.3.1).!




2.3 Confirmation of Stemness At!each!passage,!the!stemness!–!or!multilineage!potential!of!the!hMSC!populations!was!assessed.! ! To! achieve! this! QXPCR,! ICC,! FACS! and! classical! adipogenic! and! osteogenic!differentiation!protocols!were!used.!The!gene!expression!of!specific!stemness!markers!was!examined!and! the! cells! stained! for! ICC!using!a! commercial!panel! to! identify!MCS!markers.! In! addition,! some! of! the!markers!making! up! this! panel!were! used! for! FACS!analysis! to! confirm! population! ratios! for! positive! and! negative!markers.! Figure! 2X12!below!outlines!the!markers!used!for!each!method!to!confirm!stemness.!






(Q?PCR),( immunocytochemistry( (ICC),( fluorescence( assisted( cell( sorting( ( (FACS),( and(
differentiation( protocols.( ( Q?PCR( examined(markers( of(mesenchymal( stem( cells( (hMSCs)( and(
neural( stem( cells( (NSCs)( and( their( specific( lineages.( ICC( and( FACS( examined( expression( of(
specific(markers(of(MSCs(and(NSCs.(Western(blots(were(also(used,(but(with(limited(success.(The(





2.3.1 Classical hMSC Differentiation 
For! differentiation! protocols,! hMSCs! were! plated! at! 3000! cells/cm2! in! 6! well! plates!(3x!104!per!well).!Cells!were!plated!in!hMSCGM.!
2.3.1.1 Adipogeneisis 
Following!plating,!cells!were!allowed!to!proliferate! in!hMSCGM!until!confluent.! !When!confluent! hMSCGM! was! replaced! with! Adipose! Induction! Medium! (AIM).! After! three!days,! the! AIM! was! replaced! with! Adipose! Maintenance! Medium! (AMM).! ! The! cells!underwent!three!cycles!of!three!days!in!AIM!followed!by!three!days!in!AMM.!!At!the!end!of! this! period,! the! cells! were! maintained! in! AMM! for! a! further! seven! days.! At! the!completion!of!adipogenic!induction,!cells!were!stained!for!lipid!vacuoles!with!Oil!Red!O.!!Plates!were!imaged!on!a!flat!bed!scanner.!
( Oil(Red(O(Staining(
Briefly,! at! the! end!of! the! induction! and!maintenance!period,! cells!were!washed! twice!with! 1X! PBS! and! then! fixed! in! 4%! PFA! for! 15! min.! A! second! wash! in! 1X! PBS! was!conducted!and!then!70%!ethanol!was!added!to!cover!the!monolayer.!!Plates!were!stored!at!4oC!until!required!for!staining.!!
Oil!Red!O!was!diluted!to!a!1%!solution!in!ddH2O.!Prior!to!staining,!cells!were!washed!in!1XPBS.!The!cell!monolayer!was!incubated!in!1mL!of!Oil!Red!O!working!solution!at!room!temperature!for!10X20!minutes.!!The!cells!were!then!washed!3!times!in!ddH2O!and!the!plates!scanned.!




days!and!the!cells!maintained! in!OIM!for!21!days.!At! the!end!of! this!period!cells!were!stained!with!von!Kossa!stain!and!Alizarian!Red!for!calcium!deposition.!!
( Alizarian(Red(Staining(
Briefly,! following!the!conclusion!of!the!differentiation!period,!cells!were!washed!twice!with!1X!PBS.!!The!cells!were!then!fixed!in!4%!PFA!for!15min.!Following!a!second!wash!in!1X!PBS,!cells!were!stored!in!70%!ethanol!at!4oC!until!required!for!staining.!Alizarian!Red!was! diluted! to! a! 1%! solution! in! ddH2O! and! the! pH! adjusted! to! pH! 4.3! with! 1M!NaOH.! To! each!well! of! a! 6!well! plate,! 2mL! of! Alizarian! Red! dye!was! added! and! cells!incubated!at!room!temperature!for!30min.!!The!cells!were!then!washed!and!the!plates!dried.!Cells!were!visualised!on!a!flat!bed!scanner.!
( Von(Kossa(Staining(




2.4 Immunocytochemistry Immunocytochemistry!(ICC)!cell! images!were!taken!using!an!Olypmus!IX81!motorised!fluorescent!microscope,! using! 10X! (numeric! aperture;! N.A! 0.30),! 20X! (N.A! 0.45)! and!40X! (N.A.! 0.60)! objectives! in! culture! vessels! (for! expansion! and! differentiation!monitoring)! or! chamber! slides! (for! fluorescent! immunocytochemistry).! ! Images!were!adjusted!to!clarify!contrast!only.!Fluorescent!characterisation!was!visualised!using!the!Olympus! IX81! and! appropriate! filter! sets! for! each! fluorophore.! Colour! images! were!generated!using! the!Volocity!V6.3.1! software! obtained! from!PerkinXElmer.! Images! for!each! fluorophore! were! collected! individually! and! then! overlayed! to! produce!merged!images!creating!the!multicolour!images!presented.!
ICC!is!a!standard!method!for!the!identification!and!characterisation!of!MSCs!and!NSCs.!!In!addition!to!markers!used!to!define!multipotentiality!we!examined!markers!of!specific!lineages.! !Further! to! this!we!examined! the!expression!and! localisation!of!a!number!of!HSPG!core!proteins.!Following!differentiation!of! the!hMSCs! towards!neural! lineages! it!was! important! to!visualise!any!changes! in!expression!or! localisation!of!either! specific!lineage! markers! or! markers! of! stemness.! ! It! was! also! important! to! examine! the!colocalisation!of!some!of!these!neural!markers!with!key!HSPG!core!proteins.!




hour!in!appropriate!blocking!buffer.!!Following!blocking,!slides!were!washed!once!with!1X!PBS!and!then!cells!incubated!in!appropriate!blocking!buffer!containing!the!primary!antibody.!Slides!were!rocked!at!room!temperature!for!1!hour!before!being!placed!at!4oC!overnight.! ! Slides!were! then!washed! in! twice! in!1X!PBS! for!5X10min! each,! blocked! in!appropriate! blocking! buffer! for! 30! minutes.! Slides! were! incubated! with! secondary!antibodies! diluted! in! blocking! buffer! at! room! temperature! for! 2! hours! in! the! dark.!!Slides! to!detect!MSC!markers!were!washed!after!1!hour!of! incubation!with!secondary!antibody,!gaskets!removed!and!slides!incubated!in!0.1%!TweenX20!for!1!hour!to!remove!background.! After! 2! hours! (neural! marker)! slides! were! washed! in! 1X! PBS! before!removal!of!chambers.!Slides!were!mounted!in!Fluoroshield!mounting!media!containing!DAPI!and!allowed!to!dry!for!at!least!1!hour!prior!to!imaging.!
Blocking!buffer!comprised!1%!normal!goat!serum!in!1X!PBS!for!cell!surface!markers!of!MSCs.! ! For! neural! makers! nonXpermeable! and! permeable! buffers! were! used! for!extracellular! and! intracellular! makers! respectively.! ! NonXpermeable! blocking! buffer!comprised! 2%!normal! donkey! serum! in! 1X! PBS!while! the! permeable! blocking! buffer!contained!2%!normal!donkey!serum,!0.1%!TritonXXX100!in!1X!PBS.!!




In!all!ICC!experiments,!detection!of!positive!marker!staining!was!confirmed!by!!lack!of!staining! and! subsequent! detection! of! fluorescence! in! both! isotype! controls! and!secondary!only!antibody!negative!controls.!This!was!true!even!where!low!expression!of!markers!required!extended!exposure!times!for!detection.! !Negative!control!panels!can!be!found!in!Chapter!8,!Appendix!7.!
2.5 Flow Cytometry (Fluorescence assisted cell sorting; FACS) Flow! cytometry! is! a! technique! for! counting! cells! and! examining! intracellular! and!extracellular! markers! by! suspending! the! cells! in! a! stream! of! fluid! and! passing! them!through!an!electronic!detection!apparatus.!Laser!excitation!of!fluorescent!tags!attached!to!samples!provides!multiple!simultaneous!detection!parameters!including!forward!and!side! scatter! in! combination! with! as! many! as! six! fluorescent! colours.! This! allows!labelling!of! cells! for! combinations!of! specific!markers!with! individual! fluorophores! to!determine!composition!of!a!cell!population!based!on!positive!and!negative!readings!for!markers.!Detailed!protocols!can!be!found!in!chapter!2,!section!2.3.!




RNase! solution! was! removed! following! centrifugation! and! the! cells! incubated! in! 4%!goat!serum!at!room!temperature!for!15!minutes.! !This!blocking!solution!was!removed!and!the!cells!resuspended!in!4%!goat!serum!and!divided!between!sufficient!FACs!tubes!for! each! sample! (500μL/sample).! Primary! antibodies!were! added! to! cell! suspensions!(CD44!@1/300;!CD29@!1/300;!CD90!@!1/500;!CD45!@!1/500;!Nestin!@!1/200;!Sox2!@!1/200)! and! the! cells! incubated!at! room! temperature! for!30!minutes.! !The!primary!antibody! solution! was! removed! following! centrifugation! at! 900! rcf! and! the! pellet!washed! in! 4%! goat! serum! and! incubated! at! room! temperature! for! 5min.! ! Cells!were!resuspended!in!4%!goat!serum!containing!secondary!antibodies!(500uL/sample;!FITC!@!1/1000;!Cy3!@!1/1000)!and!the!cells!incubated!at!room!temperature!for!30!minutes.!A!final!wash!of!the!cell!pellet!was!conducted!in!0.5%!TweenX20/4%!goat!serum!before!the! pellet! was! finally! resuspended! in! 1%! BSA! for! analysis! on! BD! FACS! Aria! (BD!Biosciences).!Wherever!possible,!at!least!20!000!events!were!collected.!
All!buffers!were!diluted!in!1X!PBS!without!calcium!or!magnesium.!





2.7 Quantitative Real-Time PCR (Q-PCR) Quantitative!realXtime!PCR!(QXPCR)!methods!were!used!to!examine!gene!expression!of!a!number!of!heparan!sulfate!proteoglycan!(HSPG)!initiation!and!modification!enzymes!as!well! as! core!proteins.! ! In! addition!we! examined! the! expression!of! a! number!of! genes!used! in! the! identification! and! characterisation! of! both! mesenchymal! stem! cells! and!neural! stem! cells! (NSCs).! In! both! cases! the! genes! examined! included! genes! used! to!define!the!pluripotency!of!the!cells!as!well!as!genes!specific!to!individual!lineages,!both!mesenchymal! and! neural.! QXPCR! experiments! were! run! on! the! Applied! Biosystems!HT7900! system! or! the! Life! Technologies! Quant7! Studio.! ! Data! generated! from! these!experiments! was! analysed! using! Excel! to! generate! ΔΔCt! values,! mean,! standard!deviations!(SD)!and!standard!error!of!the!mean!(SEM)!for!graphing!purposes.!!Further!analysis! was! conducted! using! Life! Technologies! Expression! Suite! v! 1.3.! Fold! change!ratios! (values! between! 0! and! 1)! generated! by! the! Expression! Suite! software! were!converted!to!whole!numbers!using!the!calculation:!!
fold(change(=(?(1/ratio)(A!complete!list!of!the!genes!examined!in!this!study!can!be!found!in!Chapter!8,!Appendix!1.!




BLASTed! against! the!NCBI! reference! sequence!mRNA! for! the! human! genes! to! ensure!specificity.!For!multiple!transcripts,!primers!were!designed!to!capture!as!many!variants!as! possible.! The! genes! examined! in! this! study! are! listed! in! section! 2.8.3.! Primer!sequences!used!in!this!study!can!be!found!in!Chapter!8,!Appendix!1XPrimer!Sequences,!Table!8X1!to!Table!8X4.!
2.7.2 Assay conditions We!investigated!the!gene!expression!changes!of!30!genes! involved!in!the!biosynthesis!and! modification! of! proteoglycans! as! well! as! their! core! proteins! and! associated!enzymes.!For!the!genes!of!interest,!mRNA!levels!were!quantified!at!days!1,!3!and!5!using!QXPCR.! !Briefly,! 120ng! cDNA!was! amplified!using! the!ABI7900!HT! in!384!well! plates.!200μM! primers! were! used! with! a! 2X! supermix! (BioRad/! Promega)! in! a! 10μL! final!reaction!volume.!!Standard!(50oC!x!2!minutes,!95oC!x!10!minutes,!50!cycles!at!95oC!x!1!min,!60oC!x!30!sec)!or! fast!cycling!conditions!(50oC!x!2!minutes,!95oC!x!3!minutes,!50!cycles!at!95oC!x!1s,!60oC!x!3s)!were!applied.! !Gene!expression!was!normalised!against!expression!of!18S!and!calculated!using!the!2XΔΔCT!method.!!













2.7.3 Genes examined in this study 
Table'2)4: HSPG(Initiation(and(Modification(Enzymes(
















Heparan sulfate 2-O-sulfotransferase 1 HST2ST1 
Heparan sulfate 6-O-sulfotransferase 1 HS6ST1 
Heparan sulfate 6-O-sulfotransferase 2 HS6ST2 
























Gene Name Gene Symbol 
Smooth Muscle Actin2 ACTA2 
Adipose-Q ADIPO-Q 
Hyaluronin Receptor CD44 
Colagen 1A1 COL1A1 
Colagen 2A1 COL2A1 
B1 Catennin CTNNB1 
Fibroblast Growth Factor Receptor 2 FGFR2 
Fibronectin-1 FN1 
S100 Calcium Binding Protein A4 S100A4 (FSP1) 
Neural Cadherin NCAD 
Vimentin VIM 
Vitronectin VTN 
Alkaline Phosphatase AP 
Bone Sailiprotein II BSP II 
Peroxisome proliferator-activated receptor gamma 1 PPARG1 
Peroxisome proliferator-activated receptor gamma 2 PPARG2 
Osteocalcin OCN 
CCAAT/enhancer binding protein (C/EBP), alpha C/EBPa 





Gene Name Gene Symbol 
Albumin ALB 
Enolase 2 ENO2 (NSE) 
Forkhead box A2 FOXA2 
Glial Fibrilic Acidic Protein GFAP 
Microtubule Associated Protein 2 MAP2 
Mushasi I MSI1 
Nanog homeobox NANOG 
Neural Filament Medium Chain NEFM 
Nestin NES 
Neurogenin 2 NEUROG2 (NGN2) 
POU Class 5 homeobox 1 POU5F1 (OCT3/4) 
SRY (sex determining region Y) box 1 SOX1 
B III Tubbulin TUBB3 
Doublecortin DXC 
Oligodendrocyte transcription factor 1 Olig1 
Oligodendrocyte transcription factor 2 Olig2 
Galactosylceramidase GalC 
S100 Calcium binding protein B S100B !
2.8 Neural Differentiation There!are!a!number!of!previously!described!methods! (Hermann(et(al.,! 2004,!Fu(et(al.,!2008,!Bae(et(al.,! 2011,! Fox(et(al.,! 2010)! and!others)! for! the!differentiation!of!MSCs! to!neuronal!cells.!Predominantly,!protocols! for! the!differentiation!of!hMSCs! into!neurons!and!glial!cells!in(vitro!and!in(vivo!involve!either!direct!differentiation!to!neural!cell!types!or! conversion! to! neural! stem! cell! (NSC)Xlike! spheres! prior! to! terminal! neuronal!differentiation!(Alexanian,!2010,!Hermann!et!al.,!2004).!




(Hermann!et!al.,!2004,!Fu!et!al.,!2008).!Formation!of!neurospheres!was!observed!over!subsequent!days!with!sufficient!spheres!for!differentiation!after!7X20!days!(Hermann!et!al.,! 2004,! Fu! et! al.,! 2008).! Neural! differentiation! was! initiated! on! polyXLXlysine!(Hermann! et! al.,! 2004)! or! polyXLXornithine! (Fu! et! al.,! 2008)! in! differentiation!media.!Cultures! were! supplemented! with! BDNF! for! neuronal! induction! or! PGDF! for! glial!induction.! Cultures! were! examined! for! neuronal! and! glial! markers! after! 10X14! days!(Hermann!et!al.,!2004,!Fu!et!al.,!2008).!Immunocytochemistry!and/or!QXPCR!were!used!to!confirm!the!presence!of!neural!markers!and!MSC!markers!with!comparisons!made!to!the!basal!profile.!
There! are! a! number! of! other!methods! for! the! differentiation! of!MSCs! to! neural! cells.!Most!of!these!protocols!utilise!the!addition!of!growth!factors!such!as!epidermal!growth!factor! (EGF),! vascular! endothelial! growth! factor! (VEGF),! hepatocyte! growth! factor!(HGF)!or!fibroblast!growth!factor!(FGF)!(Nagai!et!al.,!2007,!Bae!et!al.,!2011,!Choong(et(
al.,! 2007,! Tropel( et( al.,! 2006).! A! few! protocols! utilise! epigenetic! modifiers! such! as!BrcAMP! and! rolipram! to! increase! cAMP! levels! in! combination!with!RGX108! to! inhibit!DNA!methylation! and! trichostatin! A! to! inhibit! histone! deactylation! (Alexanian,! 2007,!Alexanian,!2010,!Alexanian(et(al.,!2008).!!




stained! for! several! neural!markers! including:!Nestin,! SoxX2,! A2B5,!NCAM,! GFAP,! B3T,!MAP2!and!NeuN.!Gene!expression!changes!in!the!following!genes!were!also!examined:!cMYC,! NANOG,! OCT4,! KLF4,! SOX2,! NCAM,! βXACT,! MAP2,! B3T,! NEFM,! these! genes!comprise! a! set! of! neural! makers,! markers! for! pluripotency! and! for! neural! cells!(Alexanian,!2010).!





Figure'2)14: hMSC( neural( differentiation( protocols.( Cells( were( differentiated( via( terminal(
differentiation( protocols( and( following( formation( of( intermediate( spheres.( ( Following(
formation( of( spheres,( the( cells( underwent( the( same( terminal( differentiation( protocol( to(
generate(neural(cells(for(neuronal(and(glial(lineages.(Samples(were(collected(at(the(completion(
of( differentiation( protocols( for( quantitative( real?time( PCR( (RNA( samples),( western( blot(








Identification Sox 2 Nestin MAP-2 GFAP O1 
Pluripotent Stem Cell + - - - - 
Neural Stem Cell + + - - - 
Neuronal Lineage - - + - - 
Astrocyte Linege - - - + - 
Oligodendrocyte Lineage - - - - + 














Figure'2)15: Immunocytochemistry( staining( of( neural( stem( cells( (NSCs)( with( specific( lineage(
markers( (A)( SOX2( (B)(Nestin( (C)(microtubule( associated( protein( 2( (MAP2)( (D)( glial( fibrillic(
acidic(protein((GFAP)((E)(O1.(NSCs(were(stained(for(each(of(the(markers(from(the(panel(used(to(
identify(NSCs.(Positive(staining(in(these(cells(was(used(as(a(positive(control(for(hMSC(staining.(
Secondary( antibodies( used( were( FITC( (green),( Cy3( (yellow)( and( AlexaFluor594( (red).( All(
images( taken( in( undifferentiated( NSCs( except( (D)( which( are( NSCs( differentiated( toward( an(
astrocyte(lineage.(Nuclei(are(counterstained(with(DAPI((blue).((Images(courtesy(of(Lotta(Oikari.(!





Figure'2)16: Phase( images( of( hMSC?2( at( P+12( and(Q?PCR( expression( changes( of( neural( genes(
corresponding( to(morphological( changes( towards( neuronal( like( cells( (A)( Geltrex™( +( human(
Mesenchymal( Stem( Cell( Growth( Media( (hMSCGM)( (B)( Geltrex™( +( Neural( Stem( Cell( Growth(
Media( (NSCGM;( containing( FGF2( and( EGF).( (C)( Nestin( (D)( MAP2( (E)( GFAP;( black( bars,(
hMSCGM;(grey(bars,(NSCGM.(Scale(bars(represent(70μm.((Okolicsanyi(et(al.,(2014a)(
2.8.1 Terminal Neural Differentiation hMSC!cells!were!plated!onto!100mm!culture!dishes!coated!in!GeltrexTM.!To!coat!plates,!GeltrexTM!was!diluted!in!growth!media.!!Enough!media!was!added!to!the!culture!vessel!to! coat! the! bottom! of! the! vessel! (approx.! 6mL).! ! This! was! incubated! at! room!temperature!for!1!hour!before!plates!could!be!stored!at!4oC!for!up!to!one!month.!




culture!dishes!at!approximately!3000!cells/cm2!(2.5x105/!100mm!dish)!in!NeurobasalXA!medium!containing!5%!horse! serum,!1%! foetal! calf! serum,!2mM!GlutaMax,!5uM!all!transXretinoic! acid,! 1%!B27! supplement! and! either! 10ng/mL! platelet! derived! growth!factor! (PDGF)! for! glial! differentiation! or! 10ng/mL! bone! derived! neurotrophic! factor!(BDNF)! for! neuronal! differentiation.! ! In! addition,! cells! were! plated! for! glial!differentiation!and!neuronal!differentiation!in!the!presence!of!10μg/mL!heparin.!
Growth!factors!were!added!every!2X3!days!and!media!changed!once!a!week.!After!the!initial!attachment!and!growth!period,!cells!reached!80%!confluence!by!day!4!and!were!trypsinised!and! transferred! to!35mm!culture!dishes!coated!with!GeltrexTM.!Cells!were!plated!at!~3000!cells/cm2! (3x104/!P35).! Surplus!cells!were!stored!at! X80oC.! !After!14!days!in!differentiation!media,!cells!were!harvested!for!RNA!and!protein.!In!addition!to!storing! cells! for! future! use,! some! cells!were! plated! to! 8! chamber! slides! and! the! cells!allowed!to!attach!and!grow!in!appropriate!differentiation!media!on!slides!for!a!further!7!days!before!ICC!staining.!




cell! filter! and! the! cells! reXdosed! with! growth! factors.! Media! was! supplemented! with!growth!factors!every!two!days!and!spheres!maintained!in!KO!DMEM/F12!for!7!days.!!
At! this!point,!cells!were!plated! into!35mm!culture!dishes!(P35)!(Corning)!coated!with!GeltrexTM!in!neural!or!glial!differentiation!media!as!described!above.!The!spheres!were!divided! between! at! least! four! 35mm! dishes! depending! on! the! number! of! spheres!present.! !Cells!were!allowed!to!attach!and!were!grown!in!differentiation!media! for!28!days!after!which!cells!were!harvested!for!RNA!and!protein.!If!cells!underwent!sufficient!expansion!during! the!differentiation!phase,! some!cells!were!plated! to!8!well! chamber!slides!for!ICC.!
2.8.3 Synaptic Vesicle Stain To!test! the! functionality!of!neural!cells!generated!through!this!differentiation!process,!we! examined! the! uptake! of! the! sterophilic! membrane! dye! FM! 1X43! FX! (Life!Technologies).! This! is! a! membrane! dye! that! rapidly! stains! the! plasma! membrane! of!cells.! Following! stimulation! with! Ca2+,! the! cells! should! endocytose! the! lipophilic!membrane!dye.!




Stimulated! samples! were! treated! with! 30mM! potassium! chloride! (KCl)! for! 1! min! to!stimulate!Ca2+!dependant!membrane!uptake!following!the!initial!incubation!with!1mL!of!FM!1X43!FX!solution.!Mock!stimulated!cells!were!washed!in!1X!PBS,!incubated!with!1mL!FM! 1X43! FX! solution! then! incubated! with! 1%! TritonXXX100! for! 1! min! followed! by!incubation!with!250mM!EDTA!for!2!min.!!The!cells!were!washed!in!PBS!(without!Ca2+!or!Mg2+)! to! remove! excess! EDTA! before! the! dye! was! replaced! and! the! cells! imaged.!Following! EDTA! treatment,! cell! membranes! were! destroyed! such! that! there! were!insufficient! membranes! of! live! cells! to! determine! the! effect! of! KCl! stimulation! on!membrane! vesicle! uptake.! EDTA! treatment! was! discontinued! and! instead! of! mock!stimulation,! cells!were! examined! following! treatment!with! the! dye! only,! or! following!stimulation!with!KCl.!
KCl!stimulates!membrane!vesicle!formation!with!endocytosis!of!membranes!occurring!within!10!minutes.!The!KCl!was!removed!and!the!dye!replaced!for!imaging.!!!




1/1000! dilution.! Cells! were! then! incubated! at! room! temperature! for! 5X10! minutes.!!Spheres!were!visualised!using!a!confocal!microscope!(Leica!SP5).!
2.8.5 Immunocytochemistry of hMSC spheres hMSC!spheres!were!allowed!to!form!over!four!days.! !At!day!3!media!was!changed!and!cell!spheres!collected!using!a!40μm!cell!strainer.!!Collected!spheres!were!plated!onto!4!chamber!glass!slides!(MerkXMillipore).!Spheres!were!left!overnight!before!fixation!and!as!a!result,!partially!attached!to!the!slides.!!The!media!was!then!gently!removed!and!the!spheres!fixed!in!4%!PFA!for!30!minutes.!!!




2.9 Statistical Analysis of quantitative real-time PCR data All! quantitative! realXtime! PCR! experiments! were! performed! in! quadruplicate! on!biological!triplicates.!Variation!between!dosed!and!unXdosed!control,!at!each!time!point,!was!assessed!using!a!twoXtailed!unpaired!Student’s!TXtest!assuming!unequal!variances.!Mean!gene!expression! (2XΔΔCt)!was!calculated!between!quadruplicate!samples!of! three!independent!biological!replicates!and!graphed!with!standard!error!of!the!mean!(SEM).!Statistical!analysis!was!deemed!significant!when!P<0.05.!Although!data!was!collected!at!three! time! points! throughout! characterisation! and! while! establishing! basal! gene!expression!profiles,!data!presented!in!Chapter!3!and!Chapter!4!is!from!day!3!only.!!
Comparisons! between! different!modelling!methods! are! currently! being! conducted! to!allow! a!more! comprehensive! analysis! of! data! sets! incorporating! the! large! number! of!genes! in! the! study,! the! three! hMSC! populations,! the! three! time! points! and! three!passages!at!which!data!was!recorded.!!This!modelling!and!analysis!is!taking!place!in!R!with!the!assistance!of!Dr!HernandezXSanchez.!!




Spheres!were!visualised!on!a!Leica!SP5!confocal!microscope.!!Images!were!acquired!on!all! channels! simultaneously! and! exported! through! the! proprietary! software.! Images!were!exported!to!.tif!format.!
2.11 Niche modification through the addition of heparin or chlorate 
generates gene expression changes in a human breast cancer 




glypicanX6;! Figure! 2X18)! demonstrated! increased! gene! expression! following! heparin!treatment!(1.75X3Xfold),!suggesting!the!involvement!of!these!proteins!at!some!level.!!







treatment( in( MCF?7( and( MDA?MB?231( cell( lines.( Solid( bars:( ( Control;( Open( bars:( MCF?7(
Heparin( (10μg/mL);( Grey( bars:( MDA?MB?231( Heparin( (10μg/mL)( (A)( MCF?7( N?deacetyl/N?(
sulfotransferase( 1( (NDST1)( and( NDST2( (B)( MDA?MB?231( NDST1( and( NDST2( (C)( MCF?7(
Exotosin( 1(EXT1),( EXT2( and( C5?epimerase( (D)(MDA?MB?231( EXT1,( EXT2( and( C5?epimerase(
(E)( MCF?7( Heparan( sulfate( 2?O( sulfotransferase( 1( (HS2ST1)( and( heparan( sulfate( 6?O(






Figure'2)18: Gene( expression( changes( in(HSPG( core( proteins( in(MCF?7(and(MDA?MB?231( cells(
following(heparin(treatment.(Solid(bars:(Control;(Open(bars:(MDF?7(Heparin((10μg/mL);(Grey(
bars:(MDA?MB?231(Heparin((10μg/mL).((A)(syndecan(2((SDC2)((B)(SDC4((C)(glypican(5((GPC5)(
(D)(GPC6.(Syndecan(and(glypican(core(proteins(display( sensitivity( to(heparin( treatment(with(




For! human! mesenchymal! stem! cells,! this! means! that! we! could! modulate! their!proliferation!and!potentially!differentiation!down!specific!lineages!by!modulating!the!in!vitro! environment,! providing! additional! HS! or! inhibiting! sulfation! of! side! chains! to!achieve!specific!lineage!differentiation.!
In! a! breast! cancer!model,! HSPGs! can! promote! or! inhibit! cell! proliferation,! and! hence!tumourigeneisis,! dependent! on! type,! expression! pattern,! and! accessibility! to! ligands,!(Kjellen(et(al.,!1983,!Lindahl(et(al.,!1998,!Brickman(et(al.,!1998,!Freije(et(al.,!1994).!This!promotion!or!suppression!of!tumourigenesis!due!to!cell!proliferation!may!be!dependent!on! any! aspect! or! indeed! the! combination! of! the! specific! HSPG! (core! protein,! its!ligand/growth! factor! specificity! or! the! tumour! cell! characteristics);! its! remodelling!enzymes,! heparanse,! sulfataseX1! (sulf1),! sulfataseX2! (sufl2)! (Grobe! and! Esko,! 2002,!LemjabbarXAlaoui(et(al.,!2010,!Gotte!and!Yip,!2006,!PucciXMinafra(et(al.,!2008,!Zcharia(et(
al.,! 2001);! and! has! been! correlated! with! prognosis! in! several! malignancies! (PucciXMinafra!et!al.,!2008,!Frankel(et(al.,!2008).!




2.13 Resources Resources!required!to!both!undertake!and!complete!this!work!were!available!within!the!Genomics!Research!Centre!(GRC),!Institute!of!Health!and!Biomedical!Innovation!(IHBI),!Queensland! University! of! Technology,! or! obtained! through! local! and! international!collaborators.! ! The!project! relied!heavily! on! the!use!of! in(vitro!models!with! expertise!available!through!the!GRC,!supervision!and!collaborative!arrangements.!!
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 Chapter 3: Characterisation of human mesenchymal 
stem cells and their neural potential 
This( chapter( will( be( submitted( for( publication( to( the( journal( Stem% Cells% and%
Development.(
Okolicsanyi!RK,(Griffiths(LR,(Haupt(LM.(Human(mesenchymal(stem(cells(retain(multiAlineage(differentiative(capacity(and(neural(marker(expression(after(extended(expansion(in(vitro.((To%be%submitted%to:%Stem%Cells%&%Development((
We(aimed(to(determine(if(the(morphological(changes(observed(during(extended(in%vitro(culture( of( hMSCs( affected( the( multilineage( potential( of( these( cells.( Commercially(available(hMSC(populations(were(expanded(in%vitro(for(>(20(passages,(>(60(days(and(>(50(population(doublings.(At(passages(representing(each(growth(phase(during(expansion((P+5,(P+7,(P+13),(the(cells(were(characterised(for(stemness(and(neural(lineage(markers.(hMSCs(were(examined(for(MSC(cell(surface(markers(as(well(as(neural(stem(cell(markers(by( FACS,( ICC( and( QAPCR( revealing( positive( expression( of( MSC( and( neural( markers(throughout(expansion.(Stemness(was(maintained(for(>40(days(in(culture(with(successful(adipogenic(and(osteogenic(differentiation(performed(at(each(growth(phase.(
We(determined(that(not(only(do(hMSCs(retain(their(stemness( into( late(growth(phases,(but(they(also(continue(to(express(markers(of(neural(lineages,(suggesting(they(maintain(neural(potential,(supporting(the(extensive(therapeutic(potential(for(clinical(applications(of(these(cells.(




3.1 Introduction Traditionally,( mesenchymal( stem( cells( (MSCs)( have( been( isolated( from( the( bone(marrow(but(other(sources(exist,(such(as(fat,(umbilical(cord(blood,(dental(pulp,(skeletal(muscle(and(amniotic(fluid((Bi%et%al.,(2007,Bieback(and(Kluter,(2007,(Crisan%et%al.,(2008,(Rogers(and(Casper,(2004,(Igura%et%al.,(2004,(Shi(and(Gronthos,(2003,(Xu%et%al.,(2005)(with(one( disadvantage( being( an( invasive( harvesting(method( (Kassem( and( Abdallah,( 2008,(Prockop,( 1997).( The(multipotential( of( MSCs,( relative( ease( of( isolation( and( culture( as(well(as(high(ex%vivo(expansive(potential(makes(these(cells(an(attractive(therapeutic(tool((Minguell%et%al.,(2001).((
Identification( and( classification( of( MSCs( is( a( topic( of( ongoing( debate.( The( standard(definition(according(to(the(International(Society(of(Cell(Therapy(identifies(properties(of(MSCs,( regardless( of( their( origin( and( method( of( isolation,( as:( capable( of( adhesion( to(plastic,( easy( differentiation( into( adipoA,( chondroA( and( osteocytes( and( expression( of(CD105,( CD90,( CD73(without( expression( of( CD34,( CD45,( CD11( and( HLAADR( (Maslova,(2012,( Dominici% et%al.,( 2006).( However,( variation( between( isolation( protocols( and( cell(source(has(been(shown(to( influence(differentiative(potential,(with( for(example,(higher(adipogenic(potential(from(cells(of(adult(origin(compared(to(those(of(foetal(origin((Ragni%
et%al.,(2013).(
The(most(commonly(reported(positive(markers(include(CD105,(CD90,(CD44,(as(well(as(many(others(while(the(most(commonly(reported(negative(markers(include(CD34,(CD14,(CD45( and( others( (summarised( in( (Mafi% et% al.,( 2011)).( It( is( important( to( note( that( a(number( of( these( markers,( including( CD44( and( CD45,( have( been( reported( as( both(positive(and(negative,(providing(inconsistency(in(the(cell(surface(profile(of(MSCs((Mafi(et(al.,( 2011).( Further( confusion( arises( as( a( number( of( positive(markers( are( also(widely(




expressed( on( nonAstem( cells,( making( it( very( difficult( to( distinguish( MSCs( from(neighbouring( cells( in( tissue( preparations( (Maslova,( 2012).( The( confusion( is(compounded(by(the(fact(that(these(cell(surface(characteristics(have(not(all(been(derived(from(the(same(tissue((adipose,(bone,(dental)((Mafi(et(al.,(2011)(or(by(the(same(method(along(with(the(presence(of(conflicting(evidence(surrounding(common(markers(such(as(CD44( and( CD45( (Mafi( et( al.,( 2011).( Lodi( et( al( (2002)( reported( a( lack( of( physical( or(functional( distinction( between( different( preparations( of( adult( bone( marrow( derived(stem(cells( isolated(and(propagated(by(different(methods( in(a(sideAbyAside(comparison((Lodie%et%al.,(2002).(However,( to(date,( the( literature(has(focused(more(closely(on(what(MSCs(positively(express(rather(than(what(they(may(not((Mafi(et(al.,(2011).(
In( addition( to( controversy( surrounding( the( identification( of(MSCs,( the( differentiative(potential(of( these(cells(has(been(shown(to(vary(dependant(on(the(source((reviewed(in((Hass%et%al.,(2011,(Ragni(et(al.,(2013)).(In(a(study(comparing(the(adipogenic(potential(of(MSCs( from( two( adult( sources( and( four( foetal( sources( it( was( determined( that( the(differentiation( capacity(was( greater( in( adult( cells( (Ragni( et( al.,( 2013).(This( study( also(demonstrated( differing( degrees( of( phenotypic( plasticity( depending( on( the( source( of(MSCs((Ragni(et(al.,(2013).(
In(addition(to(the(common(triAlineage(of(bone,(cartilage(and(fat,(MSCs(retain(the(ability(to(differentiate( towards( a(neural( lineage( (SanchezARamos%et%al.,( 2000,(Hermann%et%al.,(2004,( Alexanian,( 2005,( Hermann% et% al.,( 2006).( In( addition,( a( number( of( studies( have(determined( that( undifferentiated( human( MSCs( (hMSCs)( express( markers( of( neural(lineages(in(the(absence(of(differentiation(stimuli((Foudah%et%al.,(2012,(Okolicsanyi%et%al.,(2014).(These( include(markers(of(neural(progenitor(cells(as(well(as(markers(of(specific(neural( lineages.( The( presence( of( these( neural( markers( supports( the( ability( of(




mesenchymal( stem( cells( to( give( rise( to( nonAmesenchymal( tissues( (Kopen% et%al.,( 1999,(Reyes(and(Verfaillie,(1999).((
In(addition,( the(ability(of(hMSCs( to(migrate( from( the(bone(marrow( to(a( site(of( injury,(including( the( brain( (Li% et% al.,( 2001,( Li% et% al.,( 2000,( Mareschi% et% al.,( 2006),( is( of( great(therapeutic( significance.( During( tissue( growth( and( repair,( elevated( demand( for(precursors( requires( adult( organisms( to( recruit( uncommitted( progenitors( from( other(sources((Minguell(et(al.,(2001)(highlighting(the(ability(of(hMSCs(to(leave(their(niche(and(migrate( to(sites(of( injury((Siena%et%al.,(1989,(Shields(and(Andrews,(1998,(Fernandez%et%
al.,( 1997,( Erices% et% al.,( 2000,( Reading% et% al.,( 2000).( Importantly,( to( express( a(differentiation( program,( these( migrating( stem( cells( must( locate( an( appropriate(microenvironment( (Tavassoli(and(Minguell,(1991,(Watt(and(Hogan,(2000)( in(which( to(expand.((
This( study( utilised( commercially( available( human( bone( marrow( derived( hMSCs.( We(expanded( these( cells( in% vitro( and( characterised( them( using( a( standard( commercially(available(MSC(identification(panel(to(identify(cell(surface(markers(as(well(as(markers(of(neural(stem(cells.( In(addition,(we(examined( the(cells(by( immunocytochemistry(and(QAPCR(at(different(phases(of(growth( to(determine( the(expression(profile(of(MSCAspecific(and( neuralAspecific( markers.( We( examined( whether( the( morphological( changes(observed( during( expansion( along( with( the( expression,( or( lack( there( of,( of( specific(markers(affected( the(cells’( lineage(potential.(Finally,(we(confirmed( the(ability(of( these(cells(to(differentiate(towards(adipogenic(and(osteogenic(lineages(throughout(expansion(and( with( observed( expression( of( markers( suggesting( neural( potential.( These( cells(therefore(have(enormous(therapeutic(potential(with(the(expression(by(adult(hMSCs(of(nonAimmunogenic( surface( antigens( (MHC( class( I( not( MHC( class( II)( (Le( Blanc( and(




Ringden,( 2005)( allowing( for( the( possibility( of( hMSC( transplantation( into( an( allogenic(host(without( the(need( for( immunosuppression((Schipani(and(Kronenberg,(2008),( thus(making(commercially(isolated(and(characterised(cells(viable(therapeutic(contenders(due(to(consistent,(reproducible(isolation(protocols.(In(addition,(the(use(of(these(commercial(cells(may(allow(us(to(refine(our(definition(of(hMSCs(by(removing(variability(introduced(by(fresh(hMSC(isolation.(To(date,(the(majority(of(studies(examining(the(neural(potential(of(hMSCs(through(expression(of(neural(markers(have(been(conducted(at(early(passages(after( brief( expansion( periods( in% vitro( (P+2AP+4),( with( only( a( few( studies( examining(neural(potential(after(extended(expansion( in(culture( (murine:(up( to(P+40)( (Foudah(et(al.,( 2012,( Foudah% et% al.,( 2013).( This( is( the( first( study( to( characterise( commercially(available(hMSCs(throughout(expansion(with(a(focus(on(neural(potential.(We(know(that(hMSCs(express(neural(markers,( but( is( that( expression( constant( throughout( expansion(and( does( this( affect( their(MSC( stemness?( Or,( do(we( see( variation( in( neural( and(MSC(marker(expression(suggesting(altered(ability(to(differentiate(and(hence(optimal(in%vitro(intervals(for(specific(lineage(differentiation?((
3.2 hMSCs Expansion We(successfully(expanded(five(commercially(available(hMSC(populations(through(over(20( passages( and( 60( population( doublings( in( maintenance(media( (Figure( 3A1).( These(cells(underwent(morphological(changes(over(time(but(all(populations(followed(a(similar(expansion(pattern(of(growth(with(similar(changes(observed(between(populations.(
In(general(the(expanded(populations(maintained(the(capacity(to(actively(divide(until(50A60(days( in( culture( at(which(point( active( division( slowed(or( stopped.(Briefly,( the( cells(underwent( a( multiphasic( pattern( of( growth( (Figure( 3A1A).( Under( maintenance(conditions(during(Phase(A((Figure(3A1(B(–(P+5)(the(cells(were(small,(very(homogeneous,(




with( a( fibroblastic( appearance( and( rapid( proliferation( (3A4( days( between( passages).(During(Phase(B((Figure(3A1(C(–(P+7),(the(cells(increased(in(size(and(their(proliferation(rate(slowed((4A6(days(between(passages).(By(Phase(C((Figure(3A1(D(–(P+13),( the(cells(were( large,( slowly(proliferating( (7A14(days(between(passages),(while( still(maintaining(their( fibroblastic( appearance.( During( this( stage( the( population( became( more(heterogeneous,( with( one( population( undergoing( a( morphological( change( with( the(appearance( of( colonies( of( smaller( more( rapidly( proliferating( cells( with( a( more(epithelialAlike(appearance((Figure(3A1(A(–(P+16,(P+19).(Toward(the(end(of(Phase(C(and(entering(Phase(D((not(shown)(the(proliferation(rate(of(the(population(increased(which(resulted( in( the( smaller( epithelialAlike( cells( outnumbering( the( larger(more( fibroblastic(looking(cells(with(distinct(cobbleAstoneAlike(cell(bodies(forming(small(colonies(amongst(the(larger(fibroblastic(cells.((Figure(3A1(A(–(P+19).((
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Figure'3)1: Growth% curve% of% three% hMSC% populations% selected% for% ongoing% experimentation%
based% on% the% similarities% between% their%morphologies% and% expansion% profiles.% (A)% Expansion%
continued% for% all% populations% for% over% fifteen% passages% equating% to% more% than% 60% days% in%








All( cell( populations( expanded( underwent( similar( numbers( of( population( doublings(between(passages(allowing(us(to(select(appropriate(passages(to(represent(each(phase(of(growth.( (While( there(was( small( variation( in( the( total( number( of( days( in( culture( and(population( doublings,( overall( the( differences( between( populations( were( minor.(Throughout( expansion( each( hMSC( population( showed( very( similar( morphological(characteristics.((
To( examine( whether( these( cells( maintained( stemness( and( neural( potential( through(Phase(AAC(of(growth,(expression(of(MSC(and(neural(markers(was(confirmed(in(the(three(populations( selected( for( ongoing( experimentation( following( expansion.( ( These(populations(were( selected( based( on( the( similarities( between( their( expansion( profiles(and(morphologies,( exhibiting( consistent( numbers( of( days( between( passages( between(populations(at(each(growth(phase.( (These(were:(hMSCA19604((Figure(3A1(Red),(hMSCA20176((Figure(3A1(green)(and(hMSCA21558((Figure(3A1(Blue).(Demographic(information(on( these( populations( can( be( found( in( Chapter( 2,( Section( 2.1.6.( For( remaining(characterisation(experiments(passage(5((P+5)(was(chosen(to(represent(Phase(A,(passage(7((P+7)(for(Phase(B(and(passage(13((P+13)(for(Phase(C.(
hMSC(populations(underwent(approximately(10(population(doublings((PD)(by(P+5.(By(P+7,( this(had( increased( to( approximately(20(PD.( ( In( the(next( six(passages,( these( cells(proliferated(at(a(slower(rate(with(populations(undergoing(a(further(10(PD(between(P+7(and(P+13(taking(total(PD(to(approximately(30(by(P+13.((This(rate(slowed(even(further(at(this(point(with(cells(only(undergoing(another(5(PD(by(P+15(taking(total(PD(at(P+15(to(approximately(35.((At(this(point(the(proliferation(rate(slowed(considerably(and(at(least(two(of(the(populations(ceased(proliferating,(with(no(further(increase(in(cell(number(or(population(doublings(observed(for(more(than(three(weeks.((It(was(anticipated(that(this(




was( a( stage( of( senescence( or( agonescence( (Romanov% et% al.,( 2001)( and( that( the( cells(would( undergo( a(morphological( change( resulting( in( an( increase( in( proliferation( rate(again,( however( this( only( occurred( for( one( population( examined.( At( all( stages,( all(populations(maintained(viability(greater(than(70%.(
3.3 MSCs retain their stemness throughout expansion To(examine(the(presence(of(MSC(cell(surface(markers(a(commercial(panel(of(antibodies(was( employed( for( detection( by( immunocytochemistry( (ICC)( and( fluorescent( assisted(cell( sorting( (FACS).( This( panel( consisted( of( antibodies( against( human( CD29( (alpha(integrin,(beta(1),(CD44,(CD90((ThyA1),(CD105(and(CD45.(
Examination( of( hMSC( cells( by( ICC( revealed( specific( staining( for( each( of( the( positive(markers(of(MSC(stemness((CD29,(CD44,(CD90,(CD105)(while(expression(of(the(negative(marker((CD45)(was(undetectable(in(early(passages(but(increased(to(detectable(levels(in(late(passage(cells((Figure(3A2).(
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In% addition,% expression% of% CD105% decreases% in% later% passages,% while% expression% of% CD29%was%
more%apparent%when%the%cells%were%at%higher%confluence%during%imaging.%(
A( subAselection( of( the( MSC( marker( panel( (two( positive( markers( and( one( negative(marker)(was(used(to(examine(cells(by(FACS(at(each(passage(chosen(to(represent(each(growth( phase.( This( analysis( determined( the( populations( were( greater( than( 95%(positive( for( MSC( positive( markers( (CD44,( CD29)( while( also( being( positive( for( the(negative(marker,(CD45((>90%)((Figure(3A3).(Percentages(of(the(population(can(be(found(in(Table(3A1.(While(among( the(most(commonly(cited(negative(markers(of(MSCs,(CD45(lowly( positive( cultures( have( been( reported( (Yu% et% al.,( 2010).( ( We( also( see( diversity(between( the( populations( in( percentage( of( the( population( positive( for( the( neural(markers(Nestin(and(Sox2.(















Figure'3)3: Fluorescent% assisted% cell% sorting% histograms% of% MSC% and% NSC% markers%
demonstrating%expression%of%MSC%and%neural%markers%on%normal%hMSC%populations.%Cells%are%
positive% for% the% three% MSC% markers% examined% (CD29,% CD44,% CD45)% and% for% the% two% neural%








Marker! Population! P+5! P+7! P+13!
CD44! hMSCA2( 99%( 99%( 95%(
! hMSCA3( 99%( 98%( 75%(
! Average( 99%! 98.5%! 85%!
CD29! hMSCA2( 98%( 98%( 96%(
! hMSCA3( 99%( 98%( 69%(
! Average( 98.5%! 98%! 83%!
CD45! hMSCA2( 91%( 93%( 88%(
! hMSCA3( 98%( 97%( 64%(
! Average( 95%! 95%! 76%!While(some(cells(examined(in(this(study(by(ICC(showed(strong(staining((short(exposure(times)(for(the(haematopoietic(marker,(CD45,(the(majority(of(hMSCs(seemed(to(express(this(marker(at(a(low(level((long(exposure(times:(900ms).(In(comparison(to(the(positive(hMSC(markers(examined(by(ICC,(expression(of(CD45(was(reduced((longer(exposure(than(CD44:( 100ms,( CD90:( 500ms( and( CD105:( 500ms).( Exposure( for( each( marker/label(combination( was( manually( fixed( to( allow( comparison( between( populations.( Longer(exposure( times( indicate( lower( levels( of( expression.( In( addition,( the( fluorescence(recorded(when(the(cells(were(examined(by(FACS(was(greatly(reduced(when(compared(to(CD44(and(CD29,( the(positive(hMSC(markers( examined,( demonstrating( that(while( a(high(percentage(of(the(population(expressed(this(marker,(expression(levels(were(low.(




3.4 MSCs Express Neural Markers throughout expansion FACS( analysis( of( hMSC( populations( revealed( positive( expression( of( neural( markers(Nestin( and( Sox2( throughout( expansion( (Figure( 3A3).( The( average( percentage( of( the(population( positive( for(Nestin,( as( determined( by( FACS( analysis( increased( throughout(expansion,( however,( there(was( significant( variation,( particularly( at( P+7,( between( the(two(populations(examined((Nestin(P+7:(hMSCA2(=80%,(hMSCA3(=(2%).(Similarly,(FACS(analysis( of( Sox2( expression( revealed( a( reduction( in( the( percentage( of( the( population(positive(at(P+7((on(average;(n=2)(with(increased(expression(at(P+13.(Once(again,(there(were(obvious(differences(between(the(two(populations(at(P+7((Sox2(P+7:(hMSCA2=(2%,(hMSCA3=95%;(Table(3A2).(
Table'3)2: Individual%population%percentages%of%each%hMSC%population%positive%for%the%neural%
markers% examined% by% FACS.% Distinct% differences% between% the% populations% can% be% seen% in%
percentages% of% populations% positive% for% markers% of% neural% stemness,% Nestin% and% Sox2%
highlighting%the%variability%between%populations%derived%from%different%donors.%
Marker! Population! P+5! P+7! P+13!
! Average( 95%! 95%! 76%!
Nestin! hMSCA2( 42%( 80%( 61%(
! hMSCA3( 14%( 3%( 34%(
! Average( 28%! 42%! 48%!
Sox2! hMSCA2( 60%( 2%( 91%(
! hMSCA3( 98%( 95%( 88%(
! Average( 79%! 48%! 90%!(
Examination(by(ICC(for(the(presence(of(neural(markers(occurred(after(confirmation(of(MSC(stemness(by(detection(of(MSC(markers.(The(neural(markers(selected(are(commonly(used(to( identify(neural(stem(cells( (NSCs)(and(neural( lineages.( (This(panel(consisted(of(Nestin,( Sox2( (selfArenewal),(microtubule( associated( protein( 2( (MAP2;( neuronal),( glial(fibrillic( acidic( protein( (GFAP;( astrocyte)( and( O1( (oligodendrocyte).( In( our( hands,( the(




three(hMSC(populations(examined(expressed(these(markers(at(each(passage((Figure(3A4).(Estimates(were(made(of( the(percentage(of( the(population(positive(for(each(marker(while( examining( single( fields( of( view( in( the( chamber( of( interest( and( comparing( the(number(of(cells(stained(positive(for(each(marker(to(the(number(of(nuclei(observed(in(the(same(field.(Population(estimates(were(made(after(examining(at(least(three(fields(of(view(and( percentages( extrapolated( to( represent( the( entire( population.( There( was( some(variation( in( expression( level( between( the( populations,( with( some( populations( more(positive( for( one(marker( than( another(population,( for( instance,(MAP2(was(detected( in(approximately( 10%( of( hMSCA3( with( stronger( staining( (shorter( exposure( time)(compared( to( hMSCA2.( Overall( hMSC( populations( expressed( all( five( selected( neural(markers(at(each(of(the(growth(phases(examined.((
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cells% progressed% into% late% passages.% Expression% of% the%mature% astrocyte%marker% glial% fibrillic%
acidic% protein% (GFAP)% and% the% oligodendrocyte% maker% (O1)% remained% constant% throughout%
expansion%with%detection%observed% in%over%80%%of% each%hMSC%population.%Antibody%dilutions%
can%be%found%in%Chapter%8,%Appendix%2,%Table%8W6%and%Table%8W9.%Secondary%antibodies%used%are%
Cy3% (yellow),% FITC% (green)% and%AlexaFluor594% (red).% %Nuclei%were% counterstained%with%DAPI%
(blue).%(
Levels(of(Sox2(expression(can(clearly(be(seen(to(decrease(at(P+7(and(then(increase(again(in( P+13( (Figure( 3A4).( It( is( also( interesting( to( note( the( change( in( localisation( of( Sox2(through(the(different(growth(phases(with(a(more(nuclear(expression(at(P+7(compared(to(the(more(cytoplasmic(expression(at(both(P+5(and(P+13.(In(contrast,(most(of(the(other(makers( remained( at( similar( levels( of( expression( with( similar( percentages( of( cells(expressing(the(markers(at(each(passage.(Nestin(expression(remained(low(with(less(than(50%(of(the(population(strongly(expressing(this(marker.(The(marker(for(mature(neurons,(MAP2(is(lowly(expressed(with(less(than(2A10%(of(the(populations(expressing(MAP2(as(detected(by( ICC.(Both( the( astrocyte(marker(GFAP,( and( the(oligodendrocyte(maker(O1(were(expressed(at(even(levels(throughout(growth.((For(the(three(populations(examined(by( ICC( greater( than( 80%( of( population( was( positive( for( the( astrocyte( and(oligodendrocyte(markers.(
3.5 hMSC Basal Expression Profile Including MSC and Neural 
Lineage Markers We( examined( the( gene( expression( of( a( number( of( markers( commonly( expressed( in(hMSC(populations.( ( As(with( ICC( analysis,( the( genes( included( those( specific( to( various(




mesenchymal( lineages(as(well( as(markers(used( to(define(mesenchymal( stem(cells.( ( In(addition(we(examined(the(expression(of(a(number(of(neural(specific(genes,(including(a(number(of( lineage(specific(markers(as(well(as(those(used(to(define(stemness(in(neural(stem(cells.(Expression(levels(of(MSC(and(neural(lineage(markers(were(examined(in(three(populations(at(each(passage/phase(of(growth.(In(the(three(populations(examined(there(was( noticeable( variability( in( the( expression( levels( of( the( genes( investigated( between(populations.( Data( presented( here( is( an( average( of( the( data( collected( from( the( three(individual(hMSC(populations.(((
QAPCR(analysis(revealed(that(the(three(hMSC(populations,(hMSCA1,(hMSCA2(and(hMSCA3(continue( to( express( MSC( lineage( specific( genes( at( each( phase( of( growth.( ( Relative(expression(of(bone(specific(markers(alkaline(phosphotase((AP;(A3.3(fold)((Figure(3A5(C)(and( osteocalcin( (OCN;( A1.3( fold)( and( the( adipogenic( transcription( factor( peroxisome(proliferatorAactivated( receptor( gamma( 1( (PPARγ1;( A3.3( fold)( decreased( throughout(expansion,(with(expression(at(P+13(as(much(as(one(third(of(expression(at(P+5((Figure(3A5(D).(In(contrast,(relative(expression(of(bone(sialoprotein(II((BSPII;(6(fold;(Figure(3A5(D)(and( PPARγ2( (3( fold)( increased( throughout( expansion(with( expression( by( P+13(more(than(three(times(expression(detected(at(P+5.(Of(the(remaining(adipogenic(transcription(factors(examined,(relative(expression(of(C/EBPα((Figure(3A5(D)(showed(little(variation,(while( relative( expression( of( C/EBPδ( peaked( at( P+7( at( levels( almost( double( those(recorded(at(P+5((2(fold;(Figure(3A5(C).(Relative(expression(levels(of(PPARγ(1(&(2(were(very( low(with(maximum(relative(expression(of( these(genes(more(than(10(times( lower(than(the(maximum(relative(expression(of(C/EBPδ(observed,(with(AP( levels(double(the(observed( expression( of( both( OCN( and( BSPII.( In( addition( to( common( markers( of(mesenchymal(lineages,(we(also(examined(the(relative(expression(of(a(number(of(other(





(ACTA2,(FN1(and(COL1A1((Figure(3A5(A(&(B)(are(all(expressed(at(higher(levels(in(hMSCs((greater(than(100X)(than(the(adipogenic(transcription(factors((C/EBP(and(PPARγ)(and(osteocyte(specific(markers,(AP,(BSPII(and(OCN((Figure(3A5(C(&(D).(Expression(of(CD44,(generally(accepted(as(a(marker(of(stemness( in(MSCs,(was(at(a(similar( level(to(those(of(FSP1( and( C/EBPδ(while( at( a(much( lower( level( when( compared( to( COL1A1,( FN1( and(ACTA2((Figure(3A5).(Relative(expression(was(normalised(to(the(expression(of%18S(RNA(in(these(cells.(







of%markers% of% hMSC% stemness% and%mesenchymal% lineages% display% similar% expression%patterns%
over%time,%with%the%majority%showing%a%peak%in%expression%at%P+7.%Alkaline%Phosphotoase%(AP;%W
3.3% fold),% osteocalcin% (OCN;% W1.3% fold),% Peroxisome% proliferatorWactivated% receptor% gamma% 1%
(PPARγ1;%W3.3%fold),%all%decreased%expression%throughout%expansion,%while%bone%sialoprotein%II%
(BSPII)%increased%expression%from%P+5%to%P+13%(6%fold).%C/EBPα%expression%increased%(2%fold)%
between% P+7% and% P+13.% Data% presented% is% the%mean% of% data% collected% from% three% biological%
replicates% and% four% technical% replicates% for% each% of% the% three% hMSC% populations% examined.%
Error%bars%represent%standard%error%of%the%mean.%(




Reduced( relative( expression( between( P+5( and( P+7( was( observed( for( the( neural(progenitor(markers(Nanog((A2(fold)(and(Oct3/4((A5(fold)(and(a(subsequent(increase(in(expression(by(P+13(towards(P+5(levels((Nanog:(A1.25(fold;(Oct3/4:(A1.3(fold;(Figure(3A6(A).( ( Interestingly,( the(astrocyte(maker(GFAP(and(the(oligodendrocyte(maker(GalC(also(followed( similar( expression( patterns,( with( relative( expression( of( GFAP( almost( four(times( higher( at( P+13( than( at( P+5( (Figure( 3A6( B&C).( The( other( astrocyte( marker(examined,(S100B,(showed(little(variation(throughout(expansion((Figure(3A6(C).((
Neural(progenitor(markers(Nestin(and(Sox1(showed(very(different(relative(expression(patterns.(In(contrast(to(the(other(neural(genes(presented(here,(Nestin(showed(a(peak(in(relative(expression(at(P+7((3(fold(higher(than(P+5;(Figure(3A8A).(In(comparison,(relative(Sox1(expression(increased(throughout(expansion((3(fold(P+5(to(P+7(and(3(fold(P+7(to(P+13)(demonstrating(a(similar(expression(pattern(to(two(oligodendrocyte(makers,(Olig1((3( fold( P+5( to( P+13)( and( Olig2( (10( fold( P+5( to( P+13;( Figure( 3A8( D).( Both( neuronal(markers(MAP2(and(enolase(2((ENO2)(showed(reduced(expression((A4(fold)(throughout(expansion(with(expression(at(P+13(less(than(one(quarter(of(P+5(expression((Figure(3A8(A(&(B).((
Variability( between(populations(was( greatest( in(neural(marker( expression(with( Sox1,(Olig1(and(Olig2(detected(in(only(two(of(the(three(populations(examined.(There(was(no(expression(of(doublecortin( (DCX)(or(mushashiAI( (MSI1)(detected.(Of( the(MSC(markers(examined,( only( collagen( 2( alpha( 1( (COL2A1)( was( not( detected.( This( is( a( marker( of(chondrocytes(not(expressed(until(cells(have(differentiated(to(mature(chondrocytes.(
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Figure'3)6: Neural% marker% gene% expression% in% undifferentiated% hMSCs.% Progenitor% markers%
Nanog% and% Oct3/4% display% similar% patterns% of% expression% with% reduced% expression% initially%
between%P+5%and%P+7%followed%by%subsequent%increased%expression%at%P+13.%In%contrast,%Nestin%
displayed% a% peak% in% expression% at% P+7.% In% addition,% hMSCs% were% positive% for% neural% lineage%
specific%makers%such%as%microtubule%associated%protein%2%(MAP2),%glial% fibrillic%acidic%protein%
(GFAP),%S100B%and%Glactocidease%C%(GalC).%(
3.6 hMSCs retain their ability to differentiate in Osteoblasts and 
Adipocytes throughout expansion Having( established( a( gene( expression( and( cell( surface( profile( for( hMSCs( we( then(induced( differentiation( toward( ostogenic( and( adipogenic( lineages( at( each( passage( /(growth( phase( examined.( It( is( possible( that( the( elevated( level( of( some(neural(makers,(particularly( at( late( passages,( or( the( presence( of( CD45,( a( negative( marker( of( hMSCs,(could( inhibit( or( ablate( the( ability( of( these( cells( to( differentiate( down( osteogenic( or(adipogenic(pathways.(




Successful(differentiation(of(hMSCs(expressing(neural(markers(and(CD45(was(achieved(at( each( passage.( In( all( three( hMSC( populations( (hMSCA1,( hMSCA2( and( hMSCA3),(differentiated(cells(stained(positive(for(the(adipogenic(stain,(Oil(Red(O((Figure(3A7),(and(the(osteogenic(stains,(Von(Kossa(and(Alizarian(Red((Figure(3A8),(indicating(the(presence(of( adipose( vacuoles( and( mineralisation( via( deposition( of( calcium.( ( As( expected,( we(observed( a( gradual( change( in( cellular(morphology( during( the( differentiation( process(corresponding( to( the( increase( in( adipose( vacuoles( and( calcium( deposition( observed((Figure(3A7,( Figure(3A8).(The(ability(of( these(hMSC(populations( to(differentiate(varied(between(passages,(with( fewer(adipose(vacuoles(visible(at(P+13(and(fainter(adipogenic((Oil(Red(O)(and(osteogenic( (von(Kossa)(staining(at( this(passage.(Positive(staining(was(determined(by(distinct( red( staining( for(Oil(Red(O( and(Alizarian(Red(and(brownAblack(staining( for(von(Kossa.(At( the( conclusion(of( induction(all(hMSC(populations(displayed(positive( staining( supporting( multiAlineage( potential( throughout( expansion( at( the(passages(examined.(
Taken(together(with(the(positive(expression(of(hMSC(markers(by(ICC,(FACS(and(QAPCR(this( indicates(the(continuing(multipotential(ability(of(these(cells(throughout(expansion(and( into( late( growth( phases,( despite( the( expression( of( neural( specific( markers( and(CD45.(







Red% O% confirmed% the% production% of% lipid% vacuoles% with% in% the% cells% with% red% staining%
demonstrating% lipid% deposits.% Lipid% vacuoles% were% less% pronounced% at% P+13% and% Oil% Red% O%
staining%was%not%as%strong%as%staining%observed%at%earlier%passages.%







by% mature% osteocytes% following% differentiation.% Proliferation% of% P+13% cells% was% reduced%
compared%to%cells%differentiated%at%earlier%passages%(P+5,%P+7)%resulting%in%fewer%differentiated%
cells%however,%these%cells%still%produced%calcium%deposits.%%




3.7 Discussion Our( study( revealed( that( undifferentiated( hMSCs( continue( to( express( neural( lineage(markers(after(extended(periods(in%vitro.(In(addition,(despite(the(expression(of(a(negative(hMSC(marker((CD45),(these(cells(retained(the(ability(to(differentiate(toward(traditional(lineages(into(late(growth(phases((P+13).((It(is(clear(from(this(study(that(hMSCs(express(varying( levels( of( both( mesenchymal( and( neural( markers( throughout( expansion( and(prior( to( differentiation.( It( is( equally( clear( that( this( does( not( completely( inhibit( their(ability(to(differentiate,(at(least(toward(adipogenic(and(osteogenic(lineages.(
This( study( has( also( demonstrated( that( commercially( isolated( hMSCs( have( shorter(doubling(times((4A7(days(between(passages)(than(reported(for(freshly(isolated(cultures((2(weeks(between(passages;((Foudah(et(al.,(2012)).( It( is(possible(that(these(cells(are(a(more( homogeneous( representative( population,( removing( the( confusion( that(heterogeneous(freshly(isolated(populations(bring(to(the(definition(and(characterisation(of(hMSCs.((
The(low(expression(of(CD45(detected(in(hMSC(populations(used(in(this(study(correlates(to( the( CD45low( expression( reported( previously( in(MSCs( by( Yu(where( both( CD44( and(CD45(were( reported( at( low( levels,( termed(CD45low( (Yu( et( al.,( 2010)( and( evidence( for(CD45+( direct( selection( of( mesenchymal( stem( cells( (Deschaseaux% et% al.,( 2003).( In( our(study(we( determined( that( the( increased( expression( of( CD45( at( late( passages( did( not(diminish( their(ability( to(differentiate( toward(osteogenic(and(adipogenic( lineages.(This(was(demonstrated(by( successful( differentiation( supported(by(positive( adipogenic( and(osteogenic(staining(and(positive(gene(expression(for(markers(of(each(lineage.(
Accurate( characterisation( of( adult( hMSCs( is( complicated( by( the( discrepancy( and(inconsistency( concerning( markers( used( to( define( the( cell( surface( profile( (Mafi( et( al.,(




2011).(The(commercial(identification(panel(used(in(this(is(study(comprised(of(five(of(the(most(common(markers(used(in(the(identification(and(characterisation(of(hMSCs(–(CD44,(CD29,( CD105,( CD90( (positive)( and( CD45( (negative).( In( addition,( markers( previously(reported( primarily( for( the( identification( of( other( types( of( stem( cells( have( also( been(detected( and( reported( in( MSC( populations,( for( example,( Nanog( and( Sox2,( which( are(generally(accepted(as(neural(progenitor(markers((Mafi(et(al.,(2011).(A(number(of(studies(examining( the( neural( potential( of( MSCs( have( determined( that( these( cells( express( a(number(of(neural(markers(in(their(undifferentiated(and(unstimulated(state((Foudah(et(al.,( 2012,( Okolicsanyi( et( al.,( 2014).( However,( most( studies,( with( the( exception( of(Okolicsanyi,( 2014( reporting(expression(of(MSC(and(neural(markers(have(used( freshly(isolated( MSCs( from( bone( marrow( aspirates( (Foudah( et( al.,( 2012)( or( other( sources,(including(adipose(tissue(and(dental(pulp((Foudah%et%al.,(2014).((
Murine(models(have(provided(evidence(of( fluctuations( in(neural(marker(expression( in(undifferentiated( rat( cells( (Foudah( et( al.,( 2012)( that( mimics( patterns( of( expression(observed( in( this( study( including( the( increased( expression( of(Nestin( observed( here( at(P+7( and( the( decline( of( GFAP( throughout( expansion.( In( our( cell( populations,( this(suggests(that(the(ability(to(differentiate(toward(the(neural(lineage(may(be(higher(at(P+7(than(at(later(passages.((
The(lack(of(uniformity(in(an(MSC(population(with(some(cells(expressing(neural(markers(while(others(do(not,(suggests(the(presence(of(subpopulation(of(cells(with(more(or(less(neural(differentiation(capacity.((To(maximise(the(therapeutic(potential(of(these(cells,(we(need(to(be(able(to(modify(an(MSC(population(to(maximise(their(differentiation(capacity.(
In(addition,(the(expression(of(neural(markers(is(not(limited(to(an(undifferentiated(state.(Indeed,( expression( of( neuronal( markers( has( been( detected( on( MSCs( following(





et%al.,(2009).(CD44,(one(of(the(most(commonly(reported(positive(cell(surface(markers(for(MSCs,(has(also(been(reported( to(be(a(marker(of( immature(astrocytes( (Cai%et%al.,(2012,(D'Alessandro(and(Wang,(1994,(Liu%et%al.,(2004).(The(tissueAspecific(splicing(of(multiple(CD44( isoforms( through( alternative( splicing( of( the( extracellular( domain( (Jones% et% al.,(2000,(Lesley%et%al.,(1993)(may(provide(some(explanation(to(the(varied(roles(described(for(CD44(as(a(cellAtype(specific(marker.((
What(is(becoming(increasingly(clear(is(that(it(is(not(only(the(cell(surface(profile(of(MSCs(that(is(important(for(their(definition(and(characterisation,(but(also(the(context((cellular(niche)(in(which(they(are(found(and(from(which(they(have(been(taken.(In(order(for(us(to(realise(the(therapeutic(potential(of(these(cells(we(need(to(be(able(distinguish(between(origins(of(MSCs(–(bone(marrowA,(adiposeA,(dental(pulpAderived(–(to(allow(us(to(establish(whether(one(source( is(better( than(another( for(particular(applications.(To(achieve(this,(perhaps(in(the(short(term,(the(use(of(commercially(isolated(hMSCs(may(provide(reduced(variability(in(the(isolation(process(and(provide(more(homogenous(stem(cell(populations(allowing(detailed,(consistent(characterisation(of(these(valuable(cells.(
This( study( and( others( like( it,( highlight( the( need( for( standardised( isolation,(characterisation( and( definition( of( mesenchymal( stem( cells.( Until( we( can( adequately(define(these(cells,(guaranteeing(the(same(cells(are(being(used,(we(will(continue(to(see(





3.8 Summary We( expanded( five( commercially( available( hMSCs( for( extended( in% vitro% intervals( with(cells( surviving( for( more( than( 20( passages,( 70( population( doublings( and( 90( days( in(culture.((We(then(further(characterised(three(hMSC(populations(for(their(expression(of(MSC(markers( and(markers( of( neural( lineages.( ( During( extended( in%vitro( expansion( of(hMSCs,( cells(maintained( their( stemness( throughout(expansion(and(a(proven(ability( to(differentiate( toward( classical( mesenchymal( lineages,( adipocytes( and( osteocytes.( ( In(addition(we(characterised(the(neural(potential(of(these(cells(through(the(expression(of(a(number( of( markers( of( neural( stem( cells( as( well( as( specific( neural( lineages.((Undifferentiated(hMSCs(express(markers(specifically(used(to(characterise(NSC(stemness(and( selfArenewal( as( well( as( markers( specific( to( each( of( the( three( neural( lineages,(neurons,( astrocytes( and( oligodendrocytes.( (We( achieved( this( through( ICC( staining( of(cells( in( combination( with( the( examination( of( their( gene( expression( profile.( ( For(therapeutic(applications,( the(knowledge( that(undifferentiated(hMSCs(can(be(expanded(in(culture(for(more(than(70(population(doublings(and(90(days(in(culture(may(allow(the(generation(of(sufficient(numbers(of(cells,(for(transplantation.(In(addition,(the(knowledge(that(these(hMSCs(express(and(maintain(expression(of(neural(markers(throughout(this(in%
vitro(expansion(may(allow(the(generation(of(populations(with(increased(neural(potential(for(clinical(applications.(






















Chapter 4: Heparan Sulfate Proteoglycans, 
mesenchymal stem cells and neural specification 
4.1 Introduction Heparan! sulfate! proteoglycans! (HSPGs)! are! important! contributors! to! a! number! of!cellular!processes.!To!determine!the!influence!these!proteins!have!on!proliferation!and!differentiation!of!human!mesenchymal!stem!cells!(hMSCs)!we!first!established!a!basal!expression!profile!for!the!HSPGs!in!hMSCs.! !We!determined!expression!of!a!number!of!genes!related!to!HSPGs!including!the!HS!chain!initiation!and!modification!enzymes!and!HSPG!core!protein!families,!syndecans!and!glypicans.!To!determine!alterations!to!HSPG!gene! expression! during! hMSC! proliferation,! hMSC! populations! were! treated! with!heparin,!an!analogue!of!heparan!sulfate.!!Alterations!to!gene!expression!resulting!from!inhibition! of! sulfation! of! HS! side! chains! were! induced! by! treatment! of! cultures! with!sodium! chlorate! (chlorate)! and! cells! examined! by! QOPCR! and! immunocytochemistry.!Initial!dose!response!experiments!to!determine!optimal!concentrations!of!both!heparin!and!chlorate!with!which!to!treat!the!cells!were!conducted!(Chapter!2,!section!2.1.4!and!2.1.7).!Following!establishment!of!a!basal!HPSG!profile!we!correlated!this!data!with!the!expression! of! a! number! of!MSC! and! neural! lineage!markers! and! their! response! to! in#
vitro!niche!modification.!




incorporating! an! amino! sugar! and! an! uronic! acid! (Hacker! et! al.,! 2005).! ! Due! to! their!ubiquitous! nature,! PGs! are! able! to! structurally! and! functionally! influence! cell!proliferation,! differentiation! and! gene! expression! (Lamoureux# et# al.,! 2007).! PGs! have!been!identified!as!important!extracellular!modulators!of!protein!gradient!formation!and!signal! transduction! (Hacker! et! al.,! 2005)! and! include! the! heparan! sulphate! (HS)!proteoglycans!(membrane!bound!glypicans,!syndecans)!and!chondroitin!sulphate!(CS)!proteoglycans! (matrix! localised)! (Hacker! et! al.,! 2005,!Yu!et! al.,! 1995).!HS! chains!have!been!demonstrated!to!interact!with!a!large!number!of!ligands!including!growth!factors!and! morphogens! (FGF,! Wnts,! BMPs),! their! receptors! (FGFRs),! and! ECM! structural!molecules! (collagen,! fibronectin)! (Hacker!et!al.,!2005,!Habuchi#et#al.,! 2004).!The!exact!mechanism! of! these! interactions! has! gradually! become! clearer,! and! includes! the!regulation!of!activity,!as!well!as!the!stability!of!ligands!(Sarrazin#et#al.,!2011,!Habuchi!et!al.,!2004,!Hacker!et!al.,!2005).!!Another!family!of!PGs,!the!chondroitin!sulfate!(CS)!PGs,!are! a! major! component! of! the! brain! ECM,! and! important! for! maintaining! localised!structural! integrity.! Although! CSPGs! are! known! to! be! abundant! in! the! brain! and!important! for!neural! development,! this! study! is! focusing!on! the! role! of!HSPGs! in! this!model.!!
Figure'4)1: Localisation# of# heparan#
sulfate#proteoglycans#(HSPGs)#to#the#cell#
membrane.# HSPGs# can# be# localized# to#
the# extracellular# matrix# or# attached# to#
the# cell# membrane,# enabling# them# to#
mediate#cell# signalling.#HSPGs#consist#of#
a# core# protein# (blue)# decorated# with# a#





4.1.1.1 Structure There! is! no! unifying! feature! for! core! PG! protein! structures! as! they! display! a! great!diversity!of!protein! forms.!Many!core!proteins!have!complex!modular!structures!with!protein! motifs! that! are! of! similar! sequence! to! those! found! in! other! protein! families!(Sugahara!and!Kitagawa,!2002,!Ruoslahti,!1988).!The!core!proteins!range! in!size! from!10kDa!to!>500kDa!with!each!corresponding!protein!encoded!by!a!single!gene!belonging!to! different! gene! families! (Esko! and! Selleck,! 2002,! Iozzo,! 1998).! Each! gene! encodes!multiOdomain! core! proteins! whose! structures! share! similarities! with! other! known!proteins!or!specific!binding!domains!(Sarrazin!et!al.,!2011,!Lamoureux!et!al.,!2007).!The!huge! variability! of! protein! structure! allows! for! specific! functions! for! each! of! the!different!PG!families!(Ori#et#al.,!2008,!Lamoureux!et!al.,!2007).!PGs!have!been!found!to!be! associated!with! intracellular! compartments,! the! cell! surface,! extracellular!matrices!and!basement!membranes!in!almost!all!adult!tissues!(reviewed!in!(Sarrazin!et!al.,!2011,!Lamoureux!et!al.,!2007)).!The!diversity!of!PGs!is!dependent!on!differential!expression!of!genes!encoding!core!proteins,!different!exon!usage!of!these!genes,!as!well!as!variations!in! the! length!and!types!of!glycosaminoglycan!(GAG)!chains!(Ori!et!al.,!2008,!Bandtlow!and!Zimmermann,!2000).!




Depending!on!disaccharide!structure,! they!can!be!grouped! into!chondroitin/dermatan!(CS/DS),!heparin/heparan!sulfate!(HS),!and!keratan!sulfate!(KS)!side!chains!(Bandtlow!and!Zimmermann,!2000,!Toole,!1991).!This!grouping! is!dependant!on! the!presence!of!either!of!two!hexosamine!isomers,!DOglucosamine!or!DOgalactosamine.!Hexuronic!acid!is!also!present!in!two!forms:!DOglucuronic!acid!and!LOiduronic!acid.!Diverse!modifications!through! epimerases! (CS/HS),! combined! NOdeacetylase/NOsulfotransferases! (only! HS),!and! several! OOsulfotransferases! are! responsible! for! a! great! part! of! the! structural!heterogeneity! of! the! core! protein! bound! GAG! (Laremore! et! al.,! 2009,! Peterson# et# al.,!2009,!Bandtlow!and!Zimmermann,!2000,!Lindahl#et#al.,!1998).!The!degree!and!position!of!sulfation!and!5’!epimerisation!are!extremely!variable!in!sulfated!GAGs!with!the!final!profile! dependant! on! the! tissue,! cellular! or! metabolic! context,! ensuring! structural!diversity! of! these! polysaccharides! (Hardingham! and! Fosang,! 1992,! Tveit# et# al.,! 2005,!Sarrazin!et!al.,!2011).!!There! is! increasing!evidence! that! cellO! and! tissueOspecific! expression!of! the!modifying!enzymes!and!the!formation!of!specialised!enzyme!complexes!control!the!generation!of!microstructural!domains!within!the!GAG!chains.!These!particular!microstructures!may!participate!in!the!specific!binding!of!certain!heparan!sulfates!to!growth!factors,!protease!inhibitors,! and! ECM! molecules! and! hence! may! confer! tissue! specific! function! to! a!particular! PG! ! (Bandtlow! and! Zimmermann,! 2000,! Lindahl! et! al.,! 1998,! Lyon! and!Gallagher,! 1998,! Sarrazin! et! al.,! 2011).! Biosynthesis! of! these! GAG! chains! will! be!discussed!further!in!section!4.1.5.!




and! Kitagawa,! 2002).! Its! simple! sugar! backbone! is! variously! modified! to! different!degrees! depending! on! the! local! cellular! conditions! (Bishop# et#al.,! 2007,! Sugahara! and!Kitagawa,! 2002).! Thus,! it! matures! to! have! an! enormously! complicated! structure,!exhibiting! a! considerable! number! of! unique! overlapping! sequences! with! specific!sulfation!profiles!! (Lander! and! Selleck,! 2000,! Sugahara! and! Kitagawa,! 2002).! Such!sequences! are! recognised! by! complementary! proteins,! which! form! a! huge! group! of!“heparinObinding!proteins”,!and!the!sugar!sequences!in!turn!support!unique!functions!of!the! respective! proteins! through! specific! interactions! (Sugahara! and! Kitagawa,! 2002).!Heparan! sulfate! proteoglycans! (HSPGs)! play! important! roles! in! several! biological!processes! at! the! cellOtissueOorgan! interface! (Conrad,! 1998)! and! in! cell! growth! and!development! (Perrimon!and!Bernfield,! 2000,! Sasisekharan! and!Venkataraman,! 2000),!angiogenesis!(Sasisekharan#et#al.,!1997),!viral! invasion!(Chen#et#al.,!1997,!Shukla#et#al.,!1999),!anticoagulation!(Petitou#et#al.,!1999),!and!branching!morphogenesis!(Pan#et#al.,!2008,!Qu#et#al.,!2011).!HSPGs!regulate!the!activity!of!signalling!molecules!by!modulating!their!diffusion,!receptor!on!and!off!rates,!and!effective!concentration!at!the!cell!surface!and!the!ECM!(Sasisekharan!and!Venkataraman,!2000).!The!HSPGs!perlecan,!aggrin!and!collagen!XVIII!are!found!in!basement!membranes!(Iozzo,!1998,!Erickson!and!Couchman,!2000),!while!PGs!belonging!to!the!syndecan!and!glypican!families!are!cell!surface!bound!(Tkachenko# et# al.,! 2005,! Leonova! and! Galzitskaya,! 2013,! Filmus# et# al.,! 2008,!Zimmermann!and!David,!1999).!




domain!of! these!PGs!can!be!shed! from!the!cell! surface,!generating!soluble!HSPGs! that!can!inhibit!interactions!at!the!cell!surface!(Ramani#et#al.,!2012,!Bernfield!et!al.,!1999).!As!components! of! the! extracellular! environment,! HSPGs! direct! cell! proliferation,!differentiation,!migration,!and!changes!in!cell!shape.!They!exert!their!effect!on!cells!by!binding!to!highly!specific!cell!surface!receptors,!which,!when!occupied,!are!internalised!or! transduce! intracellular! signals.! These! receptors! transmit! signals! into! the! cell! and!often!use!cell!surface!HS!to!recognise!their!ligands!or!to!regulate!their!activation!(Jorpes!and! Gardell,! 1948).! HSPGs! sequester! proteins!within! secretory! vesicles,! link! proteins!together! with! the! ECM,! as! well! as! bind! proteins! to! the! cell! surface! (Bernfield! et! al.,!1999).!With! the!HS! chains! attached! to! the! core! proteins! responsible! for!much! of! the!biological!role!of!HSPGs,!their!core!proteins!have!evolved!to!maximise!their!efficiency!in!these!roles!(Matsuo!and!KimuraOYoshida,!2014,!Bernfield!et!al.,!1999).!Several!studies!have! determined! that! various! proteins! involved! in! organising! the! basic! body! plan!depend! on! interaction! with! HS! for! their! function! (Sarrazin! et! al.,! 2011,! Carey,! 1997,!Conrad,! 1998).! Interestingly,! HS! chains! on! the! same! core! protein! from! different! cell!types! show! consistent! and! reproducible! structural! differences! such! as! variations! in!domain! number,! spacing,! or! size! and! in! their! OOsulfation! pattern! (Kato# et# al.,! 1994)!suggesting!a!tissue!specific!synthesis!and!function.!!











Figure'4)2: HSPG# Biosynthesis# G# HSPGs# undergo# a# complicated# series# of# modification# and#
sulfation# steps# to# produce# the# final# functional# HS# chain.# Following# chain# initiation# and#
polymerisation,# the# growing# chains# are# NGsulfated,# committing# the# chains# to# an#HS# lineage.##
Further# OGsulfation# is# introduced# along# the# chain# at# discrete# points# generating# the# specific#
sulfation#combinations#required#for#ligand#interactions.##(Habuchi#et#al.,#2004)#




linked!disaccharide!HS!chain!(Lind#et#al.,!1993,!Lind#et#al.,!1998).!Since!the!same!linkage!tetrasaccharide! is! found! in!CS! and!HS,! the! committing! step! for!HS!biosynthesis! is! the!addition! of! a! GlcNAc! residue! to! the! linkage! tetrasaccharide! (Esko! and! Zhang,! 1996).!Various! modifications! then! follow! including! NOdeacetylation! and! NOsulfation! of!glucosamine,! C5Oepimerisation! of! GlcA! and! multiple! OOsulfations! of! the! component!sugars! (Sugahara! and! Kitagawa,! 2002).! The! growing! chain! is! modified! by!sulfotransferases!and!a!GlcA!C5!epimerase.!
4.1.1.7 Chain Modification The!length!of!the!HS!chains!can!vary!over!10!fold!with!cell!type!and!core!protein,!but!the!chain!termination!mechanisms!are!mostly!unknown!(Liu#et#al.,!2014,!Bishop!et!al.,!2007,!Bernfield! et! al.,! 1999).! Once! the! HS! chain! is! assembled,! generally! containing! 50O150!disaccharides,! the! individual! saccharide! units! are! subjected! to! a! series! of! sequential!enzymatic! modification! reactions! in! which! the! products! of! one! reaction! are! the!substrates!for!the!next.!!




NDST3!also! found! in! the!adult!brain! (Grobe!and!Esko,!2002,!Aikawa!and!Esko,!1999)!and!NDST4!present!in!the!adult!brain!at!low!levels!(Grobe!and!Esko,!2002,!Aikawa!et!al.,!2001).!
Following!NOdeacetylation,!the!adjacent!DOglucuronic!acid!residues!are!epimerized!to!LOiduronic! acid! units! by! glucuronyl! CO5! epimerase! (C5OEp)! (Li# et# al.,! 1997).! These!modified!disaccharides!receive!the!bulk!of!subsequent!OOsulfations.!!Sequential!action!of!iduronosyl!2OOOsulfotransferase!(2OST)! followed!by!glucosaminyl!6OOOsulfotransferase!(6OST)! and! occasionally! glucosaminyl! 3OOOsulfotransferase! (3OST)! complete! the!modification!of!HS!chains! (Rosenberg#et#al.,!1997,!Habuchi#et#al.,!1998).!Each!of! these!sulfotransferases!has!multiple!isoforms!which!may!share!distinct!substrate!specificities!and!or!be!tissue!specific!(Bernfield!et!al.,!1999).!!




1997)!and!the!IdoA!2OOOsulfotransferase!(2OST)!(Liu!et!al.,!2014,!Kobayashi#et#al.,!1997)!have! been! described.! It! is! possible! that! the! number! or! proportion! of! the! different!isoforms! present! in! a! given! cell,! as! controlled! by! gene! expression! and! or!posttranslational! degradation,! may! be! critical! to! the! structure! of! the! polysaccharide!synthesized!(Lindahl!et!al.,!1998).!!While!the!introduction!of!sulfation!at!specific!points!is!critical!to!ligand!interactions,!the!ability!to!remodel!the!HS!chain!by!removing!sulfation!is!also!critical.!HS!OOdesulfation!is!the!province!of!HSulfO1!and!HSulfO2,!HS!6OOOendosulfatases!secreted!from!the!Golgi!and!localised!to!the!ECM.!HSulfs!selectively!remove!6OOOsulfate!groups!on!GlcN!residues!of!HS;!preferentially!catalysing!the!desulfation!on!trisulfated!disaccharides!(Ai#et#al.,!2003,!MorimotoOTomita#et#al.,!2005,!Ohto#et#al.,!2002,!Dai#et#al.,!2005,!Narita#et#al.,!2007).!!





4.1.1.8 Sulfation Pattern and Cellular Interactions Several! reports! have! related! the! variable! sulfation! patterns! of! HS! with! roles! in!differentiation! (Haupt# et# al.,! 2009,! Habuchi! et! al.,! 2004,! Lindahl! et! al.,! 1998)! or!transformation!of!cells!in!culture!(Jayson#et#al.,!1998,!Safaiyan#et#al.,!1998).!!!!Despite!the!lack!of!a!unified!picture,! the!data!demonstrate! that! the!structure!of!HS!produced!by!a!single! cell! may! be!modulated! because! of! distinct! stimuli! (Kjellen# et# al.,! 1983).! It! has!been!well!established!that!the!ECM!and!its!constituents!modulate!cellular!phenotypes,!cellOcell! interactions! and! signalling! cascades.! ! The! complexity! of! HS! (and! CS! chains)!brought! about! by! the! variety! in! length! and! sulfation! patterns,! may! well! give! these!proteins!their!niche!specificity,!that!is,!specific!functions!in!specific!tissues!(Haupt!et!al.,!2009).! Previous!work! by! our! group! has! demonstrated! that! an! increase! in! glypicanO3!correlates!with!differentiation!of!murine!MC3T3!cells!toward!the!osteoblast!lineage!and!is! associated!with! increased!NO! and!OO!HS! specific! sulfation! (Haupt! et! al.,! 2009).! This!data! demonstrates! the! unique! role! specific!HSPGs! can! play! in! the! localised! cell! niche!influencing!cell!fate!decisions.!








4.1.2 Syndecans In! contrast! to! other! types! of! cellOsurface! PGs! (glypicans,! cerebroglycan)! which! are!attached! to! cell!membranes!via!a!glycosylOphosyatidylOinositol! linkage! (GPI)! (David#et#





Figure'4)3: Schematic#of#Syndecan#structure#and# localization.#Syndecans#are#a# family#of# four#
transmembrane# proteins.# Members# of# the# family# can# carry# both# heparan# sulfate# (HS)# or#
chondroitin#sulfate#(CS)#chains.#Syndecans#are#expressed#in#almost#every#tissue#and#expression#
is#highly#regulated#during#development.#(Seer,#2014)##
Each! syndecan! is! expressed! in! a! distinct! temporal! and! spatial! pattern,! with! every!mammalian!cell!expressing!at! least!one!type!of!syndecan!in!a!highly!regulated!fashion!during! development! (Bernfield! et! al.,! 1992,! Tkachenko! et! al.,! 2005).! SyndecanO1! is!expressed!predominantly!in!epithelial!and!mesenchymal!tissues,!syndecanO2!in!cells!of!mesenchymal!origin!and!neuronal!epithelial!cells,!while!syndecanO3!is!expressed!almost!exclusively!in!neuronal!and!musculoskeletal!tissue.!!SyndecanO4!is!found!in!virtually!all!cell! types! but! at! a! much! lower! level! than! the! other! syndecans! (Couchman,! 2003,!Leonova!and!Galzitskaya,!2013).!




disaccharide! sequences! have! been! shown! to! result! in! remarkable! changes! in! ligand!specificity!(Guimond#et#al.,!1993,!Nurcombe#et#al.,!1993,!Sanderson#et#al.,!1994).!Growth!factors!are!able! to! regulate! the!expression!of! the! syndecan! family!members! (CizmeciOSmith# et# al.,! 1993,! Lambaerts# et# al.,! 2009,! Tkachenko! et! al.,! 2005)!with! regulation! of!syndecanO1! expression! demonstrated! by! FGFO2! and! TGFOβ! induction! of! syndecanO1!production! in! mesenchymal! 3T3! fibroblasts! (CizmeciOSmith# et# al.,! 1997,! Dobra# et# al.,!2003,! Elenius# et# al.,! 1992)! and! by! plateletOderived! growth! factor! (PDGF)! in! vascular!smooth! muscle! cells! (CizmeciOSmith! et! al.,! 1993,! Fukai# et# al.,! 2009).! The! HS! chains!bound!to!the!HSPG!core!proteins!contain!several!interspersed!FGFO2!binding!sites,!and!interestingly,!also!sequences!inhibitory!to!the!action!of!the!growth!factor!(Guimond!et!al.,!1993).!Different!members!of!the!FGF!family!seem!to!require!specific!heparan!sulfate!sequences!(Chernousov!and!Carey,!1993,!Guimond!et!al.,!1993,!Habuchi!et!al.,!2004)!and!a!single!cell!surface!PG!core!protein!may!carry!either!FGFO1!or!FGFO2!specific!HS!regions!depending!on!the!growth!factor!available!at!different!developmental!stages!(Nurcombe!et!al.,!1993).!




growthOstimulatory! effect! of! FGFO1! (Mali# et# al.,! 1993)! leading! to! the! association! of!normal! cell! growth! with! activated! syndeanO1! expression! and! abnormal! proliferation!with! suppression! of! syndecanO1.! It! is! also! possible! that! cells! deficient! in! syndecanO1,!which! anchors! them! to! the! ECM,! have! changed! their! morphology! to! become! free! to!divide!and!migrate.!!
The!mechanisms!by!which!cell!surface!HS!molecules!can!affect!growth!factorOregulated!growth!control!may,!in!addition!to!cell!surface!level,!also!include!events!taking!place!at!periOcellular/extracellular! or! intracellular! level.! Proteolytic! cleavage! of! syndecan!ectodomains!enable!the!translocation!of!the!ectodomains!to!the!ECM!where!they!could!have!activities!described!for!matrix!HSPGs!i.e.!to!form!a!reservoir!of!FGFs!(Gonzalez#et#
al.,!1990,!Klagsbrun,!1990),!to!control!diffusion!of!FGFs!(Flaumenhaft#et#al.,!1990)!or!to!protect!FGFO2!from!proteolytic!activation!(Saksela#et#al.,!1988).!!In!the!brain,!syndecanO2!as! well! as! syndecanO3! (NOsyndecan)! appear! to! be! involved! in! the! synaptic! plasticity!(Leonova! and! Galzitskaya,! 2013)! and! maturation! of! synapses! where! syndecanO2!localises! specifically! to! synaptic! junctions,!where! it! interacts!with!CASK,! a!PDZ! family!protein,! through! its!COterminal!domain!(Hsueh#et#al.,!1998).! Interaction!of! syndecanO2!with!PDZ!family!proteins!is!required!for!the!development!of!postsynaptic!specialisation!(Oohira#et#al.,!2000).!




share!the!insertion!site!for!HS!chains,!which!seems!to!be!restricted!to!the!last!50!amino!acids!at!the!COterminus,!locating!the!HS!chains!close!to!the!cell!membrane!(Veugelers!et!al.,!1999).!This! suggests!a! role! for!HS!chains! in!mediating! the! interaction!of!glypicans!with! other! cellOsurface! molecules! including! growth! factor! receptors! (Filmus! et! al.,!2008).! It! has! been! proposed! that! the! glycolipidOenriched! cellOmembrane! subdomains!facilitate! selective! proteinOprotein! interactions! that! establish! transient! cellOsignalling!platforms!(Hancock,!2006).!While!predominantly!cellOmembrane!bound,!glypicans!can!also! be! found! in! the! extracellular! environment! and! in! the! cytoplasm! (Capurro# et# al.,!2003,!Ligato#et#al.,!2008).!Glypicans!can!stimulate!or!inhibit!signalling!activity!through!interactions! with! morphogens! and! receptors! as! in! the! case! of! Wnt! signalling! where!glypicans! facilitate! or! stabilise! the! interaction! of! Wnt! with! its! receptor! Frizzled!(Capurro#et#al.,!2005).!!











It! seems! likely! that! the! cysteines! in! the! highly! conserved! region! form! intramolecular!disulfide! bonds! that! confer! a! compact! shape! to! the! core! proteins! (Bandtlow! and!Zimmermann,! 2000).! The! insertion! sites! for! the! HS! chains! are! located! close! to! the!carboxyl! terminus! thereby! locating! the! chains! close! to! the! cell! surface,! these! chains!could!mediate!the!interactions!of!glypicans!with!other!cellOsurface!molecules,!including!growth! factor! receptors! (Filmus! 2008)(Filmus! et! al.,! 2008).! Except! for! the! HS!attachment!sequences,! the!HSObearing! juxtamembrane!regions!are! the!most!divergent!sequences!in!these!core!proteins!(Bernfield!et!al.,!1999).!




but! little! or! no! OOglycosylation! sites! (Bandtlow! and! Zimmermann,! 2000).! Intact!glypicans!are!always!substituted!with!HS!chains,!but!removal!of!the!central!domain!has!been!shown!to!result!in!sideOchain!substitution!with!CS!(Chen!and!Lander,!2001).!
4.1.3.1 Glypicans and signalling  It!is!now!well!established!that!glypicans!regulate!the!activity!of!a!wide!variety!of!growth!and! survival! factors! and! play! a! critical! role! in! morphogenesis! (Filmus! and! Selleck,!2001).! In! addition! to! their! localisation! on! the! cell!membrane! and! in! the! extracellular!environment,!glypicans!can!also!be!found!in!the!cytoplasm,!where!several!studies!have!reported!the!presence!of!glypicanO3!in!the!cytoplasm!of!liver!cancer!cells!(Capurro!et!al.,!2003,! Ligato! et! al.,! 2008)! promoting! the! growth! of! hepatocellular! carcimoma! by!stimulating!Wnt!signalling!(Capurro!et!al.,!2005).!!




CNS.!Expression!of!glypicanO6!has!been!reported! in! the!heart,! liver!and!kidney!during!embryonic!development!with!subsequent!expression!in!adult!ovaries!and!intestine.!
Glypicans!can!be!shed!into!the!extracellular!environment!where!they!play!a!role!in!the!transport! of!Wnts,! Hhs! and! BMPs! for! the! purpose! of! morphogen! gradient! formation!(Belenkaya#et#al.,!2004,!Fujise#et#al.,!2003,!Han#et#al.,!2004,!Han#et#al.,!2005,!Kirkpatrick#
et#al.,!2004).!Depending!on!the!context,!glypicans!might!have!stimulatory!or!inhibitory!activity! in! signalling! processes.! ! In! the! case! of! Wnt,! it! has! been! proposed! that! the!stimulatory!mechanism!is!based!on!the!ability!of!glypicans!to!facilitate!and/or!stabilise!the!interaction!of!Wnts!with!their!signalling!receptors,!the!Frizzled!proteins.!HS!chains!appear!essential!for!some,!but!not!all,!glypican!activity!with!stimulation!of!FGF!activity!dependant!on!the!presence!of!HS!(Song#et#al.,!1997).!Surprisingly,!the!regulatory!activity!of! glypicans! in! the! Wnt,! Hedgehog! and! BMP! signalling! pathways! is! only! partially!dependent!on!the!heparan!sulfate!chains!(Filmus!et!al.,!2008).!!




4.2 Basal Heparan Sulfate Proteoglycan Expression in Human 
Mesenchymal Stem Cells We! first! established!a!basal! expression!profile! for!HSPG! core!proteins!of! interest! and!determined!that!a!number!of!the!core!proteins!had!similar!patterns!of!expression.!!We!examined! the! expression! of! a! number! of! critical! initiation! and!modification! enzymes!involved!in!the!complex!HSPG!biosynthesis!process.!These!included!chain!initiation!and!polymerisation! enzymes,! NOsulfation! and! OOsulfation! enzymes! responsible! for! the!introduction!of!NOsulfation!critical!for!the!chain!commitment!towards!HS!rather!than!CS!as! well! as! those! enzymes! responsible! for! the! introduction! of! OOsulfation! at! critical!positions!along!the!growing!chain.!
4.2.1 Initiation and modification enzymes The!NOdeacetylase/NOsulfotransferase!(NDST)!family!consists!of!four!isoforms!that!are!believed! to! exhibit! different! substrate! specificities! dependant! on! the! ratio! of!GlcNS/GlcNH2! and! the! length! of! the! GlcNS! domain! (Aikawa! et! al.,! 2001,! Sheng# et# al.,!2011).!NDST1!and!NDST2!are!widely!expressed!and!are!found!in!most!cell!types!while!expression!of!NDST3!and!NDST4!is!much!more!restricted!(Aikawa!et!al.,!2001,!Presto#et#




nature!of!NDST2! lies! in! studies! showing! that! targeted!disruption!of!NDST1! results! in!neonatal!lethality!due!to!pulmonary!hypoplasia!and!respiratory!distress!(Aikawa!et!al.,!2001,!Fan#et#al.,!2000,!Ringvall#et#al.,!2000).!In!contrast,!murine!models!lacking!NDST2!develop! and! reproduce! normally! but! show! fewer! connective! tissueOtype! mast! cells!(Forsberg#et#al.,!1999).!














Morgan#et#al.,!2007)!with!dysregulation!such!as!over!expression!promoting!excess!focal!adhesions!and!reduced!cell!migration!(Longley#et#al.,!1999).!In!addition,!syndecanO4!has!been!shown!to!have!an!antiOmigratory/antiOinvasive!effect!(Kousidou#et#al.,!2008).!The!glypicans,! linked! to! the! cell! membrane! via! a! GPIOanchor! (Fransson# et# al.,! 2004,!Vlodavsky#et#al.,!2012)!mediate!cellular!differentiation!and!proliferation!(Okolicsanyi!et!al.,!2014b).!Overexpression!of!glypicans!has!been!reported!in!a!number!of!cancers!with!increased! glypicanO1! expression! reported! in! human! breast! cancer! (Matsuda# et# al.,!2001).! Interestingly,! often,! overexpression! of! glypicanO1! is! correlated! with! increased!expression! of! syndecanO1! (Matsuda! et! al.,! 2001,! Okolicsanyi! et! al.,! 2014b).!Proteoglycans,!and!specifically!HPSGs!are!found!in!the!matrix!of!all!tissues!including!the!brain.! Increasing! evidence! suggests! that! neural! PGs! are! involved! in! developmental!events! including! cellular! proliferation,! cellular! differentiation! and! axonal! growth,!pathfinding!and!synaptogenesis!(reviewed!in!(Okolicsanyi#et#al.,!2014a)and!references!within).! The! exact! role! of! the! HSPG! core! proteins! in! these! processes! is! still! being!determined.!!






SDC1,# SDC2# and# SDC3# all# display# the# same# pattern# of# expression#with# an# increased# relative#
expression#observed#throughout#expansion.##In#contrast,#SDC4#expression#is#2#fold#less#than#the#
observed# levels# of# SDC1# and# displays# unchanged# expression# throughout# expansion.# Relative#
expression#is#represented#by#mean#ΔΔCt#calculated#from#the#three#hMSC#populations#examined.##
Means# are# graphed# ±# SEM.# n=9.# Representative# immunocytochemistry# images# of# SDC1# and#
SDC4# under# maintenance# conditions;# left# SDC1# (yellow),# right# SDC4# (green).# Nuclei# are#
counterstained#with#DAPI#(blue).##Scale#bar#represents#70μm.#




donors.!However,!lack!of!expression!of!some!glypicans!in!these!cells!is!to!be!expected!as!many!of! the!glypicans!have!very!developmentally! regulated!and!restricted!expression!(Yamaguchi,! 2001).! Indeed,! glypicanO4! in! the! brain! is! restricted! to! cells! maintaining!stem!cell!properties!with!expression!ceasing!once!cells!have!committed! to!a!neuronal!lineage!(Yamaguchi,!2001).!!





Figure'4)7: Basal# expression# profile# of# the# glypican# (GPC)# family# members.# GPC1# and# GPC4#
expression# is#more# than#10x#higher# than# that# of#GPC2,#GPC3#and#GPC6.# # Expression#of#GPC1#
increased#throughout#expansion#while#GPC4#remained#unchanged.#GPC6#demonstrated#highest#
observed# levels# of# expression# at# P+7# (1.5# –# 2# fold# of# P+5# and# P+13).# Relative# expression# is#
represented#by#mean#ΔΔCt#calculated# from#the#three#hMSC#populations#examined.# #Means#are#
graphed#±# SEM.# n=9.# Representative# immunocytochemistry# images# of# GPC1#and#GPC4#under#





4.3 Alteration to HSPG expression following modulation of the in 
vitro niche We! have! previously! examined! and! compared! in# vitro! expansion! potential! for! hMSC!cultures! allowing! us! to! select! three! populations! that! underwent! similar! growth! rates!and!population!doublings.!Common!passages!representing!three!distinct!growth!phases!were! identified! for! further! examination! of! hMSC! populations.! In! addition,! we!established! the! response! of! hMSCs! to! in# vitro! modulation! in! respect! to! their! cellular!proliferation!rates!(Chapter!2).!Having!determined!these!cells!were!sensitive!to!heparin!and! chlorate! treatment! (described! in! Chapter! 2,! Section! 2.1.4! and! 2.1.7)! we! then!examined! the!alteration! to!HSPG!gene!expression! following!modulation!of! the! in#vitro!niche.!




Significance!was!set!at!α=0.05.!Graphs!of!expression!changes!for!individual!populations!along! with! significant! changes! within! each! population! can! be! found! in! Chapter! 8,!Appendix!5.!
4.3.1 Cell proliferation induced by exogenous heparin and inhibited by 
exogenous chlorate  Treatment! of! hMSCs! under! maintenance! media! conditions! with! 10ug/mL! heparin!resulted! in! increased!proliferation!with!no!difference! in! cell! number!between! treated!cells! and! control! between! day! 1! (D1)! and! day! 3! (D3;! Figure! 4O8A).! The! observed!increase! in!cell!number! (24%)! in! treated!cultures!when!compared! to!control! cultures!was!greatest!between!day!3!and!day!5!(D5)!indicating!that!the!cells!take!some!time!to!utilise!the!heparin!(Figure!4O8!A).!By!D5!heparin!treated!cultures!had!an!approximate!increase! in! cell! number! of! 25%! over! control! cultures! at! the! same! time! point.! The!increase! in! cell! number!observed!by!D5! following! treatment!of! cultures!with!heparin!demonstrates!the!involvement!of!heparin!or!HS!in!the!proliferation!of!these!cells.!It!also!suggests!that!the!cells!may!be!undergoing!some!internal!modification!in!order!to!utilise!the!exogenous!heparin.!!















Run! files! generated! for! each! population! at! each! passage! on! the! 7900HT! (Applied!Biosystems)!were!loaded!into!a!single!study!per!passage!in!ExpressionSuite,!combining!data! from! the! three! populations.! ! In! each! study,! samples! were! assigned! to! three!biological!groups:!Control!(Ctrl),!Heparin!treated!(Hep),!Chlorate!treated!(Chl).!Negative!control! samples!were!omitted! from! the! analysis.! ! It!was!possible! to! generate! volcano!plots!for!each!of!the!treatment!conditions!(Hep/Chl)!using!the!control!biological!group!as! a! reference.! Volcano! plots! generated! at! each! passage! for! each! condition! are!presented.!





Figure'4)9: Volcano# Plots# of# P+5# Heparin# vs# Control# and# Chlorate# vs# Control.# Volcano# Plots#
were#generated#in#Expression#Suite#(Life#Technologies).#This#analysis#combines#replicates#from#
each# population,# calculates# fold# change# relative# to# the# specified# endogeneous# control# in# the#
experiments#and#calculates#a#pGvalue.##The#log2#of#the#fold#change#is#then#graphed#against#the#–






















Figure'4)10: P+7# Volcano# Plots.# Genes# in# green# represent# those# with# a# ># 2# fold# decrease# in#
expression,# while# those# in# red# represent# a# ># 2# fold# increase# in# expression.# # The# blue# line#
represents# the# level# of# significance# (a=0.05).# Genes# above# the# blue# line# represent# significant#































4.3.3 Initiation and HS Modification Enzymes As!well!as!examining! the!response!of!core!proteins! to! in#vitro#niche!modifications,!we!also! examined! the! effect! of! the! proliferative! agent,! heparin,! and! chlorateOmediated!inhibition! of! sulfation! on! initiation! and! modification! enzymes! required! for! the!biosynthesis!of!HSPGs.!
Basal! expression! of! the! chain! polymerisation! enzymes,! EXT1! and! EXT2,! increased!throughout!expansion!(Figure!4O5!B).!In!response!to!heparin!treatment!(Figure!4O12!B),!these!enzymes!displayed!an!increase!in!expression!(1.1O1.5!fold)!with!the!exception!of!EXT2! at! P+5! where! a! significant! decrease! in! expression! (O3.3! fold)! was! observed!(P=0.035)! suggesting! increased! chain! polymerisation.! Following! chlorate! treatment,!expression! of! these! enzymes! remained! constant! or! even! decreased.! Significantly!decreased!expression!was!observed!for!EXT1!at!P+7!(O1.6!fold;!P=0.047)!and!for!EXT2!at!P+5!(O5!fold;!P=0.030).!C5Oepimerase,!responsible!for!chain!elongation,!also!displayed!significantly!increased!expression!at!P+5!(2!fold;!P=0.028)!and!P+7!(2!fold;!P=0.0001)!following! heparin! treatment! (Figure! 4O12! A).! At! other! time! points! the! increase! in!expression!seen!following!heparin!treatment!was!not!statistically!significant.!Inhibition!of!sulfation!through!chlorate!treatment!did!not!affect!the!expression!of!C5Oepimerase.!




Of!the!four!HS!OOsulfation!enzymes!examined,!only!two!were!consistently!expressed!in!all! three! hMSC! populations:! HS2ST1! and!HS6ST1! (Figure! 5O12! E).! Heparin! treatment!produced! an! overall! increase! in! expression! of! both! of! these! enzymes! throughout!expansion! with! the! expression! of! HS2ST1! significantly! increased! at! P+7! (1.8! fold;!





Figure'4)12: Response# of# initiation# and# modification# enzymes# to# niche# modification.# (A)# C5G
epimerase# (C5Gep)# (B)# Exotosin# 1# (EXT1)/# EXT2# (C)# NGdeacetylase/NGsulfotransferase# 1#
(NDST1)#(D)#NDST2#(E)#heparan#sulfate#2GOGsulfotransferase#1#(HS2ST1)/#heparan#sulfate#6G
OGsulfotransferase# 1# (HS6ST1).# Significantly# increased# expression# was# observed# following#
heparin# treatment# in# C5Gep.# In# EXT2# and# NDST1,# treatment# with# heparin# resulted# in#
significantly# decreased# expression# at# early# and# intermediate# passages.# Chlorate# treatment#














(B)# SDC2/SDC3.# Syndecan# expression# generally# increased# following# treatment# with# heparin#
while#chlorate#treatment#generally#resulted#in#decreased#expression.#Blue#bars#–#control;#Red#
bars#–#heparin;#Green#bars#–#chlorate.#Mean#ΔΔCt#calculated#from#the#three#hMSC#populations#is#
graphed# ±# SEM.# n=9.# *p<0.05,# **p<0.005,# ***p<0.0001.# Representative# immunocytochemistry#
images#of#hMSC#at#P+13#under#dosed#conditions# (C)#Control# (D)#Heparin# (E)#Chlorate:#SDC1#





























graphed# ±# SEM.# n=9.# *p<0.05.# Representative# immunocytochemistry# images# of# hMSC# under#









Correlations Between HSPGs and Neural Markers In!our!cell!populations,!we!see!distinct!similarities!between!the!basal!expression!profile!of!key!HSPGs!and!neural!markers!(Figure!4O15).!Throughout!expansion,!both!SDC4!and!GFAP! expression! is! reduced! at! P+7! and! then! subsequently! increase! again! at! P+13.!Expression!of!MAP2!completely!mirrors!the!expression!of!SDC1!with!MAP2!expression!decreasing!from!P+5!to!P+13!and!SDC1!expression!increasing!throughout!expansion.!In!addition,! GPC4! and! Nestin! show! very! similar! patterns! of! expression! with! basal!expression! of! both! genes! decreasing! from! intermediate! expansion! time! points! (P+7OP+13).!!
!
Figure'4)15: Gene# expression# correlation# between# neural# markers# and# heparan# sulfate#
proteoglycan# (HSPG)# core# proteins.# We# see# some# distinct# similarities# in# the# expression# of# a#
number# of# neural#markers# and# the# basal# expression# profile# of# key#HSPG# core# proteins.# Glial#
fibrillic# acidic# protein# (GFAP)# and# syndecan# 4# (SDC4)# follow# similar# expression# profiles#
decreasing#expression#to#intermediate#growth#phase#and#then#increase#expression#as#the#cells#
age.#Nestin#and#glypican#4# (GPC4)#also# show#a# similar# pattern#of# expression#with#decreased#





Along!with! examining! the! similarities! in! gene! expression! patterns,!we! also! examined!these!cells!by!ICC!to!determine!any!coOlocalisation!between!neural!markers!and!HSPG!core!proteins.!We!found!that!although!the!level!of!detection!for!both!neural!markers!and!HSPG!core!proteins!was!very! low,!we!were!able! to!dual!stain! three!hMSC!populations!for! a! number! of!markers! of! interest.! Representative! images! showing! dual! staining! of!hMSCs!with!either!syndecan!or!glypican!core!proteins!with!markers!of!MSC!and!neural!lineages!are!shown!(Figure!4O16).!













Figure'4)16: CoGstaining# of# neural# markers# with# HSPG# core# proteins.# Representative#
immunocytochemistry# images# of# coGstaining# neural# markers# with# heparan# suflate#









4.4.1 HSPGs and their Involvement in the Neural Niche Interactions! between! HSPGs! and! their! favoured! signalling! partners! (Wnt,! FGF)! have!been! identified! to!mediate! a!number!of!neural!development!process! including! crucial!developmental!signalling!pathways!(Lin,!2004).!The!roles!played!by!FGFs!in!regulation!of! cell! proliferation,!migration! and! differentiation! during! development! (Coumoul! and!Deng,!2003,!Lin,!2004,!Ornitz!and!Itoh,!2001)!are!among!the!bestOstudied!HSPGObinding!protein! interactions! (Ornitz,! 2000).! HSPG! involvement! in! FGF! signalling! is! widely!accepted! to!be! through!one!of! two!mechanisms;!either! the!HSPG! facilitates!FGFOFGFR!interactions!within!the!FGF!signalling!complex,!or!the!HSPG!enhances!the!stability!of!the!binary!FGFOFGFR!complex!(Lin,!2004).!A!number!of!biochemical!studies!have!provided!evidence! that! demonstrate! heparin! can! increase! the! affinity! of! FGF! for! its! receptor!(Ornitz,!2000).!




integrated! involvement! of! HSPGs! in! cerebral! cortex! development! through! their!interactions!with!FGF2,!a!crucial!growth!factor!in!the!proliferation!and!differentiation!of!neural!stem!cells!in!the!developing!cerebral!cortex!(Yamaguchi,!2001).!In!addition,!low!FGF!concentrations!of!FGF2!have!been!reported!to!produce!cell!populations!consisting!predominantly! of! neurons! derived! from! neural! stem! cells,! while! high! FGF2!concentrations!generate!glial!cells!(Qian#et#al.,!1997).!!
In!addition!to!crucial!interactions!with!FGF!proteins,!HSPGs!also!play!vital!roles!in!the!establishment! of! Wnt! mophogen! gradients! essential! for! a! variety! of! developmental!processes!(Fuerer#et#al.,!2010,!Yan!and!Lin,!2009).!HSPGs!interact!with!a!variety!of!Wnt!proteins!and!have!been!shown!to!play!roles!in!differentiation!of!MSCs!(Ling#et#al.,!2009)!with!specific!HSPG!proteins!(glypicanO3)!demonstrated!in!a!murine!model!to!play!a!role!in!osteogenesis!(Haupt!et!al.,!2009).!





4.4.2 Syndecans and Glypicans in Neural Development Specific! HSPGs! have! been! shown! to! have! roles! in! development! of! specific! neural! cell!types.! In! addition,! expression! of! some! HSPG! proteins! can! distinguish! between!developing,!immature!neural!cells!and!their!mature!differentiated!subtypes.!Differences!between!in#vitro!and!in#vivo!expression!have!also!been!identified!with!neural!stem!cells!
in#vitro!expressing!glypicanO4!on!their!surface,!while! in#vivo!expression!is!restricted!to!cells!that!retain!stem!cell!properties!with!expression!of!glypicanO4!ceasing!once!the!cells!commit!to!neuronal!differentiation!(Yamaguchi,!2001).!
Although!much!evidence!comes! from!the!Drosophila!model,! tissue!specific! localisation!and! developmental! stage! specific! expression! is! common! between! model! and!mammalian! systems.! In! the! review! conducted! by! Yamaguchi! (2001),! the! author!presents! evidence! for! the! involvement!of!HS! in! axon!guidance! through!modulation!of!FGF! signalling! (Yamaguchi,! 2001)! with! data! collected! suggesting! the! involvement! of!glypicanO2!and!syndecanO3!in!axon!guidance!(Ivins#et#al.,!1997,!Yamaguchi,!2001).!!
Of! the! syndecans,! syndecanO3! was! reported! expressed! in! developing! axon! tracts!(Kinnunen# et# al.,! 1998,! Kinnunen# et# al.,! 1999,! Yamaguchi,! 2001)! and! has! been!implicated! as! a! cell! surface! receptor! for! heparinObinding! growthOassociated!molecule!(HBOGAM),! an! extracellular! neurite! outgrowthOpromoting! factor! (Raulo# et# al.,! 1994,!Yamaguchi,!2001).!




characterised!HSPG!in!neurogenesis!with!expression!in!the!developing!brain!restricted!specifically! to! the! ventricular! zone! (Hagihara# et# al.,! 2000).! ! In! contrast! to! glypianO4,!glypicanO1! was! expressed! in! the! ventricular! zone! in! postmitotic! and! differentiated!neurons!during!the!late!stages!of!embryonic!development!(Litwack#et#al.,!1998).!!
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Chapter 5: Differentiation of hMSCs towards Neural 
Lineages 
5.1 Introduction 




5.1.1 hMSC Capacity to generate neural-like cells 
Much! research! is!being! conducted! to!elucidate!optimal! conditions! to! reliably!produce!cells! of! neural! origin! from! MSCs.! Success! of! this! differentiation! is! measured! by!pheonotypic! and! morphological! changes,! expression! of! specific! neural! gene! markers!and! proteins,! along!with! the! functional! nature! of! the! resulting! neuralPlike! cell,! (with!evidence! from!murine!models!demonstrates! that!MSCs!can!migrate! through! the!brain!differentiating!into!astrocytes!and!neurons!(Kopen#et#al.,!1999)).!Suitability!of!MSCs!for!use! in! the! brain! as! a! therapeutic! tool! is! based! in! part! on! their! ability! to! differentiate!toward!neural!lineages,!but!also!on!their!contribution!to!the!neural!niche.!




studies!involved!the!injection!of!murine!bone!marrow!MSCs!into!the!lateral!ventricle!of!neonatal!mice,!which!were!then!tracked,!and!their!ability!to!migrate!without!disruption!to!the!brain!architecture!examined.! In!addition!the!subsequent!adoption!of!neural!cell!fates!was!examined!in!relation!to!exposure!to!the!brain!microenvironment!(Kopen!et!al.,!1999).! Later,! human! in# vivo! studies! demonstrated! that! patients!with! ischemic! stroke!showed!an!improvement!in!functional!recovery!following!peripheral!injection!of!hMSCs!which!migrated!across!the!bloodPbrain!barrier!to!damaged!areas!of!the!brain!(Bang#et#
al.,!2005,!Egea!et!al.,!2011).!
5.1.2 Neural Differentiation 
Many!studies!utilising!a!variety!of!differentiation!protocols!report!increased!expression!of! neural! lineage!markers! along!with! the! loss! of! expression!of!mesenchymal!markers!(Hermann#et#al.,!2004).!!In!addition,!these!protocols!are!conducted!at!relatively!short!in#
vitro! intervals! with! cells! differentiated! after! only! P+4PP+12! in! culture! (Khoo# et# al.,!2008).!In!one!study,!the!period!of!differentiation!before!neural!assessment!was!between!3P24! hours! (Choi# et# al.,! 2006),! where! a! high! number! of! cells! displaying! a! neural!phenotype!were!observed!and!the!patch!clamp!assay!conducted!detected!small!outward!currents,! but! no! voltagePdependent! inward! current! was! detected! (Choi! et! al.,! 2006).!This!data!suggests!that!while!morphological!and!phenotypic!changes!occurr!quickly,!the!acquisition!of!functional!attributes!likely!takes!significantly!longer.!





In! addition! to! protocols! utilising! growth! factors! to! induce! neural! differentiation,! a!number! of! studies! have! employed! epigenetic! modifiers! for! neural! induction.! In!particular,! Alexanian! and! colleagues! (2010)! determined! that! to! produce! cells! with! a!neural! morphology! and! expression! profile,! the! most! effective! method! involved! the!simultaneous!treatment!with!inhibitors!of!DNA!methylation,!histone!deacetylation!and!the!chemically!induced!increase!in!cAMP!levels!(Alexanian,!2010).!In!their!hands,!early!passage! cultured! cells! (P+1PP+6)! were! induced! to! produce! cells! with! a! neural!morphology,! demonstrating! a! neural! expression! profile.! This! included! a! gradual!increase!in!the!expression!of!neural!progenitor!(Nestin,!Sox2,!A2B5,!NCAM)!and!mature!neural!markers! (TUBB3,!GFAP,!NeuN!and!MAP2)!over! the!2!weeks!of! treatment,!with!approximately! 20P30%! of! cells! producing! axonP! and! dendritePlike! extensions!(Alexanian,! 2010).! This! same! study! determined! that! while! the! expression! of! some!neural!markers! such!as! Sox2!and!TUBB3!was!possible! in!undifferentiated!hMSCs,! the!levels!were! greatly! increased! in! cells! differentiated! for! 3!weeks! under! differentiative!conditions!(Alexanian,!2010).!









Figure'5)1: One-step# versus# two-step# neural# conversion# of# hMSCs.# Schematic# detailing#
conversion# protocols# for# the# differentiation# of# hMSCs# towards# neural# cell# types.# One-step#
(terminal# differentiation)# of# hMSCs# produces# neurons# and# astrocytes# while# two-step#
conversion# (via# intermediate# spheres)# produces# neurons,# oligodendrocytes# and# (Hermann# et#
al.,#2006).#Markers#used#for#the#identification#of#specific#lineages#include#β-III#tubulin#(Tub-III),#
glial# fibrillic# acidic# protein# (GFAP),#microtubule# associated# protein# 2# (MAP2ab),# α-Synuclein#
(SNCA),#galactosylceramidase#(GalC)#and#myelin#basic#protein#(MBP).#




premature! neural! phenotype! in! TNFPα! treated! hMSCs! (Egea! et! al.,! 2011)!with! nestin!becoming!downregulated!during!maturation!of!neuroepithelial! stem!cells! (Egea!et! al.,!2011,!Wiese#et#al.,!2004).!hMSCs!expanded! in#vitro! in! the!presence!of!TNFPα!has!been!suggested!to!trigger!neural!gene!expression!with!associated!functional!capabilities.!This!is! potentially! interesting! as! TNFPα! is! thought! to! exhibit! a! proinflammatory! effect! in!neurodegenerative! disorders! such! as! Alzheimer’s! disease! and! Parkinson’s! disease!where!it!is!present!at!elevated!levels!(Greig#et#al.,!2004,!Hallenbeck,!2002).!TNFPα!is!also!reported! to! have! a! neuroprotective! role! contributing! to! the! repair! and! recovery! of!localised!damage!after!stroke!(Turrin!and!Rivest,!2006).!
A!number!of!critical!signalling!pathways!including!BMP,!Wnt!and!FGF!are!suggested!to!be!positive!inducers!of!neural!specification!(BallyPCuif!and!Hammerschmidt,!2003,!Choi!et!al.,!2006).! !With!each!of! these!pathways!known!to!have!HS!dependant! interactions,!this!suggests!a!critical!role!for!HSPGs!in!neural!differentiation!and!lineage!specification.!
5.2 HSPGs and the neural lineage potential 




specification!and!exit!from!selfPrenewal.!This!is!evident!in!the!embryonic!stem!cell!(ESC)!model!where!the!HSPchain!regulating!enzyme!EXT1!has!been!shown!to!be!required!for!ESCs!to!exit!from!selfPrenewal!(Kraushaar!et!al.,!2010).!The!critical!role!for!EXT1!in!this!process!seems!to!be!through!initiation!of!HS!chain!production!ensuring!sufficient!HS!in!the! local! microenvironment! in! order! to! facilitate! FGF! signalling,! inhibition! of! Nanog!expression! and! commitment! of! ESCs! to! lineage! differentiation.! This! has! been!substantiated!with!Ext1-/-#mice! unable! to! produce!HS! demonstrating! that! ablation! of!
Ext1!completely!disrupts!HS!synthesis!in!ESCs.!
HSPGs! also! play! critical! roles! in! modulating! cell! surface! molecular! interactions,!including!ligandPreceptor,!cellPcell!and!cellPmatrix!interactions!(Yamaguchi!2001).!With!interaction! between! HS! and! FGF2! one! of! the! most! studied! PG! interactions,! strong!evidence! exists! that! FGF2! is! one! of! the! crucial! growth! factors! for! proliferation! and!differentiation! of! neural! stem! cells! in! the! developing! cerebral! cortex! (Giordano# et#al.,!1992,! Powell# et# al.,! 1991,! Weise# et# al.,! 1993,! Yamaguchi,! 2001)! where! FGF2! also!regulates! the! fate! of! progenies! generated! from! these! neural! cells! (Qian# et# al.,! 1997,!Yamaguchi,!2001).!!









Figure'5)2: Expression# of# neural# markers,# GFAP# and# Nestin# along# side# HSPG# core# proteins.##
Although#GFAP#expression# is#much# lower# than# that#of# SDC4,#we# can# see# the# same#pattern#of#
expression# with# reduced# expression# at# P+7# followed# by# increased# expression# at# P+13.# In#










(TUBB3),# display# a# decrease# in# expression# throughout# expansion,# in# stark# contrast# to# the#
increase#in#expression#shown#by#both#SDC1#and#GPC1#throughout#expansion.#Interestingly,#the#
immature# neuronal#marker,# TUBB3# is# expressed# at# a# level#more# than# 150X# higher# than# the#
mature#neuronal#marker,#MAP2.#
5.2.1 Neural marker response to niche modification 
Having!established!a!basal!profile!and!correlations!between!several!neural!markers!and!HSPGs,!we! then! examined! changes! in! expression! of! neural!markers! in! response! to! in#
vitro#niche!modification.!!We!determined!significant!changes!in!MSC!and!neural!marker!expression!following!treatment!with!heparin,!a!short!highly!sulfated!analogue!of!HS.!In!addition,! treatment! with! chlorate,! an! inhibitor! of! side! chain! sulfation! resulted! in!significant!changes!in!expression!for!several!of!these!markers.!Markers!for!pluripotency!as! well! as! a! number! of! specific! lineage! markers! were! sensitive! to! both! heparin! and!chlorate! treatment! resulting! in! significant! changes! in! gene! expression! suggesting! a!requirement! for!HS.! ! Results! presented! in! this! section! are! the! results! from! combined!analysis! of! the! three! hMSCs! populations.! ! Gene! expression! graphs! and! significance!values!for!each!individual!population!can!found!in!Chapter!8,!Appendix!5.!









Figure'5)4: Nestin# response# to# heparin# and# chlorate# treatment# in# hMSCs.# Representative#
immunocytochemistry#images#of#hMSC#at#P+7.#Cells#are#stained#for#Nestin#(green)#with#nuclei#
counterstained#with#DAPI# (blue)# # (A)# Control# (B)# 10μg/mL# heparin# (C)# 50mM# chlorate.# (D)#
Nestin# expression#by#Q-PCR.#Blue:# Control;# Red:# 10μg/mL#Heparin;#Green:# 50mM#Chlorate.# *#
P<0.05.#There#was#a# significant# reduction# in# expression# following#both#heparin#and# chlorate#
treatment# at# P+5,# with# significant# reductions# in# expression# following# chlorate# treatment# at#
P+7#and#P+13.#Heparin#treatment#at#these#timepoints#resulted#in#non-significant#increases# in#
expression.#Scale#bar#represents#70μm.#
When! all! three! hMSC! populations! were! examined! together,! neural! pluripotency!markers,!Nanog!and!Oct3/4,!and!the!selfPrenewal!marker,!Nestin,!all!showed!significant!changes! in! their! level!of!expression! in!response! to! in#vitro#niche!modifications.!Nestin!(Figure!5P5!A)!displayed!a!significant!decrease!in!expression!following!both!heparin!and!chlorate! treatment! at! P+5! (Hep:! P5! fold,!P=0.047;! Chl:! P5! fold,!P=0.049).!At! P+7! there!was! a! nonPsignificant! increase! in! Nestin! expression! following! heparin! treatment! (1.5!fold)! and! a! significant! decrease! in! expression! in! response! to! chlorate! (P2! fold;!




expression!observed! following!heparin! treatment! (1.5! fold)!and!a!significant!decrease!following!chlorate!treatment!(P5!fold;!P=0.0491).!
The!only!significant!change!in!the!expression!of!the!pluripotency!marker!Oct3/4!(Figure!5P5!B)!was!observed!at!P+7!following!heparin!treatment,!where!there!was!a!significant!decrease! in! expression! (P3.3! fold;! P=5.37x10P7).! The! neuroepithelial! marker,! NCAD!(Figure! 5P5! C),! showed! decreased! expression! following! heparin! treatment,! with! a!significant! decrease! in! expression! observed! at! P+13! (P1.3! fold;! P=4.12x10P7).! No!significant! change! for! this! gene! was! seen! following! chlorate! treatment.! Nanog!expression!(Figure!5P5!D)!varied!greatly!between!the!three!populations!accounting!for!the!large!level!of!error!when!analysed!together.!On!average,!both!heparin!and!chlorate!resulted!in!decreased!expression!of!Nanog!(P2!–!P10!fold)!at!all!passages,!with!a!slight!nonPsignificant! increase! observed! at! P+5! following! chlorate! treatment.! Heparin!treatment!resulted!in!significant!changes!in!expression!at!P+5!(P10!fold;!P=0.0336)!and!at!P+7!(P5! fold;!P=0.0013).!A!significant! reduction! in!expression!was!also!observed!at!P+7!following!chlorate!treatment!(P1.3!fold;!P=0.0065).!!















(A)# Nestin# (B)# Oct3/4# (C)# Neural# cadherin# (NCAD)# (D)# Nanog# and# Neurofilament# medium#
chain# (NEFM)# (E)# Enolase# 2# (ENO2)# (F)# β-III# Tubulin# (TUBB3)# (G)# microtubule# associated#
protein#2#(MAP2)#(H)#glial#fibrillic#acidic#protein#(GFAP).#Blue#bars:#control;#red#bars:#heparin#
(10μg/mL);#green#bars:#chlorate#(50mM);#*#P<0.05;#**#P<#0.005;#***#P<0.0001.#Treatment#with#
heparin# results# in# an# overall# reduction# in# neural# marker# expression# with# a# few# notable#
exceptions.# # Nestin# expression# increases# following# heparin# treatment# at# later# passages.#
Similarly,# ENO2# shows# a# significant# increase# in# expression# following# heparin# treatment# at#
P+13.# Expression# following# chlorate# treatment# largely# remains# similar# to# control,# however#
Nestin,# ENO2,# TUBB3# and# GFAP# display# significant# decreases# in# expression# following#
treatment.###
!
In! addition,! in! order! to! more! comprehensively! determine! specific! lineage! affects,! an!additional! neuronal! marker! (Doublecortin;! DCX),! three! oligodendrocyte! markers!(Oligodendrocyte! transcription! factor! 1:! O1;! Oligodendrocyte! transcription! factor! 2:!Olig2;! Galactosylceramidase:! GalC)! and! an! astrocyte! marker! (S100! calcium! binding!protein!B;!S100B)!were!examined! following!heparin! treatment!of! the!cultures.! !These!were! identified! as! part! of! a! concurrent! study! on! the! involvement! of! HSPGs! in! the!differentiation! of! NSCs! and! were! included! as! additional! markers! of! specific! neural!lineages.!By!examining!the!expression!of!some!neural!markers! in!NSCs!we!are!able! to!directly! compare! expression! in! native! neural! cells! pre! and! post! differentiation! to! the!levels!observed!in!hMSCs!pre!and!post!differentiation.!The!expression!of!these!markers!was!expected!to!support!specific!neural! lineage!differentiation!following! in#vitro!niche!modification! and! hence! it! was! necessary! to! determine! a! basal! expression! level! and!response!to!heparin.!









Figure'5)6: Additional# neural# lineage#markers.# Expression# changes# in# these# genes#were# only#
examined# following# heparin# treatment.# There# were# no# significant# changes# in# expression#
following# heparin# treatment# in# these# genes.# Expression# of# astrocyte# (S100B)# and#
oligodendrocyte# (GalC,#Olig1,#Olig2)# lineage#markers#remains#relatively#unchanged# following#
heparin#treatment.#Blue#bars:#control;#red#bars:#heparin#(10μg/mL).#




replicates!for!each!sample.!QPPCR!was!conducted!in!quadruplicate!generating!a!total!of!12! replicates! per! gene! for! each! cell! population! under! each! dose! condition,! for! each!passage.! The! average! ΔΔCt! was! calculated! in!Microsoft! Excel! for! each! population! and!each!gene/passage/dose.!In!addition,!standard!deviation!(SD)!and!standard!error!of!the!mean! (SEM)! were! calculated! for! each! treatment! condition! at! each! timepoint.! Mean!expression!was!plotted!with!SEM!unless!fewer!than!six!replicates!had!generated!a!ΔΔCt!in!which!case,!SD!was!used.!If!fewer!than!four!of!the!12!replicates!recorded!a!Ct!value!and! subsequent! ΔΔCt,! it! was! deemed! that! the! gene! was! not! expressed! under! that!condition.!Student’s!TPtests!were!conducted!between!heparin!or!chlorate!ΔΔCt!compared!to!control!ΔΔCt.!Significance!levels!were!set!to!P<0.05.!
5.2.2 ExpressionSuite Analysis 




employed! during! manual! analysis,! explaining! some! differences! between! levels! of!significance!observed!in!the!two!analysis!methods.!!
In! the! analysis! of! P+5! (Figure! 5P7),! volcano! plots! generated! by! the! Expression! Suite!software! suggest! that! expression! of! MAP2! (2.2! fold)! and! GFAP! (3.73! fold)! increased!following!heparin! treatment.! !This! is! in!contrast! to! results! from!our!compiled!manual!analysis! using! Student’s! TPtests! where! MAP2! and! GFAP! expression! showed! nonPsignificantly!decreased!expression!following!heparin!treatment!at!P+5.!!!



















Figure'5)8: Fold# change#of#neural#and#MSC#markers# in# treated#cultures# compared# to# control#


















Figure'5)9: Fold# change#of#MSC#and#neural#markers# in# treated#cultures# compared# to# control#
cultures,#following#niche#modification#at#P+13.#(A)#P+13#heparin#(10μg/mL)#(B)#P+13#chlorate#
(50mM).#Genes#in#red#represent#increased#expression#(>2#fold)#while#genes#in#green#represent#




Table'5)1: Comparison# of# fold# change# results# following# volcano# plot# and# manual# analysis.#
Results# are# presented# as# fold# change# calculated# from# ExpressionSuite# or# estimated# from#
relative#expression#graphs.#Volcano#Plot#(VP);#Manual#Analysis#(MA)#
! Heparin!Treatment! Chlorate!Treatment!! P+5! P+7! P+13! P+5! P+7! P+13!! VP! MA! VP! MA! VP! MA! VP! MA! VP! MA! VP! MA!
Nes! !! P5! !! 1.5! 3.3! 1.5! !! P5! P5.7! P2! P4.2! P5!
Oct3/4! P17.5! !! !! P3.3! !! ! !! !! !! !! !! !!
Nanog! !! P10! 2.67! P5! !! ! !! P5! !! P3.3! !! !!
NEFM! !! !! 2.36! !! !! ! !! !! P5.5! !! !! !!
ENO2! !! P5! !! !! !! 4! !! !! !! !! !! !!
TUBB3! !! P5! !! P1.3! !! P1.25! !! !! P3.5! P4! P3.4! P3.3!
MAP2! 2.2! !! !! P1.6! !! ! 4.24! !! 2.3! 2! !! !!
GFAP! 3.37! !! !! P2! 3.31! P5! 15.56! !! !! P1.3! !! !!!




5.3 hMSC Terminal Neural Differentiation and Intermediate Sphere 
formation  
hMSCs!were!differentiated!toward!neural! lineages!via!intermediated!sphere!formation!followed! by! terminal! neural! differentiation,! and! by! direct! terminal! differentiation.!Detailed!protocols!can!be!found!in!Chapter!2.!For!intermediate!sphere!formation,!cells!were!induced!to!produce!hMSC!neural!stem!cellPlike!spheres!by!plating!hMSCs!on!low!attachment!culture!dishes!in!neural!induction!media!supplemented!with!EGF!and!bFGF.!Spheres!were!maintained!in!sphere!induction!media!for!seven!days.!!On!day!7,!spheres!were!collected!and!distributed!evenly!between! four!35mm!culture!dishes!coated!with!GeltrexTM! and! maintained! in! NeurobasalPA! medium! containing! either! BDNF,! for!neuronal! differentiation,! or! PDGF,! for! glial! differentiation.! ! Following! attachment,!spheres!were!allowed!to!grow!on!GeltrexTM!for!28!days.!!At!this!point,!cells!were!stained!with! the! sterophillic!membrane!dye!FM!1P43!FX,! a! synaptic!membrane!marker.! ! Cells!were! stained! with! dye! only! or! stained! and! then! stimulated! with! KCl! to! induce!membrane! vesicle! uptake.! Following! staining! with! the! membrane! dye,! cells! were!harvested!for!RNA.!In!addition,!cells!were!also!stained!for!a!number!of!neural!markers!and! HSPG! core! proteins! by! ICC! as! well! as! being! examined! for! changes! to! the! gene!expression!by!QPPCR.!











protocol.# # Day# numbers# presented# depict# the# total# number# of# days# cells# have# undergone#
differentiation#(top)#as#well#as#the#number#of#days#on#coated#dishes#(bottom).#RNA#and#protein#
samples#were#harvested#at#harvest#points#following#treatment#with#FM#1-43#FX#synaptic#stain.#
Detailed!protocols!for!intermediate!sphere!formation!and!direct!terminal!differentiation!of! hMSCs! can! be! found! in! Chapter! 2! –! Materials! and! Methods,! Section! 2.8! –! Neural!Differentiation.!
5.3.1 MSC Terminal Differentiation 




When!compared!to!undifferentiated!cells!at!the!same!passage,!the!proliferation!rate!of!the! differentiating! cells! was! greatly! reduced.! Visual! changes! were! apparent! within!hours!of!plating!onto!GeltrexTM!coated!dishes! in! the!presence!of!differentiation!media!supplemented! with! either! BDNF! for! neuronal! differentiation! or! PDGF! for! glial!differentiation!and!included!changes!to!cell!morphology!described!below.!
Initial! proliferation! rates! (estimated! through! observation)! were! similar! to! those! of!hMSCs! cultured! in! maintenance! media! with! cells! requiring! passaging! after! 3P7! days!depending!on!the!plating!passage!(P+5/P+7/P+13).! !Following!the!first!passage!at!D3PD4!after!induction,!proliferation!rates!of!the!cultures!decreased,!with!cells!not!reaching!80%! confluence! over! subsequent! days! and! therefore! not! requiring! further! passaging!prior!to!the!completion!of!their!14P21!days!of!induction.!!At!day!14,!35mm!dishes!were!~70%!confluent!and!cells!appeared!generally!healthy!undergoing!collection!protocols.!Cultures! from! the! second! hMSC! population! (hMSCP2)! underwent! 21! days! of!differentiation!remained!less!than!60%!confluent!at!completion!of!differentiation.!These!cells!did!not!appear!as!healthy!as!hMSCP3!cultures,!however!still!underwent!collection!protocols.!




cells.! Interestingly,! there! were! more! oligodendrocytePlike! cells! observed! in! glial!cultures.!A!schematic!outlining!different!neural!cell!shapes!is!presented!in!Figure!5P11!below.!
!
Figure'5)11: Neural# cell# types.# This# schematic# demonstrates# the# different# morphologies#
associated#with# the# different# neural# cell# types.#Neurons# have# a# large# cell# associated#with# an#
extending# axon# terminating# in# axon# terminals# which# form# synapses# on# the# dendrites# of#
neighbouring# neurons.# In# contrast,# the# shape# of# glial# cells# are# much# more# star-shaped.##
Oligodendrocytes#have# large# foot-like#connections#wrapping#around# the#body#of#an#neuronal#




5.3.1.1 Neuronal Cultures 




the!cells!appearing!irregular!in!shape,!and!while!clearly!not!MSCPlike!they!were!also!not!entirely! neuronal! in! appearance.! While! some! cells! within! cultures! displayed!appearances! characteristic! of! neurons,! such! as! large! cell! bodies!with! elongated! axonPlike! processes! terminating! in! terminalPlike! processes,! other! cells! appeared! to! display!larger! elongated! cell! bodies! only,! with! no! extended! axonPlike! processes! or! axon!terminalPlike! terminals.! Over! subsequent! days,! the! cells! displayed! a! more!heterogeneous!morphology!with!the!cell!body!at!one!end!and!an!elongated!cell!process!extending!in!one!direction.!In!some!cases,!at!the!end!of!the!extended!process!was!what!appeared!to!be!a!growth!cone!(Figure!5P12).!!




However,! in! cultures! where! cells! were! less! confluent,! we! observed! an! increase! in!neuronal! appearance,! with! the! extra! space! apparently! allowing! cells! to! generate!elongated! cell! processes! extending! from! the! cell! body! and! in! some! cases! forming!connections!with!neighbouring!cells.!
5.3.1.2 Glial Cultures 
In!contrast!to!BDNF!treatment,!MSCs!treated!with!PDGF!exhibited!large!morphological!changes!within! hours! of! plating! and! attachment.! ! These! cells! appeared!much! smaller!than! hMSCs! and! in! addition,! the! cells! appeared! more! angular! and! spindle! like,! with!narrow!cell!bodies!and!extending!processes.!!PDGF!cells!also!produced!far!more!waste!during!their!differentiation!process;!requiring!media!changes!more!frequently!than!the!BDNF! treated! cells! and! displaying!more! rapid! proliferation!when! compared!with! the!neuronal!differentiated!cultures.!Morphologically,!these!cells!were!highly!irregular!with!some!cells!displaying!clearly!elongated!morphology!with!small!cell!bodies!and!cellular!processes! extending! from! the! body.! In! some! cases! these! cells! exhibited! starPshaped!morphology!with!cellular!process!reaching! in!all!directions! toward!neighbouring!cells!(Figure!5P12).!




differentiation.! In! addition,! the! spherical,! refractive! cells! observed! in! P+13! cultures!often!appeared!mitotic!rather!than!apoptotic!as!there!was!no!significant!increase!in!cell!numbers! returning! to! suspension! following! passaging,! as! seen! in! neuronal! cultures.!These! cells! became! less! refractive! over! time,! as! the! daughter! cells! expanded! and!flattened!onto!the!culture!surface.!





Figure'5)12: Representative#phase# contrast# images# showing#neuronal#and#glial#differentiation#
at#each#passage#via#direct#terminal#differentiation.#Images#taken#after#cells#had#been#growing#
on#GeltrexTM# for# a#minimum#of# 3# days# and# following# passaging# at#D3-D4.#Neuronal# cultures#





P+5# +PDGF+Hep# (K)# P+7# +# PDGF+Hep# (L)# P+13# +PDGF+Hep.# Arrow# in# panel# D# highlights#











5.3.1.3 Neural marker staining following terminal differentiation 
Cells! underwent! ICC! staining! protocols! at! P+7! (Figure! 5P13)! and! P+13! (Figure! 5P14)!following!terminal!differentiation.!Cells!were!seeded!in!8!chamber!slides!at!the!time!of!the!only!passage!during!differentiation.!Seeded!cells!were!subjected!to!media!changes!and!growth!factor!addition!on!the!same!cycle!as! their!counterpart!P35!culture!dishes.!Markers!examined! in! these! terminally!differentiated! cells! included! the!MSC/astrocyte!progenitor!marker,!CD44,!as!well!as!an!extended!panel!of!neural!markers.!In!addition!to!the! neural! panel! used! to! characterise! neural! potential! of! MSCs! we! included! an!additional! oligodendrocyte!marker,! GalC,! identified! and! used! in! the! concurrent! study!characterising! NSCs.! We! also! stained! neuronal! and! glial! cultures! for! the! HSPG! core!proteins! syndecanP1,! syndecanP4,! glypicanP1!and!glypicanP4.!Finally,!we!examined! the!presence! of! HS! and! CS! chains,! regardless! of! the! core! protein! to! which! they! were!attached,!using!the!panPHS!and!panPCS!antibodies,!10E4!and!CSP56,!respectively.!In!each!of! the! differentiated! cultures! expression! levels! of! markers! were! estimated! based! on!exposure! times! required! to! detect!markers! during! image! acquisition.! Short! exposure!times!suggest!high!levels!of!bound!antiPbody!and!thus!increased!expression,!while!long!exposure! times! suggest! low! levels! of! bound! antibody! and! low!marker! expression.! In!addition,! high! percentages! of! the! population! positive! for! a! marker! also! suggest!increased!expression.!




have!changed!when!compared! to!hMSCs,!appearing!more!diffuse!and! less! filamentous!than!in!undifferentiated!cells.!!Detection!of!the!mature!neural!marker,!MAP2,!was!also!at!low! levels,! however! detection! required! shorter! exposure! times! than! necessary! in!undifferentiated!hMSCs.!Localisation!of!MAP2!was!also!diffuse!rather!than!filamentous!as!expected,!but! this!could!be!due! to! the!small! cell! size!with! low!cytoplasmic!volume.!Contrary!to!expectations,!astrocyte!(GFAP)!and!oligodendrocyte!(O1)!markers!were!still!detected!in!these!cells,!although!both!markers!required!relatively!long!exposure!times!for! detection! compared! to! undifferentiated!hMSCs.! ! The! astrocyte!marker,! GFAP,!was!present!at!much!higher!levels!than!the!oligodendrocyte!markers!examined,!however,!its!localisation!was!diffuse!within!the!cell!and!somewhat!difficult!to!distinguish!from!nonPspecific! binding! of! the! antibody! present! in! these! cultures.! Isotype! controls! and!secondary! antibody! only! controls! were! negative! for! specific! staining;! however! some!nonPspecific! extraPcellular! staining! was! observed! intermittently! with! the! rabbit! IgG!isotype!control!(see!negative!control!panels,!Chapter!8,!Appendix!7).!!




syndecanP4!also!displayed!some!nonPspecific!binding!giving!a!speckledPlike!appearance!to!the!cultures!however!this!was!not!consistent!across!cultures,!with!glial!cultures!not!displaying! the! same! level! of! nonPspecific! binding.! GlypicanP1! detection! was! at! levels!equal! to! those! of! hMSCs! while! glypicanP4! detection! was! reduced.! ! Localisation! of!glypcicanP4! also! appeared! to! change! with! a! more! diffuse,! localisation! around! the!nucleus,!rather!than!the!distinct!punctate!pattern!exhibited!over!the!entire!cell!surface!of!hMSCs.!Finally,!CS!chains!were!detected!in!the!extracellular!space!surrounding!cells,!with!low!or!no!cellular!localisation!in!neuronal!cultures.!








Figure'5)13: Representative# images# of# hMSCs# following# terminal# differentiation# at# P+7.#
Neuronal# and# glial# cultures# (with# and# without# heparin)# continue# to# express# self-renewal#
markers#Nestin#and#Sox2.#Neuronal# cultures# (+/-#Hep)#also#display#expression#of# the#mature#
neuronal# marker# microtubule# associated# protein# 2# (MAP2)# while# glial# cultues# (+/-# Hep)#
display# expression# on# astrocyte# (glial# fibrillic# acid# protein;# GFAP)# and# oligodendrocyte# (O1)#
specific#makers.# In# addition,# # syndecan-4# and# glypican-1# (GPC1)# were# detected# at# relatively#
high#levels#in#both#neuronal#and#glial#cultures#while#expression#of#syndecan-4#and#glypican-4#
(GPC4)#were# greatly# reduced# compared# to# undifferentiated# hMSCs.# Images# presented# are# at#









heparin),! with! some! localisation! within! the! cell,! but! the! majority! of! CS! chains! were!detected!in!the!extracellular!space!surrounding!the!cells.!






Figure'5)14: Representative# immunocytochemistry# images# of# hMSCs# following# terminal#
neuronal#and#glial#differentiation#at#P+13.#The#mature#neuronal#marker,#MAP2,#is#expressed#in#
the#neural#cultures#while#expression#of#astrocyte#(GFAP)#and#oligodendrocyte#(GalC)#markers#
was# detected# in# the# glial# cultures.# # All# cultures# expressed# easily# detectable# levels# of# HS# as#
determined#by# strong#positive# staining# for# the#pan-HS#marker#10E4.# In#addition,#all# cultures#
expressed# the# self-renewal# markers# Nestin# and# Sox2,# with# some# variation# in# strength# of#
staining# detected# between# cultures.# All# images# at# 20x# magnification.# Scale# bar# represents#





5.3.2 Differentiation via intermediate spheres 
5.3.2.1  Sphere Formation 
The!ability!of!these!hMSC!populations!to!form!spheres!varied!between!populations!and!between!passages.! !The!most!obvious!difference!was!the!reduced!ability!of!both!hMSC!populations! to!produce! large! spheres! at! P+13! (Figure!5P15).! !While! both!populations!examined! produced! large! healthy! looking! spheres! at! both! P+5! and! P+7,! spheres!produced!at!P+13!were!much!smaller!and!did!not!appear!as!healthy.!!This!observation!was!supported!by!the!reduced!ability!of!these!cells!to!adhere!to!GeltrexTM!coated!dishes!after! 7! days! of! sphere! induction,! with! cells! from! only! one! of! the! two! populations!subsequently!adhering!to!GeltrexTM!coated!dishes.!!At!all!passages,!induction!of!sphere!formation!became!apparent!after!only!a!few!hours!in!induction!media,!with!clustering!of!cells! observed.!By!24!hours! the!presence!of! large!numbers!of! spheres!of! varying! size!was!observed,!except!at!P+13!where!cells!produced!clusters! rather! than!spheres.!The!maximum!size!of!spheres!observed!was!at!P+5!with!spheres!observed!with!diameters!greater! than! 400μm.! ! While! at! P+7! the! spheres! were! smaller! (maximum! diameter!approximately! 300μm),! they! were! still! clearly! spheres! rather! than! the! cell! clusters!observed!more!often!at!P+13.!While!a!very! few!P+13!spheres!reached!similar!sizes!to!P+7! spheres! (approximately! 200μm)! the! majority! of! cell! clusters! observed! at! this!passage!were!no!more!than!100μm!in!diameter.!




size!of!the!majority!of!spheres.!In!addition,!some!spheres!did!not!seem!to!dramatically!increase! in! size,! appearing! small! (approximately! 200μm)! in! comparison! to! more!moderate!size!spheres!formed!(approximately!300P400μm),!however,!even!these!small!spheres!maintained! an! even,! spherical! shape.! Following! sphere! collection! and!media!change! at! D3! postPinduction,! moderate! sized! spheres! maintained! their! spherical,!regular!shape.!The!larger!spheres!appeared!to!lose!some!connections!on!the!outer!layer!of!the!sphere,!resulting!in!a!surrounding,!attached!ring!of!satellite!cells,!producing!rafts!of!cells!suspended!higher!in!the!media!than!smaller!spheres!without!satellite!cells.!
At! P+7! the! overall! size! of! spheres! formed! was! smaller! (maximum! approximately!300μm)!than!those!induced!at!P+5.!However,!the!moderate!sized!spheres!(200P300μm)!that!formed!maintained!a!regular!spherical!appearance!(Figure!5P15).!!In!these!cultures,!the!smaller!cell!clusters!(approximately!100μm)!were!more!irregular!in!shape!tending!towards!a!cluster!appearance!in!contrast!to!the!spherical!appearance!of!small!clusters!in!P+5.! !Overall,! there!were!fewer!spheres!formed!at!P+7!compared!to!P+5.!Following!media! change! at! D3! postPinduction,! P+7! spheres! also! produced! some! cell! rafts,! with!more!moderate!sized!spheres!breaking!down!completely!resulting!in!a!true!raft!of!cells!suspended!higher!in!the!media!than!the!spheres.!










Figure'5)15: Representative# phase# images# of# sphere# formed# following# induction# at# each#
passage.#Images#taken#at#D3#after#sphere#induction.#It#can#clearly#be#seen#that#the#cells#have#an#











5.3.2.2 Live/Dead analysis of P+5 Spheres 
When! P+5! spheres! were! examined! by! live/dead! assay! using! FDA/PI! live! cells! were!consistently! observed! through! the! entire! sphere! indicated! by! the! presences! of! the!cleaved,! activated! from! of! FDA,! fluorocein,! which! can! only! be! achieved! by! live! cells.!!While!there!were!some!dead!cells!present,!indicated!by!nuclear!staining!with!PI,!these!cells! were! scattered! throughout! the! sphere! as! well! as! around! the! periphery! of! the!sphere,!suggesting!the!spheres!contained!a!core!of!live!cells!(Figure!5P16).!
!
Figure'5)16: hMSC-21558# P+5# Spheres# FDA/PI# -# Live/Dead# staining.# Cells# were# stained# with#
FDA/PI#staining#after#spheres#had#attached#to#slides# for# less# than#24hrs.#FDA# is#converted#to#
the#active# fluorescent# form#Fluorocein# in# live# cells# (green)#while#PI# can#only# diffuse# through#
disrupted# cellular# membranes,# indicating# dead# cells# (red).# Analysis# of# Z-stack# images# taken#
through# the# sphere# indicates# a# live# sphere# core,# rather# than# live# cells# surrounding# a# core# of#
dead#cells.#Scale#bar#represents#100μm.#
5.3.2.3 hMSC P+5 spheres are positive for neural progenitor markers and 
HSPG core proteins 









Figure'5)17: hMSC-21558# P5# spheres#
stained# for# neural# self-renewal# markers,#
HSPG# core# proteins# and# the# pan-HS#
antibody# (10E4)# to# detect# the# presence# of#
HS# chains.# Strong# staining# of# HS# chains# is#
observed# along# with# the# neural# stem# cell#
self-renewal#maker,#Nestin.# # In# addition# to#
Nestin,# Sox2# was# also# detected# in# P+5#
spheres.# # Finally,# we# observed# distinct#
staining# with# antibodies# against# the# core#
HSPG# proteins,# glypican-1# (GPC1)# and#
glypican-4# (GPC4).# Secondary# antibodies#
used# were# AlexaFluor594# (red),# FITC#
(green)# and# Cy3# (yellow).# Nuclei# were#






5.3.2.4 MSC Glial and Neuronal Differentiation 





Figure'5)18: Terminal#differentiation# following# intermediate# sphere# formation.#Representative#
hMSC# images# (20X# magnification)# following# sphere# attachment# to# GeltrexTM# coated# plates.##
Days#presented#are#total#number#of#days#following#sphere#induction.#Cells#attached#at#D8#have#
been#on#GeltrexTM#for#~24hrs.#Cells#were#allowed#to#proliferate#on#adherent#plates#for#a#further#







5.3.2.5 MSC lineage specific markers detected in neuronal and glial 
cultures following intermediate sphere formation 




In!glial! cultures!CD44!was!also!present!at! low! levels! (>800ms).!Both!Nestin!and!Sox2!were!present!at!low!levels!consistent!with!detection!in!other!cultures!differentiated!via!intermediate! sphere! formation! (>1.5s).! Sox2! localisation! was! cytoplasmic! and! more!diffuse!and!less!punctate!than!that!observed!in!hMSCs.!The!neuronal!maker!MAP2!was!present!at!low!levels!(20%!of!cells),!while!oligodendrocyte!and!astrocyte!makers!were!present!at!higher!levels!than!in!neuronal!cultures!(>80%,!~800P900ms).!These!cultures!stained! positive! for! GFAP!with! localisation! similar! to! that! observed! in! hMSCs! and! in!other! differentiated! cultures,! rather! than! the! unusual! extracellular! staining! seen! in!neuronal! cultures!differentiated!via! intermediate! spheres.!Levels!of!HS!detected!were!reduced! compared! to! neuronal! and! direct! terminal! differentiated! cultures,! as!determined!by!extended!exposure!times!during!image!acquisition.!In!addition,!levels!of!syndecanP1! were! reduced! compared! to! neuronal! cultures! (>1.5s),! although! higher!(900msP1s)! than!detected! in! the! terminal!differentiation!cultures,! returning!almost! to!levels!detected!in!hMSCs!(~900ms).!Similarly,!syndecanP4!levels!were!lower!compared!to! terminally! differentiated! cultures,! again,! similar! to! levels! detected! in! hMSCs.! Both!glypicanP1!and!glypicanP4!were!reduced!compared!to!neuronal!cultures,!although!levels!of!glypicanP4!were!higher!than!those!detected!in!terminally!differentiated!cultures.!CS!chains! detected! in! these! cultures! exhibited! a!more! cellular! localisation! in! some! cells,!with!less!extracellular!staining!observed!in!the!space!surrounding!cells!than!observed!in!other!cultures.!




of!oligodendrocyte!makers!GalC!and!O1!was!very!low!(>1.5s).!GFAP!staining!was!once!again!unusual,!with! almost! extracellular!detection.! Levels! of!HS!were! greatly! reduced!compared! to! terminal! cultures! while! syndecanP1! and! syndecanP4! were! detected! at!similar!levels!to!glial!cultures!not!supplemented!with!heparin!(~900ms).!Both!glypicanP1!and!glypicanP4!were!also!detected!at!similar!levels!to!unPsupplemented!glial!cultures!(~700P800ms)!at! levels!reduced!when!compared! to!hMSCs!(>900ms).!CS!chains!were!once!again!detected!with!predominantly!extracellular!localisation.!






of# hMSC# P+7# Spheres+GTX# following#
neuronal# or# glial# differentiation.# Cells#
were# transferred# to# slides# during#
normal# passaging# protocols# conducted#
approximately#25#days#after#plating#to#
GeltrexTM#coated#plates.#At#this#point# it#
was# determined# that# sufficient# cells#
were# present# to# divide# between# two#
P35#dishes#and#one#8-chamber# slide# to#
provide# samples# for# RNA,# protein# and#
ICC#examination.# #This#was#not# true# in#
all# cases# as# determined# by# reduced#
attachment# efficiency# (approximately#
10%)# and# low# viability# of# attached#
cells.#This#resulted#in#few#or#no#cells#for#





5.3.3 Synaptic Staining of neural differentiated cultures 
We! stained! terminally! differentiated! cells! and! those! differentiated! via! intermediate!sphere!formation!with!a!sterephilic!membrane!dye,!FM!1P43!FX.!This!dye!rapidly!stains!the!plasma!membrane!allowing!visualisation!of!any!vesicles!formed!following!treatment!with! potassium! chloride! (KCl)! to! stimulate! calcium! (Ca2+)! uptake.! If! KCl! treatment!results!in!active!Ca2+!channels,!a!characteristic!of!functional!synapses,!endocytosis!of!the!lipophilic!membrane!dye!should!be!visible.!





Figure'5)20: Synaptic#membrane# staining# following# stimulation#with#KCl# or#mock# stimulation#
with#Triton-X-100#and#EDTA.#Treatment#with#Triton-X/EDTA#resulted#in#destruction#of#the#cell#
membranes# leaving# insufficient#membranes# in# tact# to#determine#the#effect#of#KCl#stimulation#
on# these# cells.# The# lack#of# intact#membranes# can#be# seen# in#panel#A#and#C.# # (A)#FM#1-43#FX#
stained# cultures# following# Triton-X/EDTA/KCl# Treatment# (B)# FM# 1-43# FX# stained# cultures#
stimulated#with#KCl#only##(C)#Phase#image#of#cultures#following#Triton-X/EDTA/KCl#Treatment#
(D)#Phase#image#of#FM#1-43#FX#stained#cultures#stimulated#with#KCl#only#.#













Figure'5)21: Representative# images# of# terminally# differentiated# hMSCs# at# P+5# following#
synaptic# staining.# Panels# A-D# representative# images# of# neuronal# cultures.# Panels# E-F#
representative# images# of# glial# cultures# supplemented# with# heparin.# There# are# no# obvious#




dye# (D)# phase# image# of# neuronal# culture# stained# with# FM# 1-43# FX# dye# following# KCl#
stimulation# (E)# glial# culture# (+Hep)# stained# with# FM# 1-43# FX# dye# (F)# glial# culture# (+Hep)#
stained##with#FM#1-43#FX#dye#following#KCl#stimulation#(G)#phase#image#of#glial#culture#(+Hep)#
stained#with#FM#1-43#FX#dye#(H)#phase#image#of#glial#culture#(+Hep)#stained##with#FM#1-43#FX#















Figure'5)22: Synaptic# staining# of# hMSC-21558# P+5# neuronal# and# glial# differentiated# via#
intermediate# sphere# formation.# For# both# neuronal# and# glial# cells# there# are# no# obvious#
differences# between# cells# treated# with# the# membrane# dye# (FM# 1-43# FX)# only,# and# those#
subsequently# treated# with# KCl# to# stimulate# synaptic# vesicle# uptake.# There# was# also# no#
difference#between#neuronal#and#glial#cultures.#(A)#Neuronal#culture#stained#with#FM#1-43#FX#




phase# image# of# glial# culture# (+Hep)# stained# with# FM# 1-43# FX# dye# (H)# phase# image# of# glial#










5.4 ExpressionSuite Analysis 
Changes!to!the!gene!expression!profile!of!a!number!of!neural!genes!as!well!as!markers!of!mesenchymal! lineages!were! examined! following! neural! differentiation! by! terminal!differentiation!or!the!formation!of!intermediate!spheres.!Due!to!the!low!quantity!of!the!RNA!samples!collected!as!a!result!of!low!cell!number,!insufficient!data!was!generated!to!enable! conclusive! statistical! analysis.! However,! analysis! of! the! data! generated! using!ExpressionSuite!software!was!sufficient!to!suggest!trends!related!to!the!changes!in!gene!expression!observed.!!




heparin! to! either! neuronal! or! glial! cultures! as! well! as! the! difference! between!unsupplemented!glial!cultures!when!compared!to!neuronal!cultures.!
5.4.1 Terminal Differentiation 
Separating!data!from!terminal!differentiation!experiments!into!studies!to!examine!each!passage!individually!did!not!reveal!informative!trends.!Instead!it!was!decided!to!analyse!the!data!generated!across!all!passages!to!determine!trends!influencing!neuronal!or!glial!differentiation.!





Figure'5)23: Volcano# plot# analysis# comparing# gene# expression# in# terminally# differentiated#
neuronal# cultures# following# addition# of# heparin.# # Expression# of# glyican-2# (GPC2)# showed# a#
large# increase# in# expression# following# heparin# treatment# of# these# cultures,# while# glypican-1#
(GPC1)# showed#a# corresponding,# but# smaller,# decrease# in# expression.#Red# represents# greater#















greater# than# 2# fold# increased# expression# while# green# represents# a# greater# than# 2# fold#
decreased#expression.#




4!(3!fold).!In!contrast! levels!of!astrocyte!and!oligodendrocyte!makers!GFAP!(P5.9!fold)!and! GalC! (P2.3! fold)!were!moderately! reduced!with! the! neuronal!maker! TUBB3! (P8.2!fold)!also!demonstrating!a!modest!reduction!in!expression.!In!contrast!to!the!syndecans,!expression! of! glypicanP1! (P17.5! fold)! and! glypicanP3! (P18.5! fold)!was! also! reduced! in!glial!cultures!compared!to!neuronal!cultures.!
!
Figure'5)25: Volcano# plot# analysis# comparing# terminally# differentiated# glial# cultures# to#
neuronal# cultures.# Glial# cultures# demonstrate# elevated# levels# of# astrocyte# (S100B)# and#
oligodendrocyte# makers# (Olig1# &# Olig2)# in# contrast# to# the# decreased# levels# of# neuronal#
markers#such#as#TUBB3#seen#in#these#glial#cultures.#Levels#of#syndecan-1#(SDC1)#and#syndecan-
4# (SDC4)# were# elevated# in# glial# cultures,# while# levels# of# glypican-1# (GPC1)# and# glypican-3#





The!trends! in! the!data!suggest! that!overall! levels!of!neuronal!makers!are! increased! in!neuronal!cultures!and!glial!makers!in!glial!cultures.!!In!addition,!there!are!some!distinct!differences!in!the!expression!of!HSPG!core!proteins!suggesting!the!involvement!of!these!families!in!the!differentiation!of!hMSCs!toward!either!neuronal!or!glial!cells.!
5.4.2 Terminal Differentiation via intermediate spheres 
As! for! the! direct! terminal! cultures,! Expression! suite! analysis! was! conducted! on! the!combined!data!generated!across!differentiation!at!all!passages.!!Separating!the!samples!and!analysing!by!passage!did!not!generate!any!informative!results.!







astrocyte# and# oligodendrocyte#markers# in# neuronal# cultures# supplemented# with# heparin.# In#
addition,# both# syndecan-3# (SDC3)# and# syndecan-4# (SDC4)# demonstrate# elevated# expression#
under# these# conditions.#While# GPC6# also# demonstrates# increased# expression,# the# decrease# in#
glypcain-1# (GPC1)# expression# is# in# direct# contrast.# Red# represents# a# greater# than# 2# fold#
increased#expression#while#green#represents#a#greater#than#2#fold#decreased#expression.#




cultures,!with!Nestin!demonstrating!the!greatest!reduction!in!expression!(P200!fold).!As!mentioned!earlier,!the!expression!of!GFAP!(P14.3!fold),!GalC!(P3!fold)!and!Olig2!!(P24.4!fold)! demonstrated! reduced! expression.! ! Of! the! HSPGs,! glypicanP3! (P2.5! fold)! and!glypicanP6!(P7.1!fold)!also!demonstrated!reduced!expression!resulting!from!addition!of!heparin!to!glial!cultures.!
!
Figure'5)27: Volcano# plot# analysis# comparing# glial# cultures# differentiated# following#
intermediate# sphere# formation.# Expression# of# some#neuronal#markers# as#well# as# some#HSPG#
core# proteins# are# elevated# following# differentiation# in# the# presence# of# heparin.# In# contrast,#
expression# of# astrocyte# and# oligodendrocyte# markers# are# generally# decreased# under# these#
conditions.# Some#HSPG# core#proteins# (glypican-3:#GPC3;# glypican-6:#GPC6)#also# demonstrate#
reduced#expression#in#glial#cultures#supplemented#with#heparin.#Self-renewal#and#pluripotency#
markers# (Nestin,# NEFM,# Oct3/4)# also# show# moderate# to# large# decreases# in# expression# in#












intermediate# sphere# formation.# Levels# of# some# astrocyte# and# oligodendrocyte# markers# are#
elevated#in#glial#cultures#while#levels#of#some#neuronal#marker#appear#decreased.#In#addition,#
expression# of# syndecan-3# (SDC3),# syndecan-4# (SDC4)# and# glypican-6# (GPC6)# are# elevated# in#
glial# cultures# while# levels# of# glypican-1# (GPC1)# appear# decreased# in# these# cultures.# Red#
represents# greater# than# 2# fold# increased# expression.# Green# represents# greater# than# 2# fold#
decreased#expression.#
5.5 Traditional ΔΔCt analysis 




compared! relative! expression! in! differentiated! cultures! to! relative! expression! levels!observed!in!undifferentiated!hMSCs!determined!in!Chapter!4.!!
Surprisingly,! MSC! markers! such! as! the! adipogenic! marker! C/EBPδ! were! detected! in!cultures! differentiated! following! intermediate! sphere! formation! at! P+5! and! P+13!(Figure! 5P29).! Following! differentiation! at! P+5,! the! highest! level! of! expression! was!observed! in!neuronal!cultures!supplemented!with!heparin!(1.2! fold!higher!than!BDNF!only).!!In!contrast,!by!P+13,!expression!was!peaking!in!glial!cultures!without!heparin!(2!fold!higher!than!BDNF+Hep!or!PDGF+Hep).!The!presence!of!MSC!lineage!markers!could!suggest! that! the! cells! are! not! completely! differentiated! and! still! retain! some!multipotency.! This! correlates!with! evidence! previously! reported! of! the! expression! of!osteogenic!and!adipogenic!lineage!markers!in!neural!cells!(Ichikawa#et#al.,!1999,!Sarruf#
et#al.,!2009).!
!
Figure'5)29: Relative# expression# of# the# adipogenic# marker# C/EBPδ# in# neural# differentiated#
cultures# following#differentiation#via# intermediate#sphere# formation.#Data#presented# is#mean#
ΔΔCt#±#SEM.#Experiments#were#conducted#in#quadruplicate.#Expression#has#been#normalised#to#
expression#of# 18S.# It# is# interesting# to#note# the# continued# expression#of# this#marker# following#
differentiation,# suggesting# that# the# cells# are# still# not# entirely# committed# to# their# neural#
lineages.#(P+5:#n=6;#P+13:#n=3)#









Figure'5)30: Expression# of# the# pluripotency#marker# Oct3/4# following# terminal# differentiation#
via#intermediate#spheres.#(A)#OCT3/4#P+5#(n=6)#(B)#OCT3/4#P+13#(n=3)#(C)#Nanog#P+5#(n=6)#
(D)# glial# fibrillic# acidic# protein# (GFAP)# P+5# (n=6).# At# P+5# expression# of# Oct3/4# decreases#
drastically#across#the#differentiation#protocols#with#the#highest#level#of#expression#observed#in#
the#neuronal#cultures#without#heparin.#
5.6 Changes to HSPG Core Protein expression following direct 
terminal differentiation or via intermediate sphere formation 




While! we! know! that! HSPGs! are! heavily! involved! in! a! number! of! critical! cellular!processes,!and! that! they!are!highly!regulated!during!development,! the! involvement!of!HSPGs! in! the! neural! differentiation! process! of! hMSCs! has! not! previously! been!investigated.!Although!far!from!conclusive,!our!data!suggests!the!critical!involvement!of!these!ubiquitous!proteins!in!these!processes.!
Where! sufficient! data! existed! to! compare! expression! means! from! different! lineages,!relative! quantitation! graphs! were! drawn! as! outlined! in! Chapter! 2! some! interesting!trends!were!observed.!
!Both!direct!terminal!differentiation!and!terminal!differentiation!following!intermediate!sphere! formation!produced!nonPsignificant!changes! in!expression!of! the!core!proteins!that! correlates!with! changes! in!expression! seen! in! some!neural!pluripotency!markers!and!markers!of!specific!neural!lineages.!!




elevated! compared! to! hMSCs! at! P+5! (2! fold)! with! addition! of! heparin! to! the! culture!reducing!expression! to! levels!equal! to!hMSCs.!At!P+13,! expression!of! syndecanP4!was!similar! to! levels!observed! in!hMSCs!with! the!addition!of!heparin! reducing!expression!considerably.!
!
Figure'5)31: Gene# expression# changes# following# neuronal# and# glial# terminal# differentiation.#
Syndecan-1# (SDC1)# was# not# detected# in# neuronal# cultures# at# either# P+5# or# P+13.# In# glial#
cultures,# expression# of# SDC1# was# reduced# compared# to# levels# observed# in# hMSCs.# Levels# of#
(Syndecan-4)# SDC4# were# reduced# in# neuronal# cultures# compared# to# hMSCs,# while# glial#
expression#at#P+5#was#increased#compared#to#hMSCs.#(n=6)#







similar# (-1.1# fold)# to# those# observed# in# undifferentiated# hMSCs# while# glial# cultures#
demonstrated# reduced# expression# (-10# fold)# compared# to# undifferentiated# cells.# # Addition# of#
heparin# to# cultures# resulted# in# increased# expression# compared# to# un-supplemented# cultures#
with# levels# of# SDC3# in# neuronal# cultures# supplemented# with# heparin# 2# fold# higher# than#
undifferentiated#cells.#(n=6)#




closer! to! those! observed! in! hMSCs,! but! still! elevated! (approximately! 2! fold! higher).!Addition!of!heparin!to!glial!cultures!almost!completely!ablated!expression!of!glypicanP1!in!supplemented!cultures.!
!
Figure'5)33: Relative#expression#of#HSPG#core#proteins#in#neuronal#and#glial#cultures#following#










Figure'5)34: Relative# expression# of# syndecan-3# (SDC3)# at# P+7# following#neural# differentiation#





5.7.1 Terminal Differentiation 





Proliferation! rates! in! terminal! cultures! remained! rapid! for! the! first! 3P5! days! of!differentiation! with! cultures! requiring! passaging! at! 80%! confluence! by! D3! for! P+5!cultures! and! D5! for! P+13! cultures.! ! This!was! the! same! passaging! interval! as! seen! in!undifferentiated!cells.!!Following!passaging!at!D3PD5,!proliferation!rates!slowed!in!these!cultures,!as!determined!by!percentage!confluency!by!D6PD10.!Undifferentiated!cultures!at! this! stage! would! have! once! again! reached! 80%! confluence;! while! differentiated!cultures!had!only!reached!50P60%!confluence!with!reduced!proliferation!rates.!By!D14!glial!cultures!had!once!again!reached!80P90%!confluence!while!neuronal!cultures!at!this!point!displayed!a!maximum!of!60P70%!confluence.!
While!reduced!proliferation!rates!could!suggest!cell!death,!the!combination!of!observed!reduced! proliferation! rates! in! differentiated! cultures! combined! with! observed!morphological! changes! characteristic! of! mature! neural! cultures! supports! the!differentiation!of!these!hMSC!populations!toward!neural!lineages.!
5.7.2 Differentiation via Intermediate Spheres 




differentiated!at!P+13!displayed!greatly! reduced! capacity! to! adhere! to! culture!dishes,!with! cells! from!only!one!of! the! two!populations! subjected! to!differentiation!protocols!able! to! attach! (approximately! 20%).! Despite! some! cultures! displaying! reduced!attachment! efficiency,! all! cultures! displayed!morphological! and! phenotypical! changes!and!distinct!neural!characteristics!when!compared!to!the!hMSCs!from!which!they!were!derived.!In!neuronal!cultures,!cells!appeared!to!have!distinct!neuronal!cell!shapes!with!large!cell!bodies!and!elongated!axonPlike!process!extending!from!the!cell!body!as!well!as!the!presence!of!dendritePlike!processes!surrounding!the!cell!body!itself.!In!glial!cultures!cells!with!the!distinct!starPshaped!appearance!of!astrocytes!were!observed,!although!in!small! numbers.! ! Far! more! frequently,! cells! displaying! distinct! oligodendrocytePlike!characteristics!were!observed.! ! In!these!cases!cells!displayed!a!simpler!starPlike!shape!in! the! cell! body! (with! fewer! dendritePlike! projections! than! astrocytePlike! cells)! with!some!elongated!extensions!terminating!on!or!very!close!to!neighbouring!cells.!
Cultures!induced!via!intermediate!sphere!formation!also!showed!some!variation!in!their!proliferation! rates.! ! Following!plating!onto! coated!dishes,! glial! cultures!demonstrated!rapid!proliferation!until!D3!where!cultures!had!reached!approximately!20%!confluence.!Over!subsequent!days!to!complete!differentiation,!glial!cultures!reached!a!maximum!of!50%!confluence!(D21P28).!In!contrast,!neuronal!cultures!displayed!a!greater!reduction!in!proliferation!rate!immediately!following!plating!to!adherent!culture!dishes.!Neuronal!cultures! reached! approximately! 20%! confluence! by! D5! and! their! proliferation! rate!further!decreased!at! this!point!with!maximum!confluence!of!40P50%!at!completion!of!differentiation!protocols!(D21PD28).!





5.7.3 Analysis by Immunocytochemistry 
Terminal!cultures!examined!by!ICC!displayed!expression!of!neural!markers!specific!to!neuronal!and!glial!lineages!as!well!as!low!levels!(compared!to!undifferentiated!cells)!of!selfPrenewal! markers! (Nestin,! Sox2).! Neuronal! cultures! expressed! MAP2,! the! mature!neuronal!marker!while! glial! cultures! expresses!detectable! levels! of!GFAP! (astrocytes)!and!GalC!and!O1!(oligodendrocytes).!Low!levels!of!selfPrenewal!markers!are!indicative!of! reduced! selfPrenewal! capacity.! ! Combined!with! the! increased! expression!of! lineage!specific!markers!(relative!to!undifferentiated!cells)! this!supports!the!differentiation!of!these!hMSC!cultures!toward!specific!neural!lineages.!
When!examined!by!ICC,!both!neuronal!and!glial!cultures!differentiated!via!intermediate!sphere! formation! expressed!markers! specific! to! their! lineages!with! elevated! levels! of!MAP2! expression! in! neuronal! cultures! and! elevated! levels! of! GalC! and! GFAP! in! glial!cultures.! In!addition!both!cultures,!as!well! those!cultures!supplemented!with!heparin,!expressed!NSC!selfPrenewal!markers,!Nestin!and!Sox2,!although!at!visually!lower!levels!than!detected!in!undifferentiated!hMSCs,!suggesting!a!reduced!ability!of!the!cells!to!selfPrenew.!!




glial!cultures.!!Expression!was!not!limited!to!the!nucleus!with!detection!in!the!cytoplasm!observed! more! often! than! nuclear! detection.! In! both! sets! of! neuronal! cultures!expression!of!MAP2!appeared!diffuse!and!globular.! !This!could!be!due! to! the!reduced!size! of! the! cell! body,! with! reduced! cytoplasmic! volume! making! distinction! between!individual! filaments! difficult.! The! astrocyte! marker! (GFAP)! and! the! oligodendrocyte!marker!(O1)!demonstrated!the!same!staining!pattern! in!differentiated!cultures!as!had!been!observed!in!undifferentiated!cells.!!
The!presence!of!high!levels!of!HS!as!determined!by!strong!staining!and!short!exposure!times! (300P500ms)! using! the! panPHS! antibody! suggests! that! HS! is! integral! to! the!differentiation!of!hMSCs!toward!neural!lineages.!This!is!supported!by!the!dual!staining!observed!between!HS!and!neural!stem!cell!selfPrenewal!marker!Nestin.!
5.7.4 Gene Expression Analysis 




thereby! suggesting! a! lack! of! expression! of! some! genes! rather! than! reduced,! or!increased,! expression! as!determined!by! volcano!plot! analysis.!While! some! interesting!trends!were!identified,!along!with!potential!candidates!for!the!differentiation!of!hMSCs!toward!specific!neural!lineages,!further!replication!is!required!to!confirm!the!suitability!of!candidate!genes!identified.!
5.7.5 Heparan Sulfate Proteoglycans 
Both!neuronal!and!glial!cultures!that!underwent!terminal!differentiation!expressed!the!four!HSPG! core!proteins! examined.!The! addition!of! heparin! to! the! culture! resulted! in!reduced! expression!of! syndecanP1! and! glypicanP4.! !Detection! of! both! syndecanP4!was!increased! in! both! neuronal! and! glial! cultures! compared! to! undifferentiated! cells! as!determined!by!shorter!exposure!times!during!image!acquisition.!In!contrast,!detection!of! glypicanP1! was! at! similar! levels! to! that! observed! in! undifferentiated! cells,! as!determined!by!similar!exposure!times!during!image!acquisition.!




While! often! levels! of! marker! detection! were! extremely! low,! with! extended! exposure!times!required! for!detection,!positive!marker!staining!was!confirmed!by! the!complete!lack!of!staining!and!subsequent!detection!of! fluorescence! in!both! isotype!controls!and!secondary!antibody!only!negative!controls.!
Low!levels!of!syndecanP1!are!indicative!of!decreased!cellular!proliferation!(Okolicsanyi#
et#al.,! 2014b),! suggesting!a!move! towards!mature!neural! cell! types.!Elevated! levels!of!syndecanP4!are!indicative!of!increased!focal!adhesions!and!decreased!cellular!migration!(Tkachenko# et# al.,! 2005,! Woods! and! Couchman,! 2001).! The! combination! of! elevated!syndecanP1!and!decreased!syndecanP4,!or!vice!versa,!has!been!correlated!with!cellular!proliferation!and!migration! in! a!number!of!models,! including! tumorogenisis!of!breast!cancers! (Okolicsanyi! et! al.,! 2014b).! ! In! addition,! differentiation! of! stem! cells! requires!reduced!migration!and!in!neural!lineages!decreased!proliferation.!!





While! not! restricted! to! neural! cells,! elevated! levels! of! glypicanP1! observed! in!differentiated!hMSC!cultures!compared!to!undifferentiated!hMSCs!could!be!indicative!of!commitment!toward!neural! lineages.!GlypicanP1!has!previously!been!reported!to!have!neuronal! expression! (Bandtlow! and! Zimmermann,! 2000,! Litwack# et# al.,! 1994)! with!expression!also!reported!in!neurons!and!Schwann!cells,!lung!fibroblasts!and!developing!bone! (Bandtlow! and! Zimmermann,! 2000,! Carey# et# al.,! 1993,! David# et# al.,! 1990,!Karthikeyan# et# al.,! 1994,! Litwack! et! al.,! 1994).! The! reduced! expression! of! glypicanP4!observed! in! neuronal! cultures! (terminal! differentiation! and! those! differentiated! via!intermediate!spheres)!correlates!with!reported!evidence! that!glypicanP4!expression! is!reduced! in! the! CNS! of! adults! (Bandtlow! and! Zimmermann,! 2000,! Lamoureux# et# al.,!2007).! GlypicanP4! is! well! characterised! in! terms! of! neurogenesis! (Yamaguchi,! 2001)!with! developmental! stage! specific! expression! detected! in! the! kidney! and! developing!brain!in!murine!models!(Watanabe#et#al.,!1995,!Yamaguchi,!2001).!In!neural!stem!cells!
in#vitro,!glypicanP4!expression!has!been!detected!on!the!cell!surface,!but!is!restricted!to!cells! retaining! stem! cell! properties! and! is! no! longer! detected! following! commitment!toward! neuronal! differentiation! (Hagihara# et# al.,! 2000,! Yamaguchi,! 2001).! The! low!detection!level!of!glypicanP4!in!our!differentiated!cultures!supports!loss!of!stemness!and!differentiation!toward!specific!neural!lineages.!
5.8 Summary 




Although!reduced,!hMSCs!retain!the!ability!to!differentiate!toward!neural!lineages!after!extended!in#vitro#intervals!(P+13).!Indeed,!similarities!exist!in!the!expression!profile!of!cells!differentiated! toward!neural! lineages! through!direct! terminal!differentiation!and!via! the! induction! of! intermediate! spheres.! In! addition,! key! HSPG! core! proteins! have!been! identified,! the! modulation! of! which! may! enable! preferential! specific! lineage!differentiation!of!hMSCs.!




















Chapter 6: HSPGs are involved in Neural 
Differentiation of human mesenchymal stem cells 
6.1 Charactersation of hMSCs Characterisation!of!commercial!undifferentiated!hMSCs!revealed!continued!expression!of! MSC! markers! and! neural! lineage! markers! after! extended! periods! of! expansion! in!
vitro.! Despite! the! expression! of! a!marker! reported! to! be! negative! in! expanded! hMSC!cultures! (CD45),! in! our! hands! these! cells! retained! the! ability! to! differentiate! toward!traditional! lineages! into! late! growth! phases! (P+13)! demonstrating! successful!adipogenic! and!osteogenic!differentiation! confirmed!by! lineage! specific! staining.! ! It! is!clear! from! this! study! that! hMSCs! express! varying! levels! of! both! mesenchymal! and!neural!markers!throughout!expansion!and!prior!to!differentiation.!Importantly,!this!coOexpression!does!not!inhibit!their!ability!to!differentiate,!at!least!toward!adipogenic!and!osteogenic!lineages.!
This!study!did!not!aim!to!provide!conclusive!evidence!that!expression!of!neural!markers!indicated!hMSC!differentiation!towards!neural! lineages.! Instead,!we!aimed!to!examine!the!expression!profile!of!a!number!of!common!mesenchymal!and!neural!markers!during!extended!in!vitro!expansion!(P+5OP+13)!to!determine!whether!specific!in!vitro!intervals!favoured! lineage! specific! differentiation.! In! the! process! of! determining! this! we! have!contributed!to!the!growing!body!of!evidence!that!the!use!of!current!hMSC!cell!surface!marker!combinations!are!neither!accurate!nor!entirely!informative.!!




large! number! of! cellOsurface! markers! have! been! reported! to! characterise! MSCs.!However,!many!of!these!markers!have!been!reported!to!be!both!positive!and!negative!in!these!cells!(Mafi!et!al.,!2011).!A!study!examining!differential!maker!expression!in!mixed!cultures! rich! in!MSCs! (heterogeneous! samples! containing!nonOstem! cells)! determined!no! significant! differential! expression,! suggesting! that! common! MSC! markers! do! not!discriminate! between! MSC! and! nonOstem! cell! mesenchymal! cultures! (Maslova,! 2012,!Wetzig!et!al.,!2013).!Given!that!both!MSCs!and!many!of!their!mature!neighbouring!cells!commonly!express!a!selection!of!MSC!cell!surface!markers!(Manini!et!al.,!2011,!Wetzig!et! al.,! 2013),! and! exhibit! similarities! in! gene! expression,! the! need! for! a! unique! and!definitive!combination!of!cell!surface!markers!and!gene!expression!profile!is!required.!In! addition,! it! has! been! suggested! that!MSCs!may! have! different! cell! surface! profiles!dependant!on!the!isolation!procedures!used!to!harvest!the!cells!and!reseeding!methods!for!expansion!(Jones!and!McGonagle,!2008,!Rombouts!and!Ploemacher,!2003,!Sarkar!et!
al.,!2011).!
The! commercial! identification! panel! used! in! this! study! comprised! five! of! the! most!common!markers!used!in!the!identification!and!characterisation!of!MSCs!–!CD44,!CD29,!CD105,!CD90!(positive)!and!CD45!(negative)! (Dominici!et!al.,!2006,! Iwata!et!al.,!2010,!Latif! et! al.,! 2007,! Mousavi! Niri! et! al.,! 2009,! Ohgushi! et! al.,! 2005,! RoyerOPokora! et! al.,!2010).!




differentiation!of!each!cell!type!(Ahmed!et!al.,!2006,!Bianco!et!al.,!2001).!An!early!study!generated! bone! marrow! stromal! cell! lines! that! expressed! haematopoietic! markers!(Singer!et!al.,!1987).!Combined!with!the!results!from!a!more!recent!study!(Deschaseaux!et! al.,! 2003)! this! data! suggests! that!MSCs! are! able! to! express! the!panOhaematopoietic!marker,! CD45! (Deschaseaux! et! al.,! 2003)!while! retaining! their! ability! to! differentiate!toward!mesenchymal!lineages.!!
While! some! cells! in! this! study! examined! by! ICC! showed! distinct! staining! for! the!haematopoietic!marker,!CD45,!the!majority!of!hMSCs!seemed!to!express!this!marker!at!a! low! level! (>900ms!exposure).! In!comparison!to! the!positive!MSC!markers!examined!by!ICC,!expression!of!CD45!was!significantly!lower!(longer!exposure!compared!to!CD44:!100ms;!CD90:!600O700ms;!CD015:!600O700ms).!In!addition,!the!fluorescence!recorded!when!cells!were!examined!by!FACS!was!greatly!reduced!when!compared!to!CD44!and!CD29,! the! positive! MSC! markers! examined.! This! correlates! with! evidence! for! CD45+!direct! selection! of! mesenchymal! stem! cells! (Deschaseaux! et! al.,! 2003)! and! previous!reports!in!MSCs!of!CD44low!and!CD45low!expression!(Yu!et!al.,!2010).!Evidence!presented!using! CD45+! direct! selection! of!MSCs! argues! against! depleting! fresh! bone!marrow! of!haematopoietic!cells!(nonOMSC)!using!negative!selection!based!on!CD45!(Deschaseaux!et! al.,! 2003,!Tondreau!et!al.,! 2001)!with! the! fibroblastic! colony! forming!units! (CFUOF)!detected! in! the! CD45+! fraction! (Deschaseaux! et! al.,! 2003).! The! existence! of! different!CD45!isoforms!(Penninger!et!al.,!2001)!may!explain!some!of!the!discrepancies!reported!in! CD45! expression! (positive/negative),! particularly! when! MSCs! have! been! isolated!from!different!sources!(bone!marrow!compared!to!dental!pulp).!!




adipogenic! lineages.! Positive! adipogenic! and! osteogenic! staining! (Oil! Red! O,! Alizarin!Red,! von! Kossa)! demonstrated! successful! differentiation! toward! these! lineages! in!combination!with!positive!gene!expression!for!markers!of!each!lineage!(eg.!COL1A1,!AP,!OCN,!PPARγ1,!C/EBPδ)!at!all!the!passages!examined.!
6.1.2 Neural Specific lineage marker expression on undifferentiated 
hMSCs The!systematic!review!conducted!by!Mafi! (2011)!determined!that!markers!previously!reported! primarily! for! the! identification! of! other! types! of! stem! cells! have! also! been!reported! in! MSC! populations,! for! example,! Nanog! and! Sox2,! which! are! generally!accepted!as!neural!progenitor!markers!(Mafi!et!al.,!2011,!Parte!et!al.,!2011).!In!addition,!a!number!of!studies!examining!the!neural!potential!of!MSC!have!determined!that!these!cells! also! express! a! number! of! neural! markers! in! their! undifferentiated! and!unstimulated! state! (Foudah! et! al.,! 2012,! Okolicsanyi! et! al.,! 2014).! However,! most!studies,!with! the! exception! of!Okolicsanyi!et!al!(2014),! report! expression! of!MSC! and!neural!markers! in! freshly! isolated!MSCs! from! bone!marrow! aspirates! (Foudah! et! al.,!2012)!or!other!sources,!including!adipose!tissue!and!dental!pulp!(Foudah!et!al.,!2014).!Both!human!and!murine!MSCs!express!neural!markers!prior!to!differentiation!(Foudah!et!al.,!2014,!Foudah!et!al.,!2012,!Nagai!et!al.,!2007,!Okolicsanyi!et!al.,!2014).!




2012).!This!mimics!the!peak!in!Nestin!gene!expression!we!observed!by!QOPCR!at!P+7.!In!addition,! Foudah! et! al! also! reported! a! decline! in! GFAP! positive! cells! throughout! the!expansion!period,!with!55%!of!cells!positive!at!P+0!compared!to!3%!positive!at!P+40!(Foudah! et! al.,! 2012)! reflecting! the! overall! reduced! gene! expression! reported! in! this!study! throughout! expansion! (P+13! compared! to! P+5).! Finally,! both! studies! report!similar!results!for!βOIIIOtubulin,!with!our!data!showing!a!peak!in!gene!expression!at!P+7.!In!contrast,!the!number!of!positive!cells!in!the!rat!MSC!study!peaked!earlier!(P+1)!with!a!slow!decrease!in!cell!number!over!the!remaining!expansion!period!(to!P+40)!(Foudah!et!al.,! 2012).!The!heterogeneity! in!an!MSC!population!with! some!cells! expressing!neural!markers!while!others!do!not,!suggests!the!presence!of!subpopulation!of!cells!with!more!or! less!neural!differentiation!capacity.! !To!maximise!the!therapeutic!potential!of! these!cells,!we!need!to!be!able!to!modify!an!MSC!population!to!maximise!their!differentiation!capacity!toward!the!required!specific!lineage.!




(Krupkova! et!al.,! 2010)! and! as! a! predictor! of! poor! prognosis! in!malignant!melanoma!(Piras!et!al.,!2010).!!
6.1.3 CD44 as a marker of MSCs and immature astrocytes The!expression!of!neural!markers!by!MSCs!is!not!the!limit!of!crossOmarker!expression.!Markers!of!mesodermalOspecific! lineages!such!as!osteogenic!markers!osteopontin!and!osteocalcin! and! adipogenic! markers! such! as! PPARγ! have! been! detected,! in! turn,! in!neural! cells! (Ichikawa! et! al.,! 1999,! Sarruf! et! al.,! 2009).! In! addition,! one! of! the! most!commonly!reported!positive!cell!surface!markers!for!MSCs,!CD44,!is!also!reported!to!be!a!marker!of!immature!astrocytes!(Cai!et!al.,!2012,!D'Alessandro!and!Wang,!1994,!Liu!et!




cytokines! such! as! interleukinO1! (ILO1)! (Arch! et!al.,! 1992,! Fitzgerald! and!O'Neill,! 1999,!Koopman!et!al.,!1993,!Mackay!et!al.,!1994,!Weiss!et!al.,!1997).! !Further,!CD44!isoforms!carrying!heparan!sulfate!chains!have!been!demonstrated!to!regulate!fibroblast!growth!factor! activation! (Jones! et! al.,! 2000)! an! important! signalling! pathway! in! MSC!differentiation.!Perhaps,!determining!the!specific!CD44!isoform!present! in!neural!cells!compared! to! MSCs! would! more! clearly! define! the! use! of! this! marker! to! distinguish!between!MSCs!and!other!cell!types.!
6.1.4  Accurate identification and classification Not! only! is! the! cell! surface! profile! of! MSCs! important! for! their! definition! and!characterisation,! but! also! the! cellular! niche! from!which! they!have!been! isolated.! This!study!and!others! like! it,!highlight!the!need!for!standardised! isolation,!characterisation!and!definition!of!mesenchymal!stem!cells.!The!ability!to!distinguish!between!origins!of!MSCs!–!bone!marrowO,!adiposeO,!dental!pulpOderived!is!critical!in!order!for!us!to!realise!the!therapeutic!potential!of!these!cells!and!to!determine!one!source!is!better!suited!than!another! for! particular! applications.! Perhaps! a! shortOterm! solution! is! the! use! of!commercially! isolated!hMSCs!subject! to! reduced!variability! in! the! isolation!process! to!provide! a! more! homogenous! stem! cell! populations! for! the! detailed,! consistent!characterisation!of!these!valuable!cells.!




phases! of! growth.! ! It! is! also! important! to! remember,! that! despite! the! necessity! for!functional! neural! cells! at! the! completion! of! differentiation,! functional! characteristics!such!as!active!depolarisation!may!not!be!possible!to!achieve,!in!vitro.!To!achieve!active!depolarisation,! cells! may! require! extended! expansion! in! vitro,! the! duration! of! which!may!not!be! feasible!with! cells!derived! from!primary! cultures! (greater! than!100!days;!Ernst!Wolvetang;! personal! communication).! However,! functional! characteristics! have!previously!been!reported!following!Ca2+!imaging!and!electrophysiological!recording!of!neuronOlike!cells!generated!from!hMSCs!(Fox!et!al.,!2010).!
Evidence! provided! here! suggests! that! there! are! optimal! in! vitro! intervals! to! achieve!differentiation! of! hMSCs! toward! neural! lineages.! This! study! has! demonstrated! that!commercially!isolated!hMSCs!have!shorter!doubling!times!(4O7!days!between!passages)!than! freshly! isolated!cultures! (2!weeks!between!passages;! (Foudah!et!al.,!2012)).! It! is!possible!that!these!cells!are!a!more!homogeneous!representative!population,!removing!the! confusion! that! heterogeneous! freshly! isolated! populations! bring! to! the! definition!and!characterisation!of!hMSCs.!
6.2 HSPGs and their involvement in the neural niche 




(Lin,! 2004).! In! addition,! evidence! from! a! number! of! biochemical! studies! has!demonstrated! that! heparin! can! increase! the! affinity! of! FGF! for! its! receptor! (Ornitz,!2000).!
Molecular! interactions! on! the! cell! surface! are! involved! in! many! aspects! of! neural!development!with! proteoglycans!playing! crucial! roles! in! the!modulation! of!molecular!interactions! such!as! ligandOreceptor,! cellOcell! and! cellOmatrix! interactions! (Yamaguchi,!2001).! It! is! reasonable! to! infer! the! integrated! involvement! of! HSPGs! in! neural!development! through! interactions! with! FGF2,! a! crucial! growth! factor! in! the!proliferation!and!differentiation!of!neural!stem!cells! in! the!developing!cerebral!cortex!(Yamaguchi,!2001).!FGF2!concentrations!have!been!linked!to!the!fate!of!cell!progenies!derived!from!neural!stem!cells!with!low!FGF2!concentrations!producing!mainly!neurons!while!high!FGF2!concentrations!generate!glial!cells!(Qian!et!al.,!1997).!




active!axon!elongation!phase!of!development! (Ivins!et! al.,! 1997,! Stipp!et!al.,! 1994).! In!contrast!to!glypianO4,!glypicanO1!is!expressed!in!the!ventricular!zone!in!postmitotic!and!differentiated!neurons!during!the!late!stages!of!embryonic!development!(Litwack!et!al.,!1998,! Yamaguchi,! 2001).! In! addition,! glypicanO1! is! also! expressed! in! neurons! of! the!adult! brain! (Litwack! et! al.,! 1998,! Yamaguchi,! 2001).! Of! the! syndecans,! syndecanO3! is!expressed!in!developing!axon!tracts!(Kinnunen!et!al.,!1998,!Kinnunen!et!al.,!1999)!and!has! been! implicated! as! a! cell! surface! receptor! for! heparinObinding! growthOassociated!molecule!(HBOGAM),!an!extracellular!neurite!outgrowthOpromoting!factor!(Raulo!et!al.,!1994,!Yamaguchi,!2001).!
This! is! further!supported!with!evidence!examining! the!role!of! specific!GAGs! in!neural!specification! of! mouse! embryonic! stem! cells! (mES)! demonstrating! that! EXTO/O! mES!lacking! HS! cannot! undergo! neural! specification,! but! that! this! phenotype! can! be!recovered! by! adding! soluble! heparin! (Johnson! et! al.,! 2007).! The! use! of! a! selective!inhibitor! of! FGF! signal! transduction! showed! that! heparin!modulates! signalling! events!regulating! the! exit! from! pluripotency! and! subsequent! commitment! to! primitive!ectoderm!and!subsequently!the!neuroectoderm!(Pickford!et!al.,!2011).!!
6.2.2 Response of initiation and modification enzymes to in vitro niche 





The!next!critical!step!in!HS!biosynthesis!involves!NOsulfation!subsequently!followed!by!epimerisation.! Without!NOsulfation,! GAG! chains! produced! would! be! CS! chains! rather!than!HS!(Bernfield!et!al.,!1999,!Grobe!and!Esko,!2002).!The!completion!of!NOsulfation!by!the!NDSTs!is!a!prerequisite!for!subsequent!modifications!including!the!epimerisation!of!GlcA! to! IdoA! by! C5Oepimerase! (Sasisekharan! et! al.,! 1997).! In! our! study!we! observed!elevated! C5Oep! expression! at! early! passages! and! elevated! NDST! expression! at! late!passages!in!response!to!heparin!treatment,!suggesting!heparin!increases!production!of!HS! chains.! As! NDST3! and! NDST4! are! predominantly! expressed! during! embryonic!development!(Aikawa!and!Esko,!1999,!Aikawa!et!al.,!2001,!Grobe!and!Esko,!2002)!it!is!not!surprising!that!in!hMSCs!the!responsibility!for!NOsulfation!is!entirely!controlled!by!NDST1!and!NDST2.!





has! been! suggested! that! undersulfation! of! HS! exerts! a!more! severe! effect! on! various!signalling! pathways! than! the! absence! or! decrease! in! HS.! Abnormal! undersulfated! HS!may!overstimulate!and/or!inhibit!signalling!of!many!GFs!(Maeda!et!al.,!2011)!or!effect!differentiation! capacity,! as! demonstrated! in! a! murine! embryonic! stem! cell! model!(Forsberg! et! al.,! 2012).! Initial! experiments! investigating! undersulfated! HS! through!inhibition!of!sulfation!involved!the!treatment!of!hMSC!cultures!with!sodium!chlorate,!an!inhibitor! of! sulfation.! ! Further! experiments!would! require! the! artificial! generation! of!specific! HS! chains! of! known! length! and! sulfation! profile! to! examine! the! effects! of!undersulfation!on!interactions!of!HSPGs!with!specific!growth!factors.!
6.2.3 In vitro niche modification stimulates increased core protein 
expression HSPG! core! proteins! by! definition! carry! HS! chains,! however,! the! syndecan! family! and!some!members! of! the! glypican! family! can! also! carry! CS! chains.! ! The! involvement! of!syndecans! and! glypicans! in! most! signalling! pathways,! and! hence! cellular! events,! is!through!interaction!of!their!HS!chains!with!appropriate!ligands!such!as!growth!factors.!As! discussed! earlier,! the! biosynthesis! of! HS! chains! is! complicated! by! the! specific!combination! of! complex! sulfated! GAG! chain! and! specific! core! protein! determining!subsequent!molecular!interactions.!




resulted!in!decreased!expression!for!the!entire!family!at!P+5!and!P+7!(except!syndecanO2!at!P+7)!and!increased!expression!at!P+13!(except!syndecanO4).!Significant!reductions!in!expression!at!P+7!were!observed! following!chlorate! treatment! for!both!syndecanO1!and!SDC4,!the!two!members!of!the!family!known!to!carry!CS!chains!(Tkachenko!et!al.,!2005).! ! ! The! syndecan! family! is! divided! into! two! subfamilies! syndecanO1/syndecanO3!and!syndecanO2/syndecanO4)!(Bernfield!et!al.,!1999).!With!tissue!specific!expression!of!most!members!of!the!family,!syndecanO4!being!the!most!ubiquitous,!it!makes!sense!that!at! least!one!member!of!each!subfamily!would!have!the!ability!to!carry!CS!chains.!New!evidence! suggests! that! syndecanO3! also! carries! CS! chains! (Leonova! and! Galzitskaya,!2013).!With!the!expression!of!syndecanO3!predominantly!localised!to!the!brain,!and!the!highly!examined!role!of!CSPGs! in!the!neural!environment,! the!ability!of!syndecanO3!to!carry!CS!chains! is!not!entirely!surprising!and!may!suggest!a!role! for! the!syndecans! in!neural! differentiation.! Both! syndecanO1! and! syndecanO4! demonstrate! an! overall!decrease! in! expression! (except! SDC1! at! P+13)! following! treatment! of! cultures! with!chlorate.! SyndecanO3! mimics! this! expression! profile! including! the! early! increase! in!expression!observed!in!response!to!heparin.!
Glypicans!generally!only!carry!HS!chains,!however!it!has!been!postulated!that!glypicanO5!may!also!carry!CS!chains!(Li!et!al.,!2011).!Addition!of!heparin!to!cultures!resulted!in!reduced! expression! of! glypicanO1! while! inhibition! of! sulfation! stimulated! expression.!The! reverse!was! true! for!glypicanO4!and!glypicanO6!with!heparin!generally! increasing!the! expression! of! these! genes!with! no! change! in! expression! observed! in! response! to!inhibition!of!sulfation!(except!glypicanO4!at!P+13).!




developing!brain! (Hagihara!et!al.,!2000).! In!addition,!expression!on! the!cell! surface!of!neural!stem!cells!in!cultures!is!restricted!to!cells!that!retain!some!stem!cell!properties!and!is!not!expressed!on!cells!that!have!committed!to!neural!differentiation!(Hagihara!et!al.,!2000).!Potentially!we!would!also!expect! to!see! increasing!glypicanO1!expression! in!neuronal!differentiated!cultures!as!glypicanO1!is!expressed!in!neurons!of!the!adult!brain!(Litwack!et!al.,!1994,!Yamaguchi,!2000).!
6.2.4 Correlation between HSPGs and neural markers In!addition!to!the!response!of!hMSCs!to!in!vitro!niche!modification!discussed!above,!we!also! observed! some! interesting! correlations! between! the! response! of! HSPGs! and! the!response!of!neural!makers!expressed!in!these!cells.!
In!our!cell!populations,!we!see!some!distinct!similarities!between!the!basal!expression!profile!of!some!key!HSPGs!and!neural!markers! (Figure!4O14).!We!see! that! throughout!expansion,! both! syndecanO4! and! GFAP! expression! reduce! and! then! subsequently!increase!again.!We!see!that!the!expression!of!MAP2!completely!mirrors!the!expression!of!syndecanO1!with!MAP2!expression!decreasing!and!syndecanO1!expression!increasing!throughout!expansion.!In!addition,!glypicanO4!and!Nestin!show!very!similar!patterns!of!expression!with!expression!of!both!genes!decreasing!from!intermediate!expansion!time!points!(after!P+7).!!




As! discussed! as! part! of! the! characterisation! of! hMSCs,! these! cells! express! neural!pluripotency! markers! throughout! expansion.! In! addition,! we! have! demonstrated! the!simultaneous!expression!of!these!progenitor!markers!with!HSPG!core!proteins.!We!have!also!demonstrated! the!coOexpression!of!neural! lineage!specific!markers,! such!as!GFAP!and!O1!with!the!HSPG!core!proteins!examined!by!ICC.!
The! response! of! some!neural!markers! to! niche!modification! shared! some! similarities!with,! and! in! some! cases! opposing! effects! to,! the! response! of! specific! HSPGs.! The!progenitor!marker,! Nestin,! demonstrated! increased! expression! as! a! result! of! heparin!treatment! and! reduced! expression! as! a! result! of! chlorate! treatment.! ! In! contrast,! the!glypican!suggested! to!be!highly!expressed! in!adult!neurons,! glypicanO1,!demonstrated!reduced!expression!as!a!result!of!heparin!treatment!and!increased!expression!following!treatment! with! chlorate.! In! addition,! the! overall! expression! of! Nestin! in! untreated!cultures!decreased!throughout!expansion,!while!the!expression!of!glypicanO1!increased!steadily! between! P+5! and! P+13.! In! addition! to! the! similarity! in! the! basal! gene!expression! profile! between! GFAP! and! syndecanO4,! both! genes! exhibited! reduced!expression!at!intermediate!and!late!passages!in!response!to!chlorate!treatment.!




6.3 HSPGs and their role in differentiation of hSMCs towards neural 
lineages 
6.3.1 Neural Lineage Differentiation Using! the! terminal! differentiation! protocol,! all! cultures! demonstrated! morphological!changes! consistent! with! differentiation! toward! neural! lineages! (Chapter! 5,! Section!5.3.1).! ! In! addition,! both!populations!demonstrated! the! ability! to!differentiate! toward!neural! lineages! at! all! passages! examined! using! this! method.! ! As! expected,! cells!differentiated! at! early! passages! showed! obvious! visual!morphological! changes!within!hours! to! days! (D1OD3)! of! induction.! At! P+13,! these! changes! were! not! as! obvious! as!quickly,!with!distinct!morphological!changes!observed!after!days!(D5OD7)!of!induction.!It!is!possible!that!minor!morphological!changes!observed!early!in!the!induction!period!of! cells! induced! at! P+5! and! P+7! are! masked! in! P+13! cultures! due! to! the! reduced!proliferation!rates!of!P+13!cultures!prior!to!neural!induction.!





al.,!1990,!Karthikeyan!et!al.,!1994,!Litwack!et!al.,!1994),!suggesting!glypicanO1!could!be!involved! in! the! differentiation! of! cultures! toward! neuronal! lineages! via! intermediate!sphere!formation.!
By!examining!the!ability!of!hMSCs!to!differentiate!at!different!growth!phases!we!have!determined!that!their!potential!to!differentiate!via!intermediate!spheres!is!increased!at!short!in!vitro!intervals,!that!is,!they!have!greater!sphereOforming!potential!at!P+5!when!compared!to!P+13!cells.!At!the!earlier!P+5!timepoint,!the!spheres!appear!much!larger!in!size! (approximately!400μm)!and!more! regular! in! shape! than! their!P+13! counterparts!(approximately! 100μm).! In! addition! they! have! a! higher! capacity! at! low! passages! to!attach! to! adherent! culture! dishes! following! sphere! induction,! and! cells! subsequently!spread!out!from!the!focal!cell!colonies.!!




to! P+5! cells,! and! this! was! reflected! in! the! reduced! total! number! of! cells! following!completion!of!differentiation!(Chapter!5,!Section!5.3.2).!
Initiation!of!spheres!at!P+13!resulted! in!cell!clusters!of! irregular!shape!and!small!size!(approximately!100μm)! in!contrast! to! the! large!even!spheres! formed!at!P+5!and!P+7.!Clusters! of! cells! induced! during! sphere! induction! at! P+13! also! possessed! a! greatly!reduced!ability! to!attach!to!adherent!surfaces!after! the! induction!period.! ! In! fact,!only!one!of!the!hMSC!populations!examined!achieved!attachment!at!this!point.!Cell!clusters!from! hMSCO2! were! not! able! to! attach! and! so! were! not! able! to! differentiate! toward!neural!lineages!under!these!conditions.!!Interestingly,!these!cells!(hMSCO2)!were!able!to!differentiate!via!terminal!differentiation.!




Yamaguchi,! 2001)! as! well! as! in! neurons! in! the! adult! brain! (Litwack! et! al.,! 1994,!Yamaguchi,!2001).!!
When!examining!differentiated!cultures!by!ICC,!we!determined!that!glial!makers!were!expressed! more! highly! in! glial! cultures! than! in! neuronal,! and! at! higher! levels! than!observed! in! hMSCs,! as! determined! by! exposure! time! during! image! acquisition.! In!addition,! the! neuronal!maker!MAP2,!which! had!not! been! consistently! detected! in! the!hMSC!populations!examined!prior!to!any!differentiation!induction,!was!detected!in!both!differentiated!cultures!and!at!very!low!levels!in!glial!cultures.!
Overall,! the! decreased! gene! expression! observed! for! several!HSPG! core! proteins,! and!their!initiation!and!modification!enzymes!may!highlight!the!reduced!proliferation!rates!observed! in! differentiated! cultures.! Evidence! for! this! can! be! found! in! a! murine! preOosteoblast! model! where! reduced! glypicanO3! expression! correlated! with! reduced!capacity! for! osteogenic! differentiation! (Haupt! et! al.,! 2009).! Reduced! proliferation! is!characteristic! of! cells! undergoing! differentiation! and! it! is! possible! that! expression! of!some! key! proteins! may! cease! entirely! during! this! process.! In! some! cell! types,! upon!completion!of!differentiation,!expression!may!once!again!increase.!
6.4 Future Directions 




differentiation.!The!requirement!for!increased!cells!was!observed!in!each!of!the!hMSCs!populations! that!underwent!differentiation! (hMSCO2,!hMSCO3)! at! each!of! the!passages!investigated!(P+5,!P+7,!P+13).!For!therapeutic!applications!to!be!successful,! increased!cell!numbers!are!required!for!transplantation.!!
Following! analysis! of! preliminary! data! generated! at! each! passage! (n=2)! further!optimisation! can!be! undertaken! to! ensure! robustness! and! reliability! of! results.!While!cells!were!successfully!induced!to!form!spheres,!a!greater!number!of!spheres!entering!the! terminal! differentiation! phase!may! increase! the! quantity! of! adherent! spheres.! At!early! passages! where! more! spheres! of! larger! sizes! were! induced,! subsequent!differentiation!cultures!displayed!higher!cell!confluence!during!differentiation!allowing!the! creation! of! cellOcell! interactions,! many! of! which! are! likely! critical! for! the!differentiation! process.! In! addition,! a! greater! number! of! cells! entering! differentiation!would! likely! enhance! survival! rates! throughout! induction! and! differentiation,! as!demonstrated!by!similar!previously!published!studies!where!more!than10X!the!number!of!cells!used!in!this!current!study!underwent!differentiation!(Fu!et!al.,!2008,!Hermann!et!al.,! 2006).! However,! it! must! be! noted! that! in! addition! to! insufficient! cell! numbers!inhibiting! differentiation,! this! would! also! be! true!with! excessive! cell! numbers!where!contact!inhibition!may!prevent!completion!of!differentiation!programs.!!!





vitro! intervals! allowing! examination! of! the! functional! characteristics! of! the! cells!generated!after!extended!culture.!!This!may!become!critical!for!the!determination!of!the!functional! characteristics! of! differentiated! cells,! that! may! not! become! apparent! until!extended! periods! in! culture! (>100! days).! This! would! also! enable! the! fuller!characterisation! of! causes! for! the! cease! in! proliferation! observed! during! this! process!and! whether! it! is! a! result! of! completion! of! differentiation,! or! whether! the! cells! had!entered!a!senescent!phase,!after!which!they!may!continue!to!proliferate!further!before!completing!the!differentiation!process.!Additional!functional!analysis!may!include!patch!clamp! assays! to!measure! electrical! potential! across! synapses.! Analysis! using! synaptic!stains! would! allow! for! examination! of! preO! and! postOsynaptic! vesicles.! In! cultures!deemed! to! have! completed! differentiation! programs,! it! may! also! be! of! interest! to!examine! the! release! and! reuptake! of! neurotransmitters! such! as! serotonin! and!dopamine.!!




differentiation! toward!all! three!neural! lineages! (neurons,! astrocyte,! oligodendrocytes;!Hermann! 2006).! Evidence! presented! from! this! study! suggests! that! both! terminal!differentiation!cultures!and!those!differentiated!via!intermediate!spheres!are!capapble!of!differentiating!toward!oligodendrocyte!lineages.!
In! addition! to! the! optimisation! of! the! protocols,! it! may! be! of! benefit! to! examine! the!effect! of! chlorate! on! the! differentiation! of! cultures.! ! As! we! have! determined! the!importance!of!HS! chains! and!HSPG! core!proteins! in! these!processes,! the! inhibition!of!sulfation! could! potentially! affect! this! process.! ! The! addition! of! heparin! to!undifferentiated! hMSC! cultures! increased! the! rate! of! proliferation! while! inhibiting!sulfation! through! treatment! of! undifferentiated! cultures! with! chlorate! reducing!proliferation!rates.!As!cells!undergoing!differentiation!experience!reduced!proliferation!rates! it! is! reasonable! to! assume! that! inhibiting! proliferation! may! assist! the! cells! in!undergoing!differentiation!and!that!treating!differentiating!cultures!with!chlorate!could!facilitate!this.!!
In!addition!to!the!changes!to!proliferation!as!a!result!of!chlorate!treatment,!a!number!of!neural!marker!and!HSPG!genes!were!upregulated!in!response!to!inhibition!of!sulfation.!It!is!feasible!that!decreased!sulfation!could!result!in!increased!neural!differentiation.!




the! expression! of! these! CS! chains! was! generally! localised! to! the! extracellular! space!surrounding!the!cell,!with!very!low!expression!on!the!cell!surface!itself.! !As!CSPGs!are!known! to!make! up! a! large! proportion! of! the! neural!microenvironment! (Maeda! et! al.,!2011,!Morawski!et!al.,!2014),!this!may!well!be!evidence!for!the!differentiating!cultures!creating!a! suitable!ECM!composition! to! assist!differentiation.! In! this! study,! terminally!differentiated!cultures,!neuronal!cultures!demonstrated!higher! levels!of!CS!expression!in!the!extracellular!space,!while!glial!cultures!demonstrated!low,!but!detectible!levels!of!CS!on!the!cell!surface.!With!differences!in!the!expression!and!localisation!of!CS!between!neuronal!and!glial!cultures!it!may!be!possible!to!identify!key!CSPGs!that!in!combination!with!HSPGs!could!be!used!to!specify!neural!fates!of!hMSCs.!




examined! at! the! passage! and! time! point! examined.! ! Traditionally,! genes! that! are! not!expressed!cannot!be!analysed,!however,!in!this!study!the!lack!of!expression!at!one!time!point/dose! condition/population/passage! may! be! important! due! to! its! expression!under! different! conditions.! ! As! such,! we! are! currently! exploring! other! methods! of!modelling!the!data!to!enable!more!accurate!examination!of!the!complete!data!set.!!!
Currently! our! bioinformatics! team! led! by! Dr! HernandezOSanchez! is! investigating! the!suitability!of!applying!Tweedie!modelling! to! the!data.!This!allows! for!analysis!of!data,!such!as!gene!expression!levels,!where!negative!values!are!not!possible.! !Analysis!using!TOtests!and!ANOVA!assume!normal!distribution!of!the!data!(Figure!7O1),!however!data!generated!in!this!study!does!not!follow!a!normal!distribution.!
!
Figure'7)1: Example! of! data! following! a! normal! distribution! pattern.! This! histogram!





2).!!If!it!were!possible!to!have!negative!RNA!expression,!the!distribution!of!data!would!still! follow!a!normal! distribution!with! the!mean! closer! to! zero.! !However,! as! it! is! not!possible! to! have! negative! RNA! expression,! the! distribution! of! data! is! compressed!creating!a!peak!at! zero!due! to! the!number!of! genes! in! the! total! set!demonstrating!no!expression!under!any!one!condition!at!any!time!point!or!passage.!
!
Figure'7)2: Distribution! of! gene! expression! data! generated! following! modification! of! the! in!
vitro!niche.!!The!high!frequency!of!zero!data!can!be!seen,!skewing!the!distribution!of!the!data!
set! away! from! a! normal! distribution.! This! makes! analysis! of! relative! gene! expression! data!
using! traditional! analysis! methods! (TJtest,! ANOVA)! inaccurate.! Figure! courtesy! of! Dr!





6.4.3 Gender differences The! populations! used! in! this! study! originate! from! two!male! samples! and! one! female!sample.!The!investigation!of!gender!effects!on!expression!of!a!number!of!key!HSPGs!and!neural! markers! would! be! of! great! interest.! ! A! previous! report! has! demonstrated!variations! in! expression! of! HS! between!males! and! females,!with! HS! chains! in! female!mice!livers!shown!to!be!shorter!and!more!active!correlated!with!higher!gene!expression!levels! (Murali! et! al.,! 2011).! In! many! cases,! the! basal! gene! expression! level! differed!significantly!between! the!male!and! female! samples.!Expression! levels!observed! in! the!female!sample!for!some!genes!(HSPGs!and!neural!markers)!were!10O100X!greater!than!that! observed! in! the! male! samples! for! the! same! gene.! It! would! be! interesting! to!determine!if!there!is!a!true!sex!effect!or!if!the!variation!observed!between!populations!is!just!due!to!individual!variation.!!To!achieve!this,!populations!derived!from!other!female!samples!should!be!examined.!
In!addition,!it!would!be!worthwhile!examining!the!correlation!between!increased!gene!expression! levels,! shorter!more!active!HS!chains!and!neural! lineage!potential.! ! In! this!study,! the! female! population! examined! by! ICC! and! QOPCR! did! not! undergo! neural!differentiation! protocols.! The! question! of! whether! the! increased! gene! expression!observed! for! a! number! of! key! HSPGs! in! this! population! could! subsequently! elicit!increased!neural!differentiation!capacity!has!yet!to!be!investigated.!




freshly! isolated! from! bone! marrow! aspirates.! Comparisons! between! freshly! isolated!cells!and!commercially!available!populations!are!important!to!determine!the!validity!of!key! proteins! identified! in! this! study,! such! as! the! syndecans! and! glypicans,! for! use! in!enriching! populations! for! therapeutic! applications.! ! In! addition,!we!must! ensure! that!cells!isolated!ex!vivo!from!patients!for!therapy!retain!the!in!vitro!capacity!to!expand!and!differentiate,!allowing!for!enrichment!prior!to!transplantation!back!into!the!patient.!We!must! also! confirm! that! the! response! to! in! vitro! niche! modification! observed! in!commercially!isolated!cells!is!mirrored!by!the!response!of!freshly!isolated!cells.!
The! robustness! of! the! protocols! developed! to! enrich! hMSC! neural! potential! through!modulation! of! HSPGs! and! the! stem! cell! niche! are! vital! for! application! to! therapeutic!applications.!
6.4.5 Genetic Analysis More! extensive! genetic! analysis! of! cultures! preO! and! postOdifferentiation!would! allow!for!more!in!depth!analysis!of!genetic!changes!triggered!during!differentiation.!!The!use!of! global! gene! expression! arrays! such! as! the! Illumina! HT12! arrays! would! allow! the!inclusion! of! a!more! diverse! range! of! proteoglycan! related! genes! including! additional!core! proteins! and!modification! enzymes.! ! Genes! included! on! expression! arrays! could!include! enzymes! responsible! for! desulfation! of! HS! chains,! for! example! the! sulfatase!family!of!enzymes,!as!well!as!core!CSPGs!and!their!chain!modification!enzymes!as!and!CS!chains.!!





Exome!sequencing!involves!sequencing!all!the!protein!coding!genes!within!the!genome!by! selectively! enriching! the! sample! using! target! specific! probes.! In! contrast! RNAOSeq!technology!utilises!next!generation!sequencing!to!examine!the!transcriptome!of!a!cell,!that! is,! all! the! RNA! transcripts! present! in! a! cell! at! any! given! time.! This! would! allow!examination! of! changes! following! differentiation! and! as! a! result! of! in! vitro! niche!modification,!while!exome!sequencing!would!allow!for!the!identification!of!any!genetic!variations!that!may!influence!protein!translation.!
In!addition!to! the!genetic!analysis!mentioned!above,! the!effect!of!modulating! levels!of!key! HSPG! core! proteins! (syndecans,! glypicans)! to! determine! their! effect! on! neural!differentiation! should! be! examined.! These! studies! could! take! the! form! of! addition! of!exongenous! HSPG! or! knockOdown! or! knockOout! studies! using! short! interfering! RNAs!(siRNAs).!
There! are! a! range! of! studies! that! could! be! conducted! to! clearly! elucidate! the! role! of!HSPGs!identified!in!this!study!in!neural!differentiation!of!hMSCs.!




ability!of!these!cells!to!differentiate!down!classical!osteogenic!and!adipogenic!lineages!at! each! passage! examined! and! that! the! expression! of! a! negative! marker! for! hMSCs,!CD45,!does!not!inhibit!this!differentiation.!
In! addition! to! characterising! the! mesenchymal! potential! of! these! cells! throughout!expansion,! we! determined! that! hMSCs! also! express! a! number! of! neural! makers!throughout! expansion.! ! These! included!markers! of! neural! stem! cell! selfOrenewal! and!neural! lineage! specific!markers.!While!determining! the!expression!profile!of!MSC!and!neural! markers! we! established! a! basal! profile! for! HSPG! initiation! and! modification!enzymes!as!well!as!selected!core!proteins.!
By! modulating! the! in! vitro! niche! through! addition! of! heparin! and! chlorate! to!undifferentiated!hMSC!cultures!we!have!determined!changes! in! the!expression!profile!of! these! cells! implicating! the! involvement! of! HSPGs! in! important! cellular! processes,!including! proliferation! and! neural! differentiation.! In! vitro! niche! modulation! also!resulted! in! alterations! to! the! neural!maker! expression! profile,!many! of!which! closely!correlated!with!the!changes!seen!in!HSPGs.!





This! study! has! contributed! to! the! growing! body! of! evidence! that! HSPGs! play! pivotal!roles! in! a!number!of! cellular!processes! including! the!differentiation!of!hMSCs! toward!neural! lineages.! Specifically,! this! study! has! identified! syndecanO1,! glypicanO1! and!glypicanO4!as!potential!mediators!of!the!neuronal!niche!for!the!differentiation!of!hMSCs!toward!specific!neural! lineages.! !The!results! from!this!study!support! the!suitability!of!these!cells!for!therapeutic!applications!including!the!repair!and!regeneration!of!neural!cells!following!brain!trauma.!














Chapter 7:  
References 




 Chapter 7:  References 
AHMED, N., VOGEL, B., ROHDE, E., STRUNK, D., GRIFKA, J., SCHULZ, M. B. & 
GRASSEL, S. 2006. CD45-positive cells of haematopoietic origin enhance 
chondrogenic marker gene expression in rat marrow stromal cells. Int J Mol 
Med, 18, 233-40. 
AI, X., DO, A. T., LOZYNSKA, O., KUSCHE-GULLBERG, M., LINDAHL, U. & 
EMERSON, C. P., JR. 2003. QSulf1 remodels the 6-O sulfation states of cell 
surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol, 
162, 341-51. 
AIHW 2007. Disability in Australia: Acquired Brain Injury. In: AIHW (ed.). Canberra: 
AIHW. 
AIKAWA, J. & ESKO, J. D. 1999. Molecular cloning and expression of a third 
member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-
sulfotransferase family. J Biol Chem, 274, 2690-5. 
AIKAWA, J., GROBE, K., TSUJIMOTO, M. & ESKO, J. D. 2001. Multiple isozymes 
of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. 
Structure and activity of the fourth member, NDST4. J Biol Chem, 276, 5876-
82. 
AKIYAMA, T., KAMIMURA, K., FIRKUS, C., TAKEO, S., SHIMMI, O. & NAKATO, 
H. 2008. Dally regulates Dpp morphogen gradient formation by stabilizing 
Dpp on the cell surface. Dev Biol, 313, 408-19. 
ALEXANIAN, A. R. 2005. Neural stem cells induce bone-marrow-derived 
mesenchymal stem cells to generate neural stem-like cells via juxtacrine and 
paracrine interactions. Exp Cell Res, 310, 383-91. 
ALEXANIAN, A. R. 2007. Epigenetic modifiers promote efficient generation of 
neural-like cells from bone marrow-derived mesenchymal cells grown in 
neural environment. J Cell Biochem, 100, 362-71. 
ALEXANIAN, A. R. 2010. An efficient method for generation of neural-like cells from 
adult human bone marrow-derived mesenchymal stem cells. Regen Med, 5, 
891-900. 




ALEXANIAN, A. R., MAIMAN, D. J., KURPAD, S. N. & GENNARELLI, T. A. 2008. In 
vitro and in vivo characterization of neurally modified mesenchymal stem 
cells induced by epigenetic modifiers and neural stem cell environment. Stem 
Cells Dev, 17, 1123-30. 
ALFANDARI, D., COUSIN, H., GAULTIER, A., SMITH, K., WHITE, J. M., 
DARRIBERE, T. & DESIMONE, D. W. 2001. Xenopus ADAM 13 is a 
metalloprotease required for cranial neural crest-cell migration. Curr Biol, 11, 
918-30. 
ALTMAN, J. & DAS, G. D. 1965. Autoradiographic and histological evidence of 
postnatal hippocampal neurogenesis in rats. J Comp Neurol, 124, 319-35. 
ARCH, R., WIRTH, K., HOFMANN, M., PONTA, H., MATZKU, S., HERRLICH, P. & 
ZOLLER, M. 1992. Participation in normal immune responses of a 
metastasis-inducing splice variant of CD44. Science, 257, 682-5. 
ASHIKARI-HADA, S., HABUCHI, H., KARIYA, Y., ITOH, N., REDDI, A. H. & 
KIMATA, K. 2004. Characterization of growth factor-binding structures in 
heparin/heparan sulfate using an octasaccharide library. J Biol Chem, 279, 
12346-54. 
AZIZI, S. A., STOKES, D., AUGELLI, B. J., DIGIROLAMO, C. & PROCKOP, D. J. 
1998. Engraftment and migration of human bone marrow stromal cells 
implanted in the brains of albino rats--similarities to astrocyte grafts. Proc 
Natl Acad Sci U S A, 95, 3908-13. 
BAE, K. S., PARK, J. B., KIM, H. S., KIM, D. S., PARK, D. J. & KANG, S. J. 2011. 
Neuron-like differentiation of bone marrow-derived mesenchymal stem cells. 
Yonsei Med J, 52, 401-12. 
BALLY-CUIF, L. & HAMMERSCHMIDT, M. 2003. Induction and patterning of 
neuronal development, and its connection to cell cycle control. Curr Opin 
Neurobiol, 13, 16-25. 
BANDTLOW, C. E. & ZIMMERMANN, D. R. 2000. Proteoglycans in the developing 
brain: new conceptual insights for old proteins. Physiol Rev, 80, 1267-90. 
BANG, O. Y., LEE, J. S., LEE, P. H. & LEE, G. 2005. Autologous mesenchymal 
stem cell transplantation in stroke patients. Ann Neurol, 57, 874-82. 




BARZILAY, R., KAN, I., BEN-ZUR, T., BULVIK, S., MELAMED, E. & OFFEN, D. 
2008. Induction of human mesenchymal stem cells into dopamine-producing 
cells with different differentiation protocols. Stem Cells Dev, 17, 547-54. 
BEAUVAIS, D. M., ELL, B. J., MCWHORTER, A. R. & RAPRAEGER, A. C. 2009. 
Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during 
angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp 
Med, 206, 691-705. 
BELENKAYA, T. Y., HAN, C., YAN, D., OPOKA, R. J., KHODOUN, M., LIU, H. & 
LIN, X. 2004. Drosophila Dpp morphogen movement is independent of 
dynamin-mediated endocytosis but regulated by the glypican members of 
heparan sulfate proteoglycans. Cell, 119, 231-44. 
BERNFIELD, M., GOTTE, M., PARK, P. W., REIZES, O., FITZGERALD, M. L., 
LINCECUM, J. & ZAKO, M. 1999. Functions of cell surface heparan sulfate 
proteoglycans. Annu Rev Biochem, 68, 729-77. 
BERNFIELD, M., KOKENYESI, R., KATO, M., HINKES, M. T., SPRING, J., GALLO, 
R. L. & LOSE, E. J. 1992. Biology of the syndecans: a family of 
transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol, 8, 365-
93. 
BESPALOV, M. M., SIDOROVA, Y. A., TUMOVA, S., AHONEN-BISHOPP, A., 
MAGALHAES, A. C., KULESSKIY, E., PAVELIEV, M., RIVERA, C., 
RAUVALA, H. & SAARMA, M. 2011. Heparan sulfate proteoglycan 
syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J Cell Biol, 
192, 153-69. 
BI, Y., EHIRCHIOU, D., KILTS, T. M., INKSON, C. A., EMBREE, M. C., 
SONOYAMA, W., LI, L., LEET, A. I., SEO, B. M., ZHANG, L., SHI, S. & 
YOUNG, M. F. 2007. Identification of tendon stem/progenitor cells and the 
role of the extracellular matrix in their niche. Nat Med, 13, 1219-27. 
BIANCO, P., RIMINUCCI, M., GRONTHOS, S. & ROBEY, P. G. 2001. Bone marrow 
stromal stem cells: nature, biology, and potential applications. Stem Cells, 
19, 180-92. 
BIAQ 2007. Impact of acquired brain injury on the individual - Fact Sheet. In: INC, B. 
I. A. O. Q. (ed.). 




BIEBACK, K. & KLUTER, H. 2007. Mesenchymal stromal cells from umbilical cord 
blood. Curr Stem Cell Res Ther, 2, 310-23. 
BISHOP, J. R., SCHUKSZ, M. & ESKO, J. D. 2007. Heparan sulphate 
proteoglycans fine-tune mammalian physiology. Nature, 446, 1030-7. 
BLENNOW, K., HARDY, J. & ZETTERBERG, H. 2012. The neuropathology and 
neurobiology of traumatic brain injury. Neuron, 76, 886-99. 
BLONDHEIM, N. R., LEVY, Y. S., BEN-ZUR, T., BURSHTEIN, A., CHERLOW, T., 
KAN, I., BARZILAI, R., BAHAT-STROMZA, M., BARHUM, Y., BULVIK, S., 
MELAMED, E. & OFFEN, D. 2006. Human mesenchymal stem cells express 
neural genes, suggesting a neural predisposition. Stem Cells Dev, 15, 141-
64. 
BOSSOLASCO, P., COVA, L., CALZAROSSA, C., RIMOLDI, S. G., BORSOTTI, C., 
DELILIERS, G. L., SILANI, V., SOLIGO, D. & POLLI, E. 2005. Neuro-glial 
differentiation of human bone marrow stem cells in vitro. Exp Neurol, 193, 
312-25. 
BRAZELTON, T. R., ROSSI, F. M., KESHET, G. I. & BLAU, H. M. 2000. From 
marrow to brain: expression of neuronal phenotypes in adult mice. Science, 
290, 1775-9. 
BRICKMAN, Y. G., FORD, M. D., GALLAGHER, J. T., NURCOMBE, V., 
BARTLETT, P. F. & TURNBULL, J. E. 1998. Structural modification of 
fibroblast growth factor-binding heparan sulfate at a determinative stage of 
neural development. J Biol Chem, 273, 4350-9. 
BUTLER, T. & MILNER, L. 2003. The 2001 New South Wales Inmate Health 
Survey. In: SERVICE, N. S. W. C. H. (ed.). Sydney: NSW Government. 
CAI, N., KURACHI, M., SHIBASAKI, K., OKANO-UCHIDA, T. & ISHIZAKI, Y. 2012. 
CD44-positive cells are candidates for astrocyte precursor cells in developing 
mouse cerebellum. Cerebellum, 11, 181-93. 
CAPURRO, M., MARTIN, T., SHI, W. & FILMUS, J. 2014. Glypican-3 binds to 
Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. 
J Cell Sci, 127, 1565-75. 




CAPURRO, M., WANLESS, I. R., SHERMAN, M., DEBOER, G., SHI, W., MIYOSHI, 
E. & FILMUS, J. 2003. Glypican-3: a novel serum and histochemical marker 
for hepatocellular carcinoma. Gastroenterology, 125, 89-97. 
CAPURRO, M. I., XIANG, Y. Y., LOBE, C. & FILMUS, J. 2005. Glypican-3 promotes 
the growth of hepatocellular carcinoma by stimulating canonical Wnt 
signaling. Cancer Res, 65, 6245-54. 
CAPURRO, M. I., XU, P., SHI, W., LI, F., JIA, A. & FILMUS, J. 2008. Glypican-3 
inhibits Hedgehog signaling during development by competing with patched 
for Hedgehog binding. Dev Cell, 14, 700-11. 
CAREY, D. J. 1997. Syndecans: multifunctional cell-surface co-receptors. Biochem 
J, 327 ( Pt 1), 1-16. 
CAREY, D. J., STAHL, R. C., ASUNDI, V. K. & TUCKER, B. 1993. Processing and 
subcellular distribution of the Schwann cell lipid-anchored heparan sulfate 
proteoglycan and identification as glypican. Exp Cell Res, 208, 10-8. 
CASTRO-MALASPINA, H., GAY, R. E., RESNICK, G., KAPOOR, N., MEYERS, P., 
CHIARIERI, D., MCKENZIE, S., BROXMEYER, H. E. & MOORE, M. A. 1980. 
Characterization of human bone marrow fibroblast colony-forming cells 
(CFU-F) and their progeny. Blood, 56, 289-301. 
CHEN, C. Y., LIN, C. W., CHANG, C. Y., JIANG, S. T. & HSUEH, Y. P. 2011. 
Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 
and regulates neuronal morphology. J Cell Biol, 193, 769-84. 
CHEN, E., HERMANSON, S. & EKKER, S. C. 2004. Syndecan-2 is essential for 
angiogenic sprouting during zebrafish development. Blood, 103, 1710-9. 
CHEN, J., LI, Y., KATAKOWSKI, M., CHEN, X., WANG, L., LU, D., LU, M., 
GAUTAM, S. C. & CHOPP, M. 2003. Intravenous bone marrow stromal cell 
therapy reduces apoptosis and promotes endogenous cell proliferation after 
stroke in female rat. J Neurosci Res, 73, 778-86. 
CHEN, R. L. & LANDER, A. D. 2001. Mechanisms underlying preferential assembly 
of heparan sulfate on glypican-1. J Biol Chem, 276, 7507-17. 




CHEN, X. D. 2010. Extracellular matrix provides an optimal niche for the 
maintenance and propagation of mesenchymal stem cells. Birth Defects Res 
C Embryo Today, 90, 45-54. 
CHEN, Y., MAGUIRE, T., HILEMAN, R. E., FROMM, J. R., ESKO, J. D., 
LINHARDT, R. J. & MARKS, R. M. 1997. Dengue virus infectivity depends on 
envelope protein binding to target cell heparan sulfate. Nat Med, 3, 866-71. 
CHERNOUSOV, M. A. & CAREY, D. J. 1993. N-syndecan (syndecan 3) from 
neonatal rat brain binds basic fibroblast growth factor. J Biol Chem, 268, 
16810-4. 
CHICHESTER, C. O., FERNANDEZ, M. & MINGUELL, J. J. 1993. Extracellular 
matrix gene expression by human bone marrow stroma and by marrow 
fibroblasts. Cell Adhes Commun, 1, 93-9. 
CHOI, C. B., CHO, Y. K., PRAKASH, K. V., JEE, B. K., HAN, C. W., PAIK, Y. K., 
KIM, H. Y., LEE, K. H., CHUNG, N. & RHA, H. K. 2006. Analysis of neuron-
like differentiation of human bone marrow mesenchymal stem cells. Biochem 
Biophys Res Commun, 350, 138-46. 
CHOONG, P. F., MOK, P. L., CHEONG, S. K., LEONG, C. F. & THEN, K. Y. 2007. 
Generating neuron-like cells from BM-derived mesenchymal stromal cells in 
vitro. Cytotherapy, 9, 170-83. 
CHRISTIANSEN, J. H., COLES, E. G. & WILKINSON, D. G. 2000. Molecular control 
of neural crest formation, migration and differentiation. Curr Opin Cell Biol, 
12, 719-24. 
CIZMECI-SMITH, G., LANGAN, E., YOUKEY, J., SHOWALTER, L. J. & CAREY, D. 
J. 1997. Syndecan-4 is a primary-response gene induced by basic fibroblast 
growth factor and arterial injury in vascular smooth muscle cells. Arterioscler 
Thromb Vasc Biol, 17, 172-80. 
CIZMECI-SMITH, G., STAHL, R. C., SHOWALTER, L. J. & CAREY, D. J. 1993. 
Differential expression of transmembrane proteoglycans in vascular smooth 
muscle cells. J Biol Chem, 268, 18740-7. 




CLARK, R. S., KOCHANEK, P. M., CHEN, M., WATKINS, S. C., MARION, D. W., 
CHEN, J., HAMILTON, R. L., LOEFFERT, J. E. & GRAHAM, S. H. 1999. 
Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain 
after head injury. FASEB J, 13, 813-21. 
CONGET, P. A. & MINGUELL, J. J. 1999. Phenotypical and functional properties of 
human bone marrow mesenchymal progenitor cells. J Cell Physiol, 181, 67-
73. 
CONNICK, P., KOLAPPAN, M., CRAWLEY, C., WEBBER, D. J., PATANI, R., 
MICHELL, A. W., DU, M. Q., LUAN, S. L., ALTMANN, D. R., THOMPSON, A. 
J., COMPSTON, A., SCOTT, M. A., MILLER, D. H. & CHANDRAN, S. 2012. 
Autologous mesenchymal stem cells for the treatment of secondary 
progressive multiple sclerosis: an open-label phase 2a proof-of-concept 
study. Lancet Neurol, 11, 150-6. 
CONRAD, H. E. 1998. Heparin-Binding Proteins, San Diego, Academic Press. 
COOL, S. M. & NURCOMBE, V. 2006. Heparan sulfate regulation of progenitor cell 
fate. J Cell Biochem, 99, 1040-51. 
COTRAN, R. S., KUMAR, V., ABBAS, A. K., COLLINS, T., ROBBINS, S. L. & 
SCHMITT, B. 1999. Pathologic Basis of Disease. 
COUCHMAN, J. R. 2003. Syndecans: proteoglycan regulators of cell-surface 
microdomains? Nat Rev Mol Cell Biol, 4, 926-37. 
COUMOUL, X. & DENG, C. X. 2003. Roles of FGF receptors in mammalian 
development and congenital diseases. Birth Defects Res C Embryo Today, 
69, 286-304. 
CRIGLER, L., ROBEY, R. C., ASAWACHAICHARN, A., GAUPP, D. & PHINNEY, D. 
G. 2006. Human mesenchymal stem cell subpopulations express a variety of 
neuro-regulatory molecules and promote neuronal cell survival and 
neuritogenesis. Exp Neurol, 198, 54-64. 




CRISAN, M., YAP, S., CASTEILLA, L., CHEN, C. W., CORSELLI, M., PARK, T. S., 
ANDRIOLO, G., SUN, B., ZHENG, B., ZHANG, L., NOROTTE, C., TENG, P. 
N., TRAAS, J., SCHUGAR, R., DEASY, B. M., BADYLAK, S., BUHRING, H. 
J., GIACOBINO, J. P., LAZZARI, L., HUARD, J. & PEAULT, B. 2008. A 
perivascular origin for mesenchymal stem cells in multiple human organs. 
Cell Stem Cell, 3, 301-13. 
CUNNINGHAM, S. C., KAMANGAR, F., KIM, M. P., HAMMOUD, S., HAQUE, R., 
IACOBUZIO-DONAHUE, C., ASHFAQ, R., KERN, S. E., MAITRA, A., 
HEITMILLER, R. E., CHOTI, M. A., LILLEMOE, K. D., CAMERON, J. L., 
YEO, C. J., MONTGOMERY, E. & SCHULICK, R. D. 2006. MKK4 status 
predicts survival after resection of gastric adenocarcinoma. Arch Surg, 141, 
1095-9; discussion 1100. 
D'ALESSANDRO, J. S. & WANG, E. A. 1994. Bone morphogenetic proteins inhibit 
proliferation, induce reversible differentiation and prevent cell death in 
astrocyte lineage cells. Growth Factors, 11, 45-52. 
DA SILVA MEIRELLES, L., CAPLAN, A. I. & NARDI, N. B. 2008. In search of the in 
vivo identity of mesenchymal stem cells. Stem Cells, 26, 2287-99. 
DAI, Y., YANG, Y., MACLEOD, V., YUE, X., RAPRAEGER, A. C., SHRIVER, Z., 
VENKATARAMAN, G., SASISEKHARAN, R. & SANDERSON, R. D. 2005. 
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J 
Biol Chem, 280, 40066-73. 
DAVID, G. 1993. Integral membrane heparan sulfate proteoglycans. FASEB J, 7, 
1023-30. 
DAVID, G., LORIES, V., DECOCK, B., MARYNEN, P., CASSIMAN, J. J. & VAN 
DEN BERGHE, H. 1990. Molecular cloning of a phosphatidylinositol-
anchored membrane heparan sulfate proteoglycan from human lung 
fibroblasts. J Cell Biol, 111, 3165-76. 
DE HEMPTINNE, I., VERMEIREN, C., MALOTEAUX, J. M. & HERMANS, E. 2004. 
Induction of glial glutamate transporters in adult mesenchymal stem cells. J 
Neurochem, 91, 155-66. 




DEEPA, S. S., YAMADA, S., ZAKO, M., GOLDBERGER, O. & SUGAHARA, K. 
2004. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal 
murine mammary gland epithelial cells are structurally and functionally 
distinct and cooperate with heparan sulfate chains to bind growth factors. A 
novel function to control binding of midkine, pleiotrophin, and basic fibroblast 
growth factor. J Biol Chem, 279, 37368-76. 
DENHEZ, F., WILCOX-ADELMAN, S. A., BACIU, P. C., SAONCELLA, S., LEE, S., 
FRENCH, B., NEVEU, W. & GOETINCK, P. F. 2002. Syndesmos, a 
syndecan-4 cytoplasmic domain interactor, binds to the focal adhesion 
adaptor proteins paxillin and Hic-5. J Biol Chem, 277, 12270-4. 
DESCHASEAUX, F., GINDRAUX, F., SAADI, R., OBERT, L., CHALMERS, D. & 
HERVE, P. 2003. Direct selection of human bone marrow mesenchymal 
stem cells using an anti-CD49a antibody reveals their CD45med,low 
phenotype. Br J Haematol, 122, 506-17. 
DEVINE, S. M., COBBS, C., JENNINGS, M., BARTHOLOMEW, A. & HOFFMAN, R. 
2003. Mesenchymal stem cells distribute to a wide range of tissues following 
systemic infusion into nonhuman primates. Blood, 101, 2999-3001. 
DIGIROLAMO, C. M., STOKES, D., COLTER, D., PHINNEY, D. G., CLASS, R. & 
PROCKOP, D. J. 1999. Propagation and senescence of human marrow 
stromal cells in culture: a simple colony-forming assay identifies samples with 
the greatest potential to propagate and differentiate. Br J Haematol, 107, 
275-81. 
DITYATEV, A., SEIDENBECHER, C. I. & SCHACHNER, M. 2010. 
Compartmentalization from the outside: the extracellular matrix and 
functional microdomains in the brain. Trends Neurosci, 33, 503-12. 
DOBRA, K., NURMINEN, M. & HJERPE, A. 2003. Growth factors regulate the 
expression profile of their syndecan co-receptors and the differentiation of 
mesothelioma cells. Anticancer Res, 23, 2435-44. 
DOMBROWSKI, C., SONG, S. J., CHUAN, P., LIM, X., SUSANTO, E., SAWYER, A. 
A., WOODRUFF, M. A., HUTMACHER, D. W., NURCOMBE, V. & COOL, S. 
M. 2009. Heparan sulfate mediates the proliferation and differentiation of rat 
mesenchymal stem cells. Stem Cells Dev, 18, 661-70. 




DOMINICI, M., LE BLANC, K., MUELLER, I., SLAPER-CORTENBACH, I., MARINI, 
F., KRAUSE, D., DEANS, R., KEATING, A., PROCKOP, D. & HORWITZ, E. 
2006. Minimal criteria for defining multipotent mesenchymal stromal cells. 
The International Society for Cellular Therapy position statement. 
Cytotherapy, 8, 315-7. 
DUNCAN, G., MCCORMICK, C. & TUFARO, F. 2001. The link between heparan 
sulfate and hereditary bone disease: finding a function for the EXT family of 
putative tumor suppressor proteins. J Clin Invest, 108, 511-6. 
DUPREE, M. A., POLLACK, S. R., LEVINE, E. M. & LAURENCIN, C. T. 2006. 
Fibroblast growth factor 2 induced proliferation in osteoblasts and bone 
marrow stromal cells: a whole cell model. Biophys J, 91, 3097-112. 
DWIVEDI, P. P., LAM, N. & POWELL, B. C. 2013. Boning up on glypicans--
opportunities for new insights into bone biology. Cell Biochem Funct, 31, 91-
114. 
E., S. & HM., K. 2009. Adult Mesenchymal Stem Cells. In: KR, C. (ed.) StemBook. 
The Stem Cell Research Community. 
EGEA, V., VON BAUMGARTEN, L., SCHICHOR, C., BERNINGER, B., POPP, T., 
NETH, P., GOLDBRUNNER, R., KIENAST, Y., WINKLER, F., JOCHUM, M. 
& RIES, C. 2011. TNF-alpha respecifies human mesenchymal stem cells to a 
neural fate and promotes migration toward experimental glioma. Cell Death 
Differ, 18, 853-63. 
EGLITIS, M. A. & MEZEY, E. 1997. Hematopoietic cells differentiate into both 
microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S 
A, 94, 4080-5. 
ELENIUS, K. & JALKANEN, M. 1994. Function of the syndecans--a family of cell 
surface proteoglycans. J Cell Sci, 107 ( Pt 11), 2975-82. 
ELENIUS, K., MAATTA, A., SALMIVIRTA, M. & JALKANEN, M. 1992. Growth 
factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem, 
267, 6435-41. 
ELLENBOGEN, R. G., BERGER, M. S. & BATJER, H. H. 2010. The National 
Football League and concussion: leading a culture change in contact sports. 
World Neurosurg, 74, 560-5. 




ENGLER, A. J., SEN, S., SWEENEY, H. L. & DISCHER, D. E. 2006. Matrix 
elasticity directs stem cell lineage specification. Cell, 126, 677-89. 
ERICES, A., CONGET, P. & MINGUELL, J. J. 2000. Mesenchymal progenitor cells 
in human umbilical cord blood. Br J Haematol, 109, 235-42. 
ERICKSON, A. C. & COUCHMAN, J. R. 2000. Still more complexity in mammalian 
basement membranes. J Histochem Cytochem, 48, 1291-306. 
ESKO, J. D. & SELLECK, S. B. 2002. Order out of chaos: assembly of ligand 
binding sites in heparan sulfate. Annu Rev Biochem, 71, 435-71. 
ESKO, J. D. & ZHANG, L. 1996. Influence of core protein sequence on 
glycosaminoglycan assembly. Curr Opin Struct Biol, 6, 663-70. 
ETHELL, I. M., IRIE, F., KALO, M. S., COUCHMAN, J. R., PASQUALE, E. B. & 
YAMAGUCHI, Y. 2001. EphB/syndecan-2 signaling in dendritic spine 
morphogenesis. Neuron, 31, 1001-13. 
FAN, G., XIAO, L., CHENG, L., WANG, X., SUN, B. & HU, G. 2000. Targeted 
disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal 
respiratory distress in mice. FEBS Lett, 467, 7-11. 
FERNANDEZ, M., SIMON, V., HERRERA, G., CAO, C., DEL FAVERO, H. & 
MINGUELL, J. J. 1997. Detection of stromal cells in peripheral blood 
progenitor cell collections from breast cancer patients. Bone Marrow 
Transplant, 20, 265-71. 
FERRANDINA, G., MARTINELLI, E., ZANNONI, G. F., DISTEFANO, M., PAGLIA, 
A., FERLINI, C. & SCAMBIA, G. 2007. Expression of class III beta tubulin in 
cervical cancer patients administered preoperative radiochemotherapy: 
correlation with response to treatment and clinical outcome. Gynecol Oncol, 
104, 326-30. 
FERRANDINA, G., ZANNONI, G. F., MARTINELLI, E., PAGLIA, A., GALLOTTA, V., 
MOZZETTI, S., SCAMBIA, G. & FERLINI, C. 2006. Class III beta-tubulin 
overexpression is a marker of poor clinical outcome in advanced ovarian 
cancer patients. Clin Cancer Res, 12, 2774-9. 




FERRARI, G., CUSELLA-DE ANGELIS, G., COLETTA, M., PAOLUCCI, E., 
STORNAIUOLO, A., COSSU, G. & MAVILIO, F. 1998. Muscle regeneration 
by bone marrow-derived myogenic progenitors. Science, 279, 1528-30. 
FICO, A., MAINA, F. & DONO, R. 2011. Fine-tuning of cell signaling by glypicans. 
Cell Mol Life Sci, 68, 923-9. 
FILMUS, J., CAPURRO, M. & RAST, J. 2008. Glypicans. Genome Biol, 9, 224. 
FILMUS, J. & SELLECK, S. B. 2001. Glypicans: proteoglycans with a surprise. J 
Clin Invest, 108, 497-501. 
FITZGERALD, K. A. & O'NEILL, L. A. 1999. Characterization of CD44 induction by 
IL-1: a critical role for Egr-1. J Immunol, 162, 4920-7. 
FLANAGAN, L. A., REBAZA, L. M., DERZIC, S., SCHWARTZ, P. H. & MONUKI, E. 
S. 2006. Regulation of human neural precursor cells by laminin and integrins. 
J Neurosci Res, 83, 845-56. 
FLAUMENHAFT, R., MOSCATELLI, D. & RIFKIN, D. B. 1990. Heparin and heparan 
sulfate increase the radius of diffusion and action of basic fibroblast growth 
factor. J Cell Biol, 111, 1651-9. 
FORSBERG, E., PEJLER, G., RINGVALL, M., LUNDERIUS, C., TOMASINI-
JOHANSSON, B., KUSCHE-GULLBERG, M., ERIKSSON, I., LEDIN, J., 
HELLMAN, L. & KJELLEN, L. 1999. Abnormal mast cells in mice deficient in 
a heparin-synthesizing enzyme. Nature, 400, 773-6. 
FORSBERG, M., HOLMBORN, K., KUNDU, S., DAGALV, A., KJELLEN, L. & 
FORSBERG-NILSSON, K. 2012. Undersulfation of heparan sulfate restricts 
differentiation potential of mouse embryonic stem cells. J Biol Chem, 287, 
10853-62. 
FORTUNE, N. & WEN, X. 1999. The definition, incidence and prevalance of 
acquired brain injury in Australia. In: AIHW (ed.). Canberra: AIHW. 
FOUDAH, D., MONFRINI, M., DONZELLI, E., NIADA, S., BRINI, A. T., ORCIANI, 
M., TREDICI, G. & MILOSO, M. 2014. Expression of neural markers by 
undifferentiated mesenchymal-like stem cells from different sources. J 
Immunol Res, 2014, 987678. 




FOUDAH, D., REDONDO, J., CALDARA, C., CARINI, F., TREDICI, G. & MILOSO, 
M. 2012. Expression of neural markers by undifferentiated rat mesenchymal 
stem cells. J Biomed Biotechnol, 2012, 820821. 
FOUDAH, D., REDONDO, J., CALDARA, C., CARINI, F., TREDICI, G. & MILOSO, 
M. 2013. Human mesenchymal stem cells express neuronal markers after 
osteogenic and adipogenic differentiation. Cell Mol Biol Lett, 18, 163-86. 
FOX, L. E., SHEN, J., MA, K., LIU, Q., SHI, G., PAPPAS, G. D., QU, T. & CHENG, 
J. 2010. Membrane properties of neuron-like cells generated from adult 
human bone-marrow-derived mesenchymal stem cells. Stem Cells Dev, 19, 
1831-41. 
FOX, S. B., FAWCETT, J., JACKSON, D. G., COLLINS, I., GATTER, K. C., 
HARRIS, A. L., GEARING, A. & SIMMONS, D. L. 1994. Normal human 
tissues, in addition to some tumors, express multiple different CD44 isoforms. 
Cancer Res, 54, 4539-46. 
FRANKEL, P., PELLET-MANY, C., LEHTOLAINEN, P., D'ABACO, G. M., 
TICKNER, M. L., CHENG, L. & ZACHARY, I. C. 2008. Chondroitin sulphate-
modified neuropilin 1 is expressed in human tumour cells and modulates 3D 
invasion in the U87MG human glioblastoma cell line through a p130Cas-
mediated pathway. EMBO Rep, 9, 983-9. 
FRANSSON, L. A. 2003. Glypicans. Int J Biochem Cell Biol, 35, 125-9. 
FRANSSON, L. A., BELTING, M., CHENG, F., JONSSON, M., MANI, K. & 
SANDGREN, S. 2004. Novel aspects of glypican glycobiology. Cell Mol Life 
Sci, 61, 1016-24. 
FREIJE, J. M., DIEZ-ITZA, I., BALBIN, M., SANCHEZ, L. M., BLASCO, R., 
TOLIVIA, J. & LOPEZ-OTIN, C. 1994. Molecular cloning and expression of 
collagenase-3, a novel human matrix metalloproteinase produced by breast 
carcinomas. J Biol Chem, 269, 16766-73. 
FRIEDENSTEIN, A. J., CHAILAKHYAN, R. K. & GERASIMOV, U. V. 1987. Bone 
marrow osteogenic stem cells: in vitro cultivation and transplantation in 
diffusion chambers. Cell Tissue Kinet, 20, 263-72. 




FRIEDENSTEIN, A. J., CHAILAKHYAN, R. K., LATSINIK, N. V., PANASYUK, A. F. 
& KEILISS-BOROK, I. V. 1974. Stromal cells responsible for transferring the 
microenvironment of the hemopoietic tissues. Cloning in vitro and 
retransplantation in vivo. Transplantation, 17, 331-40. 
FRIEDENSTEIN, A. J., GORSKAJA, J. F. & KULAGINA, N. N. 1976. Fibroblast 
precursors in normal and irradiated mouse hematopoietic organs. Exp 
Hematol, 4, 267-74. 
FU, L., ZHU, L., HUANG, Y., LEE, T. D., FORMAN, S. J. & SHIH, C. C. 2008. 
Derivation of neural stem cells from mesenchymal stemcells: evidence for a 
bipotential stem cell population. Stem Cells Dev, 17, 1109-21. 
FUERER, C., HABIB, S. J. & NUSSE, R. 2010. A study on the interactions between 
heparan sulfate proteoglycans and Wnt proteins. Dev Dyn, 239, 184-90. 
FUJISE, M., TAKEO, S., KAMIMURA, K., MATSUO, T., AIGAKI, T., IZUMI, S. & 
NAKATO, H. 2003. Dally regulates Dpp morphogen gradient formation in the 
Drosophila wing. Development, 130, 1515-22. 
FUJITA-YAMAGUCHI, Y. & KATHURIA, S. 1988. Characterization of receptor 
tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 
100-times more potent inhibitor of insulin receptor than IGF-I receptor. 
Biochem Biophys Res Commun, 157, 955-62. 
FUKAI, N., KENAGY, R. D., CHEN, L., GAO, L., DAUM, G. & CLOWES, A. W. 
2009. Syndecan-1: An inhibitor of arterial smooth muscle cell growth and 
intimal hyperplasia. Arterioscler Thromb Vasc Biol, 29, 1356-62. 
G20-WBMTS 2014. G20 WBMTS. G20 World Brain Mapping and Therapeutics 
Summit. Brisbane, Australia. 
GALINDO, L. T., FILIPPO, T. R., SEMEDO, P., ARIZA, C. B., MOREIRA, C. M., 
CAMARA, N. O. & PORCIONATTO, M. A. 2011. Mesenchymal stem cell 
therapy modulates the inflammatory response in experimental traumatic brain 
injury. Neurol Res Int, 2011, 564089. 
GALLAGHER, J. T., TURNBULL, J. E. & LYON, M. 1992. Patterns of sulphation in 
heparan sulphate: polymorphism based on a common structural theme. Int J 
Biochem, 24, 553-60. 




GAO, W., KIM, H., FENG, M., PHUNG, Y., XAVIER, C. P., RUBIN, J. S. & HO, M. 
2014. Inactivation of Wnt signaling by a human antibody that recognizes the 
heparan sulfate chains of glypican-3 for liver cancer therapy. Hepatology, 60, 
576-87. 
GERDONI, E., GALLO, B., CASAZZA, S., MUSIO, S., BONANNI, I., PEDEMONTE, 
E., MANTEGAZZA, R., FRASSONI, F., MANCARDI, G., PEDOTTI, R. & 
UCCELLI, A. 2007. Mesenchymal stem cells effectively modulate pathogenic 
immune response in experimental autoimmune encephalomyelitis. Ann 
Neurol, 61, 219-27. 
GHIRNIKAR, R. S., LEE, Y. L. & ENG, L. F. 1998. Inflammation in traumatic brain 
injury: role of cytokines and chemokines. Neurochem Res, 23, 329-40. 
GILYAROV, A. V. 2008. Nestin in central nervous system cells. Neurosci Behav 
Physiol, 38, 165-9. 
GIORDANO, S., SHERMAN, L., LYMAN, W. & MORRISON, R. 1992. Multiple 
molecular weight forms of basic fibroblast growth factor are developmentally 
regulated in the central nervous system. Dev Biol, 152, 293-303. 
GITAY-GOREN, H., SOKER, S., VLODAVSKY, I. & NEUFELD, G. 1992. The 
binding of vascular endothelial growth factor to its receptors is dependent on 
cell surface-associated heparin-like molecules. J Biol Chem, 267, 6093-8. 
GONZALEZ, A. M., BUSCAGLIA, M., ONG, M. & BAIRD, A. 1990. Distribution of 
basic fibroblast growth factor in the 18-day rat fetus: localization in the 
basement membranes of diverse tissues. J Cell Biol, 110, 753-65. 
GOODMAN, J. C., ROBERTSON, C. S., GROSSMAN, R. G. & NARAYAN, R. K. 
1990. Elevation of tumor necrosis factor in head injury. J Neuroimmunol, 30, 
213-7. 
GOTTE, M. & YIP, G. W. 2006. Heparanase, hyaluronan, and CD44 in cancers: a 
breast carcinoma perspective. Cancer Res, 66, 10233-7. 
GREGORY, C. A., SINGH, H., PERRY, A. S. & PROCKOP, D. J. 2003. The Wnt 
signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of 
human adult stem cells from bone marrow. J Biol Chem, 278, 28067-78. 




GREIG, N. H., MATTSON, M. P., PERRY, T., CHAN, S. L., GIORDANO, T., 
SAMBAMURTI, K., ROGERS, J. T., OVADIA, H. & LAHIRI, D. K. 2004. New 
therapeutic strategies and drug candidates for neurodegenerative diseases: 
p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad 
Sci, 1035, 290-315. 
GROBE, K. & ESKO, J. D. 2002. Regulated translation of heparan sulfate N-
acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 
5'-untranslated regions and internal ribosome entry sites. J Biol Chem, 277, 
30699-706. 
GUIMOND, S., MACCARANA, M., OLWIN, B. B., LINDAHL, U. & RAPRAEGER, A. 
C. 1993. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). 
Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem, 268, 
23906-14. 
GULYAS, M. & HJERPE, A. 2003. Proteoglycans and WT1 as markers for 
distinguishing adenocarcinoma, epithelioid mesothelioma, and benign 
mesothelium. J Pathol, 199, 479-87. 
HABUCHI, H., HABUCHI, O. & KIMATA, K. 2004. Sulfation pattern in 
glycosaminoglycan: does it have a code? Glycoconj J, 21, 47-52. 
HABUCHI, H., KOBAYASHI, M. & KIMATA, K. 1998. Molecular characterization and 
expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in 
human and partial cloning in Chinese hamster ovary cells. J Biol Chem, 273, 
9208-13. 
HABUCHI, H., NAGAI, N., SUGAYA, N., ATSUMI, F., STEVENS, R. L. & KIMATA, 
K. 2007. Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit 
defective heparan sulfate biosynthesis, abnormal placentation, and late 
embryonic lethality. J Biol Chem, 282, 15578-88. 
HACKER, U., NYBAKKEN, K. & PERRIMON, N. 2005. Heparan sulphate 
proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol, 6, 530-
41. 
HAGIHARA, K., WATANABE, K., CHUN, J. & YAMAGUCHI, Y. 2000. Glypican-4 is 
an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor 
cells. Dev Dyn, 219, 353-67. 




HAKUNO, D., FUKUDA, K., MAKINO, S., KONISHI, F., TOMITA, Y., MANABE, T., 
SUZUKI, Y., UMEZAWA, A. & OGAWA, S. 2002. Bone marrow-derived 
regenerated cardiomyocytes (CMG Cells) express functional adrenergic and 
muscarinic receptors. Circulation, 105, 380-6. 
HALLENBECK, J. M. 2002. The many faces of tumor necrosis factor in stroke. Nat 
Med, 8, 1363-8. 
HAN, C., BELENKAYA, T. Y., WANG, B. & LIN, X. 2004. Drosophila glypicans 
control the cell-to-cell movement of Hedgehog by a dynamin-independent 
process. Development, 131, 601-11. 
HAN, C., YAN, D., BELENKAYA, T. Y. & LIN, X. 2005. Drosophila glypicans Dally 
and Dally-like shape the extracellular Wingless morphogen gradient in the 
wing disc. Development, 132, 667-79. 
HANAHAN, D. & WEINBERG, R. A. 2000. The hallmarks of cancer. Cell, 100, 57-
70. 
HANCOCK, J. F. 2006. Lipid rafts: contentious only from simplistic standpoints. Nat 
Rev Mol Cell Biol, 7, 456-62. 
HARDINGHAM, T. E. & FOSANG, A. J. 1992. Proteoglycans: many forms and 
many functions. FASEB J, 6, 861-70. 
HASS, R., KASPER, C., BOHM, S. & JACOBS, R. 2011. Different populations and 
sources of human mesenchymal stem cells (MSC): A comparison of adult 
and neonatal tissue-derived MSC. Cell Commun Signal, 9, 12. 
HAUPT, L. M. & GRIFFITHS, L. R. 2009. Heparan Sulfate Proteoglycans, Tumour 
Progression and the Cancer Stem Cell Niche. Current Cancer Therapy 
Reviews, 5, 256-260. 
HAUPT, L. M., MURALI, S., MUN, F. K., TEPLYUK, N., MEI, L. F., STEIN, G. S., 
VAN WIJNEN, A. J., NURCOMBE, V. & COOL, S. M. 2009. The heparan 
sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 
cells toward osteogenesis. J Cell Physiol, 220, 780-91. 
HAYNESWORTH, S. E., BABER, M. A. & CAPLAN, A. I. 1996. Cytokine expression 
by human marrow-derived mesenchymal progenitor cells in vitro: effects of 
dexamethasone and IL-1 alpha. J Cell Physiol, 166, 585-92. 




HAYNESWORTH, S. E., GOSHIMA, J., GOLDBERG, V. M. & CAPLAN, A. I. 1992. 
Characterization of cells with osteogenic potential from human marrow. 
Bone, 13, 81-8. 
HER, G. J., WU, H. C., CHEN, M. H., CHEN, M. Y., CHANG, S. C. & WANG, T. W. 
2013. Control of three-dimensional substrate stiffness to manipulate 
mesenchymal stem cell fate toward neuronal or glial lineages. Acta Biomater, 
9, 5170-80. 
HERMANN, A., GASTL, R., LIEBAU, S., POPA, M. O., FIEDLER, J., BOEHM, B. 
O., MAISEL, M., LERCHE, H., SCHWARZ, J., BRENNER, R. & STORCH, A. 
2004. Efficient generation of neural stem cell-like cells from adult human 
bone marrow stromal cells. J Cell Sci, 117, 4411-22. 
HERMANN, A., MAISEL, M. & STORCH, A. 2006. Epigenetic conversion of human 
adult bone mesodermal stromal cells into neuroectodermal cell types for 
replacement therapy of neurodegenerative disorders. Expert Opin Biol Ther, 
6, 653-70. 
HIENOLA, A., TUMOVA, S., KULESSKIY, E. & RAUVALA, H. 2006. N-syndecan 
deficiency impairs neural migration in brain. J Cell Biol, 174, 569-80. 
HIGASHIYAMA, S., ABRAHAM, J. A. & KLAGSBRUN, M. 1993. Heparin-binding 
EGF-like growth factor stimulation of smooth muscle cell migration: 
dependence on interactions with cell surface heparan sulfate. J Cell Biol, 
122, 933-40. 
HSUEH, Y. P., YANG, F. C., KHARAZIA, V., NAISBITT, S., COHEN, A. R., 
WEINBERG, R. J. & SHENG, M. 1998. Direct interaction of CASK/LIN-2 and 
syndecan heparan sulfate proteoglycan and their overlapping distribution in 
neuronal synapses. J Cell Biol, 142, 139-51. 
HU, E., TONTONOZ, P. & SPIEGELMAN, B. M. 1995. Transdifferentiation of 
myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP 
alpha. Proc Natl Acad Sci U S A, 92, 9856-60. 
HUMPHRIES, D. E., WONG, G. W., FRIEND, D. S., GURISH, M. F., QIU, W. T., 
HUANG, C., SHARPE, A. H. & STEVENS, R. L. 1999. Heparin is essential 
for the storage of specific granule proteases in mast cells. Nature, 400, 769-
72. 




IBRAHIMI, O. A., ZHANG, F., HRSTKA, S. C., MOHAMMADI, M. & LINHARDT, R. 
J. 2004. Kinetic model for FGF, FGFR, and proteoglycan signal transduction 
complex assembly. Biochemistry, 43, 4724-30. 
ICHIKAWA, H., ITOTA, T., TORII, Y., INOUE, K. & SUGIMOTO, T. 1999. 
Osteocalcin-immunoreactive primary sensory neurons in the rat spinal and 
trigeminal nervous systems. Brain Res, 838, 205-9. 
IGURA, K., ZHANG, X., TAKAHASHI, K., MITSURU, A., YAMAGUCHI, S. & 
TAKASHI, T. A. 2004. Isolation and characterization of mesenchymal 
progenitor cells from chorionic villi of human placenta. Cytotherapy, 6, 543-
53. 
IOZZO, R. V. 1998. Matrix proteoglycans: from molecular design to cellular function. 
Annu Rev Biochem, 67, 609-52. 
IVINS, J. K., LITWACK, E. D., KUMBASAR, A., STIPP, C. S. & LANDER, A. D. 
1997. Cerebroglycan, a developmentally regulated cell-surface heparan 
sulfate proteoglycan, is expressed on developing axons and growth cones. 
Dev Biol, 184, 320-32. 
IWATA, T., YAMATO, M., ZHANG, Z., MUKOBATA, S., WASHIO, K., ANDO, T., 
FEIJEN, J., OKANO, T. & ISHIKAWA, I. 2010. Validation of human 
periodontal ligament-derived cells as a reliable source for cytotherapeutic 
use. J Clin Periodontol, 37, 1088-99. 
JAYSON, G. C., LYON, M., PARASKEVA, C., TURNBULL, J. E., DEAKIN, J. A. & 
GALLAGHER, J. T. 1998. Heparan sulfate undergoes specific structural 
changes during the progression from human colon adenoma to carcinoma in 
vitro. J Biol Chem, 273, 51-7. 
JENKINS, A., TEASDALE, G., HADLEY, M. D. M., MACPHERSON, P. & ROWAN, 
J. O. 1986. Brain lesions detected by magnetic resonance imaging in mild 
and severe head injuries. Lancet Neurol, 445–6. 
JENNETT, B. & BOND, M. 1975. Assessment of outcome after severe brain 
damage: a practical scale. Lancet, 1, 480-4. 
JENNETT, B. & TEASDALE, G. 1981. Management of head injuries. Contemporary 
Neurology Series, Philadelphia, FA Davis Company. 




JOHNSON, C. E., CRAWFORD, B. E., STAVRIDIS, M., TEN DAM, G., WAT, A. L., 
RUSHTON, G., WARD, C. M., WILSON, V., VAN KUPPEVELT, T. H., ESKO, 
J. D., SMITH, A., GALLAGHER, J. T. & MERRY, C. L. 2007. Essential 
alterations of heparan sulfate during the differentiation of embryonic stem 
cells to Sox1-enhanced green fluorescent protein-expressing neural 
progenitor cells. Stem Cells, 25, 1913-23. 
JONES, E. & MCGONAGLE, D. 2008. Human bone marrow mesenchymal stem 
cells in vivo. Rheumatology (Oxford), 47, 126-31. 
JONES, M., TUSSEY, L., ATHANASOU, N. & JACKSON, D. G. 2000. Heparan 
sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in 
human inflammatory macrophages can function as paracrine regulators of 
fibroblast growth factor action. J Biol Chem, 275, 7964-74. 
JORPES, J. E. & GARDELL, S. 1948. On heparin monosulfuric acid. J Biol Chem, 
176, 267-76. 
JOUHILAHTI, E. M., PELTONEN, S. & PELTONEN, J. 2008. Class III beta-tubulin 
is a component of the mitotic spindle in multiple cell types. J Histochem 
Cytochem, 56, 1113-9. 
KAN, I., BEN-ZUR, T., BARHUM, Y., LEVY, Y. S., BURSTEIN, A., CHARLOW, T., 
BULVIK, S., MELAMED, E. & OFFEN, D. 2007. Dopaminergic differentiation 
of human mesenchymal stem cells--utilization of bioassay for tyrosine 
hydroxylase expression. Neurosci Lett, 419, 28-33. 
KARTHIKEYAN, L., FLAD, M., ENGEL, M., MEYER-PUTTLITZ, B., MARGOLIS, R. 
U. & MARGOLIS, R. K. 1994. Immunocytochemical and in situ hybridization 
studies of the heparan sulfate proteoglycan, glypican, in nervous tissue. J 
Cell Sci, 107 ( Pt 11), 3213-22. 
KASSEM, M. & ABDALLAH, B. M. 2008. Human bone-marrow-derived 
mesenchymal stem cells: biological characteristics and potential role in 
therapy of degenerative diseases. Cell Tissue Res, 331, 157-63. 
KASSIS, I., GRIGORIADIS, N., GOWDA-KURKALLI, B., MIZRACHI-KOL, R., BEN-
HUR, T., SLAVIN, S., ABRAMSKY, O. & KARUSSIS, D. 2008. 
Neuroprotection and immunomodulation with mesenchymal stem cells in 
chronic experimental autoimmune encephalomyelitis. Arch Neurol, 65, 753-
61. 




KATO, M., WANG, H., BERNFIELD, M., GALLAGHER, J. T. & TURNBULL, J. E. 
1994. Cell surface syndecan-1 on distinct cell types differs in fine structure 
and ligand binding of its heparan sulfate chains. J Biol Chem, 269, 18881-90. 
KATSETOS, C. D., HERMAN, M. M. & MORK, S. J. 2003. Class III beta-tubulin in 
human development and cancer. Cell Motil Cytoskeleton, 55, 77-96. 
KATSETOS, C. D., LEGIDO, A., PERENTES, E. & MORK, S. J. 2003. Class III 
beta-tubulin isotype: a key cytoskeletal protein at the crossroads of 
developmental neurobiology and tumor neuropathology. J Child Neurol, 18, 
851-66; discussion 867. 
KERN, S., EICHLER, H., STOEVE, J., KLUTER, H. & BIEBACK, K. 2006. 
Comparative analysis of mesenchymal stem cells from bone marrow, 
umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294-301. 
KHARE, N. 2002. Studies on the role of daily-like during Drosophila development. 
PhD Thesis, Lund University. 
KHOO, M. L., SHEN, B., TAO, H. & MA, D. D. 2008. Long-term serial passage and 
neuronal differentiation capability of human bone marrow mesenchymal stem 
cells. Stem Cells Dev, 17, 883-96. 
KIM, S. S., YOO, S. W., PARK, T. S., AHN, S. C., JEONG, H. S., KIM, J. W., 
CHANG, D. Y., CHO, K. G., KIM, S. U., HUH, Y., LEE, J. E., LEE, S. Y., LEE, 
Y. D. & SUH-KIM, H. 2008. Neural induction with neurogenin1 increases the 
therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem 
Cells, 26, 2217-28. 
KINNUNEN, A., KINNUNEN, T., KAKSONEN, M., NOLO, R., PANULA, P. & 
RAUVALA, H. 1998. N-syndecan and HB-GAM (heparin-binding growth-
associated molecule) associate with early axonal tracts in the rat brain. Eur J 
Neurosci, 10, 635-48. 
KINNUNEN, A., NIEMI, M., KINNUNEN, T., KAKSONEN, M., NOLO, R. & 
RAUVALA, H. 1999. Heparan sulphate and HB-GAM (heparin-binding 
growth-associated molecule) in the development of the thalamocortical 
pathway of rat brain. Eur J Neurosci, 11, 491-502. 




KIRKPATRICK, C. A., DIMITROFF, B. D., RAWSON, J. M. & SELLECK, S. B. 2004. 
Spatial regulation of Wingless morphogen distribution and signaling by Dally-
like protein. Dev Cell, 7, 513-23. 
KIRKPATRICK, C. A., KNOX, S. M., STAATZ, W. D., FOX, B., LERCHER, D. M. & 
SELLECK, S. B. 2006. The function of a Drosophila glypican does not 
depend entirely on heparan sulfate modification. Dev Biol, 300, 570-82. 
KISHABA, Y., MATSUBARA, D. & NIKI, T. 2010. Heterogeneous expression of 
nestin in myofibroblasts of various human tissues. Pathol Int, 60, 378-85. 
KJELLEN, L., BIELEFELD, D. & HOOK, M. 1983. Reduced sulfation of liver 
heparan sulfate in experimentally diabetic rats. Diabetes, 32, 337-42. 
KJELLEN, L. & LINDAHL, U. 1991. Proteoglycans: structures and interactions. 
Annu Rev Biochem, 60, 443-75. 
KLAGSBRUN, M. 1990. The affinity of fibroblast growth factors (FGFs) for heparin; 
FGF-heparan sulfate interactions in cells and extracellular matrix. Curr Opin 
Cell Biol, 2, 857-63. 
KOBAYASHI, M., HABUCHI, H., YONEDA, M., HABUCHI, O. & KIMATA, K. 1997. 
Molecular cloning and expression of Chinese hamster ovary cell heparan-
sulfate 2-sulfotransferase. J Biol Chem, 272, 13980-5. 
KOLF, C. M., CHO, E. & TUAN, R. S. 2007. Mesenchymal stromal cells. Biology of 
adult mesenchymal stem cells: regulation of niche, self-renewal and 
differentiation. Arthritis Res Ther, 9, 204. 
KOOPMAN, G., HEIDER, K. H., HORST, E., ADOLF, G. R., VAN DEN BERG, F., 
PONTA, H., HERRLICH, P. & PALS, S. T. 1993. Activated human 
lymphocytes and aggressive non-Hodgkin's lymphomas express a 
homologue of the rat metastasis-associated variant of CD44. J Exp Med, 
177, 897-904. 
KOPEN, G. C., PROCKOP, D. J. & PHINNEY, D. G. 1999. Marrow stromal cells 
migrate throughout forebrain and cerebellum, and they differentiate into 
astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S 
A, 96, 10711-6. 




KOUSIDOU, O., BERDIAKI, A., KLETSAS, D., ZAFIROPOULOS, A., 
THEOCHARIS, A. D., TZANAKAKIS, G. N. & KARAMANOS, N. K. 2008. 
Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 
and metalloproteinase-9 in breast cancer cells. Mol Oncol, 2, 223-32. 
KRAEMER, P. M. 1971. Heparan sulfates of cultured cells. II. Acid-soluble and -
precipitable species of different cell lines. Biochemistry, 10, 1445-51. 
KRAEMER, P. M. 1971. Heparan sulfates of cultured cells. I. Membrane-associated 
and cell-sap species in Chinese hamster cells. Biochemistry, 10, 1437-45. 
KRAUSHAAR, D. C., YAMAGUCHI, Y. & WANG, L. 2010. Heparan sulfate is 
required for embryonic stem cells to exit from self-renewal. J Biol Chem, 285, 
5907-16. 
KRUPKOVA, O., JR., LOJA, T., ZAMBO, I. & VESELSKA, R. 2010. Nestin 
expression in human tumors and tumor cell lines. Neoplasma, 57, 291-8. 
KUSCHE, M., BACKSTROM, G., RIESENFELD, J., PETITOU, M., CHOAY, J. & 
LINDAHL, U. 1988. Biosynthesis of heparin. O-sulfation of the antithrombin-
binding region. J Biol Chem, 263, 15474-84. 
KUZNETSOV, S. A., FRIEDENSTEIN, A. J. & ROBEY, P. G. 1997. Factors required 
for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol, 
97, 561-70. 
LAMBAERTS, K., WILCOX-ADELMAN, S. A. & ZIMMERMANN, P. 2009. The 
signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin 
Cell Biol, 21, 662-9. 
LAMOUREUX, F., BAUD'HUIN, M., DUPLOMB, L., HEYMANN, D. & REDINI, F. 
2007. Proteoglycans: key partners in bone cell biology. Bioessays, 29, 758-
71. 
LANDER, A. D. 1998. Proteoglycans: master regulators of molecular encounter? 
Matrix Biol, 17, 465-72. 
LANDER, A. D. & SELLECK, S. B. 2000. The elusive functions of proteoglycans: in 
vivo veritas. J Cell Biol, 148, 227-32. 




LANDER, A. D., STIPP, C. S. & IVINS, J. K. 1996. The glypican family of heparan 
sulfate proteoglycans: major cell-surface proteoglycans of the developing 
nervous system. Perspect Dev Neurobiol, 3, 347-58. 
LANZONI, G., ALVIANO, F., MARCHIONNI, C., BONSI, L., COSTA, R., FORONI, 
L., RODA, G., BELLUZZI, A., CAPONI, A., RICCI, F., LUIGI TAZZARI, P., 
PAGLIARO, P., RIZZO, R., LANZA, F., ROBERTO BARICORDI, O., 
PASQUINELLI, G., RODA, E. & PAOLO BAGNARA, G. 2009. Isolation of 
stem cell populations with trophic and immunoregulatory functions from 
human intestinal tissues: potential for cell therapy in inflammatory bowel 
disease. Cytotherapy, 11, 1020-31. 
LAREMORE, T. N., ZHANG, F., DORDICK, J. S., LIU, J. & LINHARDT, R. J. 2009. 
Recent progress and applications in glycosaminoglycan and heparin 
research. Curr Opin Chem Biol, 13, 633-40. 
LATIF, N., SARATHCHANDRA, P., THOMAS, P. S., ANTONIW, J., BATTEN, P., 
CHESTER, A. H., TAYLOR, P. M. & YACOUB, M. H. 2007. Characterization 
of structural and signaling molecules by human valve interstitial cells and 
comparison to human mesenchymal stem cells. J Heart Valve Dis, 16, 56-66. 
LE BLANC, K. & RINGDEN, O. 2005. Immunobiology of human mesenchymal stem 
cells and future use in hematopoietic stem cell transplantation. Biol Blood 
Marrow Transplant, 11, 321-34. 
LEE, O. K., KUO, T. K., CHEN, W. M., LEE, K. D., HSIEH, S. L. & CHEN, T. H. 
2004. Isolation of multipotent mesenchymal stem cells from umbilical cord 
blood. Blood, 103, 1669-75. 
LEE, P. N., PANG, K., MATUS, D. Q. & MARTINDALE, M. Q. 2006. A WNT of 
things to come: evolution of Wnt signaling and polarity in cnidarians. Semin 
Cell Dev Biol, 17, 157-67. 
LEE, S., CHOI, K., AHN, H., SONG, K., CHOE, J. & LEE, I. 2005. TuJ1 (class III 
beta-tubulin) expression suggests dynamic redistribution of follicular dendritic 
cells in lymphoid tissue. Eur J Cell Biol, 84, 453-9. 
LEMJABBAR-ALAOUI, H., VAN ZANTE, A., SINGER, M. S., XUE, Q., WANG, Y. 
Q., TSAY, D., HE, B., JABLONS, D. M. & ROSEN, S. D. 2010. Sulf-2, a 
heparan sulfate endosulfatase, promotes human lung carcinogenesis. 
Oncogene, 29, 635-46. 




LENDORF, M. E., MANON-JENSEN, T., KRONQVIST, P., MULTHAUPT, H. A. & 
COUCHMAN, J. R. 2011. Syndecan-1 and syndecan-4 are independent 
indicators in breast carcinoma. J Histochem Cytochem, 59, 615-29. 
LEONOVA, E. I. & GALZITSKAYA, O. V. 2013. Structure and functions of 
syndecans in vertebrates. Biochemistry (Mosc), 78, 1071-85. 
LESLEY, J., HYMAN, R. & KINCADE, P. W. 1993. CD44 and its interaction with 
extracellular matrix. Adv Immunol, 54, 271-335. 
LEVY, Y. S., MERIMS, D., PANET, H., BARHUM, Y., MELAMED, E. & OFFEN, D. 
2003. Induction of neuron-specific enolase promoter and neuronal markers in 
differentiated mouse bone marrow stromal cells. J Mol Neurosci, 21, 121-32. 
LEVY-ADAM, F., FELD, S., SUSS-TOBY, E., VLODAVSKY, I. & ILAN, N. 2008. 
Heparanase facilitates cell adhesion and spreading by clustering of cell 
surface heparan sulfate proteoglycans. PLoS One, 3, e2319. 
LI, F., SHI, W., CAPURRO, M. & FILMUS, J. 2011. Glypican-5 stimulates 
rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. J Cell 
Biol, 192, 691-704. 
LI, J., HAGNER-MCWHIRTER, A., KJELLEN, L., PALGI, J., JALKANEN, M. & 
LINDAHL, U. 1997. Biosynthesis of heparin/heparan sulfate. cDNA cloning 
and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem, 
272, 28158-63. 
LI, Y., CHEN, J., CHEN, X. G., WANG, L., GAUTAM, S. C., XU, Y. X., 
KATAKOWSKI, M., ZHANG, L. J., LU, M., JANAKIRAMAN, N. & CHOPP, M. 
2002. Human marrow stromal cell therapy for stroke in rat: neurotrophins and 
functional recovery. Neurology, 59, 514-23. 
LI, Y., CHEN, J., WANG, L., ZHANG, L., LU, M. & CHOPP, M. 2001. Intracerebral 
transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett, 316, 
67-70. 
LI, Y., CHOPP, M., CHEN, J., WANG, L., GAUTAM, S. C., XU, Y. X. & ZHANG, Z. 
2000. Intrastriatal transplantation of bone marrow nonhematopoietic cells 
improves functional recovery after stroke in adult mice. J Cereb Blood Flow 
Metab, 20, 1311-9. 




LIGATO, S., MANDICH, D. & CARTUN, R. W. 2008. Utility of glypican-3 in 
differentiating hepatocellular carcinoma from other primary and metastatic 
lesions in FNA of the liver: an immunocytochemical study. Mod Pathol, 21, 
626-31. 
LIN, X. 2004. Functions of heparan sulfate proteoglycans in cell signaling during 
development. Development, 131, 6009-21. 
LIN, X. & PERRIMON, N. 1999. Dally cooperates with Drosophila Frizzled 2 to 
transduce Wingless signalling. Nature, 400, 281-4. 
LIND, T., LINDAHL, U. & LIDHOLT, K. 1993. Biosynthesis of heparin/heparan 
sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- 
and the N-acetyl-D-glucosaminyltransferase reactions. J Biol Chem, 268, 
20705-8. 
LIND, T., TUFARO, F., MCCORMICK, C., LINDAHL, U. & LIDHOLT, K. 1998. The 
putative tumor suppressors EXT1 and EXT2 are glycosyltransferases 
required for the biosynthesis of heparan sulfate. J Biol Chem, 273, 26265-8. 
LINDAHL, U., KUSCHE, M., LIDHOLT, K. & OSCARSSON, L. G. 1989. 
Biosynthesis of heparin and heparan sulfate. Ann N Y Acad Sci, 556, 36-50. 
LINDAHL, U., KUSCHE-GULLBERG, M. & KJELLEN, L. 1998. Regulated diversity 
of heparan sulfate. J Biol Chem, 273, 24979-82. 
LINDNER, U., KRAMER, J., ROHWEDEL, J. & SCHLENKE, P. 2010. Mesenchymal 
Stem or Stromal Cells: Toward a Better Understanding of Their Biology? 
Transfus Med Hemother, 37, 75-83. 
LING, L., MURALI, S., DOMBROWSKI, C., HAUPT, L. M., STEIN, G. S., VAN 
WIJNEN, A. J., NURCOMBE, V. & COOL, S. M. 2006. Sulfated 
glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential 
of rat calvarial osteoprogenitor cells. J Cell Physiol, 209, 811-25. 
LING, L., NURCOMBE, V. & COOL, S. M. 2009. Wnt signaling controls the fate of 
mesenchymal stem cells. Gene, 433, 1-7. 
LITWACK, E. D., IVINS, J. K., KUMBASAR, A., PAINE-SAUNDERS, S., STIPP, C. 
S. & LANDER, A. D. 1998. Expression of the heparan sulfate proteoglycan 
glypican-1 in the developing rodent. Dev Dyn, 211, 72-87. 




LITWACK, E. D., STIPP, C. S., KUMBASAR, A. & LANDER, A. D. 1994. Neuronal 
expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored 
heparan sulfate proteoglycan, in the adult rat nervous system. J Neurosci, 
14, 3713-24. 
LIU, C., SHENG, J., KRAHN, J. M., PERERA, L., XU, Y., HSIEH, P. H., DOU, W., 
LIU, J. & PEDERSEN, L. C. 2014. Molecular mechanism of substrate 
specificity for heparan sulfate 2-O-sulfotransferase. J Biol Chem, 289, 13407-
18. 
LIU, J., SHWORAK, N. W., SINAY, P., SCHWARTZ, J. J., ZHANG, L., FRITZE, L. 
M. & ROSENBERG, R. D. 1999. Expression of heparan sulfate D-
glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate 
specificities. J Biol Chem, 274, 5185-92. 
LIU, Y., HAN, S. S., WU, Y., TUOHY, T. M., XUE, H., CAI, J., BACK, S. A., 
SHERMAN, L. S., FISCHER, I. & RAO, M. S. 2004. CD44 expression 
identifies astrocyte-restricted precursor cells. Dev Biol, 276, 31-46. 
LODIE, T. A., BLICKARZ, C. E., DEVARAKONDA, T. J., HE, C., DASH, A. B., 
CLARKE, J., GLENECK, K., SHIHABUDDIN, L. & TUBO, R. 2002. 
Systematic analysis of reportedly distinct populations of multipotent bone 
marrow-derived stem cells reveals a lack of distinction. Tissue Eng, 8, 739-
51. 
LONG, X., OLSZEWSKI, M., HUANG, W. & KLETZEL, M. 2005. Neural cell 
differentiation in vitro from adult human bone marrow mesenchymal stem 
cells. Stem Cells Dev, 14, 65-9. 
LONGLEY, R. L., WOODS, A., FLEETWOOD, A., COWLING, G. J., GALLAGHER, 
J. T. & COUCHMAN, J. R. 1999. Control of morphology, cytoskeleton and 
migration by syndecan-4. J Cell Sci, 112 ( Pt 20), 3421-31. 
LYON, M. & GALLAGHER, J. T. 1998. Bio-specific sequences and domains in 
heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol, 
17, 485-93. 
MACKAY, A. M., BECK, S. C., MURPHY, J. M., BARRY, F. P., CHICHESTER, C. 
O. & PITTENGER, M. F. 1998. Chondrogenic differentiation of cultured 
human mesenchymal stem cells from marrow. Tissue Eng, 4, 415-28. 




MACKAY, C. R., TERPE, H. J., STAUDER, R., MARSTON, W. L., STARK, H. & 
GUNTHERT, U. 1994. Expression and modulation of CD44 variant isoforms 
in humans. J Cell Biol, 124, 71-82. 
MAEDA, N. 2010. Structural variation of chondroitin sulfate and its roles in the 
central nervous system. Cent Nerv Syst Agents Med Chem, 10, 22-31. 
MAEDA, N., ISHII, M., NISHIMURA, K. & KAMIMURA, K. 2011. Functions of 
chondroitin sulfate and heparan sulfate in the developing brain. Neurochem 
Res, 36, 1228-40. 
MAFI, P., HINDOCHA, S., MAFI, R., GRIFFIN, M. & KAHN, W. S. 2011. Adult 
mesenchymal stem cells and cell surface characterization - a systematic 
review of the literature. Open Orthop J, 5, 253-60. 
MAKINO, S., FUKUDA, K., MIYOSHI, S., KONISHI, F., KODAMA, H., PAN, J., 
SANO, M., TAKAHASHI, T., HORI, S., ABE, H., HATA, J., UMEZAWA, A. & 
OGAWA, S. 1999. Cardiomyocytes can be generated from marrow stromal 
cells in vitro. J Clin Invest, 103, 697-705. 
MALI, M., ELENIUS, K., MIETTINEN, H. M. & JALKANEN, M. 1993. Inhibition of 
basic fibroblast growth factor-induced growth promotion by overexpression of 
syndecan-1. J Biol Chem, 268, 24215-22. 
MANINI, I., GULINO, L., GAVA, B., PIERANTOZZI, E., CURINA, C., ROSSI, D., 
BRAFA, A., D'ANIELLO, C. & SORRENTINO, V. 2011. Multi-potent 
progenitors in freshly isolated and cultured human mesenchymal stem cells: 
a comparison between adipose and dermal tissue. Cell Tissue Res, 344, 85-
95. 
MANSUKHANI, A., DELL'ERA, P., MOSCATELLI, D., KORNBLUTH, S., 
HANAFUSA, H. & BASILICO, C. 1992. Characterization of the murine BEK 
fibroblast growth factor (FGF) receptor: activation by three members of the 
FGF family and requirement for heparin. Proc Natl Acad Sci U S A, 89, 3305-
9. 
MARESCHI, K., NOVARA, M., RUSTICHELLI, D., FERRERO, I., GUIDO, D., 
CARBONE, E., MEDICO, E., MADON, E., VERCELLI, A. & FAGIOLI, F. 
2006. Neural differentiation of human mesenchymal stem cells: Evidence for 
expression of neural markers and eag K+ channel types. Exp Hematol, 34, 
1563-72. 




MARGOLIS, R. U. & MARGOLIS, R. K. 1997. Chondroitin sulfate proteoglycans as 
mediators of axon growth and pathfinding. Cell Tissue Res, 290, 343-8. 
MASLOVA, O. O. 2012. Current view of mesenchymal stem cells biology (brief 
review). Biopoymers and Cell, 28, 190-198. 
MATSUDA, K., MARUYAMA, H., GUO, F., KLEEFF, J., ITAKURA, J., 
MATSUMOTO, Y., LANDER, A. D. & KORC, M. 2001. Glypican-1 is 
overexpressed in human breast cancer and modulates the mitogenic effects 
of multiple heparin-binding growth factors in breast cancer cells. Cancer Res, 
61, 5562-9. 
MATSUMOTO-MIYAI, K., SOKOLOWSKA, E., ZURLINDEN, A., GEE, C. E., 
LUSCHER, D., HETTWER, S., WOLFEL, J., LADNER, A. P., STER, J., 
GERBER, U., RULICKE, T., KUNZ, B. & SONDEREGGER, P. 2009. 
Coincident pre- and postsynaptic activation induces dendritic filopodia via 
neurotrypsin-dependent agrin cleavage. Cell, 136, 1161-71. 
MATSUO, I. & KIMURA-YOSHIDA, C. 2014. Extracellular distribution of diffusible 
growth factors controlled by heparan sulfate proteoglycans during 
mammalian embryogenesis. Philos Trans R Soc Lond B Biol Sci, 369. 
MCCLAIN, C., COHEN, D., PHILLIPS, R., OTT, L. & YOUNG, B. 1991. Increased 
plasma and ventricular fluid interleukin-6 levels in patients with head injury. J 
Lab Clin Med, 118, 225-31. 
MCFARLANE, S., CORNEL, E., AMAYA, E. & HOLT, C. E. 1996. Inhibition of FGF 
receptor activity in retinal ganglion cell axons causes errors in target 
recognition. Neuron, 17, 245-54. 
MCFARLANE, S., MCNEILL, L. & HOLT, C. E. 1995. FGF signaling and target 
recognition in the developing Xenopus visual system. Neuron, 15, 1017-28. 
MCKENZIE, E. A. 2007. Heparanase: a target for drug discovery in cancer and 
inflammation. Br J Pharmacol, 151, 1-14. 
MENDEZ-FERRER, S., MICHURINA, T. V., FERRARO, F., MAZLOOM, A. R., 
MACARTHUR, B. D., LIRA, S. A., SCADDEN, D. T., MA'AYAN, A., 
ENIKOLOPOV, G. N. & FRENETTE, P. S. 2010. Mesenchymal and 
haematopoietic stem cells form a unique bone marrow niche. Nature, 466, 
829-34. 




MEZEY, E., CHANDROSS, K. J., HARTA, G., MAKI, R. A. & MCKERCHER, S. R. 
2000. Turning blood into brain: cells bearing neuronal antigens generated in 
vivo from bone marrow. Science, 290, 1779-82. 
MINGUELL, J. J. 1993. Is hyaluronic acid the "organizer" of the extracellular matrix 
in marrow stroma? Exp Hematol, 21, 7-8. 
MINGUELL, J. J., ERICES, A. & CONGET, P. 2001. Mesenchymal stem cells. Exp 
Biol Med (Maywood), 226, 507-20. 
MITHIEUX, S. M. & WEISS, A. S. 2005. Elastin. Adv Protein Chem, 70, 437-61. 
MOCHIZUKI, H., YOSHIDA, K., GOTOH, M., SUGIOKA, S., KIKUCHI, N., KWON, 
Y. D., TAWADA, A., MAEYAMA, K., INABA, N., HIRUMA, T., KIMATA, K. & 
NARIMATSU, H. 2003. Characterization of a heparan sulfate 3-O-
sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide. J 
Biol Chem, 278, 26780-7. 
MONTZKA, K., LASSONCZYK, N., TSCHOKE, B., NEUSS, S., FUHRMANN, T., 
FRANZEN, R., SMEETS, R., BROOK, G. A. & WOLTJE, M. 2009. Neural 
differentiation potential of human bone marrow-derived mesenchymal stromal 
cells: misleading marker gene expression. BMC Neurosci, 10, 16. 
MORAWSKI, M., FILIPPOV, M., TZINIA, A., TSILIBARY, E. & VARGOVA, L. 2014. 
ECM in brain aging and dementia. Prog Brain Res, 214, 207-27. 
MORETTI, M., SINNAPPAH-KANG, N. D., TOLLER, M., CURCIO, F. & 
MARCHETTI, D. 2006. HPSE-1 expression and functionality in differentiating 
neural cells. J Neurosci Res, 83, 694-701. 
MORGAN, M. R., HUMPHRIES, M. J. & BASS, M. D. 2007. Synergistic control of 
cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol, 8, 957-69. 
MORGANTI-KOSSMANN, M. C., SATGUNASEELAN, L., BYE, N. & KOSSMANN, 
T. 2007. Modulation of immune response by head injury. Injury, 38, 1392-
400. 
MORIMOTO-TOMITA, M., UCHIMURA, K., BISTRUP, A., LUM, D. H., EGEBLAD, 
M., BOUDREAU, N., WERB, Z. & ROSEN, S. D. 2005. Sulf-2, a 
proangiogenic heparan sulfate endosulfatase, is upregulated in breast 
cancer. Neoplasia, 7, 1001-10. 




MOUSAVI NIRI, N., JABERIPOUR, M., RAZMKHAH, M., GHADERI, A. & 
HABIBAGAHI, M. 2009. Mesenchymal stem cells do not suppress 
lymphoblastic leukemic cell line proliferation. Iran J Immunol, 6, 186-94. 
MUNOZ, J. R., STOUTENGER, B. R., ROBINSON, A. P., SPEES, J. L. & 
PROCKOP, D. J. 2005. Human stem/progenitor cells from bone marrow 
promote neurogenesis of endogenous neural stem cells in the hippocampus 
of mice. Proc Natl Acad Sci U S A, 102, 18171-6. 
MURALI, S., LEONG, D. F., LEE, J. J., COOL, S. M. & NURCOMBE, V. 2011. 
Comparative assessment of the effects of gender-specific heparan sulfates 
on mesenchymal stem cells. J Biol Chem, 286, 17755-65. 
MUTO, T., MIYOSHI, K., MUNESUE, S., NAKADA, H., OKAYAMA, M., MATSUO, 
T. & NOMA, T. 2007. Differential expression of syndecan isoforms during 
mouse incisor amelogenesis. J Med Invest, 54, 331-9. 
NAGAI, A., KIM, W. K., LEE, H. J., JEONG, H. S., KIM, K. S., HONG, S. H., PARK, 
I. H. & KIM, S. U. 2007. Multilineage potential of stable human mesenchymal 
stem cell line derived from fetal marrow. PLoS One, 2, e1272. 
NAPARSTEK, Y., COHEN, I. R., FUKS, Z. & VLODAVSKY, I. 1984. Activated T 
lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. 
Nature, 310, 241-4. 
NARITA, K., CHIEN, J., MULLANY, S. A., STAUB, J., QIAN, X., LINGLE, W. L. & 
SHRIDHAR, V. 2007. Loss of HSulf-1 expression enhances autocrine 
signaling mediated by amphiregulin in breast cancer. J Biol Chem, 282, 
14413-20. 
NARUSE, M., SHIBASAKI, K., YOKOYAMA, S., KURACHI, M. & ISHIZAKI, Y. 
2013. Dynamic changes of CD44 expression from progenitors to 
subpopulations of astrocytes and neurons in developing cerebellum. PLoS 
One, 8, e53109. 
NEU, R., ADAMS, S. & MUNZ, B. 2006. Differential expression of entactin-
1/nidogen-1 and entactin-2/nidogen-2 in myogenic differentiation. 
Differentiation, 74, 573-82. 
NURCOMBE, V., FORD, M. D., WILDSCHUT, J. A. & BARTLETT, P. F. 1993. 
Developmental regulation of neural response to FGF-1 and FGF-2 by 




heparan sulfate proteoglycan. Science, 260, 103-6. 
NUSSE, R. & VARMUS, H. 2012. Three decades of Wnts: a personal perspective 
on how a scientific field developed. Embo j, 31, 2670-84. 
OHGUSHI, H., KOTOBUKI, N., FUNAOKA, H., MACHIDA, H., HIROSE, M., 
TANAKA, Y. & TAKAKURA, Y. 2005. Tissue engineered ceramic artificial 
joint--ex vivo osteogenic differentiation of patient mesenchymal cells on total 
ankle joints for treatment of osteoarthritis. Biomaterials, 26, 4654-61. 
OHKAWARA, B., YAMAMOTO, T. S., TADA, M. & UENO, N. 2003. Role of glypican 
4 in the regulation of convergent extension movements during gastrulation in 
Xenopus laevis. Development, 130, 2129-38. 
OHTA, S., SUZUKI, A., SHIMADA, M., KOSUGA, M., TAGA, T., SUGIURA, Y., 
IWAI, M., MIYAHIRA, Y., OKABE, H., SUZUKI, S. & ET AL. 1991. Neuronal 
differentiation of Ewing's sarcoma induced by cholera toxin B and 
bromodeoxyuridine--establishment of Ewing's sarcoma cell line and 
histochemical study. Acta Paediatr Jpn, 33, 428-33. 
OHTO, T., UCHIDA, H., YAMAZAKI, H., KEINO-MASU, K., MATSUI, A. & MASU, 
M. 2002. Identification of a novel nonlysosomal sulphatase expressed in the 
floor plate, choroid plexus and cartilage. Genes Cells, 7, 173-85. 
OKAMOTO, O., BACHY, S., ODENTHAL, U., BERNAUD, J., RIGAL, D., LORTAT-
JACOB, H., SMYTH, N. & ROUSSELLE, P. 2003. Normal human 
keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 
through the receptor syndecan-1. J Biol Chem, 278, 44168-77. 
OKOLICSANYI, R. K., GRIFFITHS, L. R. & HAUPT, L. M. 2014. Mesenchymal 
stem cells, neural lineage potential, heparan sulphate proteoglycans and the 
matrix. Dev Biol. 
OKOLICSANYI, R. K., VAN WIJNEN, A. J., COOL, S. M., STEIN, G. S., 
GRIFFITHS, L. R. & HAUPT, L. M. 2014. Heparan sulfate proteoglycans and 
human breast cancer epithelial cell tumorigenicity. J Cell Biochem, 115, 967-
76. 
OLWIN, B. B. & RAPRAEGER, A. 1992. Repression of myogenic differentiation by 
aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J Cell 
Biol, 118, 631-9. 




OOHIRA, A., MATSUI, F., TOKITA, Y., YAMAUCHI, S. & AONO, S. 2000. 
Molecular interactions of neural chondroitin sulfate proteoglycans in the brain 
development. Arch Biochem Biophys, 374, 24-34. 
OOSTA, G. M., FAVREAU, L. V., BEELER, D. L. & ROSENBERG, R. D. 1982. 
Purification and properties of human platelet heparitinase. J Biol Chem, 257, 
11249-55. 
ORELLANA, A., HIRSCHBERG, C. B., WEI, Z., SWIEDLER, S. J. & ISHIHARA, M. 
1994. Molecular cloning and expression of a glycosaminoglycan N-
acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-
producing cell line. J Biol Chem, 269, 2270-6. 
ORI, A., WILKINSON, M. C. & FERNIG, D. G. 2008. The heparanome and 
regulation of cell function: structures, functions and challenges. Front Biosci, 
13, 4309-38. 
ORNITZ, D. M. 2000. FGFs, heparan sulfate and FGFRs: complex interactions 
essential for development. Bioessays, 22, 108-12. 
ORNITZ, D. M. & ITOH, N. 2001. Fibroblast growth factors. Genome Biol, 2, 
Reviews3005. 
ORNITZ, D. M., YAYON, A., FLANAGAN, J. G., SVAHN, C. M., LEVI, E. & LEDER, 
P. 1992. Heparin is required for cell-free binding of basic fibroblast growth 
factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol, 
12, 240-7. 
OTT, L., MCCLAIN, C. J., GILLESPIE, M. & YOUNG, B. 1994. Cytokines and 
metabolic dysfunction after severe head injury. J Neurotrauma, 11, 447-72. 
PAN, Y., CARBE, C., POWERS, A., ZHANG, E. E., ESKO, J. D., GROBE, K., 
FENG, G. S. & ZHANG, X. 2008. Bud specific N-sulfation of heparan sulfate 
regulates Shp2-dependent FGF signaling during lacrimal gland induction. 
Development, 135, 301-10. 
PARTE, S., BHARTIYA, D., TELANG, J., DAITHANKAR, V., SALVI, V., ZAVERI, K. 
& HINDUJA, I. 2011. Detection, characterization, and spontaneous 
differentiation in vitro of very small embryonic-like putative stem cells in adult 
mammalian ovary. Stem Cells Dev, 20, 1451-64. 




PATEL, V. N., KNOX, S. M., LIKAR, K. M., LATHROP, C. A., HOSSAIN, R., 
EFTEKHARI, S., WHITELOCK, J. M., ELKIN, M., VLODAVSKY, I. & 
HOFFMAN, M. P. 2007. Heparanase cleavage of perlecan heparan sulfate 
modulates FGF10 activity during ex vivo submandibular gland branching 
morphogenesis. Development, 134, 4177-86. 
PENNINGER, J. M., IRIE-SASAKI, J., SASAKI, T. & OLIVEIRA-DOS-SANTOS, A. 
J. 2001. CD45: new jobs for an old acquaintance. Nat Immunol, 2, 389-96. 
PERRIMON, N. & BERNFIELD, M. 2000. Specificities of heparan sulphate 
proteoglycans in developmental processes. Nature, 404, 725-8. 
PETERSEN, B. E., BOWEN, W. C., PATRENE, K. D., MARS, W. M., SULLIVAN, A. 
K., MURASE, N., BOGGS, S. S., GREENBERGER, J. S. & GOFF, J. P. 
1999. Bone marrow as a potential source of hepatic oval cells. Science, 284, 
1168-70. 
PETERSON, S., FRICK, A. & LIU, J. 2009. Design of biologically active heparan 
sulfate and heparin using an enzyme-based approach. Nat Prod Rep, 26, 
610-27. 
PETITOU, M., HERAULT, J. P., BERNAT, A., DRIGUEZ, P. A., DUCHAUSSOY, P., 
LORMEAU, J. C. & HERBERT, J. M. 1999. Synthesis of thrombin-inhibiting 
heparin mimetics without side effects. Nature, 398, 417-22. 
PHINNEY, D. G., HILL, K., MICHELSON, C., DUTREIL, M., HUGHES, C., 
HUMPHRIES, S., WILKINSON, R., BADDOO, M. & BAYLY, E. 2006. 
Biological activities encoded by the murine mesenchymal stem cell 
transcriptome provide a basis for their developmental potential and broad 
therapeutic efficacy. Stem Cells, 24, 186-98. 
PHINNEY, D. G. & PROCKOP, D. J. 2007. Concise review: mesenchymal 
stem/multipotent stromal cells: the state of transdifferentiation and modes of 
tissue repair--current views. Stem Cells, 25, 2896-902. 
PICKFORD, C. E., HOLLEY, R. J., RUSHTON, G., STAVRIDIS, M. P., WARD, C. 
M. & MERRY, C. L. 2011. Specific glycosaminoglycans modulate neural 
specification of mouse embryonic stem cells. Stem Cells, 29, 629-40. 




PIRAS, F., PERRA, M. T., MURTAS, D., MINERBA, L., FLORIS, C., MAXIA, C., 
DEMURTAS, P., UGALDE, J., RIBATTI, D. & SIRIGU, P. 2010. The stem cell 
marker nestin predicts poor prognosis in human melanoma. Oncol Rep, 23, 
17-24. 
PITTENGER, M. F., MACKAY, A. M., BECK, S. C., JAISWAL, R. K., DOUGLAS, R., 
MOSCA, J. D., MOORMAN, M. A., SIMONETTI, D. W., CRAIG, S. & 
MARSHAK, D. R. 1999. Multilineage potential of adult human mesenchymal 
stem cells. Science, 284, 143-7. 
PORCIONATTO, M. A. 2006. The extracellular matrix provides directional cues for 
neuronal migration during cerebellar development. Braz J Med Biol Res, 39, 
313-20. 
POWELL, P. P., FINKLESTEIN, S. P., DIONNE, C. A., JAYE, M. & KLAGSBRUN, 
M. 1991. Temporal, differential and regional expression of mRNA for basic 
fibroblast growth factor in the developing and adult rat brain. Brain Res Mol 
Brain Res, 11, 71-7. 
PRESTO, J., THUVESON, M., CARLSSON, P., BUSSE, M., WILEN, M., 
ERIKSSON, I., KUSCHE-GULLBERG, M. & KJELLEN, L. 2008. Heparan 
sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and 
heparan sulfate sulfation. Proc Natl Acad Sci U S A, 105, 4751-6. 
PROCKOP, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic 
tissues. Science, 276, 71-4. 
PUCCI-MINAFRA, I., ALBANESE, N. N., DI CARA, G., MINAFRA, L., MARABETI, 
M. R. & CANCEMI, P. 2008. Breast cancer cells exhibit selective modulation 
induced by different collagen substrates. Connect Tissue Res, 49, 252-6. 
QIAN, X., DAVIS, A. A., GODERIE, S. K. & TEMPLE, S. 1997. FGF2 concentration 
regulates the generation of neurons and glia from multipotent cortical stem 
cells. Neuron, 18, 81-93. 
QU, X., CARBE, C., TAO, C., POWERS, A., LAWRENCE, R., VAN KUPPEVELT, T. 
H., CARDOSO, W. V., GROBE, K., ESKO, J. D. & ZHANG, X. 2011. Lacrimal 
gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-
O-sulfated heparan sulfate. J Biol Chem, 286, 14435-44. 




RAGHUPATHI, R. 2004. Cell death mechanisms following traumatic brain injury. 
Brain Pathol, 14, 215-22. 
RAGNI, E., VIGANO, M., PARAZZI, V., MONTEMURRO, T., MONTELATICI, E., 
LAVAZZA, C., BUDELLI, S., VECCHINI, A., REBULLA, P., GIORDANO, R. & 
LAZZARI, L. 2013. Adipogenic potential in human mesenchymal stem cells 
strictly depends on adult or foetal tissue harvest. Int J Biochem Cell Biol, 45, 
2456-66. 
RAMAN, K. & KUBERAN, B. 2010. Chemical Tumor Biology of Heparan Sulfate 
Proteoglycans. Curr Chem Biol, 4, 20-31. 
RAMANI, V. C., PRUETT, P. S., THOMPSON, C. A., DELUCAS, L. D. & 
SANDERSON, R. D. 2012. Heparan sulfate chains of syndecan-1 regulate 
ectodomain shedding. J Biol Chem, 287, 9952-61. 
RAPRAEGER, A. 1989. Transforming growth factor (type beta) promotes the 
addition of chondroitin sulfate chains to the cell surface proteoglycan 
(syndecan) of mouse mammary epithelia. J Cell Biol, 109, 2509-18. 
RAPRAEGER, A. C., KRUFKA, A. & OLWIN, B. B. 1991. Requirement of heparan 
sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. 
Science, 252, 1705-8. 
RAPRAEGER, A. C. & OTT, V. L. 1998. Molecular interactions of the syndecan core 
proteins. Curr Opin Cell Biol, 10, 620-8. 
RAULO, E., CHERNOUSOV, M. A., CAREY, D. J., NOLO, R. & RAUVALA, H. 
1994. Isolation of a neuronal cell surface receptor of heparin binding growth-
associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). 
J Biol Chem, 269, 12999-3004. 
RAY, S. K., DIXON, C. E. & BANIK, N. L. 2002. Molecular mechanisms in the 
pathogenesis of traumatic brain injury. Histol Histopathol, 17, 1137-52. 
READING, L., STILL, K., BISHOP, N. & SCUTT, A. 2000. Peripheral Blood as an 
Alternative Source of Mesenchymal Stem Cells. Bone, 26(Suppl). 
REYES, M. & VERFAILLIE, C. M. 1999. Turning Marrow into Brain: Generation of 
Glial and Neuronal Cells From Adult Bone Marrow Mesenchymal Stem Cells. 
Blood, 94, 377a. 




RIESKE, P., AUGELLI, B. J., STAWSKI, R., GAUGHAN, J., AZIZI, S. A. & 
KRYNSKA, B. 2009. A population of human brain cells expressing 
phenotypic markers of more than one lineage can be induced in vitro to 
differentiate into mesenchymal cells. Exp Cell Res, 315, 462-73. 
RINGVALL, M., LEDIN, J., HOLMBORN, K., VAN KUPPEVELT, T., ELLIN, F., 
ERIKSSON, I., OLOFSSON, A. M., KJELLEN, L. & FORSBERG, E. 2000. 
Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking 
N-deacetylase/N-sulfotransferase-1. J Biol Chem, 275, 25926-30. 
RINK, A., FUNG, K. M., TROJANOWSKI, J. Q., LEE, V. M., NEUGEBAUER, E. & 
MCINTOSH, T. K. 1995. Evidence of apoptotic cell death after experimental 
traumatic brain injury in the rat. Am J Pathol, 147, 1575-83. 
ROGERS, I. & CASPER, R. F. 2004. Umbilical cord blood stem cells. Best Pract 
Res Clin Obstet Gynaecol, 18, 893-908. 
ROMANOV, S. R., KOZAKIEWICZ, B. K., HOLST, C. R., STAMPFER, M. R., 
HAUPT, L. M. & TLSTY, T. D. 2001. Normal human mammary epithelial cells 
spontaneously escape senescence and acquire genomic changes. Nature, 
409, 633-7. 
ROMBOUTS, W. J. & PLOEMACHER, R. E. 2003. Primary murine MSC show 
highly efficient homing to the bone marrow but lose homing ability following 
culture. Leukemia, 17, 160-70. 
ROSENBERG, R. D., SHWORAK, N. W., LIU, J., SCHWARTZ, J. J. & ZHANG, L. 
1997. Heparan sulfate proteoglycans of the cardiovascular system. Specific 
structures emerge but how is synthesis regulated? J Clin Invest, 100, S67-
75. 
ROTTER, N., ODER, J., SCHLENKE, P., LINDNER, U., BOHRNSEN, F., KRAMER, 
J., ROHWEDEL, J., HUSS, R., BRANDAU, S., WOLLENBERG, B. & LANG, 
S. 2008. Isolation and characterization of adult stem cells from human 
salivary glands. Stem Cells Dev, 17, 509-18. 
ROYER-POKORA, B., BUSCH, M., BEIER, M., DUHME, C., DE TORRES, C., 
MORA, J., BRANDT, A. & ROYER, H. D. 2010. Wilms tumor cells with WT1 
mutations have characteristic features of mesenchymal stem cells and 
express molecular markers of paraxial mesoderm. Hum Mol Genet, 19, 
1651-68. 




ROZARIO, T. & DESIMONE, D. W. 2010. The extracellular matrix in development 
and morphogenesis: a dynamic view. Dev Biol, 341, 126-40. 
RUOSLAHTI, E. 1988. Structure and biology of proteoglycans. Annu Rev Cell Biol, 
4, 229-55. 
SADAN, O., BAHAT-STROMZA, M., BARHUM, Y., LEVY, Y. S., PISNEVSKY, A., 
PERETZ, H., ILAN, A. B., BULVIK, S., SHEMESH, N., KREPEL, D., COHEN, 
Y., MELAMED, E. & OFFEN, D. 2009. Protective effects of neurotrophic 
factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem 
Cells Dev, 18, 1179-90. 
SADAN, O., MELAMED, E. & OFFEN, D. 2009. Bone-marrow-derived 
mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin 
Biol Ther, 9, 1487-97. 
SADAN, O., SHEMESH, N., BARZILAY, R., BAHAT-STROMZA, M., MELAMED, E., 
COHEN, Y. & OFFEN, D. 2008. Migration of neurotrophic factors-secreting 
mesenchymal stem cells toward a quinolinic acid lesion as viewed by 
magnetic resonance imaging. Stem Cells, 26, 2542-51. 
SAFAIYAN, F., KOLSET, S. O., PRYDZ, K., GOTTFRIDSSON, E., LINDAHL, U. & 
SALMIVIRTA, M. 1999. Selective effects of sodium chlorate treatment on the 
sulfation of heparan sulfate. J Biol Chem, 274, 36267-73. 
SAFAIYAN, F., LINDAHL, U. & SALMIVIRTA, M. 1998. Selective reduction of 6-O-
sulfation in heparan sulfate from transformed mammary epithelial cells. Eur J 
Biochem, 252, 576-82. 
SAKSELA, O., MOSCATELLI, D., SOMMER, A. & RIFKIN, D. B. 1988. Endothelial 
cell-derived heparan sulfate binds basic fibroblast growth factor and protects 
it from proteolytic degradation. J Cell Biol, 107, 743-51. 
SALMIVIRTA, M., ELENIUS, K., VAINIO, S., HOFER, U., CHIQUET-EHRISMANN, 
R., THESLEFF, I. & JALKANEN, M. 1991. Syndecan from embryonic tooth 
mesenchyme binds tenascin. J Biol Chem, 266, 7733-9. 
SALMIVIRTA, M., LIDHOLT, K. & LINDAHL, U. 1996. Heparan sulfate: a piece of 
information. FASEB J, 10, 1270-9. 




SANBERG, P. R., EVE, D. J., CRUZ, L. E. & BORLONGAN, C. V. 2012. 
Neurological disorders and the potential role for stem cells as a therapy. Br 
Med Bull, 101, 163-81. 
SANCHEZ-RAMOS, J., SONG, S., CARDOZO-PELAEZ, F., HAZZI, C., 
STEDEFORD, T., WILLING, A., FREEMAN, T. B., SAPORTA, S., JANSSEN, 
W., PATEL, N., COOPER, D. R. & SANBERG, P. R. 2000. Adult bone 
marrow stromal cells differentiate into neural cells in vitro. Exp Neurol, 164, 
247-56. 
SANDERSON, R. D. & BERNFIELD, M. 1988. Molecular polymorphism of a cell 
surface proteoglycan: distinct structures on simple and stratified epithelia. 
Proc Natl Acad Sci U S A, 85, 9562-6. 
SANDERSON, R. D., TURNBULL, J. E., GALLAGHER, J. T. & LANDER, A. D. 
1994. Fine structure of heparan sulfate regulates syndecan-1 function and 
cell behavior. J Biol Chem, 269, 13100-6. 
SARKAR, D., SPENCER, J. A., PHILLIPS, J. A., ZHAO, W., SCHAFER, S., 
SPELKE, D. P., MORTENSEN, L. J., RUIZ, J. P., VEMULA, P. K., 
SRIDHARAN, R., KUMAR, S., KARNIK, R., LIN, C. P. & KARP, J. M. 2011. 
Engineered cell homing. Blood, 118, e184-91. 
SARRAZIN, S., LAMANNA, W. C. & ESKO, J. D. 2011. Heparan sulfate 
proteoglycans. Cold Spring Harb Perspect Biol, 3. 
SARRUF, D. A., YU, F., NGUYEN, H. T., WILLIAMS, D. L., PRINTZ, R. L., 
NISWENDER, K. D. & SCHWARTZ, M. W. 2009. Expression of peroxisome 
proliferator-activated receptor-gamma in key neuronal subsets regulating 
glucose metabolism and energy homeostasis. Endocrinology, 150, 707-12. 
SASISEKHARAN, R., ERNST, S. & VENKATARAMAN, G. 1997. On the regulation 
of fibroblast growth factor activity by heparin-like glycosaminoglycans. 
Angiogenesis, 1, 45-54. 
SASISEKHARAN, R. & VENKATARAMAN, G. 2000. Heparin and heparan sulfate: 
biosynthesis, structure and function. Curr Opin Chem Biol, 4, 626-31. 
SCHIPANI, E. & KRONENBERG, H. M. 2008. Adult mesenchymal stem cells. 
StemBook. Cambridge (MA): Harvard Stem Cell Institute 




Copyright: (c) 2008 Ernestina Schipani and Henry M. Kronenberg. 
SCUTERI, A., CASSETTI, A. & TREDICI, G. 2006. Adult mesenchymal stem cells 
rescue dorsal root ganglia neurons from dying. Brain Res, 1116, 75-81. 
SEER, R. 2014. Proteoglycans [Online]. FastBleep. Available: 
http://www.fastbleep.com/biology-notes/31/179/1026 [Accessed 20 
September 2014]. 
SHENG, J., LIU, R., XU, Y. & LIU, J. 2011. The dominating role of N-deacetylase/N-
sulfotransferase 1 in forming domain structures in heparan sulfate. J Biol 
Chem, 286, 19768-76. 
SHI, S. & GRONTHOS, S. 2003. Perivascular niche of postnatal mesenchymal stem 
cells in human bone marrow and dental pulp. J Bone Miner Res, 18, 696-
704. 
SHIELDS, L. E. & ANDREWS, R. G. 1998. Gestational age changes in circulating 
CD34+ hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet 
Gynecol, 178, 931-7. 
SHUKLA, D., LIU, J., BLAIKLOCK, P., SHWORAK, N. W., BAI, X., ESKO, J. D., 
COHEN, G. H., EISENBERG, R. J., ROSENBERG, R. D. & SPEAR, P. G. 
1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 
entry. Cell, 99, 13-22. 
SHWORAK, N. W., LIU, J., FRITZE, L. M., SCHWARTZ, J. J., ZHANG, L., 
LOGEART, D. & ROSENBERG, R. D. 1997. Molecular cloning and 
expression of mouse and human cDNAs encoding heparan sulfate D-
glucosaminyl 3-O-sulfotransferase. J Biol Chem, 272, 28008-19. 
SIENA, S., BREGNI, M., BRANDO, B., RAVAGNANI, F., BONADONNA, G. & 
GIANNI, A. M. 1989. Circulation of CD34+ hematopoietic stem cells in the 
peripheral blood of high-dose cyclophosphamide-treated patients: 
enhancement by intravenous recombinant human granulocyte-macrophage 
colony-stimulating factor. Blood, 74, 1905-14. 




SINGER, J. W., CHARBORD, P., KEATING, A., NEMUNAITIS, J., RAUGI, G., 
WIGHT, T. N., LOPEZ, J. A., ROTH, G. J., DOW, L. W. & FIALKOW, P. J. 
1987. Simian virus 40-transformed adherent cells from human long-term 
marrow cultures: cloned cell lines produce cells with stromal and 
hematopoietic characteristics. Blood, 70, 464-74. 
SMEDS, E., HABUCHI, H., DO, A. T., HJERTSON, E., GRUNDBERG, H., KIMATA, 
K., LINDAHL, U. & KUSCHE-GULLBERG, M. 2003. Substrate specificities of 
mouse heparan sulphate glucosaminyl 6-O-sulphotransferases. Biochem J, 
372, 371-80. 
SONG, H. H., SHI, W. & FILMUS, J. 1997. OCI-5/rat glypican-3 binds to fibroblast 
growth factor-2 but not to insulin-like growth factor-2. J Biol Chem, 272, 
7574-7. 
SONG, H. H., SHI, W., XIANG, Y. Y. & FILMUS, J. 2005. The loss of glypican-3 
induces alterations in Wnt signaling. J Biol Chem, 280, 2116-25. 
SPIEGEL, A., ZCHARIA, E., VAGIMA, Y., ITKIN, T., KALINKOVICH, A., DAR, A., 
KOLLET, O., NETZER, N., GOLAN, K., SHAFAT, I., ILAN, N., NAGLER, A., 
VLODAVSKY, I. & LAPIDOT, T. 2008. Heparanase regulates retention and 
proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone 
marrow microenvironment. Blood, 111, 4934-43. 
STIPP, C. S., LITWACK, E. D. & LANDER, A. D. 1994. Cerebroglycan: an integral 
membrane heparan sulfate proteoglycan that is unique to the developing 
nervous system and expressed specifically during neuronal differentiation. J 
Cell Biol, 124, 149-60. 
SUGAHARA, K. & KITAGAWA, H. 2002. Heparin and heparan sulfate biosynthesis. 
IUBMB Life, 54, 163-75. 
SULKA, B., LORTAT-JACOB, H., TERREUX, R., LETOURNEUR, F. & 
ROUSSELLE, P. 2009. Tyrosine dephosphorylation of the syndecan-1 PDZ 
binding domain regulates syntenin-1 recruitment. J Biol Chem, 284, 10659-
71. 
TAMIR, A., PETROCELLI, T., STETLER, K., CHU, W., HOWARD, J., CROIX, B. S., 
SLINGERLAND, J. & BEN-DAVID, Y. 2000. Stem cell factor inhibits erythroid 
differentiation by modulating the activity of G1-cyclin-dependent kinase 
complexes: a role for p27 in erythroid differentiation coupled G1 arrest. Cell 




Growth Differ, 11, 269-77. 
TAVASSOLI, M. & MINGUELL, J. J. 1991. Homing of hemopoietic progenitor cells 
to the marrow. Proc Soc Exp Biol Med, 196, 367-73. 
THE-NERVOUS-SYSTEM. 2014. Diagram of parts of a glial cell [Online]. Available: 
https://www.tumblr.com/search/glial [Accessed 1 October 2014]. 
THI, M. M., TARBELL, J. M., WEINBAUM, S. & SPRAY, D. C. 2004. The role of the 
glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: 
a "bumper-car" model. Proc Natl Acad Sci U S A, 101, 16483-8. 
TIWARI, V., CLEMENT, C., DUNCAN, M. B., CHEN, J., LIU, J. & SHUKLA, D. 
2004. A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes 
simplex virus type 1. J Gen Virol, 85, 805-9. 
TKACHENKO, E., RHODES, J. M. & SIMONS, M. 2005. Syndecans: new kids on 
the signaling block. Circ Res, 96, 488-500. 
TOLIAS, C. M. & BULLOCK, M. R. 2004. Critical appraisal of neuroprotection trials 
in head injury: what have we learned? NeuroRx, 1, 71-9. 
TONDREAU, T., LAGNEAUX, L., DEJENEFFE, M., MASSY, M., MORTIER, C., 
DELFORGE, A. & BRON, D. 2004. Bone marrow-derived mesenchymal stem 
cells already express specific neural proteins before any differentiation. 
Differentiation, 72, 319-26. 
TONDREAU, T., LAGNEAUX, L., SCHIFFMANN, S., BANTUBUNGI, K. & BRON, 
D. 2001. The potential of human bone marrow-derived mesenchymal stem 
cells to differentiate in neural cells. Blood, 98, 125b. 
TOOLE, B. P. 1991. Proteoglycans and hyaluronan in morphogenesis and 
differentiation, New York, Plenum. 
TOOLE, B. P. 2001. Hyaluronan in morphogenesis. Semin Cell Dev Biol, 12, 79-87. 
TOPCZEWSKI, J., SEPICH, D. S., MYERS, D. C., WALKER, C., AMORES, A., 
LELE, Z., HAMMERSCHMIDT, M., POSTLETHWAIT, J. & SOLNICA-
KREZEL, L. 2001. The zebrafish glypican knypek controls cell polarity during 
gastrulation movements of convergent extension. Dev Cell, 1, 251-64. 




TRINH, L. A. & STAINIER, D. Y. 2004. Fibronectin regulates epithelial organization 
during myocardial migration in zebrafish. Dev Cell, 6, 371-82. 
TROPEL, P., PLATET, N., PLATEL, J. C., NOEL, D., ALBRIEUX, M., BENABID, A. 
L. & BERGER, F. 2006. Functional neuronal differentiation of bone marrow-
derived mesenchymal stem cells. Stem Cells, 24, 2868-76. 
TRZASKA, K. A., KUZHIKANDATHIL, E. V. & RAMESHWAR, P. 2007. 
Specification of a dopaminergic phenotype from adult human mesenchymal 
stem cells. Stem Cells, 25, 2797-808. 
TSAI, M. S., LEE, J. L., CHANG, Y. J. & HWANG, S. M. 2004. Isolation of human 
multipotent mesenchymal stem cells from second-trimester amniotic fluid 
using a novel two-stage culture protocol. Hum Reprod, 19, 1450-6. 
TUAN, R. S. 2003. Cellular signaling in developmental chondrogenesis: N-cadherin, 
Wnts, and BMP-2. J Bone Joint Surg Am, 85-A Suppl 2, 137-41. 
TURRIN, N. P. & RIVEST, S. 2006. Tumor necrosis factor alpha but not interleukin 
1 beta mediates neuroprotection in response to acute nitric oxide 
excitotoxicity. J Neurosci, 26, 143-51. 
TVEIT, H., DICK, G., SKIBELI, V. & PRYDZ, K. 2005. A proteoglycan undergoes 
different modifications en route to the apical and basolateral surfaces of 
Madin-Darby canine kidney cells. J Biol Chem, 280, 29596-603. 
UCCELLI, A., BENVENUTO, F., LARONI, A. & GIUNTI, D. 2011. Neuroprotective 
features of mesenchymal stem cells. Best Pract Res Clin Haematol, 24, 59-
64. 
UCCELLI, A., MORETTA, L. & PISTOIA, V. 2008. Mesenchymal stem cells in health 
and disease. Nat Rev Immunol, 8, 726-36. 
VEENITH, T., GOON, S. & BURNSTEIN, R. M. 2009. Molecular mechanisms of 
traumatic brain injury: the missing link in management. World J Emerg Surg, 
4, 7. 
VEUGELERS, M., DAVID, G., KREIS, T. & VALE, R. 1999. Guidebook to the 
Extracellular Matrix, Anchor and Adhesion Proteins, Oxford, UK, Oxford 
University Press. 




VLODAVSKY, I., ABBOUD-JARROUS, G., ELKIN, M., NAGGI, A., CASU, B., 
SASISEKHARAN, R. & ILAN, N. 2006. The impact of heparanese and 
heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost 
Thromb, 35, 116-27. 
VLODAVSKY, I., BECKHOVE, P., LERNER, I., PISANO, C., MEIROVITZ, A., ILAN, 
N. & ELKIN, M. 2011. Significance of Heparanase in Cancer and 
Inflammation. Cancer Microenviron, 5, 115-32. 
VLODAVSKY, I., BECKHOVE, P., LERNER, I., PISANO, C., MEIROVITZ, A., ILAN, 
N. & ELKIN, M. 2012. Significance of heparanase in cancer and 
inflammation. Cancer Microenviron, 5, 115-32. 
WALZ, A., MCFARLANE, S., BRICKMAN, Y. G., NURCOMBE, V., BARTLETT, P. 
F. & HOLT, C. E. 1997. Essential role of heparan sulfates in axon navigation 
and targeting in the developing visual system. Development, 124, 2421-30. 
WANG, L. & DENBURG, J. L. 1992. A role for proteoglycans in the guidance of a 
subset of pioneer axons in cultured embryos of the cockroach. Neuron, 8, 
701-14. 
WATANABE, K., YAMADA, H. & YAMAGUCHI, Y. 1995. K-glypican: a novel GPI-
anchored heparan sulfate proteoglycan that is highly expressed in developing 
brain and kidney. J Cell Biol, 130, 1207-18. 
WATT, F. M. & HOGAN, B. L. 2000. Out of Eden: stem cells and their niches. 
Science, 287, 1427-30. 
WEIHE, E., NOHR, D., MICHEL, S., MULLER, S., ZENTEL, H. J., FINK, T. & 
KREKEL, J. 1991. Molecular anatomy of the neuro-immune connection. Int J 
Neurosci, 59, 1-23. 
WEINBAUM, S., TARBELL, J. M. & DAMIANO, E. R. 2007. The structure and 
function of the endothelial glycocalyx layer. Annu Rev Biomed Eng, 9, 121-
67. 
WEISE, B., JANET, T. & GROTHE, C. 1993. Localization of bFGF and FGF-
receptor in the developing nervous system of the embryonic and newborn rat. 
J Neurosci Res, 34, 442-53. 




WEISS, J. M., SLEEMAN, J., RENKL, A. C., DITTMAR, H., TERMEER, C. C., 
TAXIS, S., HOWELLS, N., HOFMANN, M., KOHLER, G., SCHOPF, E., 
PONTA, H., HERRLICH, P. & SIMON, J. C. 1997. An essential role for CD44 
variant isoforms in epidermal Langerhans cell and blood dendritic cell 
function. J Cell Biol, 137, 1137-47. 
WETZIG, A., ALAIYA, A., AL-ALWAN, M., PRADEZ, C. B., PULICAT, M. S., AL-
MAZROU, A., SHINWARI, Z., SLEIMAN, G. M., GHEBEH, H., AL-
HUMAIDAN, H., GAAFAR, A., KANAAN, I. & ADRA, C. 2013. Differential 
marker expression by cultures rich in mesenchymal stem cells. BMC Cell 
Biol, 14, 54. 
WIESE, C., ROLLETSCHEK, A., KANIA, G., BLYSZCZUK, P., TARASOV, K. V., 
TARASOVA, Y., WERSTO, R. P., BOHELER, K. R. & WOBUS, A. M. 2004. 
Nestin expression--a property of multi-lineage progenitor cells? Cell Mol Life 
Sci, 61, 2510-22. 
WILKINS, A., KEMP, K., GINTY, M., HARES, K., MALLAM, E. & SCOLDING, N. 
2009. Human bone marrow-derived mesenchymal stem cells secrete brain-
derived neurotrophic factor which promotes neuronal survival in vitro. Stem 
Cell Res. 
WILSON, A. & TRUMPP, A. 2006. Bone-marrow haematopoietic-stem-cell niches. 
Nat Rev Immunol, 6, 93-106. 
WILSON, S. I. & EDLUND, T. 2001. Neural induction: toward a unifying mechanism. 
Nat Neurosci, 4 Suppl, 1161-8. 
WIPFF, P. J. & HINZ, B. 2008. Integrins and the activation of latent transforming 
growth factor beta1 - an intimate relationship. Eur J Cell Biol, 87, 601-15. 
WOLF, K. & FRIEDL, P. 2006. Molecular mechanisms of cancer cell invasion and 
plasticity. Br J Dermatol, 154 Suppl 1, 11-5. 
WOODS, A. & COUCHMAN, J. R. 2001. Syndecan-4 and focal adhesion function. 
Curr Opin Cell Biol, 13, 578-83. 
XU, Y., MALLADI, P., WAGNER, D. R. & LONGAKER, M. T. 2005. Adipose-derived 
mesenchymal cells as a potential cell source for skeletal regeneration. Curr 
Opin Mol Ther, 7, 300-5. 




YAMAGUCHI, Y. 2000. Lecticans: organizers of the brain extracellular matrix. Cell 
Mol Life Sci, 57, 276-89. 
YAMAGUCHI, Y. 2001. Heparan sulfate proteoglycans in the nervous system: their 
diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin 
Cell Dev Biol, 12, 99-106. 
YAMAZAKI, M., NAKAJIMA, F., OGASAWARA, A., MORIYA, H., MAJESKA, R. J. & 
EINHORN, T. A. 1999. Spatial and temporal distribution of CD44 and 
osteopontin in fracture callus. J Bone Joint Surg Br, 81, 508-15. 
YAN, D. & LIN, X. 2007. Drosophila glypican Dally-like acts in FGF-receiving cells to 
modulate FGF signaling during tracheal morphogenesis. Dev Biol, 312, 203-
16. 
YAN, D. & LIN, X. 2008. Opposing roles for glypicans in Hedgehog signalling. Nat 
Cell Biol, 10, 761-3. 
YAN, D. & LIN, X. 2009. Shaping morphogen gradients by proteoglycans. Cold 
Spring Harb Perspect Biol, 1, a002493. 
YOO, S. W., KIM, S. S., LEE, S. Y., LEE, H. S., KIM, H. S., LEE, Y. D. & SUH-KIM, 
H. 2008. Mesenchymal stem cells promote proliferation of endogenous 
neural stem cells and survival of newborn cells in a rat stroke model. Exp Mol 
Med, 40, 387-97. 
YOUNG, A. B., OTT, L. G., BEARD, D., DEMPSEY, R. J., TIBBS, P. A. & 
MCCLAIN, C. J. 1988. The acute-phase response of the brain-injured patient. 
J Neurosurg, 69, 375-80. 
YU, G., WU, X., DIETRICH, M. A., POLK, P., SCOTT, L. K., PTITSYN, A. A. & 
GIMBLE, J. M. 2010. Yield and characterization of subcutaneous human 
adipose-derived stem cells by flow cytometric and adipogenic mRNA 
analyzes. Cytotherapy, 12, 538-46. 
YU, M., SATO, H., SEIKI, M. & THOMPSON, E. W. 1995. Complex regulation of 
membrane-type matrix metalloproteinase expression and matrix 
metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human 
breast cancer cells. Cancer Res, 55, 3272-7. 




ZAPPIA, E., CASAZZA, S., PEDEMONTE, E., BENVENUTO, F., BONANNI, I., 
GERDONI, E., GIUNTI, D., CERAVOLO, A., CAZZANTI, F., FRASSONI, F., 
MANCARDI, G. & UCCELLI, A. 2005. Mesenchymal stem cells ameliorate 
experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 
106, 1755-61. 
ZCHARIA, E., METZGER, S., CHAJEK-SHAUL, T., FRIEDMANN, Y., PAPPO, O., 
AVIV, A., ELKIN, M., PECKER, I., PERETZ, T. & VLODAVSKY, I. 2001. 
Molecular properties and involvement of heparanase in cancer progression 
and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia, 6, 
311-22. 
ZHANG, J., LI, Y., LU, M., CUI, Y., CHEN, J., NOFFSINGER, L., ELIAS, S. B. & 
CHOPP, M. 2006. Bone marrow stromal cells reduce axonal loss in 
experimental autoimmune encephalomyelitis mice. J Neurosci Res, 84, 587-
95. 
ZHANG, L., BEELER, D. L., LAWRENCE, R., LECH, M., LIU, J., DAVIS, J. C., 
SHRIVER, Z., SASISEKHARAN, R. & ROSENBERG, R. D. 2001. 6-O-
sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan 
sulfate biosynthetic pathway. J Biol Chem, 276, 42311-21. 
ZHOU, Y., SONG, B., QIN, W. J., ZHANG, G., ZHANG, R., LUAN, Q., PAN, T. J., 
YANG, A. G. & WANG, H. 2008. Heparanase promotes bone destruction and 
invasiveness in prostate cancer. Cancer Lett, 268, 252-9. 
ZIMMERMANN, P. & DAVID, G. 1999. The syndecans, tuners of transmembrane 
signaling. FASEB J, 13 Suppl, S91-S100. 
ZUK, P. A., ZHU, M., ASHJIAN, P., DE UGARTE, D. A., HUANG, J. I., MIZUNO, H., 
ALFONSO, Z. C., FRASER, J. K., BENHAIM, P. & HEDRICK, M. H. 2002. 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8.2 Appendix 2 - Antibody Details 
Table&8(5: Primary' and' Secondary' antibodies' for' markers' of' MSC' stemness.'
Immunocytochemistry'(ICC),'Fluorescent'Assisted'Cell'Sorting'(FACS)'
Primary'
Antibody' Species' Concentration' Supplier'
Secondary'
Antibody' Application'
CD44$ Mouse'IgG' 1/500' AbCam' Chromeo546' ICC/FACS'
CD29$ Rabbit'IgG' 1/100' AbCam' Chromeo488' ICC/FACS'
CD90$ Mouse'IgG' 1/200' AbCam' Chromeo546' ICC'
CD105$ Mouse'IgG' 1/200' AbCam' Chromeo546' ICC'
CD45$ Rabbit'IgG' 1/500' AbCam' Chromeo488' ICC/FACS'!
Table&8(6: Markers' of' neural' stem' cells' and' neural' lineages.' Immunocytochemistry' (ICC),'
Fluorescent'Assisted'Cell'Sorting'(FACS)'
Primary!Antibody! Species! Concentration! Supplier! Secondary!Antibody! Application!
Nestin! Mouse!IgG! 1/200! AbCam! FITC! ICC/FACS!
MAP2! Mouse!IgG! 1/200! AbCam! FITC! ICC!
SOX2! Rabbit!IgG! 1/200F1/1000! MerkFMillipore! Cy3! ICC/FACS!
O1! Mouse!IgM! 1/500! MerkFMillipore! AlexaFluor594! ICC!
GFAP! Rabbit!IgG! 1/500! MerkFMillipore! Cy3! ICC!
GFAP2! Rabbit!IgG! 1/1000! AbCam! Cy3! ICC!
GalC! Mouse!IgG! 1/1000! MerkFMillipore! FITC! ICC!!
Table&8(7: Isotype' control' antibodies' for' ICC.' ' Antibodies' were' applied' at' the' same'
concentration'as'the'majority'of'the'primary'antibodies'for'which'they'are'a'control.'''
Primary!Antibody! Species! Concentration! Supplier! Secondary!Antibody! Application!
Mouse!IgG! Mouse! 1/200! MerkFMillipore! FITC! ICC!
Rabbit!IgG! Rabbit! 1/500! MerkFMillipore! Cy3! ICC!





to' intact'HS' chains.' ' CSH56' is' a'panHchondroitin' sulfate'antibody' that'binds' intact'CS' chains'
Immunocytochemistry'(ICC),'Fluorescent'Assisted'Cell'Sorting'(FACS)'
Primary$
Antibody$ Species$ Concentration$ Supplier$ Secondary$Antibody$ Application$
SDC1$ Mouse'IgG' 1/500' AbCam' Chromeo546/FITC' ICC'
SDC4$ Rabbit'IgG' 1/1000' AbCam' Chromeo488/Cy3' ICC'
GPC1$ Mouse'IgG' 1/1000' AbCam' Chromeo488/Cy3' ICC'
GPC4$ Rabbit'IgG' 1/500' AbCam' Chromeo546/FITC' ICC'
10>E4$ Mouse'IgM' 1/1000' Amsbio' AlexaFluor594' ICC'
CS>56$ Mouse'IgM' 1/1000' AbCam' AlexaFluor594' ICC'!
Table&8(9: 'Secondary' antibodies' and' their' applications.' ' All' secondary' antibodies' were'
applied'at'1/1000'unless'stated'otherwise'in'specific'protocols.'''
Secondary$Antibody$ Species$ Supplier$ Application$
Chromeo546$ Goat'antiImouse'IgG' Life'Technologies' ICC'
Chromeo488$ Goat'antiIrabbit'IgG' Life'Technolgies' ICC'
FITC$ Donkey'antiImouse'IgG' Life'Technologies' ICC/FACS'
Cy3$ Donkey'antiIrabbit'IgG' Life'Technoligies' ICC/FACS'




8.3 Appendix 3 – Buffers and Solutions  
8.3.1  Immunocytochemistry Buffers 
Non@Permeable!Blocking!Solution!(for!50mL)!
Component!! Weight/Volume!Normal!Donkey!Serum! 2%!(1mL)!1X!PBS! Make!up!to!50mL!(49mL)!!
Permeable!Blocking!Solution!(for!50mL)!
Component!! Weight/Volume!Normal!Donkey!Serum! 2%!(1mL)!1X!PBS! 48.85mL!TritonXF100! 0.3%!(150μL)!!
4%!Paraformaldehyde!(PFA)!(for!500mL)!
Component!! Weight/Volume!Paraformaldehyde! 4%!(20g)!1X!PBS! Make!to!500mL!Heat!gently!in!fume!hood!to!dissolve.!Do!not!exceed!65oC.!pH!to!7.4!Aliquot!and!store!at!F20oC!!
MSC!Blocking!solution!(for!50mL)!






Component!! Weight/Volume!Bovine! Serum! Albumin!(BSA)! 1%!(0.5mL)!1X!PBS! Make!up!to!50mL!(49.5mL)!!
0.2%!TritonX@100!
Component!! Weight/Volume!TritonXF100! 0.2%!(100μL)!1X!PBS! Make!up!to!50mL!(49.9mL)!!
4%!Goat!Serum!(for!50mL)!
Component!! Weight/Volume!Normal!Donkey!Serum! 4%!(2mL)!1X!PBS! Make!up!to!50mL!(48mL)!!
0.5%!Tween@20/!4%!Goat!Serum!




8.4 Appendix 4 - Cell Culture Medium 
8.4.1 Maintenance and Growth 
Dulbeco’s!Modified!Eagle!Medium/RPMI!Medium!!
For!the!maintenance!of!MDAFMBF231!cells!










Component! Supplier! %! Volume!(mL)!MSCBM! Lonza! 100! 440!Single!Quots! Lonza! ! !MSC!growth!Supplement! ! 10! 50!Gentomycin/Amphicillin!1000! ! 1X! 0.5!LFGlutamate! ! 1! 10!!
8.4.2 Neural Induction and Differentiation 
Neural!Induction!Medium!!
For!the! induction!of!neuralFlike!spheres! from!hMSCs.! !Growth!factors!and!heparin!are!supplemented!individually!!to!the!low!attachment!plates.!





For! the! terminal! differentiation! of! hMSCs.! Either!when! plated! directly! onto!GletrexTM!coated!dishes!or!when! induced! to!spheres!prior! to!plating! to!GeltrexTM!coated!dishes.!BDNF! of! PDGF! were! additional! supplements! to! the! media! for! neuronal! or! glial!differentiation.!




8.4.3 Cell Staining 
Oil!Red!O!
For!the!adipogenic!staining!of!differentiating!hMSCS.!Oil!Red!O!stains!adipose!vacuoles.!
Component! Weight/!Volume!Oil!Red!O! 0.3g!2Fpropanol! 125mL!! pH!to!7.4!! Filter!through!0.45um!filter!and!store!in!glass!bottle!protected!from!the!light.!! Immediately!prior!to!use,!dilute!8.2mL!stock!stain!with!6.8mL!ddH2O!to!make!working!solution!!
Alizarian!Red!(1%)!
For! the! osteogenic! staining! of! differentiating! hMSCS.! Alizarian! Red! stains! calcium!deposits.!































































Table&8(12: Significance' values' for'HSPG' related' genes' in' hMSCH20176'Values' highlighted' in'
yellow'reach'levels'of'significance'with'P>0.05.'




Table&8(13: Significance' values' for' hMSCH20176' for' genes' included' in' MSC' and' NSC'marker'
panels.'Values'highlighted'in'yellow'reach'levels'of'significance'with'P>0.05.'



























Table&8(14: Significance' values' for' genes' associated' with' HSPGs' in' hMSCH21558.' Values'
highlighted'in'yellow'reach'levels'of'significance'with'P>0.05.'




Table&8(15: Significance' values' for' genes' included' in' MSC' and' NSC' panels' for' hMSCH21558.'
Values'highlighted'in'yellow'reach'levels'of'significance'with'P>0.05.'








Figure&8(16: hMSCH20176' P+5' Cultures' induced' to' form' intermediate' spheres.' Representative'
phase' images'taken'at'day'3'(D3)'and'day'7'(D7)'after' induction.' 'At'D3,'spheres'are' larger'
(approx.' 400μm)' while' D7' spheres' following' media' change' at' D3' appear' smaller' (approx.'






Figure&8(17: hMSCH20176' P+5' cultures' underwent' terminal' differentiation.' Neuronal' cultures'










supplemented'with' PDGF.' At' day' 8' few' spheres' attached' to' the' GeltrexTM' coated' surface' to'
allow'migration'out'from'a'focal'sphere.''Proliferation'in'both'cultures'appeared'slow'with'less'
than' 30%' confluence' by' day' 17.' By' day' 22,' proliferation' appeared' to' have' cease' with' no'






Figure&8(19: hMSCH20176' P+7' Cultures' induced' to' form' intermediate' spheres.' As' for' P+5'
spheres' formed' within' hours' of' induction' were' large' (approx.' 400μm)' while' those' that'
maintain'sphere'appearance'after'media'change'at'day'3'were'smaller'(approx.'200H300μm).'







Figure&8(20: hMSCH20176' P+7' Neuronal' cultures' supplemented' with' BDNF' differentiated'
through' terminal' differentiation.' ' Cultures' were' grown' for' an' additional' 7' days' to' other'
terminal'cultures'as'cell'confluence'was' low'(less' than'30%)'at'day'14.' 'Cultures'underwent'




Figure&8(21: hMSCH20176' P+7' Glial' cultures' (+PDGF)' differentiated' through' terminal'
differentiation' protocols.' Cultures' underwent' 14' days' of' differentiation' with' distinct'
morphological' differences' observed' between' these' cultures' and' corresponding' neuronal'







differentiation.' Neuronal' cultures' (+BDNF)' and' glial' cultures' (+PDGF)' displayed' distinct'
morphological'differences'with'neuronal'cultures'displaying'larger'cell'bodies'and'neuronHlike'
appearances.'In'contrast,'glial'cultures'displayed'smaller'more'elongated'cell'bodies'with'the'
presence' of' starHshaped' glialHlike' cells' observed.' ' In' addition,' proliferation' rates' of' glial'
cultures'appeared'higher' than' that' of' neuronal' cultures.' 'By'day'35'glial' cultures'displayed'






Figure&8(23: hMSCH20176'P+13'Cultures' induced' to' form' intermediate' spheres.'These'cultures'
did' not' form' even' spherical' spheres.' ' Often' the' presence' of' small' cell' clusters'was' observed'
rather' than' spheres.' ' Those' spheres' that' did' form'were'much' smaller' (approx.' 100H200μm)'








PDGF.' Following' passaging' at' day' 5' to' reduce' cell' number' and' prevent' contact' inhibition'







to' terminal' differentiation.' Cell' spheres' formed' at' P+13' collapsed' prior' to' plating' onto' the'








Figure&8(26: hMSCH21558' P+5' Cultures' induced' to' form' intermediate' spheres.' P+5' spheres'
reached' an' approximate'maximum' size' of' 400μm' displaying' regular,' even,' spherical' shape.'
















cultures' were' supplemented'with' BDNF'while' glial' cultures' were' supplemented'with' PDGF.''
Cultures'underwent'distinct'morphological'changes'that'distinguished'neuronal'cultures'from'
glial.' Generally' neuronal' cultures' displayed' larger' cell' bodies'while' glialHlike' cells' displayed'










focal' sphere.' By' day' 16' distinct'morphological' changes' can' be' seen' distinguishing' neuronal'







Figure&8(30: hMSCH21558' P+7' Cultures' induced' to' form' intermediate' spheres.' By' day' 3' (D3)'
spheres'had'increased'in'size'to'approximately'300H400μm'with'regular,'even'spherical'shape.'
Following' media' change' at' D3' some' spheres' collapsed' and' did' not' subsequently' reach' the'






Figure&8(31: hMSCH21558'P+7'Cultures' underwent' terminal' differentiation.'Neuronal' cultures'
(+BDNF)'and'glial'cultures'(+PDGF)'demonstrated'distinct'differences'in'morphology'between'










differentiation.'Both'neuronal'(+BDNF)'and'glial' (+PDGF)'cultures' in' the'absence'of'heparin'
displayed'attachment'of'sphere'like'structures'at'D8H9'with'the'migration'of'satellite'cells'out'









form' spheres' at' this' passage' demonstrated' a' reduced' capacity' to' form' spheres' with' the'
maximum' size' of' spheres' observed' at' day' 3' approximately' 200H300μm.'While' initially' cells'
rapidly'formed'clusters'of'cells,'these'cells'did'not'continue'to'increase'in'size'over'subsequent'
hours' and' days' of' sphere' induction.' In' addition,' spheres' formed' at' this' passage'were'more'
irregular'in'size'and'shape'than'those'observed'at'P+5'and'P+7.''





by'D14.' Glial' cultures'maintained' higher' proliferation' rates' as' determined' by' confluence' at'












Figure&8(35: hMSCH21558' P+13' Cultures' differentiated' following' induction' of' intermediate'
spheres.' Any' spheres' collected' following' induction' collapsed' during' harvesting' allowing'
attachment'of'single'cells'only'rather'than'spheres.'Both'neuronal'(+BDNF)'and'glial'(+PDGF)'
cultures' (+/H' heparin)' underwent' very' little' proliferation' over' subsequent' days' with' cell'





8.7 Appendix 7: Immunocytochemistry Negative Control Panels 
!















Figure&8(38: Representative' ICC' isotype' and' secondary' antibody' only' negative' controls' from'
differentiated' cultures' at' P+13.' (A)'mouse' IgG' isotype' control' (MIG)' (B)' FITC' secondary' Ab'
only' (C)' rabbit' IgG' isotype' control' (RIG)' (D)' Cy3' secondary' Ab' only' (E)'mouse' IgM' isotype'
control'(MIM)'(F)'AF594'secondary'antibody'only.''Scale'bars'represent'130'μm'
